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ABSTRACT 
Pawel Mateusz Mordaka 
Reductions using Clostridium sporogenes 
 
Clostridium sporogenes was previously shown to be an extraordinary source for 
unusual reductases. It can catalyze reduction of wide a range of substrates such as 
nitroalkenes, enoates and nitro compounds, and can be used to generate chiral products.  
In preliminary studies, the ClosTron gene knock-out system for Clostridia was used 
to inactivate the fldZ gene assumed to encode the enzyme responsible for reduction of 
cinnamic acid in the reductive branch of L-phenylalanine fermentation via the Stickland 
reaction. 
Biotransformations with the fldZ mutant showed that C. sporogenes possesses 
ŵƵůƚŝƉůĞ ĞŶǌǇŵĂƚŝĐ ĂĐƚŝǀŝƚŝĞƐ ? ƌĞĚƵĐŝŶŐ ĞŶŽĂƚĞƐ ? ɴ ?ɴ- ĂŶĚ ɲ ?ɴ-disubstituted nitroalkenes 
with different yields and enantioselectivities. The fldZ reductase was found to be 
responsible for reduction of cinnamic acid, (E)-1-nitro-2-phenylpropene, (E)-2-nitro-1-
ƉŚĞŶǇůƉƌŽƉĞŶĞ ĂŶĚ ɴ-nitrostyrene. However, the mutant could still reduce (E)-2-nitro-1-
ƉŚĞŶǇůƉƌŽƉĞŶĞ ? ɴ-nitrostyrene and cinnamic acid confirming the presence of other C=C 
double bond reductases in C. sporogenes. 
The analysis of the C. sporogenes genome sequence allowed identification of two 
hypothetical genes encoding proteins with homology to flavin-containing C=C double bond 
reductases, fldZ 2-enoate reductase and OYE-like reductase, which were subsequently 
cloned, overexpressed in E. coli under anaerobic conditions and tested for reduction of 
unsaturated compounds. The activity tests showed that fldZ possesses a narrow substrate 
range and can reduce only aromatic enoates such as cinnamic acid or p-coumaric acid. FldZ 
also reduced (E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-phenylpropene with excellent 
and poor enantioselectivities (>99% and 16% respectively). On the other hand, the OYE-like 
reductase did not show activity towards unsaturated substrates in the activity assays and 
the substrate range of this reductase is unknown.  
Growth experiments comparing wild type C. sporogenes and the mutant in complex 
and minimal media showed that the fldZ reductase in not involved in the L-phenylalanine 
fermentation. Further analysis of the C. sporogenes genome resulted in identification of a 
novel reductase that might be involved in reduction of cinnamoyl-CoA to 3-
phenylpropionyl-CoA in the Stickland reaction. 
Biocatalytic reduction of aromatic nitro compounds to amines can be used as 
alternative to chemo-reductive routes in preparation of pharmaceutical and agrochemical 
products. Protein extracts of C. sporogenes were found to reduce aromatic nitro 
compounds with different yields depending on the substrate structure and electron donor 
used in the reaction. The genome of C. sporogenes was screened and that allowed 
identification of six genes encoding hypothetical nitroreductases, which were subsequently 
overexpressed in E. coli. However, biotransformations using the recombinant 
nitroreductases did not show amine product formation. 
A novel Nylon 6 biosynthesis pathway was designed starting from biorenewable 
feedstocks. The crucial step in this pathway, reductive cleavage of pipecolic acid to 6-
aminocaproic acid was proposed to be catalysed by C. sporogenes D-proline reductase. 
Thus, the activity of this enzyme was tested towards L- and D-pipecolic acid. 
Biotransformations showed that pipecolic acid was not accepted as a substrate. In the 
future, the idea of using D-proline reductase for Nylon biosynthesis may be exploited by 
improving the reductase activity using protein engineering techniques. 
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LIST OF ABBREVIATIONS 
 
ATCC  American Type Culture Collection 
ATP  adenosine- ? ?-triphosphate 
bp  base pair 
BSA  bovine serum albumin 
C=C  carbon-carbon double bond 
CoA  coenzyme A 
dNTP  deoxyribonucleotide 
DSMZ  Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH 
DTT  dithiothreitol 
EDTA  ethylenediaminetetraacetic acid 
ee.  enantiomeric excess 
FAD  flavin adenine dinucleotide 
FMN  ƌŝďŽĨůĂǀŝŶ ? ?-monophosphate 
g  gravitational acceleration 
IPTG  iƐŽƉƌŽƉǇůɴ-D-1-thiogalactopyranoside 
kDa  kilodalton 
LB  lysogeny broth 
NAD(P)
+
 ɴ-ŶŝĐŽƚŝŶĂŵŝĚĞĂĚĞŶŝŶĞĚŝŶƵĐůĞŽƚŝĚĞ ? ? ?-phosphate) oxidised 
NAD(P)H ɴ-ŶŝĐŽƚŝŶĂŵŝĚĞĂĚĞŶŝŶĞĚŝŶƵĐůĞŽƚŝĚĞ ? ? ?-phosphate) reduced 
NCIMB  National Collection of Industrial, Food and Marine Bacteria 
ORF  open reading frame 
OYE  Old Yellow Enzyme  
PCR  polymerase chain reaction 
SDS  sodium dodecyl sulphate 
spp.  species pluralis 
THP  tris(hydroxypropyl)phosphine 
Tris  tris(hydroxymethyl)aminomethane 
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1. Introduction 
Whole microorganisms and isolated enzymes can be used as biocatalysts for 
modifications of chemical compounds providing major advantages over chemical catalysis. 
Biocatalysts are usually efficient, environmentally acceptable and show chemo-, regio- and 
enantioselectivity. As they catalyse a broad spectrum of chemical reactions, they are an 
attractive alternative to traditional chemical synthesis in the pharmaceutical, chemical and 
textile industries (Faber, 2011). Nowadays, there is a great need for discovery of new 
enzymes showing unique properties. 
The majority of Clostridia are benign and possess a variety of biocatalytic abilities, 
which could be exploited for the biosynthesis of chemicals in a process alternative to 
traditional industrial routes. Certain members of Clostridia (C. acetobutylicum, C. beijerinkii, 
C. thermocellum and C. phytofermentas) are employed to produce biofuels such as butanol 
and ethanol from biomass derived substrates (Kuehne et al., 2011). Also, attempts have 
been made to use Clostridia as an effective system for delivery of anti-cancer agents, as 
clostridial spores can selectively germinate in the hypoxic regions of solid tumours (Minton, 
2003). However, Clostridia achieved significant notoriety and bad publicity for the members 
which cause severe diseases in humans and animals. Tetanospasmin and botulin, toxins 
produced by C. tetani and C. botulinum respectively, are among the most dangerous known 
and have been even considered as a potential bioweapon that could be used in terrorist 
attacks (Farrar et al., 2000; Wein and Liu, 2005). C. difficile is responsible for antibiotic 
induced diarrhoea and is the main nosocomial pathogen responsible for hundreds of deaths 
in hospitals (Eggertson, 2004). C. perfringens is the third most common causative agent for 
enteritis necroticans food poisoning and causes infections, necrosis and gas gangrene 
(Warrel et al., 2003).  
At present, 114 genome sequences of Clostridium spp. have been deposited in the 
Genbank. Therefore, unique clostridial enzymes or whole metabolic pathways can be 
identified, cloned and expressed in non-pathogenic heterologous hosts, which can be easily 
and inexpensively grown in a laboratory or an industrial plant. This strategy, which is 
alternative to classical biotechnology methods, overcomes the disadvantages of using 
Clostridia, as working with anaerobic bacteria introduces additional challenges when 
compare to the usage of standard laboratory strains like E. coli or yeasts. Cultivation of 
oxygen sensitive strains requires dedicated workstations for maintaining anoxic 
environment. Moreover, handling of pathogenic bacteria is associated with a certain risk 
and requires additional safety measures. Therefore, genetically engineered (C. botulinum 
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with mutated gene encoding the toxin, Bradshaw et al., 2010) or natural non-pathogenic 
strains (such as C. difficile lacking genes encoding toxin A and toxin B) are used (Fluit et al., 
1991). An alternative is to use non-pathogenic analogous species, such as C. sporogenes, for 
predicting growth models of C. botulinum in the food industry. For efficient growth 
Clostridia require also complex media containing rare trace elements and vitamins (Lovitt et 
al., 1987). Finally the genetic methods to manipulate Clostridia are limited and in clear need 
of development. Recently, new tools were developed such as standardized modular system 
for Clostridium-E. coli shuttle plasmids (Heap et al., 2009), the ClosTron gene knock out 
system for production of stable genomic mutants (Heap et al., 2010) and a system for 
integration of DNA into bacterial chromosomes without a counter-selection marker (Heap 
et al., 2012). These methods were shown to be easily available and very efficient and can 
significantly improve the molecular biology techniques for Clostridia.  
C. sporogenes is an anaerobic bacterium obtaining energy for growth from an 
unusual fermentation of amino acids called the Stickland reaction, in which one molecule of 
amino acid acts as electron donor and another acts as electron acceptor (Stickland, 1934). 
C. sporogenes can use a variety of amino acids as growth substrates (Barker, 1980). That 
makes it an excellent source of unique proteins, especially responsible for catalysing redox 
reactions. 
Whole cells and crude protein extracts of C. sporogenes were successfully used to 
reduce activated alkenes such as enoates and nitroolefins (Bühler et al., 1980; Fryszkowska 
et al., 2008), amides (Dipeolu et al., 2005), imines (Monticello and Costilow, 1981), 
aromatic and aliphatic nitro compounds (Angermaier and Simon, 1983a; Angermaier and 
Simon, 1983b; Dipeolu, 2008; Dipeolu et al., 2010) and proline (Stickland, 1935; Lovitt et al., 
1986).  
Hydrogenation of C=C double bonds in activated alkenes is highly desirable as it can 
introduce up to two new asymmetric carbons in the product. C. sporogenes was found to 
ƌĞĚƵĐĞ ɲ ?ɴ- ĂŶĚ ɴ ?ɴ-disubstituted nitroolefins with different yields and enantiomeric 
excesses depending on the substrate structure (Fryszkowska et al., 2008). In this thesis the 
hypothesis that nitroolefins can be reduced by a clostridial 2-enoate reductase involved in 
the L-phenylalanine fermentation was tested by generation of genomic knock out mutants. 
Preliminary studies using the C. sporogenes fldZ enoate reductase mutant showed that this 
enzyme may be involved in reduction of (E)-1-nitro-2-phenylpropene with an excellent 
enantioselectivity (Mordaka, 2010). Attempts to purify the reductase responsible for 
reduction of (E)-2-nitro-1-phenylpropene showed that C. sporogenes may possess more 
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than one C=C double bond reductase (Karl Fisher, personal communication). Therefore, the 
scope for reduction of unsaturated nitroolefins and enoates by the C. sporogenes fldZ 
enoate reductase mutant was further tested.  The physiological role of fldZ in fermentation 
of amino acids by C. sporogenes was also discussed. The fldZ reductase was identified, 
overexpressed in a heterologous host and characterized. Moreover, the analysis of the C. 
sporogenes genome revealed the presence of novel enzymes that can be responsible for 
reduction of C=C double bonds in activated alkenes and enoyl-CoA compounds. 
Amines are used as building blocks for preparation of agrochemical and 
pharmaceutical products (Breuer, 2004). Therefore, C. sporogenes was also tested as 
biocatalysts for reduction of aromatic nitro compounds to amines, which was reported for 
the first time by Dipeolu (2008). The reaction was further optimized by using protein 
extracts and different electron donors. The analysis of the C. sporogenes genome allowed 
identification of six hypothetical nitroreductases, which were subsequently overexpressed 
and tested in biotransformations. 
Finally, a novel Nylon 6 biosynthesis pathway starting from L-lysine was postulated. 
The crucial step in the pathway, conversion of L-pipecolic acid into 6-aminocaproic acid, 
was proposed to be carried out by proline racemase and D-proline reductase, enzymes 
involved in reduction of proline in amino acid fermentation by C. sporogenes. Thus, the 
substrate range of D-proline reductase was tested. 
Overall, the purpose of this project was to use C. sporogenes as a source of novel 
enzymes showing unique properties such as substrate range and enantioselectivity that can 
be used in industrially relevant biotransformations. 
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2. Literature review 
2.1. Biotransformations in organic chemistry 
 Biotransformation is a process where an organic compound is chemically altered by 
biological systems (called biocatalysts) such as whole organisms or isolated enzymes. The 
difference between biotransformation and biosynthesis is that the former process 
describes the natural capability of biological systems to change xenobiotic compounds that 
are not normally produced or expected to be present in the system. It relies on the fact that 
some enzymes can accept broad substrate ranges and show catalytic activities to analogues 
of the natural substrates or intermediates of the catalyzed reaction (Leuenberger, 1984).  
Biocatalysis has a long tradition from the first experiences with manufacturing food 
and alcoholic drinks in ancient Mesopotamia, China and Japan. Nowadays, 
biotransformations are mainly used in food manufacturing, pharmaceutical, fine chemical, 
textile and starch industries (Bornscheuer and Buchholz, 2005). Biocatalysts are also used in 
bioremediation processes, as microbes are characterized by catabolic diversity allowing 
them to transform or accumulate a huge range of compounds (Diaz, 2008).  
  Biocatalysis has many advantages over chemical catalysis (Faber, 2011). Enzymes 
are usually very efficient and accelerate the rate of reactions by a factor of 10
8
-10
10
. Thus, 
they can be employed in much lower concentrations than chemical catalysts. Biocatalysts 
are environmentally acceptable and biodegradable, in contrast to heavy metals used in 
chemical catalysis. They usually act under mild conditions, neutral pH and low temperature. 
Enzymes are compatible with each other and several biocatalytic reactions can be carried 
out as a reaction cascade at the same time. That simplifies the reaction process, allows 
unstable intermediates to be avoided and shifts the reaction towards the products when 
single reactions are characterized by an unfavourable equilibrium. Enzymes can catalyze a 
broad spectrum of reactions and are not restricted to their natural roles, accepting also 
non-natural substrates. However, the biggest advantage of using enzymes comes from their 
selectivities. Biocatalysts show chemoselectivity (act on a single type of functional group in 
the substrate), regioselectivity (distinguish identical functional groups situated in different 
positions in the substrate) and enantioselectivity (prochiral substrates may be converted 
into chiral products or enzymes may convert only one enantiomer of the substrate).  
 However, using biocatalysts for catalysing chemical reactions is connected with 
certain limitations (Faber, 2011). Enzymes are characterized by narrow operation 
parameters and elevated temperatures, extreme pH or high salt concentrations may inhibit 
their activity. They display the highest catalytic activity in water. Biotransformations in 
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organic solvents or biphasic systems are still possible, but the reactions are usually less 
efficient. Moreover, enzymes require their natural cofactors such as NAD(P)H or ATP, which 
are usually unstable and expensive. However, cofactors in redox reactions can be 
regenerated by using a second redox reaction to allow them to re-enter the reaction cycle. 
Finally, enzymes are subject to inhibition phenomena, which require optimization of the 
reaction to avoid substrate- and product-inhibition.  
 Biotransformations can be carried out by whole cells or isolated enzymes (Faber, 
2011). Using whole microbial cells as biocatalysts eliminates a need to recycle cofactors as 
inexpensive equivalents such as carbohydrates can be used to drive the reaction. 
Moreover, large quantities of the biocatalyst can be produced from cheap carbon sources, 
however this requires expensive equipment. Whole cell biotransformations give more by-
products in the reactions. On the other hand, isolated enzymes are characterized by higher 
activities and a higher tolerance to organic solvents. They can be used in simple apparatus, 
but using the cofactor recycling system is necessary.  
All of these features make biocatalysis an attractive tool in modern synthetic 
chemistry and causes a rapidly increasing need for discovery of new or more efficient 
biocatalysts. 
2.2. Biocatalytic reductions in chiral synthesis 
New types of enzymes are needed for currently inaccessible biotransformations. 
Oxidoreductases were successfully used for profitable biosynthesis of both chiral and 
achiral compounds. About 25% of proteins delivered from sequences deposited in the 
databases are responsible for catalysing redox reactions. A variety of substrates accepted 
by these enzymes makes them an excellent tool for synthesis purposes (Hall and 
Bommarius, 2011). Different strategies leading to formation of chiral products were applied 
to the industrially relevant biotransformations (Hall and Bommarius, 2011).  
 Biocatalytic reductions can be used for deracemization of racemic mixtures via 
stereoinversion or dynamic reductive kinetic resolution (Hall and Bommarius, 2011). 
Stereoinversion employs a sequence of enantioselective oxidation combined with 
asymmetric reduction. Deracemization of rac-2-decanol using stereoinversion approach 
was accomplished by a combined oxidation/reduction sequence using lyophilised cells of 
Rhodococci spp. for both steps. Racemic 2-decanol was transformed to (S)-2-decanol with 
excellent enantiomeric excess of 92% and yield of 82% in the combined one-pot 
oxidation/reduction sequence (Voss et al., 2007). On the other hand, the alcohol 
dehydrogenase isozyme-10 (SsADH-10) from Sulfolobus solfataricus was used for dynamic 
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reductive kinetic resolution of 2-arylpropanal substrates. Treatment of the substrates with 
the enzyme in the presence of NADH led to efficient kinetic resolution with ee. exceeding 
90%. Importantly, the SsADH-10 enzyme could be conveniently recycled by exploiting the 
differential solubility of the organic substrate/product and used in several reaction cycles 
without decrease of ee. (Friest et al., 2010). 
Chiral compounds can also be obtained by stereospecific biocatalytic reductions of 
prochiral compounds containing carbonyl groups or activated C=C double bonds according 
to Fig. 2.1. (Faber, 2011). 
 
 
Fig. 2.1. Reductions of carbonyl groups or C=C double bonds in chiral synthesis (Faber, 2011). 
  
Alcohol dehydrogenases (ADHs) were used for enantioselective reduction of various 
ketones to produce enantiopure secondary alcohols. Because these reductase-catalyzed 
reactions are dependent on NAD(P)H, an effective method for regeneration of the 
consumed cofactors was developed by using recycling systems comprising of glucose/ 
glucose dehydrogenases, glucose-6-phosphate/glucose-6-phosphate dehydrogenases or 
alcohol/alcohol dehydrogenases (Goldberg et al., 2008). The reduction proceeds through 
hydride attack on either the si- or re- face of the substrate, while the enzyme transfers the 
hydride of the nicotinamide cofactor (Hall and Bommarius, 2011). The enantioselectivity of 
the reaction depends on the size of substituents on the carbonyl group. The selectivity of 
ADHs was successfully changed by protein engineering. The mutation of Cys-295 to alanine 
in Thermoanaerobacter ethanolicus secondary alcohol dehydrogenase (SADH) was found to 
cause a significant shift of enantioselectivity towards the (S)-configuration in the reduction 
of some ethynyl ketones to the corresponding chiral propargyl alcohols. Furthermore, 
C295A SADH was characterized with much higher activity towards t-butyl and some alpha-
branched ketones than the wild-type SADH (Heiss et al., 2001). On the other hand, 
mutation W110A changed the substrate range of the enzyme, which now uses (S)-1-phenyl-
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2-propanol, (S)-4-phenyl-2-butanol and the corresponding ketones as substrates. Kinetic 
parameters on these substrates are in the same range as those of the wild type enzyme 
substrate 2-butanol, making W110A an excellent catalyst (Ziegelmann-Fjeld et al., 2007). 
 Aldehyde reductase from Sporobolomyces salmonicolor was successfully used for 
reduction of ethyl 4,4,4-trifluoroacetoacetate to (R)-ethyl 4,4,4-trifluoro-3-hydroxy-
butanoate, a building block for pharmaceuticals such as antidepressant Befloxatone (Fig. 
2.2.).  
 
Fig. 2.2. Reduction of ethyl 4,4,4-trifluoroacetoacetate to (R)-ethyl 4,4,4-trifluoro-3-
hydroxybutanoate by the aldehyde reductase from Sporobolomyces salmonicolor using 
glucose dehydrogenase cofactor regeneration. 
 
The reaction was carried out in a water/butyl acetate biphasic system using E. coli whole 
cells expressing the aldehyde reductase and glucose dehydrogenase for NADH recycling. 
The biotransformation resulted in 50% yield and 100% enantiomeric excess of the product 
(Shaw et al., 2003). 
 The reduction of two carbonyl groups of 3,5-dioxo-6-(benzyloxy)hexanoic acid ethyl 
ester by diketoreductase was carried out with whole cells and cell extracts of Acinetobacter 
calcoaceticus grown on glycerol. Reaction yield of 72% and optical purity of 99% were 
obtained when the reaction was carried out with glucose dehydrogenase cofactor recycling 
system (Patel et al., 1993). 
 The second type of biocatalytic reaction leading to chiral products, hydrogenation 
of C=C double bonds in activated alkenes, is highly desirable as it can introduce up to two 
new asymmetric carbons in the product. The first C=C double bond reductase, Old Yellow 
Enzyme (OYE1), was isolated ĨƌŽŵďƌĞǁĞƌƐ ?ďŽƚƚŽŵǇĞĂƐƚSaccharomyces pastorianus and 
ĐĂůůĞĚ ‘ǇĞůůŽǁĞŶǌǇŵĞ ?ĚƵĞƚŽǇĞůůŽǁĐŽůŽƵƌĚĞƚĞƌŵŝŶĞĚďǇƚŚĞƉƌĞƐĞŶĐĞŽĨĨůĂǀŝŶĐŽĨĂĐƚŽƌ
(Warburg and Christian, 1932). Enzymes belonging to the OYE-family were found to 
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catalyze the reduction of various compounds such as nitro esters, nitro aromatics or 
ĂĐƚŝǀĂƚĞĚɲ ?ɴ-unsaturated compounds (Hall and Bommarius, 2011). The reaction proceeds 
through a Michael-type addition of [H2] onto C=C double bond, following a ping-pong 
mechanism where hydride from the flavin attacks the Cɴ atom and a proton from the 
solvent is added onto the Cɲ atom (Fig. 2.3.; Stuermer et al., 2007; Toogood et al., 2010). 
 
Fig. 2.3. Reaction catalyzed by OYE enzymes (taken from Toogood et al., 2010). 
 
 The OYE-family reductases play diverse physiological roles. The general role of OYEs 
is the detoxification of electrophilic compounds such as acrolein reduction by OYE2 from 
Saccharomyces cerevisiae (Toogood et al., 2010). Other roles are dependent on the species. 
Reductases from plants such as Oryza sativa and Solanum lycopersicum were found to be 
involved in biosynthesis of a plant hormone, jasmonic acid. OYE from Aspergillus fumigatus 
is responsible for biosynthesis of ergot alkaloid. The enzyme from Azoarcus evansii 
catalyses reduction in the aerobic metabolism of anthranilate, whereas reductase from 
Trypanosoma cruzi ŝƐŝŶǀŽůǀĞĚŝŶƉƌŽƐƚĂŐůĂŶĚŝŶ& ?ɲƐǇŶƚŚĞƐŝƐ ?dŽŽŐŽŽĚet al., 2010). 
 Reduction of activated C=C double bonds by OYE is an attractive tool in biocatalysis, 
as the enzymes can accept a wide range of activating groups (ketone, carboxylic acid, 
carboxylic ester, lactone, imide, nitrile, nitro, aldehyde and ynone) and the reaction often 
provides good enantiomeric excess of the product (Hall and Bommarius, 2011). 
 Nitroalkenes are important intermediates in organic synthesis as they can be easily 
converted to corresponding amines, aldehydes, carboxylic acids or denitrated compounds 
(Toogood et al., 2008). Highly enantioselective reduction of C=C double bond in 
nitroalkenes was shown for a wide range of enzymes such as YqjM from Bacillus subtilis, 
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OPR1 and OPR3 from Arabidopsis thaliana, OYE2 and OYE3 from Saccharomyces cerevisiae, 
OYE1 from Saccharomyces pastorianus, NCR from Zymomonas mobilis, PETNR from 
Enterobacter cloacae, NEM reductase from E. coli or XenA from Pseudomonas putida 
(Toogood et al., 2010).   
 Several OYEs were found to be stereocomplementary. 12-Oxophytodienoate 
reductase isoenzymes OPR1 and OPR3 from Solanum lycopersicum were found to possess a 
broad substraƚĞ ƐƉĞĐƚƌƵŵ ĨŽƌ ƚŚĞ ĂƐǇŵŵĞƚƌŝĐ ďŝŽƌĞĚƵĐƚŝŽŶ ŽĨ ɲ ?ɴ-unsaturated enals, 
enones, dicarboxylic acids, nitro compounds and N-substituted maleimides. 
Stereocomplementary behavior of both isoenzymes was observed in the reduction of a 
nitroalkene that led to the formation of opposite stereoisomers in high enantiomeric excess 
(Fig. 2.4; Hall et al., 2007). 
 
 
Fig. 2.4. Enzyme based stereocontrol with OPR1 and OPR3 reductases (Hall et al., 2007). 
 
 Members of the OYEs were recently applied to the synthesis of non-racemic aryl-
substituted ɲ-methyldihydrocinnamaldehyde derivatives used as olfactory principles in 
perfumes. (R)-Enantiomers were obtained using the YqjM and 12-oxophytodienoic acid 
reductase isoenzyme OPR1 from S. lycopersicum with e.e. 53%. On the other hand (S)-
aldehydes were produced up to 97% ee. using isoenzyme OPR3, nicotinamide 2-
cyclohexene-1-one reductase NCR from Zymomonas mobilis and yeast OYE isoenzymes 1-3 
(Stueckler et al., 2010a). Another example of applied reduction using OYEs is asymmetric 
bioreduction of methyl 2-hydroxymethylacrylate and its O-allyl, O-benzyl and O-TBDMS 
derivatives to form (R)-enantiomer of methyl 3-hydroxy-2-methylpropionate. The reactions 
were characterized by high e.e. of the products (Stueckler et al., 2010b).  
 A separate class of C=C double bond reductases are 2-enoate reductases from 
anaerobic bacteria such as Clostridium spp. (Simon et al., 1985; Fryszkowska et al., 2008). 
dŚĞǇĐĂƚĂůǇǌĞƌĞĚƵĐƚŝŽŶŽĨɲ ?ɴ-disubstituted aldehydes, cyclic ketones, methyl ketones and 
aromatic nitroalkenes in a stereoselective manner and were applied to synthesis of 
optically pure compounds (Simon et al., 1985; Fryszkowska et al., 2008; Fryszkowska et al., 
2010). 2-Enoate reductases were proposed to be involved in the unique metabolic 
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pathways, in which Clostridium spp. can obtain carbon and energy for growth (Bühler et al., 
1980). 
The restrictions and limitations of using reductases as biocatalysts in synthetic 
chemistry come from their specificity and enantioselectivity. Nowadays, enzymes with new 
properties can be created using protein engineering methods. Alternatively, new enzymatic 
activities can be obtained by identification of new proteins by metagenomic approaches or 
traditional screening of microbes from environmental samples. 
2.3. The Stickland reaction in Clostridium spp. 
A large number of reductases used in biocatalysis have been identified in strict or 
facultative anaerobic organisms. Anaerobic microorganisms in the absence of oxygen must 
use alternative electron acceptors to maintain metabolism. Therefore, they developed a 
variety of unique metabolic pathways leading to reduction of naturally occurring 
compounds. 
Clostridium sporogenes is a Gram positive obligate anaerobic endospore-forming 
bacterium. It belongs to the clostridial cluster I (converts proline to 5-aminovaleric acid), 
subgroup B (utilizes arginine, phenylalanine, serine, tyrosine, tryptophan, methionine and 
glycine and produces 2-aminobutyric acid and 4-aminobutyric acid; Mead, 1971). C. 
sporogenes is a proteolytic organism unable to grow except in media containing proteins or 
amino acids. However, carbohydrates are fermented too, but they are not sufficient to 
maintain growth (Stickland, 1934). C. sporogenes can obtain energy from coupled 
deamination of pairs of amino acids (acting as donor and acceptor of hydrogen 
respectively) in the Stickland reaction. In the presence of C. sporogenes cells, certain amino 
acids reduced methylene blue, brilliant cresylblue and benzylviologen, thus acting as 
hydrogen donors. On the other hand, some amino acids could reoxidize reduced 
phenosafranine, benzylviologen and methyl viologen, acting as electron acceptors. 
 Reactions can occur between any electron donor and electron acceptor according 
to scheme presented in Fig. 2.5. The electron donor amino acid is oxidized to a volatile 
carboxylic acid one carbon atom shorter than the original amino acid. Thus, D-alanine is 
converted to acetate, carbon dioxide and ammonia. The electron acceptor amino acid is 
reduced to a volatile carboxylic acid the same length as the original amino acid. For 
example, glycine is converted to acetate and ammonia, whereas L-proline is reductively 
cleaved to 5-aminovaleric acid (Nisman, 1954). 
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Fig. 2.5. Examples of couple deamination of alanine/glycine and alanine/proline in the Stickland 
reaction by C. sporogenes (Stickland, 1935a; Stickland, 1935b). 
 
A list of compounds tested for being electron donors and acceptors in the Stickland 
reaction is presented in Table 2.1. 
Table 2.1. List of compounds tested for donating and accepting electrons in Clostridium spp. 
Substrate Electron donor Electron acceptor 
ɲ-aminovaleric acid + (3)  
ɴ-alanine  ?  (2)  ? (2) 
D-alanine + (1,3)  ? (4) 
L-alanine  ? (1)  
D-arginine  ? (1)  ? (1); + (2,4) 
L-asparagine + (3)  ? (4) 
L-aspartic acid + (1)  ? (1) 
L-cysteine + (2)  ? (2); + (4) 
D-glucose + (3)  ? (4) 
D-glutamic acid + (1)  ? (1) 
glyceric aldehyde + (3) + (4) 
glycine  ? (1) + (1,4) 
glycolic acid  ? (2)  ? (2,4) 
L-histidine + (1,3)  ? (1,4) 
L-hydroxyproline  ? (1) + (1,4) 
L-isoleucine + (3)  ? (4,6) 
lactic acid + (3)  
L-leucine + (1,3,6)  ? (4); + (6) 
D-lysine  ? (1); + (3)  ? (1,4) 
L-methionine  + (5) 
D,L-ornithine  ? (2); + (3,6) + (2,4,6) 
L-phenylalanine + (1,3)  ? (4); + (7) 
D-proline  + (8) 
L-proline  ? (1) + (1,4) 
pyruvic acid + (1,3)  
D,L-serine + (1,3)  ? (1,4) 
taurine  ? (2)  ? (2) 
threonine  + (5) 
L-tryptophan + (1,3) + (4) 
L-tyrosine + (1,3)  ? (1); + (4) 
D-valine + (1,3)  ? (4,6) 
1. Stickland (1934); 2. Woods (1936); 3. Nisman (1954); 4. Barker (1981); 5. Mean (1971); 6. Elsden 
and Hilton (1978); 7. Bader et al. (1982).  
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 Proteins responsible for reduction of proline and glycine in proteolytic Clostridium 
sticklandii have been identified and characterized. Both enzymes contain selenium and are 
processed post-translationally to form a catalytic active pyruvoyl group (Garcia and 
Stadtman, 1992; Bednarski et al., 2001).  
 Some amino acids can act as both electron donors and electron acceptors in the 
Stickland reaction (Fig. 2.6.). L-Phenylalanine was found to be fermented to ammonia, 
carbon dioxide, phenylacetic acid and 3-phenylpropionic acid (Elsden and Hilton, (1978). 
The metabolic pathway in which C. sporogenes oxidizes and reduces L-phenylalanine was 
proposed by Bühler et al. (1980). In the first step, which is common for both oxidative and 
reductive branches, an amino group is transferred from L-phenylalanine to 2-oxoglutarate 
resulting in the formation of phenylpyruvic acid. Then, in the oxidative branch phenypyruvic 
acid is converted to phenlacetyl-CoA, which is subsequently used to form phenylacetate. 
This reaction is coupled to ATP conservation via the substrate level phosphorylation. In the 
reductive branch of the pathway, phenylpyruvic acid is reduced to (R)-phenyllactate, which 
is converted to CoA derivative and subsequently reduced to (E)-cinnamic acid. In the last 
step of the pathway, cinnamic acid is reduced to 3-phenylpropionic acid by the enoate 
reductase (Bühler et al., 1980; Dickert et al., 2000).  
 
Fig. 2.6. Fermentation of L-phenylalanine by C. sporogenes (taken from Dickert et al., 2000). 
Enzymes: 1. aromatic amino acid aminotransferase (EC 2.6.1.57); 2. phenyllactate dehydrogenase 
(EC 1.1.1.-); 3. phenyllactate dehydratase; 4. cinnamate reductase (EC 1.3.1.31); 5. glutamate 
dehydrogenase (EC 1.4.1.2); Glu, glutamate; 2-OG, 2-oxoglutarate; 6. phenylpyruvate:ferredoxin 2-
oxidoreductase (CoA-acetylating) (EC 1.2.7.-); 7. phosphate phenylacetyltransferase (EC 2.3.1.-) and 
phenylacetate kinase (EC 2.7.2.-). 
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 The phenyllactate dehydrogenase (fldH) responsible for reduction of phenylpyruvic 
acid to (R)-phenyllactic acid was successfully purified and identified in C. sporogenes 
(Dickert et al., 2000). The enzyme was found to consist of two subunits (38 kDa and 42 kDa) 
and accepted electrons from NADH.  
 The phenyllactate dehydratase, which catalyses the reversible syn-dehydration of 
(R)-phenyllactate to (E)-cinnamate, was purified from Clostridium sporogenes grown 
anaerobically on L-phenylalanine (Dickert et al., 2000). The dehydration proceeded in two 
steps, a CoA-transfer from cinnamoyl-CoA to phenyllactate followed by the dehydration of 
phenyllactyl-CoA. The purification yielded in an enzyme complex consisting of three 
subunits, fldA (46 kDa), fldB (43 kDa) and fldC (40 kDa).  
FldA was found to possess activity of cinnamoyl-CoA:phenyllactate CoA-transferase, 
which was not sensitive to oxygen (Dickert et al., 2000). The N-terminus of fldA (39 amino 
acids) showed homology to CaiB (39% sequence identity), which is involved in carnitine 
metabolism in E. coli. Both enzymes are CoA-transferases exhibiting high substrate 
specificity and they do not form enzyme CoA-ester intermediates. 
The FldBC complex was found to be responsible for phenyllactate dehydratase 
activity and the reaction was inhibited in the presence of oxygen. The dehydratase contains 
[4Fe-4S] cluster (Dickert et al., 2000). Both subunits of phenyllactyl-CoA dehydratase 
(FldBC) show significant sequence similarities to both subunits of 2-hydroxyglutaryl-CoA 
dehydratase (HgdAB) from Acidaminococcus fermentans. Phenyllactate dehydratase 
required initiation by ATP, MgCl2 and a reducing agent such as dithionite. The initiation was 
mediated by an extremely oxygen-sensitive initiator protein (FldI), which was present in the 
cell-free extract (Dickert et al., 2002). FldI was identified, overexpressed, purified from E. 
coli and characterized as a homodimeric protein containing one [4Fe-4S] cluster. Oxidized 
FldI showed significant ATPase activity, which was suggested to be essential for 
unidirectional electron transfer. FldI showed significant homology to the component A of 2-
hydroxyglutaryl-CoA dehydratase from A. fermentans, which could replace FldI in the 
activation of fldBC phenyllactate dehydratase.  
All four genes encoding proteins were identified and shown to be clustered in the 
order fldAIBC, which showed over 95% sequence identity of nucleotide and protein levels 
with a gene cluster detected in the genome of the closely related Clostridium botulinum 
Hall strain A. and with a cluster encoding hadAIBC proteins in the genome of Clostridium 
difficile (Dickert et al., 2002). 
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The last step of the pathway, reduction of (E)-cinnamic acid to 3-phenylpropionic 
acid, was proposed to be catalysed by the 2-enoate reductase (Bühler et al., 1980). The 
reaction is coupled to ATP formation (Bader and Simon, 1983). ATP formation was observed 
in C. sporogenes whole cells incubated with cinnamic acid under atmosphere of hydrogen. 
ATP generation was strongly inhibited in the presence of p-trifluoromethoxy carbonyl 
cyanide phenyl hydrazone (FCCP), which is known to uncouple proton transfer. Moreover, 
ATP formation was only observed with intact, freshly harvested cells (Bader and Simon, 
1983). When protein extract were used, cinnamic acid was reduced at the expense of 
NADH, however ATP formation was not restored, which suggested that ATP was generated 
via electron transfer phosphorylation. 
 It was also shown that C. sporogenes reduces L-tryptophan, L-tyrosine and L-leucine 
to indole-3-propanoic acid, 3-(p-hydroxyphenyl)propanoic acid and 4-methylvaleric 
respectively (Jellet et al., 1980; Barker, 1981). On the other hand L-valine and L-isoleucine 
were oxidized to isobutyric acid and 2-methylbutyric acid, but not reduced (Barker, 1981). 
The capability of whole cells to form ATP during the hydrogenation of enoates derived from 
amino acids acting as electron acceptors and donors was compared with the substrate 
specificity of the enoate reductase. Only substrates of the enoate reductase increased the 
generation of ATP showing that the enoate reductase may determine the substrate range 
of the Stickland reaction (Bader and Simon, 1983). 
The variety of compounds that are accepted in the Stickland reaction makes 
proteolytic Clostridia an excellent source of unusual oxidoreductases, which may be used in 
industrial biotransformations.  
 
2.4. Clostridial 2-enoate reductases 
 Clostridial 2-enoate reductases are extremely useful in chiral synthesis as they 
catalyse the stereospecific hydrogenation of activated C=C double bonds (Fig. 2.7.).  
 
Fig. 2.7. Stereospecific hydrogenation of enoates by 2-enoate reductase. 
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 The activity of the enoate reductase activity in Clostridia was first described by 
Simon and co-workers in 1974. Clostridium kluyveri ǁĂƐ ĨŽƵŶĚ ƚŽ ƌĞĚƵĐĞ ŶƵŵĞƌŽƵƐ ɲ ?ɴ-
unsaturated carboxylic acids with hydrogen gas used as the electron donor (Table 2.2.). The 
procedure enabled to obtain on a preparative scale a wide variety of chiral compounds 
(Simon et al., 1974).  
Table 2.2. List of 2-enoates hydrogenated by C. kluyveri (from Simon et al., 1974). 
Acid 
 
Relative rate 
of reduction 
R1 R2 R3 
tiglic CH3 CH3 H 1.0 
angelic acid CH3 H CH3 0.2 
acrylic acid H H H 3.2 
methacrylic acid CH3 H H 2.0 
dimethylacrylic acid H CH3 CH3 0.2 
E-2-pentenoic acid H C2H5 H 1.0 
E-2-hexenoic acid H n-C3H7 H 0.9 
sorbic acid H n-C3H5 H 1.0 
ethyl hydrogen fumarate H C2H5O2C H 0.6 
E-3-furfurylacrylic acid H 
 
H 1.0 
E-3-(2-thienyl)acrylic acid H 
 
H 1.3 
cinnamic acid H C6H5 H 0.9 
E-ɲ-methylcinnamic acid CH3 C6H5 H 0.7 
Z-p-chloro-ɲ-methoxycinnamic 
acid 
OCH3 C6H4Cl H 0.8 
Z-p-bromo-ɲ-methoxycinnamic 
acid 
OCH3 C6H4Br H 0.8 
1-cyclohexanecarboxylic acid -(CH2)4- H 0.1 
   
 2-Enoate reductases were found in various saccharolytic and proteolytic Clostridia 
such as C. kluyveri and C. tyrobutyricum, C. sporogenes, C. thermoaceticum and in 
Peptostreptococcus anaerobius (Tischer et al., 1979; Bader et al., 1980; Giesel et al., 1981; 
Rohdich et al., 2001). 
 Structural properties of enoate reductase were determined for enzymes from C. 
kluyveri and C. tyrobutyricum (Tischer et al., 1979; Kuno et al., 1985). The enzyme has a 
molecular weight of 940,000 ± 20,000 Da and is a dodecamer (tetramer of trimers) of a 
single type of 73,000 ± 2,000 Da subunit. The purified enzymes showed the presence of 
FMN, FAD and iron and acid labile sulphur.  
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 The reduction of C=C double bonds proceeds through a Bi Bi ping pong mechanism 
and is not reversible (Bühler and Simon, 1982).  The reaction is extremely oxygen sensitive 
and relatively stable against hydrogen peroxide. Experiments using different types of 
inhibitors showed that three binding domains are present in the reductase. The first 
domain is responsible for binding of NADH and can be blocked with dicoumarol or morin. 
The second domain binds enoates and can be blocked with fumarate, whereas the third 
one is an electron transfer subunit that can bind reduced methylviologen (Bühler and 
Simon, 1982).   
 Although the substrate specificity of reductases from saccharolytic C. tyrobutyricum 
and C. kluyveri is broad, the stereospecificity of reaction remains very high. Enoate 
reductases from proteolytic strains such as C. sporogenes show much narrower substrate 
range and accept only aromatic enoates such as cinnamic acid (Bühler et al., 1980). The 
enoate reductases accept electrons from NADH and reduced methyl viologen showing that 
they are able to accept both electron pairs as well as single electrons (Simon, 1991). They 
are able to deliver electron pairs and single electrons to NAD
+
, viologens, dichlorophenol 
indophenol, hexacyano ferrate-III and oxygen.  
 Regarding the substrate range, some general rules have been found to apply (Simon 
et al., 1985). R1 cannot be too large and R2 can be a phenyl ring (Fig. 2.7.). Halogens are 
accepted on the ɲ-ĐĂƌďŽŶ ?ďƵƚĂƌĞƌĞĚƵĐƚŝǀĞůǇĞůŝŵŝŶĂƚĞĚĨƌŽŵƚŚĞɴ-position. If R2 and R3 
are different and E/Z isomers are used as substrates, different enantiomers are produced if 
the ɴ-carbon becomes chiral. Therefore, pure isomers of substrates should be used when 
enantiopure product is needed. The C=C double bond can also be a part of a ring as shown 
for reduction of cyclohexene-1-carboxylate.  
 Enoate reductase from C. tyrobutyricum and C. kluyveri were also found to catalyze 
ƌĞĚƵĐƚŝŽŶ ŽĨ ɲ ?ɴ-unsaturated aldehydes and alcohols (Simon, 1991). However, these 
reactions are not enantioselective as the enoate reductase causes the racemization of the 
products.  
 The physiological role of 2-enoate reductases is reduction of enoates at the 
expense of NADH generated from oxidation of amino acids or carbohydrates. An additional 
function may be conservation of energy, as ATP formation is coupled to the reduction of 
cinnamic acid by C. sporogenes. The physiological role of enoate reductase in saccharolytic 
Clostridia is not known (Bühler et al., 1980; Bader and Simon, 1983). 
 The genes encoding enoate reductases were identified in C. tyrobutyricum and 
Moorella thermoacetica (Rohdich et al., 2001). Sequence comparison showed that enoate 
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reductases are similar to the Old Yellow Enzyme from yeasts and to a family of 
flavoproteins comprising 2,4-dienoyl-coenzyme A reductase from E. coli. The recombinant 
enoate reductase from M. thermoacetica was overexpressed in E. coli grown under 
anaerobic conditions. The protein produced was soluble and active and showed enzymatic 
activity towards (E)-methylbutenoate using NADH as the electron donor. The expression of 
the enoate reductase from C. tyrobutyricum resulted in insoluble and inactive product.  
 Due to the broad substrate range and high stereoselectivity of the reaction, enoate 
reductases were successfully used for preparation of chiral carboxylates (Simon et al., 
1985). High yields and good enantiomeric excess of the products were achieved when 
whole cells of Clostridia were used as biocatalysts with hydrogen gas as the electron donor. 
The efficiency of the biotransformations was improved by using catalytic concentrations of 
methylviologen, which was reduced by endogenous clostridial hydrogenase at the expense 
of hydrogen gas and served as electron donor in the biotransformations of enoates (Simon 
et al., 1985). Reduced methylviologen could also be recycled by using electrochemical cells 
together with enoate reductases immobilized on cellulose filters or modified carbon 
electrodes (Thanos and Simon, 1987). 
 Although the enoate reductase from C. sporogenes has never been purified and 
identified, it was successfully applied to industrially relevant biotransformations. Crude 
protein extracts of C. sporogenes containing the enoate reductase were used for highly 
enantioselective reduction of C=C double bonds in ɴ ?ɴ- ĂŶĚɲ ?ɴ-disubstituted nitroalkenes 
(Fig. 2.8.; Fryszkowska et al., 2008). 
 
Fig. 2.8. ŶĂŶƚŝŽƐĞůĞĐƚŝǀĞ ƌĞĚƵĐƚŝŽŶ ŽĨ A? ĚŽƵďůĞ ďŽŶĚƐ ŝŶ ɴ ?ɴ- ĂŶĚ ɲ ?ɴ-disubstituted 
nitroalkenes by cell-free extracts of C. sporogenes (taken from Fryszkowska et al., 2008). 
 
Aryl derivatives of ɴ ?ɴ-disubstituted nitroalkenes such as (E)-1-nitro-2-phenylpropene were 
reduced in 35-86% yield with more than 97% ee for (R)-enantiomers. In contrast, ɲ ?ɴ-
disubstituted nitroalkenes such as (E)-2-nitro-1-phenylpropene were poor substrates, 
yielding (S)-enantiomer products in low yield (10-20%), and the ee varying from 30 to 70% 
depending on NADH concentration. 
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 2-Enoate reductases from anaerobic bacteria such as C. sporogenes, 
Acetobacterium woodii and Ruminococcus productus were successfully used for the 
synthesis of chiral ɶ-amino acids (Fig. 2.9.; Fryszkowska et al., 2010).  
 
 
Fig. 2.9 Chemoenzymatic asymmetric synthesis of ɴ-aryl-ɶ-amino acids using enoate reductases from 
anaerobic bacteria (taken from Fryszkowska et al., 2010). 
 
A new asymmetric methodology was proposed for preparation of ɶ-amino butyric acid 
(GABA) derivatives, which can be used to treat a range of central nervous system diseases. 
The key step in the new method was the use of crude extracts containing the enoate 
reductase for asymmetric synthesis of (S)-ɴ-aryl-ɴ-cyanopropanoic acid. The usefulness of 
the new approach was demonstrated by synthesis of the (S)-enantiomer of baclofen with 
99% ee and 43% overall yield (Fryszkowska et al., 2010). 
 The enoate reductases from Clostridium spp. were found to be an extremely useful 
tool in the synthetic chemistry. However, they cannot be fully exploited in the industrial 
biotransformations without making them more accessible to chemists. Thus, enoate 
reductases should be expressed in heterologous hosts such as E. coli for easier processing. 
Development of new efficient methods for recombinant protein expression under 
anaerobic conditions is needed. 
2.5. Nitroreductases 
 New routes for synthesis of achiral as well as chiral amines are increasingly in 
demand, as these compounds are widely used as building blocks for preparation of 
pharmaceuticals and agrochemical products (Roldán et al., 2008; Dipeolu, 2008). 
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Biocatalytic routes for amine synthesis are often based on activities of hydrolases and 
transaminases (Koszelewski et al., 2010). The most frequently used method for generation 
of chiral amines is the kinetic resolution of racemic materials by enantioselective hydrolysis. 
Another approach employs transaminases for asymmetric amination of ketones or kinetic 
resolution starting from racemic amines. Using chemical catalysts, chiral and achiral amines 
are synthesized by a direct reduction of amides, azides, imines or nitro compounds with 
metal catalysts (Clayden et al., 2000), which are associated with high toxicity. Therefore, 
new biocatalytic methods are needed for generation of amines and reductive biosynthesis 
of amines using nitroreductases would create an attractive alternative to existing methods.  
 Only a few natural nitroaromatic compounds are present in nature such as 
chloramphenicol, nitropyoluteorin, oxypyrrolnitrin and phidolopin (Roldán et al., 2008). 
Most nitro compounds are xenobiotic chemicals and are released to the environment as a 
consequence of industrial processes. Thus, nitroreductases are involved in the 
bioremediation process of soil, water and air. Another aspect of using nitroreductases is the 
anticancer therapy, in which the pro-drug is enzymatically reduced to the highly cytotoxic 
hydroxylamine derivative to sensitize the tumour cells (Minton, 2003; Roldán et al., 2008).  
Nitroreductases are NAD(P)-dependent flavoenzymes catalysing reduction of nitro 
groups in a variety of polynitrated aromatic compounds (Roldán et al., 2008). The reduction 
of nitro group can be carried out through one- or two-electron mechanism (Fig. 2.9.). The 
bacterial nitroreductases type I are oxygen-insensitive enzymes catalysing the sequential 
reduction of nitro groups through the addition of electron pairs to generate nitroso, 
hydroxylamino and amino products. They have been found in a variety of organisms 
including bacteria, archea and eukaryote. They are homodimers of molecular weight about 
50-60 kDa and consisting of 24-30 kDa subunits. The reaction proceeds through a Bi Bi ping 
pong mechanism. Nitroreductases are strongly inhibited by dicoumarol, p-
hydroxymercuribenzoate, p-iodosobenzoic acid, sodium azide and Cu
2+
 ions (Kinouchi and 
Ohnishi, 1983; Roldán et al., 2008). 
Most bacteria contain several types of type I nitroreductases showing different 
specificities towards nitro substrates and accepting different electron donors (Kinouchi and 
Ohnishi, 1983). Two groups of nitroreductases are distinguished depending on homology to 
nitroreductases NfsA and NfsB from E. coli. Nitroreductases group A show homology to 
NfsA nitroreductase and are usually NADPH-dependent, whereas nitroreductases group B 
are similar to NfsB and accept electrons from NADH. Main substrates for type I 
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nitroreductases are nitrofurazone, p-nitrobenzoate, nitrofuran and other nitro compounds 
as well as quinones (Roldán et al., 2008). 
In contrast, bacterial nitroreductases type II catalyze the reduction of nitro group by 
the addition of one electron, forming a nitro anion radical, which is subsequently oxidised 
by molecular oxygen in futile cycle (Fig. 2.10.).  
 
 
 
Fig. 2.10. Reduction of nitro compounds by oxygen-sensitive and 
insensitive nitroreductases (taken from Roldán et al., 2008). 
 
 Nitro compounds can also be denitrated by OYE family reductases. PETN reductase 
from Enterobacter cloacae, NemA reductase from E. coli and xenobiotic reductases from 
Pseudomonas putida were found to reduce the nitro groups of polynitroaromatic 
compounds such as pentaerythritol tetranitrate, glycerol trinitrate and trinitrotoluene 
(Roldán et al., 2008). 
Most nitroreductases do not catalyze the complete reduction of nitro group to 
amines and hydroxylamine products are formed (Roldán et al., 2008). There are few reports 
of successful biocatalytic reduction of aromatic nitro compounds to amines. Whole cells of 
Peptostreptococcus productus U-1 grown in a fructose-limited chemostat with caffeate 
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were used to reduce (E)-2-nitro-1-phenylpropene and (E)-2-nitro-1-phenylbutene in a two-
liquid phase reaction system (Fig. 2.11.; Korbekandi et al., 2008).  
 
 
Fig. 2.11. Proposed reaction scheme for nitroalkene reduction using P. productus 
(taken from Korbekandi et al., 2008). 
 
The aminoalkanes were formed in 47% and 7.5% yields respectively, by reduction of both 
the aliphatic nitro group and the C=C double bond. Direct reduction of nitroalkanes was 
also demonstrated using synthetic racemic nitrophenylpropane as a substrate, which was 
reduced to amine derivative in 45% yield. 
 The biocatalytic activity of nitroreductase from Salmonella typhimurium (NRSal) 
was investigated for the reduction of nitroalkenes and nitroaromatics (Yanto et al., 2010). 
The recombinant protein was purified to homogeneity and NRSal showed broad substrate 
acceptance for various nitro compounds such as 1-nitrocyclohexene and aliphatic 
nitroalkenes as well as nitrobenzene. Nitrobenzene was reduced to form nitrosobenzene 
first and phenylhydroxylamine next. Azoxybenzene was the side product and was formed 
by spontaneous condensation of intermediates. However, the yield for amine product, 
aniline, was very poor (6%). 
Aromatic nitro compounds were also successfully reduced by C. sporogenes. The 
NADH-dependent reduction of the nitro group of p-nitrobenzoate was catalysed using 
protein crude extracts.  Two different enzymatic activities were found to reduce aromatic 
nitro groups. At first the nitro radical anion was formed as a result of transfer of one 
electron. Subsequently, the intermediate compound was hydrogenated further, but 
extremely slowly (Angermaier and Simon, 1983b). Nitrobenzene was also reduced to aniline 
using whole cells with yields of 8% in aqueous ethanol (4% v/v) and 45% in a biphasic 
heptane/aqueous system (Dipeolu, 2008). The reaction was improved by using water 
miscible ionic liquids as the co-solvent. [EMim][EtSO4] was toxic to C. sporogenes and 
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decreased the growth rate by 58%, but allowed reduction of nitrobenzene with higher yield 
up to 79% (Dipeolu et al., 2009). 
 C. sporogenes was also found to reduce aliphatic nitro compounds. Reduction of 2-
nitroethanol was catalyzed by protein extracts in the presence of hydrogen, however the 
reaction rate was much lower than for reduction of aromatic nitro compounds (Angermaier 
and Simon, 1983a). 
2.6. Reduction of proline by Clostridium spp. 
Biocatalysis in not limited to preparation of fine chemicals only. Fossil fuel shortage 
and environmental issues make a great need for engineered pathways in production of bulk 
chemicals as well. Biosynthesis of xenobiotic compounds that are not naturally synthesized 
in living organisms is extremely challenging. Therefore, identification of new enzymes with 
previously unknown activities is highly demanded. Proteolytic Clostridia possess a unique 
reductase responsible for the cleavage of proline ring to form 5-aminovaleric acid. This 
enzymatic activity may possibly be exploited for biosynthesis of bifunctional compounds 
that are used in the polymer industry. 
L-Proline and L-4-hydroxyproline were found to oxidise leuco dyes such as benzyl 
viologen and neutral red, when suspension of C. sporogenes were used as biocatalyst 
(Stickland, 1934). Thus, these two amino acids were proposed to act as hydrogen acceptors 
in the chemical reaction by which C. sporogenes obtains energy for growth in media 
containing proteins or amino acids. This hypothesis was confirmed by the observation that 
L-proline could accept electrons from amino acids such as D-alanine, D-valine and L-leucine, 
which acted as electron donors in the reaction (Stickland, 1934). The product of L-proline 
reduction was 5-aminovaleric acid and the reaction took place by a simple ring opening 
without deamination (Stickland, 1935a). The reduction of proline was found to be coupled 
to a vectorial transmembrane proton translocation allowing for ATP synthesis via electron 
transfer phosphorylation (Lovitt et al., 1986). 
Another proteolytic strain, Clostridium sticklandii (previously Clostridium HF) was 
found to reduce proline at the expense of L-ornithine (Stadtman, 1954). Both L- and D-
proline were accepted as substrates and converted into 5-aminovaleric acid when crude 
exctracts and partially purified enzyme fractions were used (Stadtman, 1956). The 
biotransformation depended on the presence of dithiols, magnesium ions and reduced 
nicotinamide adenine dinucleotide in the reaction mixture. The proline reduction system 
was found to comprise two components, a proline racemase and a D-proline reductase 
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(Stadtman and Elliott, 1957). The racemase component rapidly converted either optical 
isomer of proline to the racemic mixture, but exhibited no reductase activity. The latter 
component catalyzed the reduction of D-proline to 5-aminovaleric acid and had no activity 
on L-proline. The reduction was coupled to the oxidation of 1,3-dimercaptopropanol, which 
could not be replaced by molecular hydrogen or NADH. 
The C. sticklandii D-proline reductase was purified to homogeneity (Seto and 
Stadtman, 1976). Initial experiments showed the enzyme was a membrane-bound protein 
and was released by treatment with detergents. The molecular weight was determined to 
be approximately 300 kDa containing 10 subunits of about 31 kDa (Seto and Stadtman, 
1976). However, further studies showed that the reductase was a soluble protein located in 
the cytoplasm. It was a decamer having a molecular mass of about 870 kDa consisting of 23, 
26 and 45 kDa subunits (Kabisch et al., 1999). The specific activity of the 870 kDa reductase 
was 100 times higher than the activity of previously purified 300 kDa protein, showing that 
the 23, 26 and 45 kDa subunits were essential components of active D-proline reductase. 
The 26 kDa polypeptide contained selenocysteine, which correlated with the presence of 
selenium in the enzyme, determined by inductively coupled plasma mass spectrometry 
(Kabisch et al., 1999).  
The reductase accepted NADH as electron donor, but not NADPH (Seto and 
Stadtman, 1976). The electrons from NADH to the reductase were transferred by two 
proteins involving FAD-containing NADH dehydrogenase and a 250 kDa iron-containing 
protein (Schwartz and Müller, 1979). However, dithiothreitol and other dithiols could also 
be used as artificial reducing agents in the reactions (Seto and Stadtman, 1976).  
Studies of the mechanism of D-proline reductase action showed that a carbonyl 
group of pyruvate was required for the catalytic activity (Hodgins and Abeles, 1969). The 
pyruvate was found to be located on a polypeptide connected with the N-terminus of the 
reductase via an ester bond (Seto, 1978; Seto, 1980). The carbonyl group formed an adduct 
with the nitrogen of the substrate and nucleophilic ĂƚƚĂĐŬĂƚ ƚŚĞɲ-carbon of proline was 
carried out by an electron-donating selenol anion of selenocysteine (Fig. 2.12.). That 
resulted in the ring cleavage after hydrolytic release of the product from the pyruvate 
adduct (Hodgins and Abeles, 1969). Subsequently the selenide/sulphide group was reduced 
by the electron donor (Kabisch et al., 1999). 
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Fig. 2.12. Proposed reaction mechanism of D-proline reductase (taken from Kabisch et al., 1999). 
 
The genes encoding D-proline reductase subunits were identified in C. sticklandii 
(Kabisch et al., 1999). The prdA gene encoded a proprotein consisting of 630 amino acids 
that was posttranslationally cleaved to form 23 and 45 kDa subunits. The product of the 
prdB gene encoding 242 amino acids had 26 kDa and contained a TGA codon for 
selenocysteine. 
The proline reductase was also identified in the proteolytic nosocomial pathogen 
Clostridium difficile (Jackson et al., 2006). Genes prdA and prdB predicted to encode 
subunits of the enzyme were located within the prd operon and showed organization 
similar to that found in C. sticklandii. Located downstream was an open reading frame 
predicted to encode the proline racemase (prdF). The product of prdR gene located 
upstream of prdA was found to activate transcription of the proline reductase system genes 
in the presence of proline and negatively regulated the expression of genes encoding 
glycine reductase (Bouillaut et al., 2013). 
The purified reductase utilized D-proline as a substrate, but in the presence of L-
proline no formation of 5-aminovaleric acid was observed (Jackson et al., 2006). It was also 
shown that L- and D-4-hydroxyproline could replace proline as the electron acceptor in the 
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fermentation and the presence of these amino acids induced the expression of D-proline 
reductase. However, they were not utilized as substrates by the purified proline reductase. 
In contrast to previous reports, the proline reductase from C. difficile did not require 
divalent cations such as Mg
2+
 and remained active in the presence of chelating agents. That 
suggested that C. difficile proline reductase may reduce proline by a different mechanism 
than the enzyme from C. sticklandii (Jackson et al., 2006). 
The enzymatic activities described in this literature review show that anaerobic 
bacteria, such as C. sporogenes, possess unusual metabolic pathways and unique enzymes 
that may be used as biocatalysts for industrially relevant reactions. Therefore, further 
characterization of reductases responsible for hydrogenation of C=C double bonds, 
aromatic nitro reduction and proline reduction is highly desirable and may possibly make a 
great contribution in the field of biocatalysis. 
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3. Objectives of investigation 
The main aim of this study was to test C. sporogenes as a whole cell biocatalyst and 
source of enzymes for industrially relevant reductions of C=C double bonds, aromatic nitro 
groups and novel intermediates in Nylon production.  
Biocatalytic reduction of nitroalkenes is a promising reaction in chiral synthesis, as it 
gives up to two new asymmetric carbons in the structure and the product can be easily 
converted into corresponding amines, aldehydes, carboxylic acids or denitrated compounds 
(Fryszkowska et al., 2008). C. sporogenes was found to hydrogenate the C=C double bonds 
in ɲ ?ɴ- ĂŶĚɴ ?ɴ-disubstituted nitroalkenes, but purification of  enzyme catalysing this type of 
reduction was unsuccessful (Fryszkowska et al., 2008). Preliminary studies on the C. 
sporogenes fldZ enoate reductase knock out mutant showed that this enzyme may be 
involved in reduction of (E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-phenylpropene 
(Mordaka, 2010). However, additional biotransformations and attempts to purify the 
nitroalkene reductase suggested that C. sporogenes may possess more than one enzyme 
reducing C=C double bonds. Thus, the aims of this part of the project were: 
 
x Genetic analysis of the fldZ mutant (testing the strain stability, determination of 
number of intron integration sites in the genome); 
x Testing wild type C. sporogenes and the fldZ mutant for reduction of unsaturated 
carboxylic acids, nitroalkenes and nitro compounds; 
x Identification of genes encoding C=C double bond reductases in C. sporogenes 
DSM795 by analysis of the genome sequences available in the Genbank; 
x Overexpression of C. sporogenes C=C double bond reductases in a heterologous 
host, purification and characterization of the enzymes. 
 
The fldZ mutant showed unexpected physiological behaviour when grown in media 
supplemented with carbohydrates and amino acids. Therefore, a side objective of the 
project was: 
 
x Determination of physiological function of the fldZ enoate reductase in C. 
sporogenes. 
 
Whole cells of C. sporogenes were also found to reduce aromatic and aliphatic nitro 
groups to amines (Angermaier and Simon, 1983a; Angermaier and Simon, 1983b; Dipeolu, 
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2008; Dipeolu et al., 2009). However, the enzymes responsible have not been purified and 
identified. The aims of the second part of the project were: 
 
x Testing protein extracts of wild type C. sporogenes for nitroreductase activity, 
optimization of reaction conditions in respect to electron donors; 
x Identification of genes encoding hypothetical nitroreductases in C. sporogenes 
DSM795 by analysis of genomic sequences; 
x Overexpression of nitroreductases in a heterologous host and testing their activity 
towards a library of aromatic nitro compounds. 
 
Traditional metabolic pathways are engineered to develop microorganisms for 
efficient production of chemicals, fuels and materials from renewable feedstocks. Currently 
Nylon 6 is synthesised by ring-opening polymerization of caprolactam, which is produced at 
industrial scale starting from fossil fuels. Thus, identification of new methods for 
sustainable synthesis of Nylon 6 is highly demanded. The aims of the third part of the 
project were: 
 
x Analysis of metabolic pathway databases, screening for new routes leading to 
production of Nylon 6 monomers;  
x Development of a method for detection of 6-aminocaproic acid; 
x Testing C. sporogenes D-proline reductase activity towards pipecolic acid. 
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4. Materials and methods 
4.1. Materials 
4.1.1. Reagents 
Acids, bases and salts: acetic acid (Fisher), ammonium chloride (Sigma-Aldrich), ammonium 
molybdate (BDH), ammonium persulphate (Fisher), ammonium sulphate (Sigma-Aldrich), 
boric acid (Sigma-Aldrich), calcium chloride (Sigma-Aldrich), dipotassium hydrogen 
orthophosphate (Fisher), hydrochloric acid (Sigma-Aldrich), imidazole (Sigma-Aldrich), iron 
sulphate heptahydrate (Rectapur), magnesium chloride (BDH), magnesium sulphate 
(Fisher), magnesium sulphate heptahydrate (Sigma-Aldrich), manganese sulphate 
tetrahydrate (Analar), potassium hydroxide (Fisher), potassium phosphate monobasic 
(Sigma-Aldrich), sodium dodecyl sulphate (Fisher), sodium fumarate (Sigma-Aldrich), 
sodium hydrogen carbonate (Sigma-Aldrich), sodium hydroxide (Fisher), sodium phosphate 
dibasic dodecahydrate (Sigma-Aldrich), sodium selenite pentahydrate (Acros), Tris base 
(Melford);  
Amino acids: D-alanine (Sigma-Aldrich), glycine (Fisher, Sigma-Aldrich), L-alanine (Sigma-
Aldrich), L-arginine (Sigma-Aldrich), L-cysteine (Sigma-Aldrich), L-cysteine HCl (Sigma-
Aldrich), L-histidine (Sigma-Aldrich), L-isoleucine (Sigma-Aldrich), L-leucine (Sigma-Aldrich), 
L-methionine (Sigma-Aldrich), L-phenylalanine (Sigma-Aldrich), L-tryptophan (Sigma-
Aldrich), L-tyrosine (Sigma-Aldrich), L-valine (Sigma-Aldrich);  
Antibiotics: carbenicillin (Sigma-Aldrich), chloramphenicol (Sigma-Aldrich), erythromycin 
(Sigma-Aldrich), kanamycin sulphate (Novagen);  
Biotransformation substrates: cinnamic acid (Aldrich), DL-pipecolic acid (Sigma-Aldrich), D-
pipecolic acid (Tokyo Chemical Industry), L-pipecolic acid (Tokyo Chemical Industry), NADH 
(Sigma-Aldrich), NADPH (Sigma-Aldrich);  
Derivatization agents: o-phthalaldehyde (Sigma-Aldrich), trimethylsilyldiazomethane 
(Sigma-Aldrich); 
Electrophoresis reagents and molecular-weight size markers: 1kb DNA Ladder (New England 
Biolabs); 1kb Plus Ladder (Invitrogen), ĂĐƌǇůĂŵŝĚĞ PE ?E ?-methylenebisacrylamide (Sigma-
Aldrich), Agarose (Fisher), bromophenol blue (Sigma-Aldrich), EZBlue stain (Sigma-Aldrich), 
Instant Blue Stain (Novexin), Loading Dye Buffer 6x (Fermentas), Mini-WZKdE ? d'y ?
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Precast Gels (Bio-Rad), E ?E ?E ? ?E ?-tetramethylethylenediamine (Sigma-Aldrich), 
PageRuler
TM
Prestained Protein Ladder (Fermentas), Spectra Protein Ladder (Fermentas);  
Enzymes: Antarctic Phosphatase (New England Biolabs), Benzonase® Nuclease (Sigma-
Aldrich), BglII FD (Fermentas), cytochrome c (Sigma-Aldrich), EcoRI FD (Fermentas), High 
Activity Bovine Thrombin (Novagen), HindIII FD (Fermentas), JumpStart REDTaq DNA 
Polymerase (Sigma-Aldrich), KOD Polymerase (Novagen), NdeI FD (Fermentas), NotI FD 
(Fermentas), Proteinase K solution (QIAGEN), RNase A (QIAGEN), T4 ligase (Fermentas), 
XbaI FD (Fermentas);  
Gases: CO2 (BOC), H2 (BOC), He ultra-high purity (BOC), N2 (BOC);  
Kits: BugBuster® Protein Extraction Reagent (Novagen), Chelex 100 (Sigma-Aldrich), 
ůŽŶĞ:d ? WZ ůŽŶŝŶŐ <ŝƚ (Fermentas), cOmpleteMiniEDTA-free protease inhibitor 
(Roche), dNTP mix (Roche), Dynabeads® His-Tag Isolation (Invitrogen), FailSĂĨĞ ? WZ
System (Epicentre), His-Bind Purification Kit (Novagen), Ni-NTA Spin Kit (QIAGEN), Pierce 
Protein Refolding Kit (Fisher), Plasmid Midi Kit (QIAGEN), QIAprep Spin Miniprep Kit 
(QIAGEN), QIAquick Gel Extraction Kit (QIAGEN), QIAquick PCR Purification Kit (QIAGEN), 
dƌĂŶƐĨŽƌŵŝĚ ?ĂĐƚĞƌŝĂůdƌĂŶƐĨŽƌŵĂƚŝŽŶ<ŝƚ (Fermentas);  
Media components: agar (Melford), casamino acids (Sigma-Aldrich), cooked meat medium 
(Lab M Limited), D-glucose (Fisher), glycerol (Fluka, Sigma-Aldrich), LB granulated medium 
(Melford), peptone (Foremedium, Melford), resazurin (Aldrich), tryptone (Foremedium, 
Melford), yeast extract (Melford);  
Reducing agents: 2-ɴ-mercaptoethanol (Sigma-Aldrich), dithiothreitol (Sigma-Aldrich), 
glutathione (Sigma-Aldrich), sodium thioglycollate (Fluka), tris(hydroxypropyl)phosphine 
(Novagen); 
Solvents and detergents: [EMim][EtSO4] (Sigma-Aldrich), 3,4-dinitrotoluene (Sigma-Aldrich), 
butan-2-ol (Sigma-Aldrich), ethanol absolute (Fisher), iso-octane (Sigma-Aldrich), 
phenol:chloroform:isoamyl alcohol (Sigma-Aldrich), propan-2-ol (Sigma-Aldrich), tert-
butylbenzene (Acros), tert-butylmetylether (Sigma-Aldrich), Triton X-100 (Sigma-Aldrich), 
Tween®-20 (Sigma-Aldrich); 
Vitamins and cofactors: biotin (Sigma-Aldrich), cyanocobalamin (Sigma-Aldrich), FAD 
(Sigma-Aldrich), FMN (Sigma-Aldrich), folic acid (Sigma-Aldrich), lipoic acid (Sigma-Aldrich), 
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nicotinic acid (Sigma-Aldrich), p-aminobenzoic acid (Sigma-Aldrich), pantothenic acid 
(Sigma-Aldrich), pyridoxyamine HCl (Sigma-Aldrich), riboflavin HCl (Sigma-Aldrich),  
thiamine HCl (Sigma-Aldrich). 
4.1.2. Substrates and products for biotransformations 
Substrates and racemic products for phenylnitropropene biotransformations ((E)-1-
nitro-2-phenyl-propene and (E)-1-phenyl-2-nitropropene) were synthesised by Dr. A. 
Fryszkowska (Manchester Interdisciplinary Biocentre, University of Manchester) according 
to methods described in Fryszkowska et al., 2008. Other substrates and products of 
biotransformations were purchased from Sigma-Aldrich with the highest purity grades 
available. 
4.1.3. Bacterial strains 
Clostridium sporogenes DSM795 and Escherichia coli DSM5911 (K-12, W3110) 
cultures were obtained from DSMZ (Deutsche Sammlung von Mikroorganismen und 
Zellkulturen GmbH). E. coli JM107 strain was obtained from Fermentas. E. coli 
BL21(DE3)pLysS competent cells were obtained from Merck. C. sporogenes NCIMB10696, E. 
coli TOP10 and E. coli CA434 were obtained from the Clostridia Research Group, Centre for 
Biomolecular Sciences, University of Nottingham.  
Clostridium sporogenes genomic knockout mutant (fldZ::CTermB) was prepared 
using the Clostron technique (see Appendix 8.1.) by Dr. Benjamin Blount and Prof. Nigel 
Minton (Clostridia Research Group, Centre for Biomolecular Sciences, University of 
Nottingham). 
4.1.4. Oligonucleotides  and synthetic genes 
Synthetic oligonucleotides (Tab. 4.1) were synthesised by Eurofins Genetic Service. 
Tab. 4.1. List of synthetic oligonucleotides. 
Name Sequence  
CLOSPO_02780f 5'-GAATTAGAGCTTCCATTAGGTCTACACAC-3' 
CLOSPO_02780r 5'-AGATTGCGGTGGTACTATTATCTCTTATAC-3' 
EBSUni ¶±CGAAATTAGAAACTTGCGTTCAGTAAAC-¶ 
ENR-F1 5'-GACAGAAAGAGTCCATGCATATGG-3' 
ENR-R1 5'-TCCATTCCTGCAACACCGCCACC-3' 
ErmRAM-F 5'-ACGCGTTATATTGATAAAAATAATAATAGTGGG-¶ 
ErmRAM-R 5'-ACGCGTGCGACTCATAGAATTATTTCCTCCCG-¶ 
pJET1.2 Forward ¶-CGACTCACTATAGGGAGAGCGGC-¶ 
pJET1.2 Reverse ¶-AAGAACATCGATTTTCCATGGCAG-¶ 
PM001 ¶-AACCATGGCTATGAAGGATAAGTATAAGGTACTTTATGAC-¶ 
PM002 ¶-AAGCGGCCGCAATATTTTTAGCTACTTCATAT-¶ 
PM003 5'-GGATGTACTACAAGTGCTATTCAC-3' 
PM004 5'-CCTACAATAGATGGTATACTTACTCTACC-3' 
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PM006 5'-CTATTATTACAGCAGGAAGAATG-3' 
PM008 5'-AGTGCTGGATTTAGYCTAC-3' 
PM011 5'-GAAAGTTCAACATTAAATCAAAYTATGC-3' 
PM012 5'-CAACCTCTGTTTCTCTTATTCC-3' 
PM015 5'-ATCGTCATGATGTTTTTCACAGAACAACATGA-3' 
PM016 5'-AAAGCGGCCGCCTTTAAAAGATTTGATG-3' 
PM017 5'-AAACATATGAAAGACAAATACAAAGTGCTGTATGAC-3' 
PM018 5'-AAAGCGGCCGCAATATTCTTCGCTACTTCATAGGCTGAC-3' 
PM019 5'-AAAGCGGCCGCTCAAATATTCTTCGCTACTTCATAGGCTGAC-3' 
PM020 5'-CGTACATATGAAAAGTTTATTTGATAAAACCTGC-3' 
PM021 5'-AGTGCGGCCGCCATATTAAATATGCA-3' 
PM022 5'-AAAGCGGCCGCTCACATATTAAATATGCA-3' 
PM023 5'-TAGATACTATAATACAAATAAGTGCGTACTTGTAA-3' 
PM024 5'-GGACTTATTATACAACTGATGGTAAACCT-3' 
PM025 5'-CTAGTATATCATGTTTACTTGACAAAAGT-3' 
PM026 5'-TTCAGCTGCTCTTACAATCATTGA-3' 
PM027 5'-CTACTAAAAAGTGCATACTTCTTTTTCTG-3' 
PM028 5'-AATGATTATARAAAACAGTTTGGGAAATATC-3' 
PM029 5'-TTATGTTAGATTTATTAAAACAAAGAAGAAG-3' 
PM030 5'-CTAAGTATATACCGAGTATAATTGCA-3' 
PM031 5'-AGAACACACATACTAATGAAAAAGGAGTG-3' 
PM032 5'-CATAATGGAAGTATCATTCTATTACATGCAGT-3' 
PM033 5'-GGGAATTATAAATGAATGCTATATTAAAG-3' 
PM034 5'-CTTGACTAATATACCTTATATCTGATC-3' 
PM035 5'-TCATTGAACAAATTATATGTTAGTTAGAGGA-3' 
PM036 5'-CGTAATTTCCTTATCTTATGTAAGTTATTACATTTT-3' 
SalI-R1  ¶-ATTACTGTGACTGGTTTGCACCACCCTCTTCG-¶ 
T7 promoter 5'-TAATACGACTCACTATAGGG-3' 
T7 terminator 5'-GCTAGTTATTGCTCAGCGG-3' 
 
 Synthetic genes were synthesised by Eurofins Genetic Service (fldZ gene) and 
Biomatik USA, LLC (CsNTR1, CsNTR3, CsNTR4, CsNTR5, CsNTR6 and CsNTR7 genes).  
 
4.2. Methods 
4.2.1. Maintenance media 
4.2.1.1. Maintenance of E. coli JM107, K-12 and BL21(DE3)pLysS 
The LB medium was composed of tryptone (10 g/L), yeast extract (5 g/L), NaCl (10 
g/L) and agar (20 g/L) in final volume 200 mL in 0.5 L Duran bottles. The medium was 
autoclaved (12L Classic Media Portable Autoclave, Prestige Medical) and left in the water 
bath to cool down to 50°C (GLS Aqua Plus, Grant). The medium for BL21(DE3)pLysS strain 
was supplemented with glucose (1% final concentration, filter sterilized using a syringe 
filter, pore size 0.2 µm, Sartorius) and chloramphenicol (272 µL, 25 mg/mL solution in 
ethanol). Agar plates were poured when the medium was still warm and fluid. 
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4.2.1.2. Maintenance of C. sporogenes DSM795 
The medium was composed of cooked meat medium (5 g/L), KH2PO4 (5 g/L), L-
cysteine HCl (0.5 g/L), resazurin (0.2 mL of 1% w/v stock solution) and agar (20 g/L) with 
final volume 200 mL in 0.5 L narrow neck Pyrex bottles. The solution was sparged with 
oxygen-free N2 for at least 1 h. The suba seals cap was held in place with copper wire and 
the medium was sterilized by autoclaving using a desk top autoclave. The medium was left 
to cool down to 50-60°C and agar plates were poured in the anaerobic cabinet (MARK3 
Anaerobic Workstation or MACS, Don Whitley Scientific Limited) when the medium was still 
warm and fluid. 
4.2.1.3. Maintenance of C. sporogenes fldZ::CTermB 
The TYG medium was composed of tryptone (30 g/L), yeast extract (20 g/L), sodium 
thioglycollate (1 g/L), resazurin (0.1 mL of 1% w/v stock solution) and agar (20 g/L) with 
final volume 100 mL in a 0.5 L narrow neck Pyrex bottle. The solution was sparged with 
oxygen-free N2 for at least 1 h. The suba seals cap was held in place with copper wire and 
the medium was sterilized by autoclaving using a desk top autoclave. The medium was left 
to cool down to 50°C. In the anaerobic cabinet, erythromycin was dissolved in ethanol, 
sterilized by filtration and added to final concentration 2.5 ʅg/mL. Agar plates were poured 
when the medium was still warm and fluid. 
 
4.2.2. Growth media (culture media) 
4.2.2.1. LB medium 
LB medium was composed of LB granulated medium (25 g) with final volume of 1 L 
in Duran bottle and sterilized by autoclaving. For BL21(DE3)pLysS strain, medium was 
composed of LB granulated medium (25 g) in 0.95 L of dH2O. The medium was sterilized, let 
to cool down to the room temperature and supplemented with 20% D-glucose solution (50 
mL, filter sterilized). 
4.2.2.2. TB medium (terrific broth medium) 
Terrific broth was composed of tryptone (12 g), yeast extract (24 g) and glycerol (4 
mL) with final volume 900 mL in 1 L Duran bottle. The medium was autoclaved, cooled 
down to room temperature and supplemented with phosphate buffer/glucose solution 
(100 mL, filter sterilized, containing glucose, 100 g/L; KH2PO4, 23.1 g/L; K2HPO4, 125.4 g/L). 
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4.2.2.3. Nouguchi medium 
Nouguchi medium (Nouguchi et al., 1997) was composed of LB granulated medium 
(25 g) with final volume of 900 mL in Duran bottle and sterilized by autoclaving. After 
cooling down, the medium was supplemented with glucose/magnesium/nitrate solution 
(100 mL, filter sterilized, containing glucose, 1g/L; MgSO4·7H2O, 2.465 g/L; NaNO3, 5.1 g/L). 
4.2.2.4. M9 mineral medium 
M9 mineral medium was composed of NH4Cl (0.8 g), NaCl (0.5 g), Na2HPO4·12H2O 
(15.08 g) and KH2PO4 (3 g) with the final volume of 910 mL in 1 L Duran bottle. The medium 
was autoclaved, cooled down to room temperature and supplemented with trace element 
solution (50 mL, filter sterilized; containing MgSO4·7H2O, 4 g/L; CaCl2, 2 g/L; thiamine HCl, 
22.4 mg/L; FeCl3·6H2O, 0.2 g/L; ZnSO4·7H2O, 36 mg/L; CuCl2·2H2O, 24 mg/L; MnSO4·4H2O, 
31.6 mg/L; CoCl2·6H2O, 36 mg/L) and glucose/carbonate solution (40 mL, filter sterilized, 
containing glucose, 112.5 g/L; NaHCO3, 250 g/L). 
4.2.2.5. GF medium 
GF medium (Spencer et al., 1973) was composed of KH2PO4 (5.44 g), K2HPO4 (10.5 
g), (NH4)2SO4 (1 g), MgSO4·7H2O (0.05 g), MnSO4·4H2O (5 mg), FeSO4·7H2O (0.125 mg), CaCl2 
(0.5 mg) with the final volume of 900 mL in 1 L Duran bottle. The medium was autoclaved, 
cooled down and supplemented with glycerol (15 mL, 80% solution, autoclaved) and 
fumarate/amino acid solution (85 mL, containing sodium fumarate, 75.26 g/L; casamino 
acids, 5.88 g/L). 
4.2.2.6. Sodium formate medium 
Sodium formate medium (Ingledew and Poole, 1984) was composed of LB 
granulated medium (25 g) with final volume of 900 mL in Duran bottle and sterilized by 
autoclaving. After cooling down, the medium was supplemented with glucose/fumarate 
solution (100 mL, filter sterilized, containing glucose, 200 g/L; NaHCO3, 10 g/L; sodium 
formate, 34 g/L). 
4.2.2.7. Preparation of C. sporogenes growth medium (Giesel et al., 1981) 
The solution (1 L) was composed of basal medium (900 mL; containing peptone, 20 
g/L; yeast extract, 5 g/L; 1 mL resazurin 1% w/v stock solution), trace element solution (10 
mL; MgCl2·6H2O, 3.3 g/L; CaCl2·2H2O, 4 g/L; MnSO4·5H2O, 0.04 g/L; (NH4)6Mo7O24·4H2O, 1 
g/L; Fe2SO4·7 H2O, 2.93 g/L), salt solution (20 mL; KH2PO4, 34 g/L; K2HPO4, 131 g/L; 
NaSeO3·5H2O, 0.02 g/L), vitamin solution (10 mL; p-aminobenzoic acid, 0.08 g/L; biotin, 
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0.004 g/L; riboflavin, 0.02 g/L), reducing agent solution (10 mL; sodium thioglycollate, 30 
g/L) and energy source (L-phenylalanine, final concentration 12.1 mM or D-glucose, final 
concentration 27 mM). All solutions were degassed by sparging with N2 for 20-60 min. Basal 
medium, reducing agent solution and energy source solution were prepared freshly every 
time. Salt solution and trace element solution were stored in a fridge (+4°C) whereas 
vitamin solution was kept at -20°C. Basal medium, trace element solution, salt solution and 
reducing agent solution were sterilized by autoclaving in bottles sealed with the suba seals 
caps held in place with copper wire. Vitamin solution and energy source solution were 
sterilized by filtration using a syringe filter in the anaerobic work station. All solutions were 
mixed together in the anaerobic work station. Medium was pre-reduced by overnight 
incubation in the anaerobic cabinet. 
4.2.2.8. Preparation of C. sporogenes minimal medium (Lovitt et al., 1987) 
The solution (1 L) was composed of basal medium (containing KH2PO4, 2 g/L; 
K2HPO4, 2 g/L; MgCl2·6H2O, 0.2 g/L; (NH4)2SO4, 5.0 g/L), 10% NaHCO3, (25 mL, added after 
sterilization); 0.01% w/v resazurin, general vitamin solution (1 mL; biotin, 2 g/L; folic acid, 2 
g/L; pyridoxyamine HCl, 10 g/L; thiamine HCl, 5 g/L; riboflavin HCl, 5 g/L; nicotinic acid, 5 
g/L; pantothenic acid, 5 g/L; cyanocobalamin, 1 g/L; p-aminobenzoic acid, 5 g/L; lipoic acid, 
5 g/L), amino acid solution (100 mL; glicyne, 30 mM; valine, 20 mM; isoleucine, 20 mM; 
arginine, 20 mM; leucine, 10 mM;  histidine, 10 mM;  methionine, 10 mM;  phenylalanine, 
10 mM;  tryptophan, 10 mM;  tyrosine, 1.25 mM) trace element solution (10 mL; 
nitrilotriacetic acid, 12.8 g/L; Fe2SO4·7H2O, 0.1 g/L; MnCl2·4H2O, 0.1 g/L; CoCl2·2H2O, 0.17 
g/L; CaCl2·2H2O, 0.1 g/L; ZnCl2, 0.1 g/L; CuCl2, 0.01 g/L; H3BO4, 0.01 g/L; NaMoO4·2H2O, 0.01 
g/L; NaCl, 1 g/L; NaSeO3, 0.017 g/L; NiSO4·6H2O, 0.026 g/L; NaWO4·2H2O, 0.1 g/L) and 
reducing reagent (L-cysteine, 5%, from 5 to 10 mL as judged by the discolouration of 
resazurin). All solutions were degassed by sparging with N2 for at least 1 h. Basal medium, 
reducing agent solution and amino acid solution were prepared freshly every time. Trace 
element solution was stored in a fridge (+4°C) whereas vitamin solution was frozen at  
-20°C. Basal medium and trace element solution were sterilized by autoclaving in bottles 
sealed with the suba seals caps held in place with copper wire. Other solutions were 
sterilized by filtration using a syringe filter in the anaerobic work station. All solutions were 
mixed together in the anaerobic work station. The medium was pre-reduced by overnight 
incubation in the anaerobic cabinet. 
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4.2.2.9. TYG medium 
The TYG medium was composed of tryptone (30 g/L), yeast extract (20 g/L) and 
resazurin (0.2 mL of 1% w/v stock solution) with final volume 200 mL in a 0.5 L Duran 
bottle. The medium was sterilized by autoclaving using a desk top autoclave and 
immediately transferred to the anaerobic cabinet. The medium was left to cool down and 
be reduced in the cabinet overnight. Then the medium was dispensed to sterile 20 or 50 mL 
polypropylene sample tubes (Falcon). For cultivation of C. sporogenes knock out mutants, 
erythromycin was dissolved in ethanol, sterilized by filtration and added to the medium to 
the final concentration 2.5 ʅg/mL. 
4.2.3. Preparation of large scale C. sporogenes cultures 
In the anaerobic work station (Mark 3 or MACS, Don Whitley Scientific Limited), 
agar medium in Petri dishes was inoculated with C. sporogenes taken from a single colony 
of the working culture growing on a plate using an inoculation plastic loop and re-cultured 
every week. 
Pre-cultures were grown in universal bottles containing about 20 mL of growing 
medium and inoculated from the single bacteria colony grown in a Petri dish. The culture 
was incubated in an anaerobic work station with shaking (200 rpm, POS-300 Orbital Shaking 
Platform, Grant Bio) at 30°C overnight. Then the pre-culture (20 mL) was used to inoculate 
the main culture (500 mL). The culture was cultivated until it reached the desired phase of 
growth based on the OD measurements (UVmini 1240, Shimadzu). Then cells were 
harvested under anaerobic conditions and used for whole cell biotransformations or 
preparation of protein crude extracts. 
4.2.4. Growth of C. sporogenes in 96-well plates 
Growth rates and biomass production of triplicate C. sporogenes cultures were 
measured in 96-well plates. The inoculum was prepared in the Lovitt medium (10 mL) in a 
glass universal bottle (27 mL) supplemented with the desired electron donors (27 mM D-
glucose, D- or L-alanine) and acceptors (45 mM glycine, L-proline, L-phenylalanine, L-
tryptophan, L-valine, L-leucine or L-isoleucine). The medium was inoculated with a single 
colony of C. sporogenes from an agar plate using an inoculation loop. The pre-culture was 
incubated at 30°C overnight with shaking at 200 rpm. The stationary phase pre-culture (500 
ʅL) was used to inoculate fresh Lovitt medium (10 mL). The main culture was incubated at 
30°C for 1 h with shaking (200 rpm). After the adaptation phase, the aliquots of the culture 
(240 ʅL) were added to wells of a sterile flat bottom 96-well plate (Corning). The cultures 
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were sealed with the Breathe Easy film (R.B. Radley and Co.) and transferred into a 
Nephelostar plate reader (BMG Labtech Ltd.). Anaerobic conditions were maintained by 
ƉůĂĐŝŶŐ ƚŚĞƉůĂƚĞ ƌĞĂĚĞƌ ŝŶĂŶƚŵŽƐĂŐ ?  ?^ŝŐŵĂ )ĂŶĚ ĨůƵƐŚŝŶŐǁŝƚŚŶŝtrogen throughout 
the experiment. The cultures were incubated at 30°C for 48 h with orbital shaking (shaking 
width 4 mm). The light scattering in the wells was measured every 20 min (2 s per well, 
period delay 0.5 s). The gain was set at 40, with the laser beam focus at 2.5 mm. The optical 
densities of the cultures at 660 nm were calculated using calibration curves prepared using 
conventional OD measurements (UVmini 1240, Shimadzu). Optimization of the 
NEPHELOstar settings and the calibration curve is presented in Appendix 8.2. 
4.2.5. Harvesting of C. sporogenes 
In the anaerobic cabinet the cell culture was transferred into centrifuge pots (Bottle 
Assembly, Polypropylene, Beckman Coulter, 500 mL) and sealed. The bottle was taken out 
of the cabinet and centrifuged at 4500 x g for 10 minutes using a high performance 
centrifuge (Avanti J26-XP, J-LITE® JLA-10.500 fixed angle rotor, Beckman Coulter). After 
centrifugation the pots were transferred into the anaerobic cabinet, where the supernatant 
was discarded and the cells were resuspended in degassed phosphate buffer (50 mM, pH 7) 
to give an OD of 200 (87 mg of dry-weight/mL; calibration curve presented in Appendix 
8.3.). The centrifugation and washing procedures were repeated two more times to remove 
the residual medium before the cells were used for biotransformations or preparation of 
protein crude extracts. 
4.2.6. Preparation of C. sporogenes membrane-free protein extracts 
Harvested and washed cells were re-suspended anaerobically in degassed 100 mM 
phosphate buffer pH 7.0 containing dithiothreitol (0.1 g/L), flavin adenine dinucleotide (10 
ʅM) and protease inhibitor (cOmpleteMiniEDTA-free protease inhibitor cocktail tablets, 
ĂĐĐŽƌĚŝŶŐƚŽƚŚĞƉƌŽĚƵĐĞƌ ?ƐŝŶƐƚƌƵĐƚŝŽŶƐ )ĂƚƚŚĞĂƉƉƌŽǆŝŵĂƚĞƌĂƚŝŽŽĨ ?ŐĚƌǇ-weight cells to 
2.0 mL of buffer. Cells were lysed by passage a cell disruptor (Constant Systems Ltd.) at 
pressure of 40,000 psi. The protein extract (about 5-6 mL) was collected under a flow of 
nitrogen gas in a 30 mL universal bottle. The bottle was immediately transferred into an ice 
bath, sealed using a suba seal cap and the headspace of the bottle was flushed with 
nitrogen for at least 15 minutes. The bottle was transferred to the anaerobic workstation 
where the extract was poured into 50 mL polypropylene screw-on-cap centrifuge bottles 
(polypropylene, Beckman Coulter). The extracts were centrifuged at 75000 x g for 30 min at 
4ºC (Avanti J26-XP, JA-25.50 fixed angle rotor, Beckman Coulter) and the high speed 
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supernatant was separated from the cell debris and insoluble protein fraction using a 
pipette. The quality of the extracts was determined by enzyme assays, biotransformations 
and SDS-PAGE. 
4.2.7. Protein quantification  
The DC Protein Assay (Bio-Rad) was used to determine protein concentration in the 
samples. dŚĞǁŽƌŬŝŶŐZĞĂŐĞŶƚ ?ǁĂƐĐŽŵƉŽƐĞĚŽĨZĞĂŐĞŶƚ^ ? ? ?ʅL) and Reagent A (1 mL). 
Protein extracts were diluted 10 and 50 times. A sample (100 ʅL) was pipetted into a 15 mL 
ƚĞƐƚƚƵďĞ ?ZĞĂŐĞŶƚ ? ? ? ? ?ʅL) was added and the sample was vortexed. Then Reagent B (4 
mL) was added into each tube and vortexed immediately. After incubation (15 min) 
absorbance at 750 nm was read using a spectrophotometer (Agilent 8453 UV-Vis). Protein 
concentration was calculated based on the freshly prepared calibration curve of bovine 
serum albumin protein standard (Appendix 8.4.). 
4.2.8. Assays and analytical methods 
4.2.8.1 Assay and analytical method for phenylnitroalkene reduction 
The biotransformation was performed in 30 mL screw top vials with silicon-PTFE 
caps. Each assay contained substrate (1.7 mM final concentration) in anaerobic iso-octane 
(4.8 mL) mixed with anaerobic 50 mM potassium phosphate buffer (7.2 mL) containing C. 
sporogenes cells (final OD 1.0) or protein crude extract (1 mL, 20 mg) and tert-butylbenzene 
(25 ʅL) as an internal standard. Whole cell reactions were started by injection of hydrogen 
gas using a gas manifold (2 min). To the reactions with protein crude extracts, NADH or 
NADPH (15 µmoles) was added. Reactions were shaken in the anaerobic cabinet at 200 rpm 
at 30°C for 72 h. Samples of the organic phase, which separated readily, were analyzed 
using HPLC (Agilent). The samples (15 ʅL) were auto-injected to a Chiralcel OJ column 
(diameter 4.6 mm × 250 mm) and compounds were separated with hexane/isopropyl 
alcohol (9:1) and detected using UV spectrophotometer (by wavelength 254 nm). Retention 
times of the internal standard, substrates and products were compared to the retention 
times of analytical standards.  
4.2.8.2. Assay and analytical method for cinnamic acid reduction 
The biotransformation was performed in 30 mL screw top vials with silicon-PTFE 
caps. Each assay contained substrate (2 mM final concentration) in anaerobic 50 mM 
potassium phosphate buffer (5 mL) containing C. sporogenes cells (OD 1.0) or protein 
extract (1 mL, 20 mg). For biotransformations using protein extracts the reaction contained 
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also NADH or NADPH (3 mM final concentration). When whole cells were used the 
reactions was started by injection of hydrogen gas using the gas manifold (2 min). Reactions 
were shaken in the anaerobic cabinet at 200 rpm at 30°C for 72 h. After incubation, samples 
(2 mL) were centrifuged (13000 rpm, 1 min, Eppendorf MiniSpin). The supernatants were 
transferred into fresh 15 mL centrifuge tubes (Falcon), acidified with 5 M HCl (0.2 mL) and 
extracted with diethyl ether (2.5 mL) containing an internal standard (tert-butylbenzene, 5 
ʅL). After centrifugation (4000 rpm, 15 min, Eppendorf 5810) the ethereal phase was dried 
by passing through a 1 mL pipette tip containing anhydrous MgSO4. To 0.5 mL of dried 
sample methanol (0.1 mL) was added, followed by a few drops (approx. 30 ʅL) of 
(trimethylsilyl)diazomethane solution (2.0 M in diethyl ether), until the mixture had a 
persistent yellow colour. Acetic acid (15 ʅL) was added to quench the reaction after 30 min. 
Samples were analysed using GC-MS (Agilent) on HP5-MS column (Agilent). The 
temperature program was as follows: carrier gas: ultra-pure helium; injector and detector 
temperature at 300°C; split ratio 100:1; start at 45°C, hold 5 min, then 20°C/min to 300°C, 
hold 10 min. Retention times of the internal standard, substrates and products were 
compared to the retention times of analytical standards (Appendix 8.5). 
4.2.8.3. Assay and analytical method for nitrobenzene reduction 
The biotransformation of nitrobenzene was performed in 30 mL screw top vials 
with silicon-PTFE caps. Each assay contained substrate (2 mM final concentration) in 4% 
[EMim][EtSO4] diluted in 50 mM potassium phosphate buffer containing C. sporogenes cells 
(OD 1.0) or protein extract (20 mg). Reactions were started by injection of hydrogen gas 
using the gas manifold (2 min). Reactions were shaken in the anaerobic cabinet at 200 rpm 
at 30°C for 72 h. Samples were analyzed using GC-MS (Agilent) on HP5-MS column (method 
as above). 
4.2.8.4. Assay and analytical method for aromatic nitro reduction 
The biotransformation was performed in 2 mL polypropylene microcentrifuge 
tubes. Each assay contained the substrate (3 mM final concentration) in 0.6 mL of 
anaerobic heptane, 1.2 mL anaerobic 50 mM potassium phosphate buffer pH 7.0 containing 
protein crude extract (0.1 mL, 2 mg) and NAD(P)H (2 mM). Reactions were shaken in the 
anaerobic cabinet at 200 rpm at 30°C for 24 h. Then limonene (15 ʅL; 121.7 mM in 
heptane) and 3,4-diaminotoluene (60 ʅL; 60 mM in 50 mM potassium phosphate buffer pH 
7.0) were added as internal standards. The samples were vortexed for 30 s and centrifuged 
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at 13000 for 5 min. The heptane and aqueous fractions were analysed separately by GC-MS 
using HP5-MS column (method as above).  
4.2.8.5. Assay and analytical method for proline reduction (Kabisch et al., 1999) 
The biotransformation was performed in a polypropylene microcentrifuge tube (2 
mL). The reaction mixture (0.5 mL) contained potassium phosphate buffer (100 mM pH 
8.0), MgCl2 (10 mM), dithioerythritol or NADH (20 mM), proline or pipecolic acid (10 mM), 
and enzyme. The reaction was incubated at 30°C with shaking (200 rpm) and terminated 
after 22 h by addition of 5% HClO4 (0.3 mL). To remove precipitation, the reaction was 
centrifuged at 13000 rpm for 5 min and the supernatant (5 µL) of was transferred into 96-
well plate and the fluorescence solution was added (195 µL, see below). The fluorescence 
was determined at 470 nm using excitation at 340 nm (FLUOstar OPTIMA, BMG Labtech). 
The fluorescence solution was prepared by adding an o-phthalaldehyde solution (1 ml; 80 
mg/mL in ethanol) and 2-mercaptoethanol (0.2 mL) to 0.4 M HBO3 buffer (100 mL, pH 9.7, 
adjusted with KOH). The product concentration was determined by comparison of the 
fluorescence with the calibration curves prepared for 5-aminovaleric acid and 6-
aminocaproic acid (see Results 7.3.2.). 
4.2.8.6. Spectrophotometric cinnamic acid reduction assay 
Cinnamic acid reduction activity of C. sporogenes and E. coli crude extracts was 
determined using a spectrophotometric assay. The reaction was set up in anaerobic 
conditions in gas-tight quartz cuvettes (Hellma-Analytics) containing protein extract (20 ʅL), 
10 mM cinnamic acid dissolved in water (100 ʅL, pH adjusted to 7.0), 2.5 mM NADH (50 ʅL) 
and 50 mM potassium buffer pH 7.0 (830 ʅL). The reduction of the substrate was observed 
by measuring the decrease in absorbance at 340 nm due to consumption of NADH. The 
reaction was continued for 5 min reading the absorbance every 2 s. Enzyme activity was 
calculated using the initial rate of decrease and the extinction coefficient NADH as 6,220 
M
AL1
·cm
AL1
. 
4.2.9. Nucleic acid extraction and purification 
4.2.9.1. Genomic DNA extraction 
Overnight culture grown in TYG medium (10 mL) was centrifuged at 6000 rpm for 
10 min (Agilent 5810) and the supernatant was discarded. The pellet was re-suspended in 
PBS-lysozyme lysis buffer (180 ʅL; containing NaCl, 8 g/L; KCl, 0.2 g/L; Na2HPO4, 1.44 g/L; 
KH2PO4, 0.24 g/L; lysozyme, 10g/L) and incubated at 37°C for 30 min gently agitated 
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occasionally. RNase A solution (4 ʅL; 10 mg/mL) was added and the sample was incubated 
at 37°C for 15 min. Proteinase K solution (25 ʅL; >600 mAU/ml), dH2O (85 ʅL) and sodium 
dodecyl sulphate solution (110 ʅL; 10% w/v) were added and the sample was mixed by 
inversion and incubated at 65°C for 30 min gently agitated occasionally. After incubation 
phenol:chloroform:isoamyl alcohol solution (400 ʅL; 25:24:1, saturated with 10 mM Tris 
HCl, pH 8.0; 1 mM EDTA) was added and mixed thoroughly by inversion. The sample was 
transferred to a phase-lock tube (phase-lock gel heavy 2.0 mL, Eppendorf) and centrifuged 
at 13000 rpm for 3 min. The top layer was transferred into a fresh phase-lock tube and the 
phenol:chloroform:isoamyl alcohol extraction was repeated further two times. The top 
layer was transferred into a 1.5 mL microcentrifuge tube containing 3 M sodium acetate 
solution pH 5.2 (40 ʅL) and ice cold absolute ethanol (800 ʅL). The mixture was mixed 
gently but thoroughly and incubated at -80°C for 30 min. The sample was centrifuged at 
13000 rpm for 15 min and the supernatant was poured off quickly to avoid re-suspension of 
the pellet. The sample was washed by adding ethanol solution (1 mL; 70% v/v) and 
centrifuged at full speed for 3 min. The supernatant was poured off quickly and the DNA 
pellet was air dried for 45 min at room temperature. The pellet was re-dissolved in 50 ʅL of 
EB buffer (QIAGEN).  
4.2.9.2. Small scale plasmid purification (QIAprep Spin Miniprep Kit, QIAGEN) 
LB medium (5 mL) was prepared in round bottom polypropylene tube (14 mL, 
Falcon), supplemented with desired antibiotic(s) (carbenicillin, final concentration 50 
µg/mL; chloramphenicol in ethanol, 34 µg /mL; kanamycin sulphate, 30 µg/mL) and 
inoculated with a single bacterial colony of E. coli from a Petri dish culture. The cultures 
were incubated at 37°C overnight with shaking (200 rpm). Then samples were harvested by 
centrifugation at 4000 rpm for 20 min (Eppendorf 5810R). When low copy plasmids were 
purified from E. coli JM107 or TOP10, chloramphenicol was added to the cultures (final 
concentration 170 µg/mL) 1 h before harvesting the cells in order to increase the plasmid 
yields. The pellets were re-suspended in P1 buffer (250 ʅL). Then P2 lysis buffer (250 ʅL) 
was added and samples were mixed thoroughly by inverting the tubes 4-6 times and 
incubated for 2 min at room temperature. The lysis reaction was stopped with chilled N3 
buffer (350 ʅL). The samples were centrifuged at 13000 rpm for 10 min in a table-top 
microcentrifuge (Eppendorf MiniSpin). The supernatants were transferred to the QIAprep 
spin columns by pipetting. The samples were centrifuged for 1 min and the flow-throughs 
were discarded. To remove trace nuclease activity in JM107 strains, the spin columns were 
washed by adding PB buffer (0.5 mL), centrifuged for 1 min and the flow-throughs were 
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discarded. The columns were washed by adding PE buffer (0.75 mL) and centrifuged for 1 
min. The flow-throughs were discarded and columns were centrifuged for an additional 1 
min to remove residual wash buffer. Then QIAprep columns were placed in clean 
microcentrifuge tubes (1.5 mL) and plasmids were eluted by adding EB buffer (30-50 ʅL), 
letting them stand for 1 min and centrifugation for 1 min at 13000 rpm. 
4.2.9.3. Large scale plasmid purification (Plasmid Midi Kit, QIAGEN) 
LB medium (100 mL) in Erlenmeyer flask (250 mL) was supplemented with desired 
antibiotic(s) (carbenicillin, final concentration 50 µg/mL; kanamycin sulphate, 30 µg/mL) 
and inoculated with a single bacterial colony of E. coli taken from a Petri dish culture. The 
culture was incubated at 37°C overnight with shaking (200 rpm). The culture was 
transferred into polypropylene centrifuge tubes (50 mL, Falcon). The cells were harvested 
by centrifugation at 6000 rpm for 10 min (Eppendorf 5810R). The pellets were re-
suspended in P1 buffer (4 mL) and vortexed. Then P2 lysis buffer (4 mL) was added and 
samples were mixed thoroughly by inverting the tubes 4-6 times and incubated for 5 min at 
room temperature. The lysis reaction was stopped with chilled P3 buffer (4 mL). The 
samples were mixed immediately and thoroughly by vigorously inverting 4-6 times and 
incubated on ice for 15 min. The samples were centrifuged at 18000 x g for 30 min at 4°C 
(Eppendorf 5810R) and the supernatants containing plasmid DNA were transferred 
promptly to fresh centrifuge tubes (50 mL). The supernatants were centrifuged again at 
18000 x g for 15 min at 4°C and removed promptly. QIAGEN-tips 100 were equilibrated by 
applying Buffer QBT (4 mL) and the columns were emptied by gravity flow. The 
supernatants were applied to the QIAGEN-tips and allowed to enter the resin by gravity 
flow. The QIAGEN-tips were washed with Buffer QC (2 x 10 mL) and plasmids were eluted 
with Buffer QF (5 mL) to a fresh polypropylene tube (15 mL). The plasmids were 
precipitated by adding room temperature ethanol (3.5 mL), mixing and centrifugation at 
18000 x g for 30 min at 4°C. The supernatants were decanted carefully and the pellets were 
washed with room temperature 70% ethanol (2 mL). The samples were centrifuged again at 
18000 x g for 10 min and the supernatants were carefully removed without disturbing the 
pellets. The pellets were air-dried for 10-30 min and the DNA was re-dissolved in EB buffer 
(200 ʅL). The concentrations of the plasmid DNA were determined by spectrophotometric 
analysis (Nanodrop ND1000). 
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4.2.9.4. PCR product purification (QIAquick PCR Purification Kit) 
PB Buffer (250 ʅL) was added to the PCR reaction mixture (50 ʅL). It was checked 
that the colour of the mixture was yellow. If the colour of the mixture was orange or violet, 
3 M sodium acetate pH 5.0 was added (10 ʅL). A QIAquick spin column was placed in a 2 ml 
collection tube. The DNA was bound by applying the sample to the QIAquick column and 
centrifugation for 1 min at 13000 rpm (Eppendorf MiniSpin). The flow-through was 
discarded and the QIAquick column was placed back into the same tube. The column was 
washed by adding PE Buffer (0.75 mL) and centrifugation for 1 min. The flow-through was 
discarded. The QIAquick column was placed back in the same tube and centrifuged for an 
additional 1 min. Then the QIAquick column was placed in a clean microcentrifuge tube (1.5 
mL). DNA was eluted by adding EB Buffer (50 ʅL) to the centre of the QIAquick membrane 
and the column was centrifuged for 1 min at 13000 rpm.  
4.2.9.5. DNA gel extraction (QIAquick Gel Extraction Kit) 
The DNA fragment was excised from the agarose gel under UV light with a clean, 
sharp scalpel. The exposure of the agarose gel to the UV radiation was shortened to the 
minimum to avoid creation of mutations in the DNA. The gel slice was weighed in a 
colourless microcentrifuge tube (1.5 mL). Three volumes of Buffer QG were added to 1 
volume of gel (100 mg ~ 100 ʅL). When the gel slice was heavier than 400 mg it was split 
into separate fragments to avoid the spin column overloading. The sample was incubated at 
50°C for 10 min and mixed by vortexing every 2-3 min to help dissolve the gel. After the gel 
slice was dissolved completely, it was checked the colour of the mixture is yellow. If the 
colour of the mixture was orange or violet, 3 M sodium acetate pH 5.0 was added (10 ʅL). 
One gel volume of isopropanol was added to the sample and mixed. A QIAquick spin 
column was placed in a collection tube (2 mL). The DNA was bound by applying the sample 
to the QIAquick column and centrifugation for 1 min at 1300 rpm (Eppendorf MiniSpin). The 
flow-through was discarded and the QIAquick column was placed back into the same tube. 
To remove traces of agarose, the spin column was washed by adding QG buffer (0.5 mL), 
centrifuged for 1 min and the flow-through was discarded. The column was washed by 
adding PE Buffer (0.75 mL) and centrifugation for 1 min. The flow-through was discarded. 
The QIAquick column was placed back in the same tube and centrifuged for an additional 1 
min. Then the QIAquick column was placed in a clean microcentrifuge tube (1.5 mL). DNA 
was eluted by adding EB Buffer (30 ʅL) to the centre of the QIAquick membrane. The 
column was let to stand for 1 min and centrifuged for 1 min. 
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4.2.10. Southern blot hybridisation 
The hybridisation probe was amplified by PCR using the PCR-based intron as the 
template (Clostridia Research Group, Nottingham) and primers EBSUni and SalI-R1 (Table 
4.1.). Three separate reactions were resolved on an agarose gel and the size of the products 
was checked. The samples were merged, gel purified and eluted in a final volume of 20 ʅL 
dH2O. The probe for the ladder was composed of O DNA/HindIII marker (1 ʅL) and dH2O (14 
ʅL). The DNA was denatured by heating at 100°C for 10 min and then quickly chilled on ice. 
DIG-High Prime (4 ʅL) was added and the reaction was incubated at 37°C overnight. The 
reaction was stopped by adding 0.2 M EDTA pH 8.0 (2 ʅL) and heating at 65°C for 10 min. 
 Genomic DNA (1-5 ʅg) was digested with restriction enzymes. The reaction mixture 
(25 ʅL) was composed of genomic DNA (2 ʅL), 10x bovine serum albumin solution (2.5 ʅL), 
10x restriction buffer (2.5 ʅL), restriction enzyme (2 ʅL, HindIII or EcoRI; New England 
Biolabs) and dH2O (16 ʅL). The reaction was incubated at 37°C overnight. The control 
plasmid (pMTL007-E2) was digested in 15 PL and the reaction was composed of plasmid 
DNA (2 PL), 10x BSA (1.5 PL), 10x restriction buffer (1.5 PL) and restriction enzyme (0.5 PL). 
The reaction was incubated at 37°C for 4 h.  
 The reaction mixtures were mixed with the loading dye and run out on a 0.8% 
agarose gel with O DNA/HindIII marker (5 ʅL). The gel was run at 120 V for 1.5-2 h. A picture 
of the gel was taken to be sure that the digestion was successful (even DNA smear in the 
wells containing digested genomic DNA).  
 The DNA was transferred onto nitrocellulose membrane. An empty gel tray was 
placed upside down in a plastic box. The wick was soaked in 0.4 M NaOH and laid over the 
base. The air bubbles were removed by rolling a serological pipette over the surface. The 
agarose gel was placed on the top of the wick. Hydrobond H+ membrane (GE Healthcare) 
was cut exactly the same size as the gel using a scalpel blade holding the membrane with 
forceps. The membrane was pre-wetted in 0.4 M NaOH and laid over the gel in one 
movement. Five blotting pads (Sigma) were cut to the same size as the membrane. One of 
the pads was pre-wetted in 0.4 M NaOH and laid over the membrane. The air bubbles were 
removed again. Four remaining dry blotting pads were laid over the top. The plastic box 
was filled with 0.4 M NaOH to ensure that the wick was not dried out.  A weight (about 500 
g) was placed on top and the apparatus was left for 2-3 h while the transfer occurred. 
 The transfer rig was disassembled down to the membrane. The gel lanes were marked 
on the membrane using a pencil. The membrane was placed inside cling film and the DNA 
was cross-linked to the membrane under UV light (2 min each side). The membrane was 
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briefly washed in 2x SSC buffer (containing 0.3 M NaCl, 30 mM Tris-Na-citrate buffer) to 
remove excess of NaOH. The membrane was placed into a hybridisation tube (DNA side in, 
pencil side out). DIG-Easy Hyb (Pre-hyb) buffer (8-10 mL) was added and the tube was 
incubated at 42°C for at least 1 h. The probes were made up in polypropylene centrifuge 
tubes (50 mL) into 10 mL DIG-Easy Hyb and boiled for 10 min, then placed into ice 
immediately. DIG-Easy Hyb (Pre-hyb) buffer was replaced with probe mix and the tube was 
incubated at 42°C overnight.  
 The membrane was washed twice with the low stringency washing buffer (100 mL; 2x 
SSC, 0.1% SDS) at room temperature for 5 min and twice with the high stringency washing 
buffer (100 mL; 0.5x SSC, 0.1% SDS) at 68°C for 15 min. The membrane was equilibrated in 
1x maleic acid buffer (100 mL, 0.1 M maleic acid, 0.15 M NaCl, pH 7.5) + 0.3% Tween®-20 
and incubated at room temperature for 1 min. 1x Blocking buffer (Roche EasyHyb kit) was 
made up in 1x maleic acid buffer. The membrane was blocked in 1x blocking buffer (25 mL) 
at room temperature for 30 min. The anti-DIG Ab probe was diluted 1:10,000 in 1x blocking 
solution, added to the tube and incubated at room temperature for 30 min. The membrane 
was washed with 1x maleic acid buffer + 0.3% Tween®20 (100 mL) at room temperature for 
15 min. The membrane was equilibrated in 25 mL of the detection buffer composed of Tris-
HCl pH 9.5 (100 mM) and NaCl (100 mM) at room temperature for 2 min. 
 The blot was developed using the Single filter method. CSDP ready-to-use enzyme 
substrate (1.5 mL) was dispensed into a tube. The membrane was taken out of the 
hybridisation tube and laid DNA side up on an acetate sheet. The enzyme substrate was 
pipetted directly onto the membrane and the second acetate sheet was laid over the top of 
the membrane. The edges of the acetate sheets were sealed with tape and the membrane 
was incubated at 37°C for 10 min. The membrane was placed in a cassette, covered with a 
sheet of photo film (GE Healthcare) under red light and left for 15 min. The film was 
dropped into developer and fixative solution (500 mL). 
4.2.11. Polymerase chain reaction 
4.2.11.1. PCR using ŐĞŶŽŵŝĐEƚĞŵƉůĂƚĞƐ ?&Ăŝů^ĂĨĞ ?WZ^ǇƐƚĞŵ ? 
Polymerase chain reactions (final volume 50 ʅL) were prepared with the following 
components: C. sporogenes genomic DNA (10 ng), FailSafe PCR 2xPreMix (25 ʅL), FailSafe 
PCR Enzyme Mix (0.5 ʅL; 1.25 units), 50 ʅM forward and reverse primers (1 ʅL of each). The 
hot start protocol was performed. The reactions were assembled on ice and added directly 
to a thermal cycler pre-heated to 98°C. Reactions were carried out with the following 
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cycling conditions (35 cycles): initial denaturation, 98°C for 3 min; denaturation, 95°C for 30 
s; annealing, from 48 to 62°C (2-5°C below the Tm of primers) for 30-50 s; elongation, 72°C, 
1-2min (1 min for every kb of expected product) and final elongation, 72°C for 10 min. After 
amplification, the reactions were analysed by DNA gel electrophoresis and frozen at -20°C. 
4.2.11.2. Introduction of restriction sites by PCR (KOD Polymerase) 
Polymerase chain reactions (final volume 50 ʅL) were prepared with the following 
components: plasmid DNA (1 ʅL; 0.01-1 ng), 10x Buffer #1 for KOD DNA Polymerase (5 ʅL, 
Novagen), 5 mM dNTP mix (2 ʅL), 25 mM MgCl2 (2 ʅL), primers forward and reverse (10 
µM, 2 ʅL of each), DMSO (1 ʅL) and KOD DNA Polymerase (0.4 ʅL; 1 U). Reactions were 
carried out with the following cycling conditions (25 cycles): initial denaturation, 98°C for 3 
min; denaturation, 98°C for 15 s; annealing, from 55 to 64°C (1-2°C below the Tm of primers) 
for 10 s; elongation, 72°C, 20-40 s and final elongation, 72°C for 5 min. After amplification, 
the reaction mixtures were analysed by DNA gel electrophoresis and frozen at -20°C. 
4.2.11.3. Colony PCR (JumpStart REDTaq DNA Polymerase) 
Colony PCR was used to quickly screen for plasmid inserts directly from E. coli 
(JM107, BL21(DE3)pLysS or TOP10) colonies. The reactions were assembled on ice in thin 
wall PCR tubes (0.5 mL) and were composed of 10x JumpStart REDTaq PCR Buffer (5 ʅL), 2 
mM dNTP mix (5 ʅL), 10 µM forward primer (1.25 ʅL; T7 promoter or pJET1.2 forward), 10 
µM reverse primer (1.25 ʅL; T7 terminator or pJET1.2 reverse), JumpStart REDTaq DNA 
Polymerase (2.5 ʅL, SIGMA) and dH2O (35 ʅL). A small amount of E. coli colony was 
transferred from an agar plate using a sterile 100 ʅL pipette tip. A trace of the colony was 
transferred on a fresh LB agar plate supplemented with the relevant antibiotics and the rest 
was added to the PCR mix. Reactions were carried out with the following cycling conditions 
(35 cycles): initial denaturation, 94°C for 3 min; denaturation, 94°C for 30 s; annealing, 50°C 
for 30s; elongation, 72°C, 1.5-2.5 min (1 min for every kb of expected product) and final 
elongation, 72°C for 5 min. The reaction mixtures analysed by DNA electrophoresis. 
4.2.12. Plasmid DNA restriction digestion 
Plasmid DNA was digested using the FastDigest restriction enzymes BglII, NcoI, 
NdeI, NotI and XbaI (Fermentas). The reaction (50 ʅL) was composed of the plasmid DNA 
(0.5-5 ʅg), 10x Green FD Reaction Buffer (5 ʅL) and the enzyme(s) (1-2 ʅL of each). The 
reaction was incubated at 37°C for 1-6 hours or overnight. When the digestion reaction was 
incubated overnight, the reaction mixture was covered with mineral oil (50 ʅL, SIGMA) to 
prevent evaporation. When the reaction was complete, the enzymes were inactivated at 
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65-80°C for 5-10 min depending on the enzyme properties. The products of the restriction 
digestion were analysed using DNA agarose gel electrophoresis. 
4.2.13. DNA vector dephosphorylation 
The dephosphorylation reaction was composed of plasmid DNA (28 ʅL), 10x 
Antarctic Phosphatase Reaction Buffer (5 ʅL, New England Biolabs), Antarctic Phosphatase 
enzyme (1.5 ʅL; 7.5 U) and dH2O (up to 50 ʅL).  The sample was incubated at 37°C for 1 h. 
The enzyme was inactivated at 65°C for 5 min. DNA was precipitated by addition of 3 M 
sodium acetate (5 ʅL; pH 5.2, adjusted with acetic acid) and absolute ethanol (110 ʅL) and 
incubated at -20°C overnight. Then the sample was centrifuged at 13000 rpm (Eppendorf 
MiniSpin) for 20 min and the supernatant was removed. The pellet was washed with 70% 
ethanol (1 mL) and centrifuged again at 13000 rpm for 10 min. The supernatant was 
removed. The pellet was air-dried and re-suspended in EB buffer (30 ʅL; QIAGEN). 
4.2.14. DNA ligation 
 ? ? ? ? ? ? ? ? ?>ŝŐĂƚŝŽŶŽĨWZƉƌŽĚƵĐƚƐƵƐŝŶŐůŽŶĞ:d ?WZůŽŶŝŶŐ<ŝƚ 
Three independent PCR reaction mixtures were resolved on a 1% agarose gel and 
the size of the products was checked. The products were purified from primers, 
nucleotides, polymerases and salts using the QIAquick PCR Purification Kit (QIAGEN). When 
unspecific products occurred in the reaction, the products were additionally purified by gel 
electrophoresis. 
 dŽ ƌĞŵŽǀĞ  ? ?-dA overhangs generated by enzyme mixtures containing Taq DNA 
polymerase, the blunting reaction was set up in microcentrifuge tube (1.5 mL). The reaction 
mixture was composed of the PCR product (1-2 ʅL), 2x Reaction Buffer (10 ʅL), DNA 
Blunting Enzyme (1 ʅL) and dH2O (up to 18 ʅL). The sample was vortexed, incubated at 70ºC 
for 5 min and chilled briefly on ice. Then pJET1.2/blunt Cloning Vector (1 ʅL; 50 ng) and T4 
DNA Ligase (1 ʅL; 5 U) were added to the reaction mixture. The sample was vortexed briefly 
and incubated at room temperature for 30 min. The ligation mixture was used directly for 
the bacterial transformation. 
4.2.14.2. Ligation into expression vectors 
A cloning vector (pJET1.2, pUC19 or pBMH) carrying the gene insert was digested 
using restriction enzymes (NdeI FD and NotI FD, NcoI FD and NotI FD or XbaI and NotI). The 
gene insert was separated from the linearized vector by gel electrophoresis purification. 
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 The expression vectors (pET20b(+) and pET28a(+)) were digested with the 
corresponding enzymes. The linear vector DNA was purified by gel electrophoresis and 
dephosphorylated to reduce its self-ligation.  
 The ligation mixture was composed of 10x T4 ligase buffer (3 ʅL), the 
dephosphorylated vector (50 ng), the gene insert (20-75 ng; vector/insert molar ratio 3:1), 
T4 ligase (1 ʅL, 5 units) and dH2O (up to 30 ʅL). The reaction was incubated at room 
temperature for 1 h. Then the enzyme was inactivated at 70ºC for 10 min. The reaction 
mixture (2.5 ʅL) was immediately used to transform E. coli JM107 or TOP10. 
4.2.15. E. coli transformation 
4.2.15.1. Transformation of JM107 and TOP10 strains 
LB agar plate was seeded from a single bacterial colony of E. coli (JM107 or TOP10) 
using an inoculating loop and incubated overnight at 37ºC. For preparation of competent 
cells, freshly streaked bacterial colonies were used (not older than 1-2 days). 
 C-medium (2 mL) in a round bottom polypropylene tube (14 mL; Falcon) was 
inoculated with a single bacterial colony from the LB plate and incubated overnight at 37ºC. 
The stock culture was kept at 4ºC for one week and used for preparation of competent 
cells.  
 On the day of transformation, C-medium (1.5 mL) and LB agar plates with desired 
antibiotics (carbenicillin or kanamycin sulphate) were pre-warmed at 37ºC for at least 20 
min. The T-solution (500 ʅL) was composed of T-solution A (250 ʅL) and T-solution B (250 
ʅL) and kept on ice. The overnight bacterial stock culture in C-medium (150 ʅL) was added 
to pre-warmed C-medium and incubated at 37ºC for 20 min with shaking (200 rpm). Then 
the cells were poured into a microcentrifuge tube (1.5 mL) and harvested by centrifugation 
(1 min; 13000 rpm). The pellet was re-suspended in chilled T-solution (300 ʅL) and 
incubated on ice for 5 min. The sample was centrifuged for 1 min at 13000 rpm and the 
supernatant was discarded. The pellet was re-suspended in chilled T-solution (120 ʅL) and 
incubated of ice for another 5 min. The ligation mixture (2.5 ʅL) was added to a new 
microcentrifuge tube and chilled on ice for 2 min. The prepared cells (50 ʅL) were added to 
the tube containing DNA, mixed and incubated on ice for 5 min. Then the cells (30-50 ʅL) 
were plated immediately on pre-warmed LB antibiotic agar plates using a sterile spreader 
and incubated overnight at 37ºC. 
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4.2.15.2. Heat-shock transformation of BL21(DE3)pLysS 
E. coli BL21(DE3)pLysS competent cells (Novagen) were removed from the -80ºC 
freezer and thawed on ice for 2-5 min. The tube was gently finger-flicked 1-2 times to 
evenly resuspend the cells. The required number of 1.5 mL microcentrifuge tubes was 
placed on ice to pre-chill. Aliquots of cells (20 ʅL) were pipetted into pre-chilled tubes. 
Purified pET20b(+) plasmid (1 ʅL; 10 ng) was added directly to the cells and the tube was 
stirred gently. The tube was incubated on ice for 5 min and then heated for exactly 30 s in a 
42ºC water bath. The tubes were placed on ice for 2 min and room temperature SOC 
medium (80 ʅL, Novagen) was added to the tube. The cells were incubated at 37°C while 
shaking at 250 rpm for 60 min prior to plating on LB agar plates supplemented with 
antibiotics (carbenicillin, final concentration: 50 µg/mL; chloramphenicol: 34 µg/mL). 
Positive transformants were maintained on LB agar plates at 4°C and as 8% glycerol stocks 
at -80°C. 
4.2.16. Electrophoresis 
4.2.16.1. DNA electrophoresis in agarose gel 
TAE buffer (1 L) was composed of Tris base (4.84 g), glacial acetic acid (1.14 mL) and 
0.5 M EDTA pH 8.0 (2 mL). Agarose powder (1 g) and TAE buffer (100 mL) were mixed 
together in an Erlenmeyer flask (250 mL). The agarose was melted in a microwave until the 
solution became clear. The solution was let to cool down to about 50°C, swirling the flask 
occasionally to cool evenly. The gel casting tray (Alpha Laboratories) was assembled and 
the comb was placed. Ethidium bromide solution (7 ʅL; 1% w/v) was added to the melted 
agarose. The gel was poured into the casting tray and let cool until it was solid. The comb 
was carefully pulled out and the gel was placed in the electrophoresis chamber filled with 
the TAE buffer.  
 The samples (10ʅL each) were mixed with the 6x Loading Dye Buffer (2 ʅL; 
Fermentas). Each sample (10-12 ʅL) and the relevant DNA ladder (5 ʅL) were carefully 
pipetted into separate wells in the gel. The lid was placed on the gel box and the electrodes 
were connected to the power supply. The power supply was turned on to about 60-70 V 
and the electrophoresis was run until the blue dye approached the end of the gel. The 
power was turned off and the gel was observed under UV light. Pictures of the gel were 
taken using the Gel Imagining System (U:Genius3, Syngene). 
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4.2.16.2. SDS-PAGE electrophoresis 
The separating buffer (100 mL) contained Tris base (18.15 g) and SDS (0.4 g) and the 
pH was adjusted to 8.8. The separating gel was composed of  ? ?A? ĂĐƌǇůĂŵŝĚĞ PE ?E഻-
methylenebisacrylamide (37.5:1) water solution (8 mL, Sigma), dH2O (6.8 mL), separating 
buffer (5 mL), 10% ammonium persulfate (100 ʅL) and TEMED (10 ʅL). The stacking buffer 
(100 mL) contained Tris base (6.04 g) and SDS (0.4 g) and the pH was adjusted to 6.8. The 
ƐƚĂĐŬŝŶŐŐĞůǁĂƐƉƌĞƉĂƌĞĚŽĨ  ? ?A?ĂĐƌǇůĂŵŝĚĞ PE ?E഻-methylenebisacrylamide (37.5:1) water 
solution (1.3 mL), dH2O (6.1 mL), separating buffer (2.5 mL), 10% ammonium persulfate (50 
ʅL) and TEMED (5 ʅL). The running buffer (1 L) contained glycine (14.4 g), Tris base (3 g) and 
SDS (1 g). The loading buffer contained 2.6% SDS, 1.3% 2-ɴ-mercaptoethanol, 6% glycerol, 
0.2% bromophenol blue, 0.05 M Tris HCl, pH 6.8. 
Plates, spacers, combs and gaskets were washed with ethanol and allowed to dry. 
Plates were assembled and checked with deionised water. The separating gel was poured 
straight away and covered with water saturated butan-2-ol. After 45 min the butan-2-ol 
was removed and the headspaces of plates were washed with water five times. The 
stacking gel was poured, the comb was inserted and gel was left for 1 h. The gel cassette 
was assembled, the comb was removed and the inner and outer tanks were filled with the 
running buffer. The loading buffer was added to samples to a final volume of 30 ʅL. 
Samples were incubated in a water bath at 95°C for 5 min and loaded onto the gel. 
PageRulerTM Prestained Protein Ladder (Fermentas) was used as a molecular weight 
marker. Electrophoresis was run at 35 mV for 2 h. The gel was washed with water twice and 
stained overnight with Instant Blue Stain (Novexin) or EZBlue Stain (Sigma). 
Alternatively Mini-PROTEAN TGX Precast Gels (Bio-Rad) were used together with 4x 
Laemmli Sample Buffer (Bio-Rad) supplemented with ɴ-mercaptoethanol (final 
concentration 5%) and 10x Tris/glycine/SDS running buffer (Bio-Rad).  
4.2.17. Protein overexpression in E. coli under anaerobic conditions 
E. coli BL21(DE3)pLysS strain carrying pET20b(+) plasmid encoding the desired 
enzyme was maintained as an 8% glycerol cryo-stock and kept at -80°C. LB medium (10 mL) 
supplemented with carbenicillin (50 µg/mL) and chloramphenicol (34 µg/mL) was 
inoculated using a 10 ʅL loop with bacterial strain directly from the cryo-stock. The culture 
was incubated at 37°C overnight with shaking at 200 rpm. The culture (100-500 ʅL) was 
used to inoculate LB medium (20 mL) with antibiotics in a sterile 50 mL centrifuge tube 
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(Falcon). The culture was incubated at 37°C for about 6-7 h with shaking (200 rpm) until the 
OD600 of the culture reached 0.9-1. The culture was kept at 4°C overnight. 
 The next day the cells were centrifuged at 6000 rpm for 10 min at 4°C (Eppendorf 
5810R). The supernatant was discarded and the pellet was transferred into the anaerobic 
cabinet. The cells were used to inoculate anaerobic TB medium (100 mL) supplemented 
with antibiotics, glucose (final concentration 1%) and riboflavin (1 ʅg/mL) in a Duran screw 
cap bottle (100 mL) containing a magnetic flea. The culture was mixed using a magnetic 
stirrer at 100 rpm. When the culture reached OD600 0.4-0.5, the expression of the protein 
was induced by adding sterile 1 M isopropyl ɴ-D-1-thiogalactopyranoside (40 ʅL). Samples 
of the culture (2 mL) were harvested before induction and at intervals after induction in 
order to determine the time point giving the higher protein production yield. The cells were 
harvested by centrifugation at 6000 rpm for 10 min at 4°C. 
 The anaerobic lysis buffer (10 mL) was composed of 100 mM potassium phosphate 
buffer pH 7.0, flavin adenine dinucleotide (10 ʅM), riboflavin- ?഻-phosphate (10 ʅM), 
Benzonase® Nuclease (1 ʅ> ?A? ? ? ?h ) ? ? ?ǆƵŐƵƐƚĞƌ ?WƌŽƚĞŝŶǆƚƌĂĐƚŝŽŶZĞagent (1 mL) and 
cOmplete MiniEDTA-free protease inhibitor (1 tablet). Depending on the further 
purification steps, the lysis buffer was also supplemented with dithiothreitol (0.1 mg/mL) or 
tris(hydroxypropyl)phosphine (1 mM). The lysis buffer was sparged with nitrogen for at 
least 1 h.  
The pellet was resuspended in the lysis buffer (250 ʅL of the buffer for every 1 mL 
of the culture of OD600 1). The sample was incubated at room temperature for 10-15 min 
with shaking at 250 rpm and additional vortexing every 2-3 min. The tube was centrifuged 
at 18000 x g for 20 min at 4°C (Eppendorf 5810R). The supernatant (cell-free crude extract) 
was transferred into a fresh tube. The pellet was re-suspended in the original volume of the 
lysis buffer and represented the insoluble protein fraction. Both protein fractions were 
analysed using SDS-PAGE technique (20 ʅL of each sample was loaded onto the gel). The 
soluble protein fraction was used in enzymatic assays and biotransformations. 
The culture for protein overexpression was scaled up to 1 L by increasing the 
volumes of the cultures and scaling up the protein preparation. In the 1 L scale 
experiments, the protein extracts (final volume 7 mL) were prepared using the cell 
disruptor (Constant Systems Ltd.) as described elsewhere (4.2.6.). 
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4.2.18. His-Tag purification 
4.2.18.1. His-Bind Purification Kit (Novagen) 
8x Binding Buffer pH 7.9 contained NaCl (4 M), Tris HCl (160 mM) and imidazole (40 
mM). 8x Wash Buffer pH 7.9 contained NaCl (4 M), imidazole (480 mM) and Tris -HCl (160 
mM). 4x Elute Buffer pH 7.9 contained imidazole (4 M), NaCl (2 M) and Tris HCl (80 mM). 4x 
Strip Buffer pH 7.9 contained NaCl (2 M), EDTA (400 mM) and Tris HCl (80 mM). 8x Charge 
Buffer contained NiSO4 (400 mM). Buffers were supplemented with FMN (final 
concentration 10 µM), FAD (final concentration 10 µM) and sparged with nitrogen for at 
least 1 h.  
Small polypropylene columns (Chromatography Columns, Novagen) held 2.5 mL of 
the settled resin and were used to purify up to 20 mg target protein. The bottle of His·Bind® 
Resin was gently mixed by inversion until completely suspended. The desired volume of 
slurry (1.5-2 mL) was transferred to the column using a wide mouth pipet. The column was 
transferred to the anaerobic work station where the resin was allowed to pack under 
gravity flow. When the level of the storage buffer dropped to the top of the column bed, 
the resin was charged and equilibrated by a sequence of washes, 3 resin volumes of sterile 
degassed dH2O, 5 volumes of 1x Charge Buffer and 3 volumes of 1x Binding Buffer. 
1x Binding Buffer was allowed to drain to the top of the column bed. The protein 
extract (7 mL) was loaded into the column and allowed to drain under gravity flow. The 
flow throughs were collected for further analysis. The column was washed with 10 volumes 
of 1x Binding Buffer and 6 volumes of 1x Wash Buffer. The bound protein was eluted with 6 
volumes of 1x Elute Buffer. The column was washed with 6 volumes of 1x Strip Buffer to 
remove residual proteins by stripping Ni
2+
 from the column. The purified protein and the 
flow throughs were analysed using SDS-PAGE and used in enzyme activity assays. 
4.2.18.2. Ni-NTA Spin Kit (QIAGEN) 
The Lysis Buffer (NPI-10) contained 50 mM NaH2PO4, 300 mM NaCl and 10 mM 
imidazole, pH 8.0. The Wash Buffer (NPI-20) contained 50 mM NaH2PO4, 300 mM NaCl and 
20 mM imidazole, pH 8.0.  The Elution Buffer (NPI-500) contained 50 mM NaH2PO4, 300 mM 
NaCl and 500 mM imidazole, pH 8.0. The buffers were also supplemented with FMN (final 
concentration 10 µM), FAD (final concentration 10 µM), sparged with nitrogen and 
equilibrated in the anaerobic work station overnight. All the buffers were also 
supplemented with different concentrations of dithioerythritol used as the reducing agent. 
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The pellet derived from 5 mL cell culture volume was resuspended in 630 ʅL Lysis 
Buffer (NPI-10). Lysozyme Stock Solution (70 ʅL; 10 mg/mL) and Benzonase® Nuclease (15 
U) were added and the sample was incubated at 4°C for 30 min. The lysate was centrifuged 
at 12000 x g for 30 min at 4°C and the supernatant was collected. The Ni-NTA spin column 
was equilibrated with NPI-10 Buffer (600 ʅL) and centrifuged at 2900 rpm for 2 min 
(Eppendorf MiniSpin). The cleared lysate containing the 6xHis-tagged protein was loaded 
onto the pre-equilibrated Ni-NTA spin column and the column was centrifuged at 1600 rpm 
for 5 min. The Ni-NTA spin column was washed twice with NPI-20 Buffer (600 ʅL) and 
centrifuged at 2900 rpm for 2 min. The protein was eluted twice with NPI-500 Buffer (300 
ʅL) and centrifuged at 2900 rpm for 2 min. The eluate was collected and used in the 
enzyme activity assays. 
4.2.18.3. Dynabeads® His-Tag Isolation (Invitrogen) 
2x Binding/Wash Buffer was composed of sodium phosphate, pH 8.0 (100 mM), 
NaCl (600 mM) and Tween®-20 (0.02%). His Elution Buffer contained imidazole (300 mM), 
sodium phosphate pH 8.0 (50 mM), NaCl (300 mM) and Tween®-20 (0.01%). Buffers were 
also supplemented with FMN (final concentration 10 µM), FAD (final concentration 10 µM) 
and sparged with nitrogen for at least 1 h.  
 The sample containing the 6-His-tagged protein was prepared in 1x Binding/Wash 
Buffer (700 ʅL). The Dynabeads® were thoroughly resuspended in the vial by vortexing for 
30 s. The Dynabeads® (50 ʅL; 2 mg) were transferred to a microcentrifuge tube (1.5 mL). 
dŚĞ ƚƵďĞ ǁĂƐ ƉůĂĐĞĚ ŽŶ Ă ŵĂŐŶĞƚ  ?ǇŶĂDĂŐ ?-2, Invitrogen) for 2 min. The beads were 
collected on the wall of the tube and the supernatant was discarded. The protein extract 
was added to the beads. The tube was mixed well and incubated on a shaker at room 
temperature for 10 min. The tube was placed on the magnet for 2 min and the supernatant 
was discarded. The beads were washed 4 times with 1x Binding/Wash Buffer (300 ʅL) by 
placing the tube on the magnet for 2 min and discarding the supernatants. The beads were 
resuspended thoroughly between each washing step. To elute the protein, His-Elution 
Buffer (100 ʅL) was added and the tube was incubated on a shaker at room temperature 
for 5 min. The tube was placed on the magnet for 2 min and the supernatant containing the 
eluted histidine-tagged protein was transferred to a clean tube. The purified protein was 
analysed using SDS-PAGE and used in enzyme activity assays. 
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4.2.19. His-tag excision and protein refolding 
The 6-His-tagged protein was purified in the anaerobic cabinet using His·Bind 
Purification Kit (see section 4.2.18.1) and eluted in 1x Elution Buffer pH 7.9 (6 mL). To 
remove the salts from the buffer and make the protein more concentrated, the sample was 
poured into Vivaspin Concentrator 6 (Vivaproducts) with 10,000 molecular weight cut off 
membrane. The assembled concentrator was inserted into a centrifuge (Eppendorf 5810R) 
and centrifuged at 4000 x g in a swing bucket rotor (A-4-62, Eppendorf) at room 
temperature until the volume of the sample decreased to about 1 mL (for about 10-15 
min). In the cabinet, anaerobic 100 mM potassium phosphate buffer (5 mL) was added and 
the sample was gently mixed by pipetting. The concentrator was centrifuged again until the 
volume of the sample decreased to about 1 mL. 
 The 6-His-tag was cut off from the overexpressed protein by thrombin digestion. 
The reaction mixture was composed of purified and concentrated protein (450 ʅL) and High 
Activity Bovine Thrombin (50ʅL, 10 U; lyophilized powder resuspended in 200 mM NaCl, 50 
mM sodium citrate, 1 ml 0.1% PEG, pH 6.5). The reaction was incubated at 37°C for 3 h.  
 The protein was refolded using Pierce Protein Refolding Kit (Fermentas). Nine Base 
Refolding Buffers and seven additional buffer additives were used to create a matrix 
covering a range of strong and weak denaturant conditions for the suppression of protein 
aggregation. The stock buffers were composed of Tris base (55 mM), NaCl (21 mM), KCl 
(0.88 mM), FMN (11 µM), FAD (11 µM), pH 8.2. Each buffer stock also contained the 
indicated denaturant concentrations (up to 1.1 M guanidine and up to 0.88 M arginine). 
The additives such as dithioerythritol (5 mM), reduced glutathione (up to 2 mM) and 
oxidized glutathione (up to 0.4 mM) were used as secondary matrix factors. The buffers 
were sparged with nitrogen for at least 1 h. 
In the anaerobic workstation the Base Refolding Buffers (900 ʅL) were dispensed in 
nine 1.5 mL microcentrifuge tubes. The additives were added and the volumes were 
adjusted to 950 ʅL. The purified and concentrated protein sample (50 ʅL) was slowly added 
to each of the nine tubes and mixed. The samples were incubated for 6-24 h and the 
refolding efficiency was tested in the enzyme activity assay.  
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5. Results 
5.1. Reduction of C=C double bonds by Clostridium sporogenes DSM795 
Clostridium sporogenes was shown to catalyze hydrogenation of C=C double bonds 
in cinnamic acid (reported for the first time by Bühler in 1980), a range of ɲ,ɴ- and ɴ,ɴ-
disubstituted nitroolefins (Fryszkowska et al., 2008), pyrimidines, such as uracil (Hilton et 
al., 1975) and unsaturated fatty acids (Verhulst et al., 1985).   
The purification and identification of the enzyme responsible for reduction of 
nitroolefins, (E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-phenylpropene, was 
unsuccessful, although it was found that C. sporogenes possessed at least two enzymes that 
could reduce (E)-2-nitro-1-phenylpropene at the expense of NADH showing different 
enantioselectivities (Fryszkowska et al., 2008; Dr. Karl Fisher, Manchester Interdisciplinary 
Biocentre, unpublished data, for details see Appendix 8.7.).  
The similarities in structure between cinnamate and nitroolefins tested (Fig. 5.1.) 
led to a hypothesis that one of these enzymes could be the reductase responsible for 
hydrogenation of cinnamic acid in the L-phenylalanine fermentation by the Stickland 
reaction. The reduction of cinnamic acid to 3-phenylpropionic acid was found to be 
catalyzed by NADH-dependent 2-enoate reductase (Bühler et al., 1980), belonging to a 
family of clostridial oxidoreductases containing a flavin adenine dinucleotide and an iron-
sulphur centre (Tischer et al., 1979). 
 
Fig. 5.1. Structures of (E)-cinnamate, (E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-phenylpropene. 
 
The nucleotide sequence of the gene encoding fldZ reductase remained unknown 
at that time, since the amino acid primary structure of the reductase was not determined 
and the sequence of C. sporogenes genome was not available in the genomic libraries. 
Moreover, previous attempts to overexpress clostridial 2-enoate reductases from C. 
tyrobutyricum and C. thermoaceticum in a heterologous host have met with the limited 
success due to their complex cofactor requirement and oxygen sensitivity.  
Thus, to test the hypothesis that 2-enoate reductase is responsible for reduction of 
nitroolefins, an approach based on production of genomic knock out mutants was 
proposed. C. sporogenes 2-enoate reductase knock out mutant strain (called C. sporogenes 
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fldZ::CTermB) was prepared by Dr. Benjamin Blount from the Clostridia Research Group 
using the ClosTron gene knock out system based on the sequence of the fldZ gene encoding 
2-enoate reductase from closely related strain, C. botulinum Hall A ATCC3502 (for details 
see Appendix 8.1.). Preliminary experiments, showed that the crude extracts of the fldZ 
mutant, contrary to those of wild type, did not show activity towards cinnamic acid in the 
spectrophotometric reduction assay (published in Mordaka, 2010). The mutants were not 
able to reduce (E)-1-nitro-2-phenylpropene, whereas reduction of (E)-2-nitro-1-
phenylpropene was still possible, but with a lower yield when compared to the wild type 
strain. The growth of fldZ::CTermB was significantly decreased in complex media when 
glucose and L-phenylalanine were used as energy substrates suggesting that fldZ may be 
involved in the process of obtaining carbon and energy for growth. These experiments 
corroborated the hypothesis that C. sporogenes possessed multiple enzymes reducing C=C 
double bond in nitroolefins and that the fldZ reductase was one of them. Therefore, further 
experiments testing the scope for reduction of enoates and nitroalkenes using C. 
sporogenes C=C double bond reductases and the contribution of fldZ in the process of 
amino acid fermentation are presented here. 
 
5.1.1. Stability and the Southern blot analysis of fldZ::CTermB mutant 
 The ClosTron system used for the creation of fldZ::CTermB is based on group II 
intron retrohoming process and the mutants produced with this method were extremely 
stable (Heap et al., 2007). However, to validate the fldZ::CTermB strain stability and prevent 
cross-contaminations between different C. sporogenes strains, a robust and simple method 
for the wild type and the fldZ mutant identification was used based on detection of L1.LtrB 
intron with polymerase chain reaction. After every culture, cells (1 mL) were harvested and 
genomic DNA was extracted. DNA was used as a template in PCR reaction using primers 
ENR-F1 and EBSUni. The reaction products were separated on 1% agarose gel (Fig. 5.2.). 
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Fig. 5.2. Erm intron PCR screen. Reaction mixtures (10 ʅL) were run on 1% agarose 
gel with 1 kb Plus Ladder (Invitrogen; M). Templates: 1  ? fldZ::CTermB, 2  ? C. 
sporogenes DSM795. Expected product for fldZ::CTermB was about 870 bp. 
 
The presence of the L1.LtrB intron integrated in the fldZ gene resulted in a PCR 
product of a size about 870 bp. No product was observed when C. sporogenes DSM795 
genomic DNA was used as the reaction template, confirming the strain identities. This test 
was carried out after every experiment when fldZ::CTermB was used. It also confirmed that 
genomic mutant knock out strains created with the ClosTron are extremely stable and the 
L1.LtrB intron remains integrated in the bacterial chromosome for many generations (more 
than fifty successful re-cultures). 
The ClosTron system can be targeted to insertionaly inactivate any gene based on 
the possible integration sites for L1.LtrB-derived introns designed by the Perutka algorithm 
(Perutka et al., 2004). However, considering the preliminary experiments showing multiple 
enzymatic activities reducing C=C double bonds in C. sporogenes and in the absence of the 
C. sporogenes genome sequence, additional genetic analysis of fldZ::CTermB was 
performed. To determine the number of L1.LtrB integration events and thus, the number of 
inactivated genes, the Southern blot technique was used (Fig. 5.3.). 
Genomic DNA was extracted from the wild type strain and the mutant and digested 
using two different restriction enzymes, EcoRI and HindIII. DNA fragments were separated 
using electrophoresis in 1% agarose gel, denatured in alkaline solution and transferred onto 
a cellulose membrane. The membrane was hybridised with a DIG-labelled erm probe 
overnight and the pattern of hybridization was visualized by autoradiography.  
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 The probe hybridized to the erm plasmid used as a positive control in the 
experiment as well as to single bands in samples containing fldZ::CTermB genomic DNA 
digested with EcoRI and HindIII restrictases. As expected, no bands were visible in samples 
containing genomic DNA of the wild type strain DSM795. The Southern blot showed that 
the fldZ::CTermB mutant possessed only one intron integration site and thus only one gene 
in the C. sporogenes chromosome was knocked out. 
 
5.1.2. Role of the fldZ reductase in amino acid fermentation 
2-Enoate reductase was proposed to be involved in the L-phenylalanine 
fermentation via the Stickland reaction (Bühler et al., 1980).  In the last step of the 
reductive branch, cinnamic acid is reduced to 3-phenylpropionic acid and this reaction is 
coupled to ATP formation by electron transfer phosphorylation (Bader and Simon, 1983). 
The fldZ mutant showed decreased biomass production when L-phenylalanine was used as 
the energy substrate in the complex Giesel medium. However, a much more drastic 
Fig. 5.3. Southern blot analysis of fldZ::CTermB 
mutant using erm DIG labelled probe. Lanes: 1  ? 
fldZ::CTermB digested with HindIII, 2  ? fldZ::CTermB 
digested with EcoRI, 3  ? DSM795 digested with 
HindIII, 4  ? DSM795 digested with EcoRI, 5  ? 
pMTL007 plasmid containing erm gene (positive 
control). 
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decrease in the growth was observed for medium supplemented with D-glucose (Mordaka, 
2010). That was surprising since the fldZ activity was not postulated to be associated with 
metabolism of carbohydrates. To further exploit this subject, a series of growth 
experiments and metabolic footprinting analysis were performed for the fldZ::CTermB 
strain. 
 
5.1.2.1. L-Phenylalanine fermentation in a complex medium 
C. sporogenes is a proteolytic organism unable to grow except in media containing 
proteins and amino acids. Carbohydrates are also fermented, but they are neither sufficient 
nor essential for growth (Stickland, 1934), although C. sporogenes has a high rate of glucose 
fermentation and its cell free extract contains all glycolytic enzymes catalysing glucose 
degradation to pyruvate (Golovchenko et al., 1983). Thus, the growth of C. sporogenes in 
the complex Giesel medium relies on a mixed fermentation of amino acids and proteins 
(present in peptone and yeast extract) and carbohydrates (from yeast extract). To test the 
role of the fldZ reductase it was better to minimise the effect of glucose dissimilation by 
elimination of the yeast extract from the medium. However, apart from carbohydrates and 
proteins, yeast extract contains also essential water soluble vitamins, growth factors and 
purine and pyrimidine bases and cannot be completely excluded from the complex 
medium. Thus, for the growth experiments the yeast extract concentration in Giesel 
medium was decreased from 0.5 to 0.1% w/v. Growth of DSM795 and fldZ::CTermB was 
determined in the modified Giesel medium supplemented with 12.1 mM L-phenylalanine.  
Moreover, the formation of 3-phenylpropionic acid during the growth was also determined 
by gas chromatography (Fig. 5.4.).  
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Fig. 5.4. A. growth of DSM795 (භ) and fldZ::CTermB (Ŷ) in modified Giesel medium supplemented 
with 12.1 mM L-phenylalanine. Average of three independent replicates. Error bars correspond to 
standard deviations. B. Concentration of 3-phenylpropionic acid in the growth medium of DSM795 
(භ) and fldZ::CTermB (Ŷ) determined by GC-MS.  Average of two independent replicates. Error bars 
correspond to standard error of mean. 
 
 
It was found that growth rates of C. sporogenes DSM795 and fldZ::CTermB in the 
modified medium were similar. In contrast to the previous experiments (Mordaka, 2010) 
where the original Giesel medium was used, no decrease of biomass production was 
observed for the mutant when compared to the wild type. Analysis of the medium 
footprints showed that despite inactivation of fldZ gene, the mutant fermented L-
phenylalanine to 3-phenylpropionic acid and the formation of the product was even greater 
than in the wild type strain. No cinnamic acid was found in the residual medium. Thus, the 
experiment suggested that fldZ is not involved in the reductive branch of L-phenylalanine 
fermentation by the Stickland reaction.  
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5.1.2.2. Growth of DSM795 in a minimal defined medium 
The growth of DSM795 and fldZ::CTermB was tested in the minimal defined 
medium (the Lovitt medium; Lovitt et al., 1997a). The medium contained only compounds 
necessary for growth (such as buffering agents, salts, trace elements, vitamins and essential 
amino acids). To support the growth, the Lovitt medium was also supplemented with pairs 
of electron donors and acceptors tested for the fermentation.  
 Different amino acids and organic acid salts could serve as electron donors for 
reduction of methylene blue or brilliant cresyl blue (Stickland, 1934). It was shown that D-
alanine was a good electron donor whereas L-alanine did not reduce the dye at all, 
suggesting that the enzyme involved in the oxidation of alanine was highly enantioselective. 
D-alanine was selected as the electron donor for the physiological experiments as it was 
oxidized by C. sporogenes to acetic acid in a simple two stage reaction and could not serve 
as electron acceptor in the Stickland fermentation (Stickland, 1935b).  
To test if alanine could support the growth of C. sporogenes DSM795, the minimal 
Lovitt medium (10 mL) was supplemented with L- or D-alanine (final concentration 27 mM). 
The media were also supplemented with L-proline (final concentration 45 mM), which was 
previously shown to act as an excellent electron acceptor in C. sporogenes fermentation 
(Lovitt et al., 1987b). The experimental cultures were set by inoculation with the overnight 
DSM795 pre-culture in the basal Lovitt medium (0.5 mL). After 1 h pre-incubation at 30°C 
with shaking, the aliquots (200 µL) were transferred into the wells of a 96-well plate and 
the growth of bacteria was observed for 44 h using automated NEPHELOstar plate reader 
(Fig. 5.5.). 
 
Fig. 5.5. Growth of C. sporogenes DSM795 in the Lovitt medium with 45 mM L-proline (Ÿ) and Lovitt 
medium with 45 mM L-proline supplemented with 27 mM L-alanine (භ) or 27 mM D-alanine (Ŷ). 
Average of five independent replicates. Error bars correspond to standard deviations. 
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 The experiment showed that C. sporogenes can use L-alanine and L-proline as a pair 
of electron donor and acceptor to produce energy for growth. When the minimal medium 
was supplemented with D-alanine, no increase in the growth rate or biomass production 
was observed when compared to the basal medium. Therefore, in contrast to the findings 
by Stickland, 1934, D-alanine was not accepted as a substrate for fermentation. 
 
5.1.2.3. Growth of DSM795 and fldZ::CTermB with different fermentation substrates 
 To determine the role of the fldZ reductase in the metabolism of C. sporogenes, the 
growth of wild type DSM795 and fldZ::CTermB mutant was tested in different variants of 
Lovitt medium. 2-Enoate reductase was proposed to be responsible for reduction of 
cinnamic acid in the L-phenylalanine pathway (Bühler et al., 1980). Fermentation of L-
tyrosine and L-tryptophan resulted in formation of 3-(p-hydroxyphenyl)propanoic acid and 
indole-3-propanoic acid, products corresponding to those produced in the reductive branch 
of Stickland reaction from L-phenylalanine (Jellet et al., 1980). Some proteolytic Clostridium 
spp. also reduced L-leucine to give the final product 4-methylvaleric acid, whereas L-valine 
and L-isoleucine were not reduced at all and gave only products of their oxidation (Barker 
et al., 1981).  That suggested that L-tyrosine, L-tryptophan and L-leucine may be reduced 
through the same metabolic pathway as L-phenylalanine. L-Proline and glycine were also 
accepted as electron acceptors in the Stickland fermentation, but these two amino acids 
possessed their own reduction pathways (Schwartz and Müller, 1979; Venugopalan, 1980) 
and were selected for use as control substrates. 
The Lovitt minimal medium was supplemented with L-alanine (as electron donor, 
final concentration 27 mM) and different amino acids served as electron acceptors: glycine, 
L-proline, L-phenylalanine, L-tryptophan, L-isoleucine, L-leucine or L-valine (final 
concentration 45 mM). L-Tyrosine was not used as the electron acceptor, because of its 
poor water solubility. Cultures were inoculated with an overnight pre-culture in the basal 
Lovitt medium, pre-incubated for 1 h at 30°C and samples (200 µL) were transferred into a 
96-well plate where the growth of bacteria was observed for 44 h (Fig. 5.6.).  
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Fig. 5.6. Growth of C. sporogenes DSM795 (A) and fldZ::CTermB (B) in Lovitt medium supplemented 
with 27 mM L-alanine as the electron donor. The electron acceptors (45 mM) were L-proline (Ŷ), 
glycine (Ÿ), L-phenylalanine (ź), L-tryptophan (Ƈ), L-isoleucine (භ), L-leucine (Ŷ) and L-valine (Ÿ). 
ŽŶƚƌŽůĐƵůƚƵƌĞǁŝƚŚŶŽĞůĞĐƚƌŽŶĂĐĐĞƉƚŽƌ ?භ ) ?ǀĞƌĂŐĞŽĨĨ ƵƌŝŶĚĞƉĞŶĚĞŶƚƌĞƉůŝĐĂƚĞƐ ? 
 
 From all pairs of electron donors and acceptors only L-alanine and L-proline showed 
increased biomass production of the wild type and the mutant when compared to the 
control sample. The presence of L-tryptophan caused an inhibitory effect in the wild type 
but not in the mutant. When the medium was supplemented with glycine, phenylalanine, 
isoleucine, leucine and valine the mutant gave slightly (but statistically significant) higher 
biomass production.  
 A similar experiment was performed using a different electron donor, 27 mM 
glucose (Fig. 5.7.). 
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Fig. 5.7. Growth of C. sporogenes DSM795 (A) and fldZ::CTermB (B) in Lovitt medium supplemented 
with 27 mM D-glucose as the electron donor. The electron acceptors (45 mM) were L-proline (Ŷ), 
glycine (Ÿ), L-phenylalanine (ź), L-tryptophan (Ƈ), L-isoleucine (භ), L-leucine (Ŷ) and L-valine (Ÿ). 
ŽŶƚƌŽůĐƵůƚƵƌĞǁŝƚŚŶŽĞůĞĐƚƌŽŶĂĐĐĞƉƚŽƌ ?භ ) ?ǀĞƌĂŐĞŽĨĨ ƵƌŝŶĚĞƉĞŶĚĞŶƚƌĞƉůŝĐĂƚĞƐ ? 
 
  The pair of electron donor and acceptor that gave the best growth was D-glucose 
and L-proline confirming that the latter substrate is an excellent electron acceptor in the 
Stickland fermentation. L-Tryptophan inhibited the growth of the wild type strain causing 
an extended lag phase. Again, the fldZ mutant gave a slight (about 20%), but statistically 
significant (based on the t-tests) increase in the biomass production when compared to the 
wild type. 
 Results of the growth experiments showed unexpected physiological behaviour of 
the fldZ::CTermB. The inactivation of the fldZ enoate reductase should limit the number of 
electron acceptors that can be used for fermentation. That should decrease the growth 
compared to the wild type strain. This suggested that fldZ reductase may not be the 
enzyme involved in the Strickland reaction. 
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5.1.2.4. Analysis of the final products of fermentation 
 To analyze the final products of amino acid fermentation in the wild type and the 
fldZ mutant, cultures grown in minimal medium supplemented with glucose (electron 
donor) and either L-phenylalanine or L-tryptophan (electron acceptors) were used for the 
footprinting analysis in the late stationary phase. Culture supernatants extracted into 
diethyl ether were derivatized with (trimethylsilyl)diazomethane (see method 4.8.2.8.) and 
analyzed using GC-MS. 
 
Fig. 5.8. Analysis of the final products of L-phenylalanine fermentation in the wild type DSM795 and 
the fldZ::CTermB mutant grown in minimal medium. Unlabelled peaks were side products of the 
derivatization method.  
 
 Even though fldZ::CTermB mutant had the fldZ gene knocked out, both strains gave 
similar products from the L-phenylalanine, namely 3-phenylpropionic acid and phenyllactic 
acid. The mutant accumulated also significant amounts of cinnamic acid, whereas the wild 
type did not (Fig. 5.8). 
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Fig. 5.9. Analysis of the final products of L-tryptophan fermentation in the wild type DSM795 and 
fldZ::CTermB mutant grown in minimal medium. Unlabelled peaks were side products of the 
derivatization method. 
 
 When the medium was supplemented with L-tryptophan (Fig. 5.9.), C. sporogenes 
DSM795 and fldZ::CTermB mutant produced 3-indolepropionic acid, 3-indoleacrylic acid 
and skatole. 3-Phenylpropionic acid, the product of phenylalanine fermentation, was also 
detected. This can be explained by the fact that the basal medium contained L-
phenylalanine, as this amino acid is essential for growth of C. sporogenes and cannot be 
replaced with any other derivative. 3-Indolepropionic acid and 3-indoleacrylic acid were 
products of the reductive branch of tryptophan fermentation in the Stickland reaction. 
Skatole could be a product of the decarboxylation of indoleacetic acid that was formed in 
the oxidative branch of the Stickland fermentation. 
 The analysis of the final products of fermentation showed that surprisingly the 
mutant produced 3-phenylpropionic acid (when the medium was supplemented with L-
phenylalanine and L-tryptophan) and 3-indolepropionic acid (when the medium was 
supplemented with L-tryptophan). These compounds were postulated to be products of the 
enoate reductase activity in the reductive branch of the Stickland reaction. Thus it was 
confirmed that fldZ enoate reductase is not essential for fermentation of L-phenylalanine 
and L-tryptophan by C. sporogenes. 
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5.1.2.5. Reduction of cinnamic acid by C. sporogenes fldZ mutant 
 Preliminary experiments with protein cell-free extracts of the fldZ::CTermB mutant 
showed that cinnamic acid was not reduced in the spectrophotometric assay (Mordaka, 
2010). However, further growth experiments in both complex and minimal defined media 
showed that fldZ::CTermB produced 3-phenylpropionic and 3-indolepropionic acid, 
products of the cinnamate reductase activity in the reductive branch of the Stickland 
fermentation. 
 To investigate the scope for reduction of cinnamic acid by the mutant, DSM795 and 
fldZ::CTermB strains were grown in the Giesel medium and harvested. Half of the culture 
was used for whole cell cinnamic acid biotransformation using hydrogen gas as the electron 
donor. Reactions were incubated for 24 h at 30°C, the products were derivatized using 
(trimethylsilyl)diazomethane and analyzed using gas chromatography (Fig. 5.10.).  
 
Fig. 5.10. Reduction of cinnamic acid using whole cells of C. sporogenes DSM795 
and fldZ::CTermB (grown in Giesel medium with 12.1 mM L-phenylalanine) and 
hydrogen gas as the electron donor. Error bars correspond to standard 
deviations.  
 
 Cinnamic acid was converted to 3-phenylpropionic acid by the whole cells of both 
strains. The yield of the reaction was greater for the mutant (57%) than for the wild type 
(44%).  
 The second part of the culture was used to prepare protein cell-free extracts. The 
cells were disrupted using the cell disruptor at pressure of 40,000 psi. The cell debris and 
insoluble proteins were separated from the soluble protein fraction by centrifugation at 
75,000 x g for 30 min at 4ºC. The supernatant was used in the spectrophotometric cinnamic 
acid reduction assay (Fig. 5.11.). 
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Fig. 5.11. Cinnamic acid reduction in the spectrophotometric assay using 
membrane-free protein extracts of C. sporogenes DSM795 and fldZ::CTermB 
(grown in Giesel medium with 12.1 mM L-phenylalanine) and NADH as the 
electron donor. 
 
Reduction of cinnamic acid coupled to consumption of NADH (resulting in a 
decrease of absorbance at 340 nm) was observed only for crude extracts of DSM795 
(activity 13.5 µmol/min). No activity was detected when extracts of fldZ::CTermB were used 
and in the control experiments without cinnamic acid. 
Cinnamic acid biotransformations showed that the mutant reduced the substrate 
when whole cells were used but not with protein crude extracts. The wild type C. 
sporogenes reduced cinnamic acid in both types of reaction. Thus, C. sporogenes possesses 
at least two cinnamic acid reductases. One of them is the NADH-dependent soluble fldZ 
reductase. The second unknown enzyme may not accept NADH as the electron donor since 
no activity was observed in the spectrophotometric assay or may be a membrane 
attached/associated protein that was removed from the sample with the cell debris and 
insoluble proteins. 
5.1.3. Biotransformations using DSM795 and fldZ::CTermB 
5.1.3.1. Reduction of nitroalkenes, cinnamic acid and nitrobenzene using harvested cells 
 To test if the protein encoded by fldZ gene is involved in reduction of C=C bonds, 
whole cells of C. sporogenes DSM795 and fldZ::CTermB were used to reduce ɴ-nitrostyrene, 
(E)-1-nitro-2-phenylpropene, (E)-1-phenyl-2-nitropropene and cinnamic acid. Since 
reduction of nitro groups was found to be catalyzed by flavin-containing enzymes, the 
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reduction of aromatic nitro compounds (represented by nitrobenzene) was tested as well. 
The effect of the growth substrate on the expression of reductases was also determined. 
Cells were cultivated in the basal Giesel medium or Giesel medium supplemented with 27 
mM glucose or 12.1 mM L-phenylalanine. The cultures were harvested in the early 
stationary phase of growth and resuspended in 100 mM phosphate buffer.  The reaction 
was started by injection of hydrogen gas as an electron donor. The products were analyzed 
after 72 h using chiral HPLC or GC-MS (Table 5.1.). 
Table 5.1. Whole cell biocatalyst reduction of ɴ-nitrostyrene, (E)-1-nitro-2-phenylpropene, (E)-1-
phenyl-2-nitropropene, cinnamic acid and nitrobenzene using DSM795 and fldZ::CTermB grown in 
Giesel medium. Data present means of three independent experiments with two replicates each. 
Standard errors of mean < 5%. 
Substrate Strain 
Growth 
substrate 
Yield (%) Ee. (%) 
 ɴ-nitrostyrene 
DSM795 
- 11.6 - 
D-glucose 0.9 - 
L-phenylalanine 13.2 - 
fldZ::CTermB 
- 15.0 - 
D-glucose 6.4 - 
L-phenylalanine 13.4 - 
 
(E)-1-nitro-2-phenyl-
propene 
DSM795 
- 33.0 A? ? ? ? ?(R) 
D-glucose 23.6 A? ? ? ? ?(R) 
L-phenylalanine 35.4 A? ? ? ? ?(R) 
fldZ::CTermB 
- 0.0 - 
D-glucose 0.0 - 
L-phenylalanine 0.0 - 
 
(E)-1-phenyl-2-nitro-
propene 
DSM795 
- 6.3 23.0 (S) 
D-glucose 4.3 20.7 (S) 
L-phenylalanine 5.8 1.0  (S) 
fldZ::CTermB 
- 1.2 15.2 (S) 
D-glucose 1,4 16.0 (S) 
L-phenylalanine 5.0 0.2  (S) 
 
(E)-cinnamic acid 
DSM795 
- 16.5 - 
D-glucose 10.0 - 
L-phenylalanine 38.2 - 
fldZ::CTermB 
- 11.5 - 
D-glucose 11.7 - 
L-phenylalanine 39.6 - 
 
nitrobenzene 
DSM795 
- 0.0 - 
D-glucose 0.0 - 
L-phenylalanine 0.0 - 
fldZ::CTermB 
- 0.0 - 
D-glucose 0.0 - 
L-phenylalanine 0.0 - 
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 (E)-1-nitro-2-phenylpropene was reduced by the wild type with 35.5% yield and 
almost 100% enantiomeric excess, whereas no product was found in samples in the 
reaction containing fldZ::CTermB cells. DSM795 reduced ɴ-nitrostyrene with 13% yield and 
(E)-1-phenyl-2-nitropropene with 4.7%. When fldZ::CTermB cells were used, yields were 
similar (13.4% and 5.0% respectively) but only for cells that were grown on L-phenylalanine. 
Mutants growing in the basal medium or on glucose showed reduced yields of (E)-1-phenyl-
2-nitropropene hydrogenation product (1.2% and 1.4%). Cinnamic acid was reduced by 
both the wild type and the mutant and the reductase activity was induced by the presence 
of L-phenylalanine in the growth medium. No product of biotransformation was found 
when nitrobenzene was used as substrate. 
 Results showed that fldZ enoate reductase is responsible for the reduction of C=C 
bond in (E)-1-nitro-2-phenylpropene, whereas the reduction of ɴ-nitrostyrene, (E)-1-
phenyl-2-nitropropene and cinnamic acid may be driven by some other enzyme(s). The 
other enzyme responsible for reduction of (E)-1-phenyl-2-nitropropene is more active when 
L-phenylalanine is present in the growth medium. 
5.1.3.2. Reduction of nitroalkenes, cinnamic acid and nitrobenzene using protein extracts 
 Membrane-free protein extracts were used to reduce ɴ-nitrostyrene, (E)-1-nitro-2-
phenylpropene, (E)-1-phenyl-2-nitropropene, cinnamic acid and nitrobenzene. The cells 
used for preparation of protein extracts were grown in Giesel medium supplemented with 
12.1 mM L-phenylalanine and were harvested in the early stationary phase of growth. In 
the reactions H2, NADH and NADPH were used as the electron donors (Table 5.2.). 
 
Table 5.2. Reduction of ɴ-nitrostyrene, (E)-1-nitro-2-phenylpropene, (E)-1-phenyl-2-nitropropene, 
cinnamic acid and nitrobenzene using DSM795 and fldZ::CTermB protein extracts. Data present 
means of three independent experiments with two replicates each. Standard errors of mean < 5%. 
Substrate Strain Electron donor Yield (%) Ee. (%) 
 ɴ-nitrostyrene 
DSM795 
H2 2.0 - 
NADH 71.4 - 
NADPH 72.2 - 
fldZ::CTermB 
H2 3.5 - 
NADH 46.5 - 
NADPH 57.4 - 
 
(E)-1-nitro-2-phenyl-
propene 
DSM795 
H2 10.1 A? 99.9 (R) 
NADH A? 99.9 A? 99.9 (R) 
NADPH 57.1 A? 99.9 (R) 
fldZ::CTermB 
H2 0.0 - 
NADH 0.0 - 
NADPH 0.0 - 
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(E)-1-phenyl-2-nitro-
propene 
DSM795 
H2 15.7 4.5 (S) 
NADH 58.1 11.5 (S) 
NADPH 50.5 4.0 (S) 
fldZ::CTermB 
H2 4.3 3.2 (S) 
NADH 22.0 5.6 (S) 
NADPH 10.2 5.3 (S) 
 
(E)-cinnamic acid 
DSM795 
H2 9.5 - 
NADH A? 99.9 - 
NADPH 68.9 - 
fldZ::CTermB 
H2 0.0 - 
NADH 0.0 - 
NADPH 0.0 - 
 
nitrobenzene 
DSM795 
H2 0.0 - 
NADH 46.4 - 
NADPH 24.6 - 
fldZ::CTermB 
H2 0.0 - 
NADH 39.6 - 
NADPH 19.9 - 
 
Using membrane-free protein extracts the yield of (E)-1-nitro-2-phenylpropene 
reduction by DSM795 was improved to almost 100% and almost 100% enantiomeric excess, 
when compared with whole cell biocatalysts assay. No product of (E)-1-nitro-2-
phenylpropene reduction was found in samples of fldZ::CTermB mutant. Reduction of ɴ-
nitrostyrene and (E)-1-phenyl-2-nitropropene was also more efficient than for whole cells 
and product formation was observed for both the wild type and the mutant. Cinnamic acid 
was reduced by protein extracts of DSM795 with a good yield (100% when NADH was used 
and 69% for NADPH), but no product was found when protein extract of the mutant was 
used. Nitrobenzene was reduced by both strains (no statistically significant differences of 
yields were observed between DSM795 and fldZ::CTermB) but not when H2 was used to 
start the biotransformation. NADH was better electron donor than hydrogen gas or NADPH 
in all of the reactions, with an exception for ɴ-nitrostyrene. 
5.1.3.3. Oxygen sensitivity of C. sporogenes phenylnitropropene reductases 
 Experiments on clostridial enoate reductases showed that the 2-enoate reductase 
in the reduced state was instantly inactivated by oxygen (Tischer et al., 1979). The activity 
could be restored 3 h after removal of oxygen. To test the oxygen sensitivity of C=C double 
bond reductases, C. sporogenes membrane-free protein extracts were exposed to air for 3 
h in an ice bath. Then the sample vials were closed with suba seals and the headspace of 
the vials was flushed with nitrogen for 1 h. After that the biotransformations were 
assembled under anoxic conditions in the anaerobic workstation (Table 5.3.).  
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Table 5.3. Reduction of (E)-1-nitro-2-phenylpropene and (E)-1-phenyl-2-nitropropene by protein 
extracts exposed to air. Data present means of three independent experiments with two replicates 
each.  Standard errors of mean < 5%. 
Substrate Strain Variant Yield (%) Ee. (%) 
 
(E)-1-nitro-2-phenyl-
propene 
DSM795 
Anaerobic A? ? ? ? ? A? ? ? ? ? (R) 
Aerobic A? ? ? ? ? A? ? ? ? ? (R) 
fldZ::CTermB 
Anaerobic 0.0 - 
Aerobic 0.0 - 
 
(E)-1-phenyl-2-nitro-
propene 
DSM795 
Anaerobic 57.1 11.1 (S) 
Aerobic 43.5 2.6 (S) 
fldZ::CTermB 
Anaerobic 21.0 5.6 (S) 
Aerobic 0.2 4.7 (S) 
 
 
Reduction of (E)-1-nitro-2-phenylpropene by DSM795 extracts was not affected by 
the exposure to air suggesting that fldZ enoate reductase responsible for reduction of this 
substrate is not sensitive to oxygen or its activity was restored after removal of oxygen. On 
the other hand reduction of (E)-1-phenyl-2-nitropropene showed significantly lower yield 
for wild type and no reaction for the mutant, when their protein extracts were exposed to 
air. Thus, (E)-1-phenyl-2-nitropropene was reduced in the wild type by the fldZ reductase 
and the second enzyme that was irreversibly inhibited by the presence of oxygen.  
5.1.4. Identification of C. sporogenes C=C double bond reductases 
 Reduction of the C=C double bond using DSM795 and the fldZ::CTermB mutant 
showed that C. sporogenes possesses multiple reductase activities. One of them was fldZ 2-
enoate reductase whereas other enzyme(s) remained unknown. Since attempts to purify 
the reductases have met with a limited success and no literature data suggested which 
other enzymes could be responsible for the reduction of nitroolefins by C. sporogenes 
DSM795, a different strategy was chosen to identify the reductases.  
In 2010 a partial sequence of the C. sporogenes ATCC15579 genome was published 
as a part of the human gut microbiome sequencing project (Washington University Genome 
Sequencing Center; http://www.ncbi.nlm.nih.gov/sites/entrez?db=genome&cmd=Retrieve 
&dopt=Overview&list_uids=5936). A genome of another C. sporogenes strain NCIMB10696 
was sequenced by Prof. Nigel Minton ?Ɛ group (Centre for Biomolecular Sciences, University 
of Nottingham, personal communication). The genome sequences of these strains were 
analyzed for the presence of genes encoding hypothetical proteins, that showed homology 
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to C=C double bond reductases described in the literature. To confirm that these genes 
encode reductases, they were cloned, their protein products were expressed in E. coli and 
tested in the activity assays. This allowed for identification and characterization of new 
reductases that are present in C. sporogenes DSM795. 
5.1.4.1. Identification of fldZ enoate reductase in C. sporogenes 
 Initially a 949 bp fragment of C. sporogenes encoding the fldZ enoate reductase was 
PCR amplified using primers designed for fldZ gene from C. botulinum strain Hall A 3502 (Dr. 
Benjamin Blount, personal communication; Appendix 8.1.). This DNA sequence was 
translated to an amino acid sequence (Appendix 8.8.2.) and used as a query sequence for 
browsing the C. sporogenes ATCC15579 genome using blast p tool 
(http://blast.ncbi.nlm.nih.gov). A hypothetical protein sequence CLOSPO_02780 
(Csp15579.fldZ, Appendix 8.8.3.) was found to show 99% identity to the query. 
CLOSPO_02780 sequence was composed of 665 amino acids and showed 99% identity to 
the fldZ enoate reductase from C. botulinum str. Hall A 3502. The 1998 bp DNA fragment of 
genomic sequence encoding hypothetical protein CLOSPO_02780 was extracted from the 
Genbank (Csp15579.fldZ, Appendix 8.8.4.). PCR primers (CLOSPO_02780_f and 
CLOSPO_02780_r) were designed to allow the amplification of the full-length sequence 
gene. Initial PCR experiments using genomic DNA extracted from C. sporogenes DSM795 as 
a template were unsuccessful and no product was obtained. Detailed analysis of the fldZ 
gene from ATCC15579 and homologous sequences from C. sporogenes NCIMB10696 and C. 
botulinum ATCC3502 showed significant differences in the non-coding parts of these genes 
between different strains even within one genus (Appendix 8.8.5.). To identify the 
sequence of the fldZ gene in DSM795 it was necessary to design the forward primer to the 
gene located upstream of fldZ and the reverse primer to the gene located downstream of 
fldZ, because only these sequences showed significant homology between different strains 
of Clostridia. The gene was divided into three shorter parts to allow easier amplification 
with PCR and three sets of primers were designed: PM001 and PM002 (amplification of the 
coding sequence of the gene; product fldZ-KZ& ) ? WD ? ? ? ĂŶĚ WD ? ? ?  ? ? ? Ĩůanking region 
containing the promoter and fragment encoding N terminus of the fldZ; product fldZ- ? ? )
ĂŶĚWD ? ? ?ĂŶĚWD ? ? ?  ? ? ?ƉĂƌƚŽĨ ƚŚĞŐĞŶĞĂŶĚĚŽǁŶƐƚƌĞĂŵƌĞŐŝŽŶĐŽŶƚĂŝŶŝŶŐ ƚŚĞŐĞŶĞ
terminator; product fldZ- ? ? ) ? dŚĞ ƉƌŝŵĞƌƐ ǁĞƌĞ ƵƐĞĚ ŝŶ WZ ŽŶC. sporogenes DSM795 
genomic DNA using the FailSafe Polymerase system containing different premixes for 
optimization of the reaction. After PCR, the reaction mixtures were separated by 
electrophoresis (Fig. 5.12-14.).  
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Fig. 5.12. Electrophoresis of fldZ-ORF PCR products. A-L: different premixes of the FailSafe 
Polymerase system. Products (10 ʅL of each) were run on 1% agarose gel with 1 kb DNA Ladder 
(NEB). The size of products was about 2000 bp. 
 
 
Fig. 5.13. Electrophoresis of fldZ- ? ?WZƉƌŽĚƵĐƚƐ ?-L: different premixes of the FailSafe Polymerase 
system. Products (10 ʅL of each) were run on 1% agarose gel with 1 kb DNA Ladder (NEB). The size of 
products was about 1200 bp. 
 
 
Fig. 5.14. Electrophoresis of fldZ- ? ?WZƉƌŽĚƵĐƚƐ ?-L: different premixes of the FailSafe Polymerase 
system. Products (10 ʅL of each) were run on 1% agarose gel with 1 kb DNA Ladder (NEB). The size of 
products was about 1500 bp. 
 
 The electrophoresis showed the presence of PCR products of the expected length in 
almost all samples. To the further analysis three of the products obtained with each set of 
primers containing no side products were mixed together (samples B, C and K for fldZ-OFR, 
B, C, E, F and I for fldZ- ? ?ĂŶĚ ? ?&ĂŶĚ/ĨŽƌĨůĚ- ? ? )ĂŶĚůŝŐĂƚĞĚŝŶƚŽƉ:d ? ? ? ?ďůƵŶƚǀĞĐƚŽƌ
using ůŽŶĞ:d ?WZůŽŶŝŶŐ<ŝƚ ? >ŝŐĂƚŝŽŶŵŝǆƚƵƌĞƐǁĞƌĞƵƐĞĚƚŽ ƚƌĂŶƐĨŽƌŵ E. coli JM107 
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ƵƐŝŶŐ dƌĂŶƐĨŽƌŵŝĚ ? ĂĐƚĞƌŝĂů dƌĂŶƐĨŽƌŵĂƚŝŽŶ <ŝƚ ? WůĂƐŵŝĚƐ ĨƌŽŵ ƉŽƐŝƚŝǀĞ ƚƌĂŶƐĨŽƌŵĂŶƚƐ
were purified and digested with the restriction enzyme BglII to detect the presence of PCR 
product. Plasmids containing inserts of the expected lengths were sent for sequencing using 
pJET1.2.for and pJET1.2.rev primers. All plasmids carried fragments of the fldZ gene with 
the consensus sequences of fldZ-ORF 2031 bp, fldZ- ? ?  ? ? ? ? ďƉ ĂŶĚ ĨůĚ- ? ?  ? ? ? ? ďƉ
(Appendix 8.8.6.). These three fragments were aligned and the full fldZ gene sequence was 
obtained, containing 3274 bp (Appendix 8.8.7.). The analysis of the sequence showed the 
presence of the open reading frame encoding 665 amino acid sequence, the C. sporogenes 
DSM795 fldZ enoate reductase (Appendix 8.8.8.). The primary structure of the fldZ 
reductase was analyzed in the Protein Conserved Domain Tool (http:// 
www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi; Fig. 5.15.). 
 
 
Fig. 5.15. Analysis of the fldZ reductase primary structure in the Protein Conserved Domain Tool. 
 
 The analysis showed that fldZ possessed conserved domains for binding of 
phosphate groups (TIM motif, characteristic for proteins interacting with cofactors, such as 
FMN) and NADH/FAD (pyridine nucleotide-disulphide oxidoreductases motif). The amino 
acid sequence of fldZ reductase showed 98% identity and 99% similarity to fldZ from C. 
sporogenes ATCC1559 and 99% identity and 99% similarity to fldZ from C. botulinum str. 
Hall A ATCC3502. Expression of fldZ in a heterologous host is described later (see 5.1.5.2.). 
 
5.1.4.2. Identification of OYE-like reductase in C. sporogenes 
 Biotransformations using fldZ::CTermB strain (see 5.1.3.1-2) showed that C. 
sporogenes contains more than one C=C double bond reductase. Genomes of some 
organisms encode more than one enoate reductase that can act as enantiocomplementary 
enzymes such as old yellow enzymes from Saccharomyces cerevisiae (Faber, 2004) or OPR1 
and OPR3 from Lycopersicon esculentum (Hall et al., 2007; Hall et al., 2008). Thus, the 
amino acid sequence of fldZ enoate reductase was used as a query to find homologous 
proteins encoded by the genome of C. sporogenes ATCC15579. One sequence, 
CLOSPO_03444 was found showing 30% identity and 48% similarity to fldZ (Appendix 
8.9.1.). CLOSPO_03444 contained 339 amino acid and showed significant homology to OYE-
like reductases from Bacillus subtilis, Lycopersicon esculentum and Saccharomyces 
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cerevisiae. The gene sequence encoding CLOSPO_03444 was extracted from C. sporogenes 
ATCC15579 genome (Appendix 8.9.2.). The gene sequence was compared to corresponding 
genomic sequences from C. botulinum ATCC3502 and C. sporogenes NCIMB10696 and PCR 
primers were designed to the most conserved regions (primers PM011 and PM012).  
Primers were used in PCR on C. sporogenes DSM795 genomic DNA using the FailSafe 
Polymerase system containing different premixes for optimization of the reaction. Products 
of reactions were analyzed by gel electrophoresis (Fig. 5.16.). 
 
Fig. 5.16. Electrophoresis of CLOSPO_03444 PCR products. A-L: different premixes of the FailSafe 
Polymerase system. Products (10 ʅ>ŽĨĞĂĐŚ )ǁĞƌĞƌƵŶŽŶ ?A?ĂŐĂƌŽƐĞŐĞůǁŝƚŚ'ĞŶĞZƵůĞƌ ?ŬďWůƵƐ
DNA Ladder (Fermentas). Bands are visible around 1500 bp. 
 
 Products of three reactions (B, C and F) were mixed together, purified by gel 
electrophoresis and recovered using QIAquick Gel Extraction Kit (QIAGEN). The purified 
EǁĂƐůŝŐĂƚĞĚƚŽƉ:d ? ? ? ?ďůƵŶƚǀĞĐƚŽƌƵƐŝŶŐůŽŶĞ:d ?WZůŽŶŝŶŐ<ŝƚ ?>ŝŐĂƚŝŽŶŵŝǆƚƵƌĞƐ
were used to transform E. coli :D ? ? ? ƵƐŝŶŐ dƌĂŶƐĨŽƌŵŝĚ ? ĂĐƚĞƌŝĂů dƌĂŶƐĨŽƌŵĂƚŝŽŶ <ŝƚ ?
Plasmids from positive transformants were purified and digested with restriction enzyme 
BglII to detect the presence of PCR product. Plasmids containing inserts of expected length 
(about 1500 bp) were sent for sequencing using pJET1.2.for and pJET1.2.rev primers. The 
consensus sequence of the CLOSPO_03444 encoding gene was created by alignment of 
three independent PCR products sequences (Appendix 8.9.3.). The analysis of the gene 
sequence showed the presence of an open reading frame encoding 339 amino acids.  The 
primary structure of the CLOSPO_03444 reductase was analyzed in the Protein Conserved 
Domain Tool (Fig. 5.17.). 
 
Fig. 5.17. Analysis of the CLOSPO_03444 reductase primary structure in the Protein Conserved 
Domain Tool. 
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The analysis showed that CLOSPO_03444 possessed conserved domains for binding 
of phosphate groups (TIM motif, characteristic for proteins interacting with cofactors, such 
as FMN) and showed homology to Old Yellow Enzyme (OYE)-like FMN binding domain. The 
OYE-like reductase CLOSPO_03444 from C. sporogenes showed 97% identity and 99% 
similarity to CLOSPO_03444 from C. sporogenes ATCC15579 and 97% identity and 99% 
similarity to the putative NADH/NADPH oxidoreductase from C. botulinum strain Hall A. 
Expression of fldZ in E. coli is described later (see 5.1.5.3.). 
5.1.4.3. Identification of the hypothetical cinnamic acid reductase 
 In the reductive branch of L-phenylalanine fermentation by the Stickland reaction, 
phenylpyruvate is reduced to (R)-phenyllactate, which is then reversibly syn-dehydrated to 
cinnamic acid followed by reduction to 3-phenylpropionic acid. The analysis of the C. 
sporogenes ATCC15579 genome showed that the genes encoding enzymes involved in the 
pathway were localized in one gene cluster. It was found that the gene CLOSPO_00308 
encoded fldA cinnamoyl-CoA:phenyllactate-CoA transferase responsible for formation of 
phenyllactate-CoA. The genes located downstream, CLOSPO_00309, CLOSPO_00310 and 
CLOSPO_00311, encoded subunits of the fldBC phenyllactate-CoA dehydratase and its 
oxygen-sensitive initiator protein fldI described by Dickert et al., 2002. N-terminal 
sequences of fldH phenyllactate dehydrogenase (Dickert et al., 2000) were found to be 
encoded by the genes CLOSPO_00316 and CLOSPO_00317 (Fig. 5.18.). 
 
 
Fig. 5.18. Arrangement of genes encoding enzymes involved in the reductive branch of L-
phenylalanine fermentation in the Stickland reaction in C. sporogenes.  
 
 The analysis of the gene cluster showed the presence of a previously undescribed 
operon encoding a hypothetical acyl-CoA dehydrogenase (CLOSPO_00312, sequence in 
Appendix 8.10.1.) with two electron transfer flavoproteins (ETF; genes CLOSPO_00313 and 
CLOSPO_00314). On the amino acid level, the acyl-CoA dehydrogenase showed significant 
homology (66% identity and 82% similarity) to CarC reductase responsible for reduction of 
caffeyl-CoA to dihydrocaffeyl-CoA in the acetogenic bacterium Acetobacterium woodii. CarC 
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was found to be transcribed together with two electron transfer flavoproteins that were 
found to be involved in the synthesis of ATP by a chemiosmotic mechanism using sodium 
ions as coupling ions during the caffeate respiration (Hess et al., 2011). 
 The colocalization of CLOSPO_00312 with other enzymes involved in the L-
phenylalanine reduction, a high homology to caffeyl-CoA reductase from A. woodii and the 
presence of two ETFs that could couple cinnamic acid reduction to the electron transfer 
phosphorylation may suggest that the acyl-CoA dehydrogenase is responsible for reduction 
of cinnamic acid in the Stickland fermentation.  The substrate for this reaction would not be 
cinnamate, but rather cinnamoyl-CoA, which is the product of phenyllactate dehydration in 
the previous step of the pathway.  
 To identify the acyl-CoA dehydrogenase gene sequence in C. sporogenes DSM795, 
PCR primers (PM015 and PM016) were designed based on the CLOSPO_00312 gene 
sequence from C. sporogenes ATCC15579 (Appendix 8.10.2.). Primers were used in the PCR 
on C. sporogenes DSM795 genomic DNA using the KOD Polymerase system and different 
conditions (magnesium and template concentration, presence of 5% DMSO) were used for 
the optimization of the reaction (Fig. 5.19.). 
 
Fig. 5.19. Electrophoresis of CLOSPO_00312 PCR products. 1-12: different reaction conditions 
(magnesium and template concentration, presence of DMSO) in the KOD Polymerase system. 
Products (10 ʅ> ŽĨ ĞĂĐŚ ) ǁĞƌĞ ƌƵŶ ŽŶ  ?A? ĂŐĂƌŽƐĞ ŐĞů ǁŝƚŚ 'ĞŶĞZƵůĞƌ ?  Ŭď WůƵƐ E >ĂĚĚĞƌ
(Fermentas). Bands are visible around 1150 bp. 
 
 Products of three reactions (4, 7 and 10) were mixed together, purified by gel 
electrophoresis, excised from the gel and recovered using QIAquick Gel Extraction Kit. The 
ƉƵƌŝĨŝĞĚEǁĂƐůŝŐĂƚĞĚƚŽƉ:d ? ? ? ?ďůƵŶƚǀĞĐƚŽƌƵƐŝŶŐůŽŶĞ:d ?WZůŽŶŝŶŐ<ŝƚ ?>ŝŐĂƚŝŽŶ
mixtures were used to transform E. coli :D ? ? ? ƵƐŝŶŐ dƌĂŶƐĨŽƌŵŝĚ ? ĂĐƚĞƌŝĂů
Transformation Kit. Plasmids from positive transformants were purified and digested with 
restriction enzyme BglII to detect the presence of the inserts. Plasmids containing inserts of 
expected length (about 1150 bp) were sent for sequencing using pJET1.2.for and 
pJET1.2.rev primers. The consensus sequence of the CLOSPO_00312 gene was created by 
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alignment of three independent insert sequences (Appendix 8.10.3.). The analysis of the 
gene sequence showed the presence of an open reading frame encoding 377 amino acids 
(Appendix 8.10.4.). The primary structure of the CLOSPO_00312 dehydrogenase was 
analyzed in the Protein Conserved Domain Tool (Fig. 5.20.). 
 
Fig. 5.20. Analysis of the CLOSPO_00312 acyl-CoA dehydrogenase primary structure in the Protein 
Conserved Domain Tool. 
 
The analysis showed that CLOSPO_00312 had a structure characteristic to ACAD 
superfamily of acyl-CoA dehydrogenases accepting short chain acyl-CoA as substrates 
(Marchler-Bauer et al., 2013). The reduced form of ACAD tends to be reoxidized in the 
oxidative half-reaction by electron-transferring flavoprotein, from which the electrons are 
transferred to the respiratory chain coupled with ATP synthesis.  
The CLOSPO_00312 acyl-CoA dehydrogenase from C. sporogenes DSM795 showed 
100% identity and 99% similarity to CLOSPO_00312 from C. sporogenes ATCC15579, 100% 
identity to the putative acyl-CoA dehydrogenase from C. botulinum strain Hall A and 67% 
identity and 82% similarity to CarC caffeyl-CoA reductase from A. woodii DSM1030. 
Whilst it would be possible to express this gene, its enzymatic activity depends on 
co-expression with the electro transfer flavoproteins which was beyond the scope of this 
work. 
 
5.1.5. Overexpression of C. sporogenes C=C double bond reductases 
 Biotransformations using whole cells and protein crude extracts of C. sporogenes 
showed that this bacterium contains unique enzyme activities. The analysis of the genomic 
sequences allowed for identification of genes encoding promising enzymes that may be 
useful for reduction of unsaturated compounds. Therefore, the fldZ enoate reductase and 
the OYE-like reductase were overexpressed in E. coli and their scope for reduction of 
enoates and nitroalkenes was tested. 
5.1.5.1. Optimization of E. coli growth under anaerobic conditions 
 The presence of oxygen inactivated 2-enoate reductases from C. kluyveri and C. 
tyrobutyricum. The activity could be restored 3 h after the removal of oxygen (see 5.1.3.3; 
Tischer et al., 1979). Attempts to overexpress clostridial 2-enoate reductases from C. 
tyrobutyricum and C. thermoaceticum (Moorella thermoacetica) using the E. coli expression 
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system in aerobic conditions resulted in a production of insoluble and inactive proteins 
(Rohdich et al., 2001) and it was possible that the C. sporogenes fldZ would behave 
similarly. Therefore, an attempt to overexpress C. sporogenes C=C double bond reductase 
in E. coli BL21(DE3)pLysS under anaerobic conditions was made. The conditions for 
anaerobic growth of E. coli K-12 (DSM5911, W3110, parental strain for BL21(DE3)pLysS) 
were optimized.  
 E. coli growth can be driven by aerobic or anaerobic respiration, using a large 
variety of redox pairs, including electron acceptors such as oxygen, nitrate (Nouguchi et al., 
1997), fumarate (Spencer et al., 1973) and dimethyl sulfoxide. The E. coli growth in complex 
and defined minimal media containing a variety of electron acceptors was tested in 96-well 
plate cultures and observed for 24 h using an automated NEPHELOstar plate reader (Fig. 
5.21.). 
 
Fig. 5.21. Optimization of the E. coli K-12 growth under anaerobic conditions. The media were: Luria 
ĞƌƚĂŶŝďƌŽƚŚ  ?භ ) ?dĞƌƌŝĨŝĐƌŽƚŚ  ?Ŷ), Nouguchi medium (Ÿ), sodium formate medium (ź), defined 
M9 medium (Ƈ) and defined glycerol-fumarate GF medium (භ). Average of five independent 
replicates. 
 
The best growth (in case of the growth rate and biomass production) was observed 
for the Terrific Broth, which was the richest medium tested. The presence of nitrate 
(Nouguchi medium) or formate did not improve the growth when compared to a standard 
LB medium. Minimal defined media (M9 and glycerol-fumarate GF) were characterized by 
lower growth rates. However, the biomass production for M9 was the same as for the 
complex TB medium. Thus, TB medium was chosen as providing the best growth conditions 
and used in the subsequent experiments. 
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5.1.5.2. Overexpression and purification of the fldZ reductase 
5.1.5.2.1. Expression of the fldZ reductase 
 The fldZ reductase was overexpressed in E. coli BL21(DE3)pLysS using the pET 
expression system. Considering previous limited attempts in expression of clostridial enoate 
reductases in E. coli (Rohdich et al., 2001) and significant differences in the codon usage 
between E. coli and C. sporogenes, the fldZ gene was optimized for expression using the 
GENEius sequence adaptation tool (http://www.eurofinsgenomics.eu/en/gene-synthesis-
molecular-biology/geneius/sequence-optimisation.aspx) and the optimized fldZ gene was 
synthesized de novo (Eurofins MWG). The pUC57-Csp-fldZ-adapted plasmid carrying the 
optimized fldZ gene was used as the template in a PCR reaction. Two different sets of 
primers introducing different restriction sites in the products were used: PM017 and 
PM018 (introducing Nde/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚĂŶĚNot/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚ
with a stop codon at the end of the open reading frame) and PM017 and PM019 
(introducing Nde/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚĂŶĚNot/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚǁŝƚŚŽƵƚ
a stop codon at the end of the open reading frame). The PCR products were cloned into 
pJET1.2 vector and their sequences were verified by the DNA sequencing. Then, the inserts 
were excised using NdeI and NotI restriction enzymes and purified by electrophoresis. The 
pUC57-Csp-fldZ plasmid was also digested with NcoI and NotI enzymes and the insert was 
purified as well. These inserts were ligated into the pET20b(+) expression vector, previously 
ĚŝŐĞƐƚĞĚǁŝƚŚƚŚĞĞŶǌǇŵĞƐĐŽƌƌĞƐƉŽŶĚŝŶŐƚŽƚŚĞŝŶƐĞƌƚƐ ?ƐƚŝĐŬǇĞŶĚƐ ?ĚĞƉŚŽƐƉŚŽƌǇůĂƚĞĚĂŶĚ
purified. That allowed for creation of three expression constructs encoding the wild type 
fldZ, fldZ containing C-terminal HisTag (fldZ:CtH) and fldZ containing N-terminal pelB leader 
and C-terminal HisTag (fldZ:pelB). Moreover, the insert derived from the PCR with PM017 
and PM019 primers was ligated into pET28b(+) vector. Then, the plasmid was digested with 
XbaI and NotI restrictases and transferred into pET20b(+) vector, previously linearized with 
the same enzymes. That created the fourth expression construct encoding fldZ reductase 
containing N-terminal HisTag (fldZ:NtH). The HisTag was introduced to make the 
purification easier using the HisTag bind resins, whereas the pelB leader was supposed to 
direct the protein product into the E. coli periplasm reducing its toxicity to the cells. The 
strains carrying the pET expression constructs were grown in a 100 mL scale and the 
plasmids were purified using the Plasmid Midi Kit. The plasmids were digested with XbaI 
and NotI restrictases and analyzed by gel electrophoresis to confirm the size of their inserts 
(Fig. 5.22, Table 5.4.). The expression constructs were also analyzed by DNA sequencing 
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using T7 promoter and T7 terminator primers (Appendix 8.11.) and used to transform 
BL21(DE3)pLysS expression strain. 
Table 5.4. Comparison of the fldZ expression constructs. For the alignment of the protein sequences 
see Appendix 8.12. 
Plasmid 
Size of ORF 
(bp) 
N-terminus C-terminus 
Predicted Mw 
of protein 
product  
(kDa) 
fldZ 1998  - - 73.02 
fldZ:pelB 2097  pelB leader HisTag 76.51 
fldZ:NtH 2058  HisTag - 75.19 
fldZ:CtH 2031  - HisTag 74.30 
 
 
Fig. 5.22. Electrophoresis of pET20b(+) plasmids carrying fldZ inserts. The plasmids 
were digested with XbaI and NotI restriction enzymes. M - 1 kb Plus DNA Ladder 
(Fermentas). 
 
 Initially the wild type fldZ reductase was expressed at small scale (100 mL) in 
aerobic and anaerobic conditions at 30°C. The samples were taken before induction of the 
expression with IPTG and 1, 2, 3 and 5 h after induction. The protein extracts were 
prepared using the BugBuster reagent and the insoluble proteins were removed by 
centrifugation at 18000 x g for 20 min at 4°C. The protein extracts were analyzed using SDS-
PAGE technique (Fig. 5.23.). 
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Fig. 5.23. Expression of the wild type fldZ reductase in aerobic and anaerobic 
conditions. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚWƌŽƚĞŝŶ>ĂĚĚĞƌ ?&ĞƌŵĞŶƚĂƐ ) ? 
 
Initial expression of reductase using untagged fldZ construct under anaerobic 
conditions resulted in formation of the soluble and insoluble products of an expected size 
about 73 kDa. In E. coli cells growing under aerobic conditions the fldZ gene was expressed 
as insoluble protein only.  
Therefore fldZ, fldZ:pelB, fldZ:NtH and fldZ:CtH constructs were expressed in E. coli 
BL21(DE3)pLysS growing under anaerobic conditions. The cells were harvested 5 h after 
induction of the protein expression. The protein extracts were prepared with the BugBuster 
reagent and analysed by SDS-PAGE (5.24.).  
 
Fig. 5.24. Expression of fldZ, fldZ:pelB, fldZ:NtH and fldZ:CtH in anaerobic conditions.  
M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚWƌŽƚĞŝŶ>ĂĚĚĞƌ ?&ĞƌŵĞŶƚĂƐ ) ? 
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All constructs expressed the proteins of the expected molecular weight, but only 
the wild type fldZ and fldZ with the N-terminal HisTag were soluble. The activity of the 
protein extracts for reduction of cinnamic acid was tested in the spectrophotometric 
activity assay (Table 5.5.).   
Table 5.5. Cinnamic acid reduction by protein extracts of fldZ, fldZ:pelB, fldZ:NtH and fldZ:CtH. For 
the example of spectral changes during the assay see Appendix 8.13. 
Sample 
Specific activity 
(nmol·s
-1
·mg
1
)  
Relative activity 
pET20b(+) 0.0 - 
fldZ 6.3 100% 
fldZ:pelB 0.0 - 
fldZ:NtH 2.9 46% 
fldZ:CtH 0.0 - 
 
As expected the spectrophotometric assay showed the enoate reductase activity in 
protein extracts expressing fldZ and fldZ:NtH proteins. The specific activity for fldZ 
containing N-terminal HisTag was only a half of the wild type one. However, judging from 
the intensity of the fldZ:NtH band in the SDS-PAGE, the expression level of fldZ:NtH was 
also lower than the wild type and this probably caused decrease in specific activity. 
Alternatively, the presence of the N-terminal HisTag could cause structural changes in the 
enzyme and limit the activity of fldZ reductase. No reaction was observed in the control 
sample expressing an empty pET20b(+) and in fldZ:pelB and fldZ:CtH showing that only 
correctly folded, soluble fldZ reductase possessed the enzymatic activity.  
5.1.5.2.2. Purification of fldZ-NtH using His-Bind Purification Kit 
 The fldZ reductase containing the N-terminal HisTag was successfully expressed as 
soluble and active protein. An attempt to purify fldZ to homogeneity using the Ni-NTA resin 
in column chromatography was made. An anaerobic culture of E. coli expressing fldZ:NtH 
(500 mL) was started from a pre-culture. Expression was induced by injection of IPTG when 
the culture reached an OD660 nm of 0.3. The cells were harvested after 5 h at 30°C, 
centrifuged and washed with 50 mM phosphate buffer pH 7.0. After centrifugation the cells 
were resuspended in the protein extraction buffer (7 mL) containing 
tris(hydroxypropyl)phosphine as the reducing agent (final concentration 1 mM; compatible 
with the resin). The protein cell-free extract was produced using the cell disruptor at 
pressure 20,000 psi under nitrogen flow. The protein extract was centrifuged anaerobically 
at 75,000 x g for 20 min at 4°C and then transferred to the anaerobic cabinet. The soluble 
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protein fraction was loaded onto a polypropylene column containing the His·Bind resin and 
the column was let to drain under gravity flow in the cabinet. The resin was washed twice 
with the Binding buffer and one time with the Wash buffer. Then the protein was eluted 
with the elution buffer containing imidazole and the resin was stripped by applying the strip 
buffer. The protein fractions were analyzed by SDS-PAGE (Fig. 5.25.) and the enoate 
reductase activity was tested in the spectrophotometric assay (Table 5.6). 
 
Fig. 5.25. Purification of fldZ:NtH using His-Bind Purification Kit. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚWƌŽƚĞŝŶ
Ladder (Fermentas), CE - protein crude extract, FL - flow through, W1 - wash with Binding buffer,  W2 
- wash with Binding buffer, W3 - wash with Wash buffer, E - elution with the imidazole buffer. 
 
 
Table 5.6. Results of the cinnamic acid reductase activity assay with the protein fractions from 
fldZ:NtH purification. 
Protein fraction 
Specific activity 
(nmol·s
-1
·mg
-1
) 
Relative activity 
Crude extract 5.1 100% 
Flow through 0.0 - 
Wash 1 0.0 - 
Wash 2 0.0 - 
Wash 3 0.0 - 
Elution 0.0 - 
Strip buffer 0.0 - 
 
 The SDS-PAGE analysis showed that fldZ:NtH was successfully purified, however the 
elution fraction was contaminated with two other proteins with lower molecular weights. 
No activity of the purified reductase was detected in the spectrophotometric assay.  
The high concentration of imidazole in the elution buffer could have an inhibitory 
effect on the fldZ activity. To test that, the protein crude extract was mixed with the 
imidazole solution, but no decrease of the fldZ activity was observed in the assay (Table 
5.7.).  
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Table 5.7. Attempts to restore the purified fldZ:NtH activity. 
Protein fraction 
Specific activity 
(nmol·s
-1
·mg
-1
)  
Relative activity 
Crude extract +  
Imidazole solution 
5.1 100% 
Elution + FAD/FMN 0.0 - 
Elution + Flow through 0.0 - 
Elution +  
10% diluted Crude extract 
0.4 8% 
 
The purified reductase was also supplemented with the cofactors (FAD and FMN), 
but no reaction was detected. FldZ activity could also depend on other factors that were 
removed in the purification process. Thus, the purified fldZ:NtH was mixed with the flow 
through fraction and with diluted crude extract, but the activity of the reductase was not 
restored. 
5.1.5.2.3. Purification of fldZ-NtH using Ni-NTA Spin Kit 
 The His-Bind Purification Kit used previously for purification of fldZ was not 
compatible with reducing agents such as dithiothreitol (DTT) or 2-mercaptoethanol. Thus, 
the loss of the enzymatic activity of the fldZ reductase could be a result of an insufficiently 
reducing environment during the purification process. Moreover, the His-Bind resin was 
sensitive to elevated temperatures, which did not allow pre-reducing it in the anaerobic 
cabinet before the chromatography and increased a risk to contaminate the reductase with 
oxygen. Thus, an attempt to purify the fldZ:NtH reductase with Ni-NTA Spin Kit (QIAGEN) 
ǁĂƐŵĂĚĞ ? ĐĐŽƌĚŝŶŐ ƚŽ ƚŚĞ ŵĂŶƵĨĂĐƚƵƌĞƌ ?Ɛ ŶŽƚĞ ƚŚĞ Eŝ-NTA Spin Kit can be successfully 
used with up to 10 mM DTT. All buffers used in the purification process were autoclaved 
and cooled down under nitrogen flow in a sonicating water bath to ensure complete 
removal of oxygen. Then the buffers were transferred into the anaerobic cabinet, 
supplemented with DTT (2, 5 and 10 mM) and pre-reduced overnight.  
E. coli cultures (100 mL) carrying pET20(+), fldZ and fldZ:NtH plasmids were grown 
under anaerobic conditions. The expression was induced with IPTG and the cells were 
harvested after 5 h at 30°C with shaking. The protein extracts were prepared in the 
extraction buffer containing the BugBuster reagent and different concentrations of DTT. 
The soluble protein fractions were purified using the Ni-NTA spin columns and analyzed by 
SDS-PAGE (Fig. 2.26.). The cinnamic acid reductase activity was tested in the 
spectrophotometric assay. 
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Fig. 5.26. Purification of fldZ:NtH using Ni-NTA Spin Kit. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚWƌŽƚĞŝŶ>ĂĚĚĞƌ
(Fermentas), CE - protein crude extract, FL - flow through, Elution - elution with the imidazole buffer 
containing DTT (from 0 to 10 mM). 
 
 The fldZ:NtH polypeptide was purified using the Ni-NTA spin columns. The highest 
yield of the purified protein was eluted when no DTT was present in the buffers. The higher 
reducing agent concentration the lower yields were observed, which might have been 
caused by DTT stripping the nickel ions from the resin and decreasing the binding capacity 
of the columns. The activity assay showed that none of the elution fractions was able to 
reduce cinnamic acid. Therefore, the loss of the fldZ activity was not a result of oxygen 
contamination or insufficient reducing environment during the purification process. 
5.1.5.2.4. Purification of fldZ-NtH using Dynabeads His-Tag Isolation Kit 
 To elucidate the factor responsible for inactivation of the fldZ reductase during the 
HisTag purification process, the Dynabeads HisTag Isolation & Pulldown Kit was used. 
Dynabeads are magnetic beads covered with cobalt which guarantee highly specific 
interaction with histidine tags. They allow elution of purified His-tagged proteins or the 
option to leave proteins on Dynabeads for use in the subsequent experiments. E. coli 
cultures (100 mL) were used for anaerobic overexpression of pET20b(+), fldZ and fldZ:NtH. 
The expression was induced with IPTG and the cells were harvested after 4 h at 30°C with 
shaking. The cells were harvested and re-suspended in the Dynabeads Binding Buffer 
supplemented with the BugBuster reagent and FAD/FMN. The soluble protein fractions (0.7 
mL) were used for the purification process. The extracts were added to the polypropylene 
microcentrifuge vials containing the Dynabeads (50 µL), mixed and incubated for 5 min at 
30°C. Then the tubes were placed on a magnet, the Dynabeads were collected on the wall 
and the supernatant was removed by pipetting. After four consecutive washing steps the 
protein was eluted with the Elution Buffer (100 µL). The protein fractions were analyzed by 
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SDS-PAGE (Fig. 5.27.). The activity of the crude extracts, crude extracts mixed with the 
beads and elution fractions were tested for the cinnamic acid reduction. 
 
Fig. 5.27. Purification of fldZ:NtH using Dynabeads His-Tag Isolation Kit. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚ
Protein Ladder (Fermentas), CE - protein crude extract, FL - flow through, Washing  ? washing with 
the Binding Buffer, Elution - elution with the buffer containing imidazole. 
 
 Using the Dynabeads the fldZ:NtH polypeptide was purified almost to homogeneity. 
However the purified protein did not show any enzymatic activity in the 
spectrophotometric assay. The wild type fldZ showed the reductase activity in the crude 
extracts. When the extract was mixed with the beads no change in activity was observed 
(fldZ + BEADS, Fig. 5.28.). Intriguing, when the beads were mixed with the fldZ:NtH crude 
extract, previously active fldZ:NtH crude extract immediately lost its activity (fldZ:NtH + 
BEADS).  
 
Fig. 5.28. Traces of the spectrophotometric cinnamic acid reduction assay using the protein fractions 
from purification with the Dynabeads His-Tag Isolation Kit. Protein fractions used in the assay: fldZ 
ĐƌƵĚĞĞǆƚƌĂĐƚ ?භ ) ?ĨůĚ PEƚ,ĐƌƵĚĞĞǆƚƌĂĐƚ ?Ŷ), fldZ + BEADS (Ÿ), fldZ:NtH + BEADS (ź), fldZ:NtH wash 
fraction (Ƈ) and fldZ:NtH elution (භ). 
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 The presence of the Dynabeads inactivated the fldZ containing the N-terminal 
HisTag and did not affect the wild type fldZ reductase. This suggested that physical 
interaction between the fldZ:NtH and the histidine bind resin may cause the structural 
changes in the protein structure resulting in the loss of enzymatic activity.  
5.1.5.2.5. Refolding of fldZ-NtH using Pierce Protein Refolding Kit 
 The enzymatic activity of inactive, misfolded or insoluble enzymes may be restored 
by a refolding process allowing the proteins to reach their native conformation. Thus, the 
fldZ:NtH reductase was purified for a large scale starting from a 500 mL E. coli culture using 
the His-Bind Purification Kit (as described in 5.1.5.2.2.). The N-terminal HisTag encoded by 
the expression construct was cleaved off by digestion with the thrombin endopeptidase for 
3 h at 30°C. Then the fldZ was reconstituted in a matrix of refolding buffers (Pierce Protein 
Refolding Kit) containing FMN and FAD cofactors as well as different concentrations of 
denaturing agents such as guanidine and L-arginine and additives providing diverse redox 
environment (Table 5.8.). The refolding process was carried out for 5 and 24 h at room 
temperature with gentle shaking. The activity of the samples was tested in the cinnamic 
acid spectrophotometric assay. 
Table 5.8. Results of the fldZ refolding using Pierce Protein Refolding Kit. 
Buffer 
Guanidine 
(M) 
L-arginine 
(M) 
Redox 
environment 
Precipitation Activity 
1 0.0 0.0 5 mM DTT + (yellow) 
0.0 
2 0.0 0.4 
2 mM GSH 
0.2 mM GSSG 
- 
3 0.0 0.8 
2 mM GSH 
0.4 mM GSSG 
+ (white) 
4 0.5 0.0 
2 mM GSH 
0.2 mM GSSG 
- 
5 0.5 0.4 
2 mM GSH 
0.4 mM GSSG 
- 
6 0.5 0.8 5 mM DTT + (white) 
7 1.0 0.0 
2 mM GSH 
0.4 mM GSSG 
- 
8 1.0 0.4 5 mM DTT - 
9 1.0 0.8 
2 mM GSH 
0.2 mM GSSG 
+ (white) 
 
 The refolding process resulted in formation of precipitation in buffer 1 (yellow 
pellet) and 3, 6 and 9 (white pellets). No activity was observed in the cinnamic acid activity 
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assay for any of the samples. This may suggest that denaturing conditions used in the 
experiment were not sufficient to restore the active conformation of the enzyme. It is also 
possible that during the purification process the enzyme was deprived of the cofactors. The 
refolding buffers were supplemented with FMN and FAD. However, they did not contained 
agents which could allow reconstitution of the iron-sulphur cluster. Thus the fldZ reductase 
was not successfully restored. 
5.1.5.2.6. Temperature and pH optimum of the fldZ reductase 
 The attempts to purify recombinant polyhistidine-tagged fldZ expressed in E. coli 
using the affinity purification procedures were unsuccessful. Therefore, the fldZ reductase 
was characterized using the protein extracts of E. coli expressing the wild type enzyme. A 
large scale culture of E. coli (1 L) expressing fldZ was grown under anaerobic conditions. The 
expression of the recombinant protein was induced with IPTG and the cells were harvested 
after 5 h at 30°C. The protein cell-free extract (7 mL) was prepared using the cell disrupter 
at the pressure of 20,000 psi. The sample was centrifuged at 75,000 x g for 30 min at 4°C 
and the soluble protein fraction was used in the activity assays and biotransformations. The 
extract was stored for 6 months in a cryogenic vessel containing liquid nitrogen without 
losing activity. 
 The activity of fldZ was tested in the cinnamic acid spectrophotometric assay at a 
range of temperatures (Fig. 5.29.; traces in Appendix 8.14.). The highest reaction rate was 
observed at 40-45°C. The higher temperature caused a gradual decrease in fldZ activity to 
completely inactivate the enzyme at 60°C. 
 
 
Fig. 5.29. The temperature profile of fldZ activity in the cinnamic acid spectrophotometric assay.  
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 The activity tests were also performed at a range of pH varying from 4.5 to 8 in 50 
mM potassium phosphate buffer (Fig. 5.30; traces in Appendix 8.14.).  
 
Fig. 5.30. The pH profile of fldZ activity in the cinnamic acid spectrophotometric assay.  
 
It was found that the optimum pH for the fldZ activity was 7.0-7.5. These values 
differed from the ones published for the enoate reductase purified from C. kluyveri 
(optimum pH 6.0 in sodium citrate buffer and temperature 55°C; Tischer et al., 1979). 
 
5.1.5.2.7. Biotransformation of cinnamic acid by fldZ reductase 
 The E. coli protein extracts containing fldZ reductase were used to reduce cinnamic 
acid at the expense of NADH in anaerobic biotransformations. The reactions were 
performed in phosphate buffer pH 7.0 at 40°C. The samples of the supernatant were 
collected at intervals from 15 min to 7 h and after overnight incubation. The samples were 
derivatized with (trimethylsilyl)diazomethane and the substrate and product 
concentrations were determined by gas chromatography-mass spectroscopy (Fig. 5.31; for 
chromatograms and mass spectra of reaction products see Appendix 8.15.). 
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Fig. 5.31. Biotransformation of cinnamic acid in the expense of NADH using the crude extracts of E. 
coli expressing fldZ reductase (20 mg).  Conversion of cinnamic acid (භ) and formation of 3-
phenylpropionic acid (Ŷ) were determined by gas chromatography-mass spectroscopy. 
 
 Cinnamic acid was reduced by protein extracts of E. coli expressing the wild type 
fldZ with almost 100% yield after overnight incubation. No 3-phenylpropionic acid 
formation was observed in the control experiments with E. coli expressing empty pET20b(+) 
(see Appendix 8.15). The biotransformations confirmed the results of the previous 
spectrophotometric activity assays and showed that fldZ was expressed as an active protein 
possessing C=C double bond reductase activity towards cinnamic acid.  
5.1.5.2.8. Inhibition of the fldZ activity with oxygen 
 The test the inhibition of the fldZ reductase by the presence of oxygen, the protein 
extract of E. coli expressing the wild type enzyme was exposed to air for 15 min - 3 h. To 
avoid heat inactivation of the enzyme, the samples were kept in an ice bath throughout the 
exposure time. As a control fldZ incubated under anaerobic conditions at 4°C was used to 
test the possible loss of enzymatic activity in time. After the exposure to oxygen the 
samples were transferred into glass vials closed with suba seals and the headspace above 
the samples was flushed with nitrogen for 1 h. Then the protein extracts were used as 
biocatalysts in the cinnamic acid reduction biotransformation using NADH as the electron 
donor. The reactions were incubated for 2 h at 40°C. The biotransformation products were 
derivatized and analyzed using gas chromatography-mass spectroscopy (Fig. 5.32.). 
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Fig. 5.32. Inactivation of the fldZ reductase by oxygen. The yields of the biotransformations were 
normalized to the yield of the control sample (fldZ not exposed to oxygen). Protein extracts exposed 
(Ŷ) and not exposed (භ) to oxygen. 
 
The biotransformations showed that the presence of oxygen had an inhibitory 
effect on the fldZ reductase activity. The reductase lost about a half of the activity after 2 h 
of exposure to oxygen. The activity could not be restored by 1 h incubation in anaerobic 
conditions. 
5.1.5.2.9. Substrate range of fldZ 
The fldZ reductase was tested for NADH oxidation in the presence of unsaturated 
aromatic and aliphatic carboxylic acids and phenylnitroalkenes. The activity was measured 
using the spectrophotometric assay (see 4.2.8.6.). Reactions containing the protein extracts 
of E. coli expressing the empty pET20b(+) were used as controls to subtract the background 
activity that was present in E. coli. Because of poor solubility in water of some chemicals 
tested, the stock solutions of all the substrates were prepared in tetrahydrofuran (THF) and 
diluted to give 1 mM concentration in the reaction mixtures (5% tetrahydrofuran final 
concentration v/v). THF was successfully used as a co-solvent in biotransformations using 
PETN reductase from Enterobacter cloacae (Dr. Fryszkowska, personal communication).  
Table 5.9. Substrate range of the fldZ reductase 
Substrate Structure 
Activity 
(nmol·s
-1
·mg
-1
) 
Relative 
activity 
cinnamic acid 
 
8.3 100% 
ɲ-methyl-
cinnamic acid 
 
<0.05 <0.7% 
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ɴ-methyl-
cinnamic acid 
 
0.13 1.6% 
p-coumaric acid 
 
3.64 43.3% 
caffeic acid 
 
0.07 0.8% 
3-indoleacrylic 
acid 
 
<0.04 < 0.5% 
crotonic acid  0.0 - 
2,3-dimethyl-
acrylic acid 
 
0.0 - 
3,3-dimethyla-
crylic acid 
 
0.0 - 
2-methyl- 
2-pentenoic acid 
 
0.0 - 
sorbic acid 
 
0.0 - 
ɴ-nitrostyrene 
 
0.0 - 
(E)-1-nitro- 
2-phenylpropene 
 
<0.07 0.8% 
(E)-1-phenyl- 
2-nitropropene 
 
<0.03 <0.4% 
 
 The activity tests showed that fldZ possessed a very narrow substrate range. The 
highest activity was observed for cinnamic acid. The presence of methyl groups in the alpha 
or beta positions in cinnamic acid drastically decreased the activity of the reductase to 
about 1%. p-Coumaric acid was a relatively good substrate (43% activity when compared to 
cinnamic acid). However, further alternation in the aromatic ring (caffeic acid and 
indoleacrylic acid) caused a significant decrease in the activity. FldZ did not accept aliphatic 
enoates at all, what may suggest that the aromatic ring plays a crucial role in the interaction 
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between the enzyme and the substrate. No activity was observed towards ɴ-nitrostyrene, 
whereas phenylnitropropenes were poor substrates when compared to cinnamic acid 
(relative activity lower than 1%). 
 
5.1.5.2.10. Reduction of phenylnitropropenes using fldZ 
The protein extracts produced as described above were also used to measure 
reduction of two phenylnitropropene isomers (E)-1-nitro-2-phenylpropene and (E)-2-nitro-
1-phenylpropene in the biphasic biotransformation. In the reaction NADH was used as the 
electron donor. The samples were incubated at 40°C and the yield of reactions was 
determined after 24, 48 and 72 h. The products were analyzed using chiral HPLC (Table 
5.10). 
Table 5.10. Reduction of phenylnitropropenes using the fldZ reductase. 
Substrate Sample 
Yield (%) Ee. (%) 
24 h 48 h 72 h 24 h 48 h 72 h 
(E)-1-nitro- 
2-phenylpropene 
fldZ 
72.0 
±4.5 
81.0 
±3.3 
90.1 
±3.8 
A? ? ? 
(R) 
A? ? ? 
(R) 
A? ? ? 
(R) 
pET20b(+) 
6.3 
±0.1 
7.5 
±0.2 
7.7 
±0.4 
54.8 
±4.5 
(R) 
52.6 
±0.6 
(R) 
51.4 
±9.1 
(R) 
(E)-1-phenyl- 
2-nitropropene 
fldZ 
35.2 
±0.3 
48.9 
±0.4 
56.0 
±1.9 
17.0 
±0.5 
(R) 
16.1 
±1.6 
(R) 
16.9 
±0.2 
(R) 
pET20b(+) 
10.2 
±4.2 
17.2 
±2.8 
17.0 
±0.6 
16.8 
±5.5 
(R) 
17.2 
±1.6 
(R) 
20.3 
±2.3 
(R) 
 
The biotransformations showed that the wild type E. coli reduced both (E)-1-nitro-
2-phenylpropene and (E)-1-phenyl-2-nitropropene with poor yields (7 and 17% after 72 h 
respectively) and moderate enantiomeric excess (51 and 20%). The expression of fldZ 
significantly improved the yields of biotransformations (90 and 56% respectively). 
Surprisingly, the enantiomeric excess for the product of (E)-1-phenyl-2-nitropropene 
reduction was A? ? ?% for (R)-enantiomer. No (S)-enantiomer was detected in the reaction 
mixture as a product of the background activity of E. coli enzymes shown in the control 
experiment. This may be caused by a limitation of the analytical method, where the (S)-
product could not be detected at low concentrations in the presence of an excess of the 
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(R)-enantiomer. Therefore, it was shown that fldZ accepted both phenylnitropropenes as 
substrates in the reduction driven by NADH and the reductase demonstrated perfect 
enantioselectivity towards (E)-1-phenyl-2-nitropropene. 
5.1.5.3. Overexpression and purification of OYE-like reductase 
Old Yellow Enzyme-like reductase (OYE, CLOSPO_03444) was overexpressed in E. 
coli BL21(DE3)pLysS using the pET expression system. The pJET1.2 cloning plasmid carrying 
the nucleotide sequence encoding the open reading frame of OYE-like reductase (see 
5.1.4.2.) was used as the template in a PCR with KOD polymerase. Two different sets of 
primers introducing different restriction sites in the products were used: PM020 and 
PM021 (introducing Nde/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚĂŶĚNot/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚ
without the stop codon at the end of the open reading frame) and PM020 and PM021 
(introducing Nde/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚĂŶĚNot/ƌĞƐƚƌŝĐƚŝŽŶƐŝƚĞĂƚƚŚĞ ? ?ĞŶĚǁŝƚŚout 
a stop codon at the end of the open reading frame). The PCR products were cloned into 
pJET1.2 vector and their sequences were verified by the DNA sequencing. Then, the inserts 
were excised using NdeI and NotI restrictases and purified by electrophoresis. These inserts 
were ligated into the pET20b(+) expression vector, previously digested with the NdeI and 
NotI, dephosphorylated and purified. That allowed creation of two constructs for the 
expression of the wild type OYE-like reductase and OYE containing a C-terminal HisTag 
(OYE:CtH).The C-terminal HisTag was used since other OYE-like reductases (such as PETNR 
from Enterobacter cloacae) were successfully overexpressed and purified using this strategy 
(Hulley et al., 2010). The strains carrying the pET expression constructs were grown at a 100 
mL scale and the plasmids were purified using the Plasmid Midi Kit. The plasmids were 
analyzed by DNA sequencing using T7 promoter and T7 terminator primers (Appendix 8.16.) 
and used to transform BL21(DE3)pLysS expression strain.  
 The wild type OYE and OYE:CtH reductases were expressed at a 100 mL scale  in 
anaerobic conditions at 30°C. Samples were taken before induction of the expression with 
IPTG and 1, 3 and 5 h after induction. The cell-free protein extracts were prepared using the 
BugBuster reagent and the insoluble proteins were removed by centrifugation at 18000 x g 
for 20 min at 4°C. The protein extracts were analyzed using SDS-PAGE technique (Fig. 5.33.). 
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Fig. 5.33. Expression of the wild type OYE reductase and His-tagged OYE in anaerobic 
conditions. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚWƌŽƚĞŝŶ>ĂĚĚĞƌ ?&ĞƌŵĞŶƚĂƐ ) ? 
 
Expression of OYE and OYE:CtH in anaerobic conditions resulted in formation of 
soluble products of an expected size about 38 and 40 kDa respectively. Since the OYE 
reductase containing the C-terminal HisTag was successfully expressed as soluble protein, 
an attempt to purify the enzyme using the Dynabeads His-Tag Isolation Kit was made as 
described previously (5.1.5.2.4.). The protein fractions were analyzed by SDS-PAGE (Fig. 
5.34.). 
 
 
Fig. 5.34. Purification of OYE:CtH using Dynabeads His-Tag Isolation Kit. M - WĂŐĞZƵůĞƌ ?WƌĞƐƚĂŝŶĞĚ
Protein Ladder (Fermentas), CE - protein crude extract, FL - flow through, Washing - washing with the 
Binding Buffer, Elution - elution with the buffer containing imidazole. 
 
The SDS-PAGE analysis showed that OYE:CtH polypeptide was successfully purified 
to homogeneity. The purified reductase was tested in the spectrophotometric activity 
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assays using a range of unsaturated compounds as substrates (cinnamic acid, ɴ-
nitrostyrene, (E)-1-nitro-2-phenylpropene, (E)-2-nitro-1-phenylpropene and 
cyclohexenone). The reactions were driven by NADH or NADPH. No conversion of the 
electron donors was observed in the reactions (data not shown). Therefore, the substrate 
range of the OYE-like reductase encoded by C. sporogenes remained unknown. 
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5.2. Reduction of aromatic nitro groups by C. sporogenes 
 C. sporogenes was found to catalyse reduction of aliphatic (Angermaier and Simon, 
1983a) and aromatic nitro groups (Dipeolu, 2008; Dipeolu et al., 2009). Attempts to purify 
the reductase responsible for NADH-dependent hydrogenation of the nitro group of p-
nitrobenzoate showed the presence of two different enzymatic activities in the protein 
extracts of C. sporogenes (Angermaier and Simon, 1983b). However, the C. sporogenes 
nitroreductase has never been successfully purified and identified. Therefore, an attempt 
was made to identify and overexpress the nitroreductases present in C. sporogenes 
DSM795. 
5.2.1. Reduction of aromatic nitro compounds using C. sporogenes crude extracts 
Protein extracts of C. sporogenes DSM795 were used in biotransformations of 
aromatic nitro compounds to confirm the presence of nitroreductase activity. The culture 
used for preparation of protein extracts was grown in Giesel medium supplemented with 
12.1 mM L-phenylalanine. The cells were harvested in the early stationary phase of growth 
and disrupted using the cell disruptor at pressure of 40,000 psi under nitrogen flow. The cell 
debris and insoluble proteins were separated from the soluble protein fraction by 
centrifugation at 75,000 x g for 30 min at 4ºC. A small library of aromatic nitro compounds 
was tested as substrates for the reductase activity. In the reactions NADH and NADPH were 
used as the electron donors. The biphasic heptane/buffer biotransformations were 
prepared in anaerobic conditions and incubated for 24 h at 30ºC. The reaction products 
were analyzed by gas chromatography-mass spectroscopy (Table 5.11.). 
Table 5.11. Reduction of aromatic nitro compounds to amines using protein extracts of C. 
sporogenes. Results present means of three independent replicates with standard deviations. 
Substrate Structure 
NADH NADPH 
Conv.  
(%) 
Yield  
(%) 
Conv. 
(%) 
Yield  
(%) 
nitrobenzene 
 
86.0 
±1.8 
6.5 
±0.8 
80.4 
±5.8 
4.1 
±0.5 
2-chloro- 
nitrobenzene 
 
60.5 
±3.8 
1.8 
±0.1 
55.8 
±1.6 
1.2 
±0.1 
3-chloro- 
nitrobenzene 
 
65.7 
±3.8 
5.9 
±0.2 
60.8 
±5.7 
4.5 
±0.2 
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4-chloro- 
nitrobenzene 
 
50.4 
±2.5 
17.2 
±0.9 
43.3 
±1.7 
8.5 
±0.3 
2,4-dinitro- 
toluene 
 
100.0 
67.8
1)
 
±7.3 
100.0 
99.3
1)
 
±1.2 
1-chloro-2,4-
dinitrobenzene 
 
100.0 
55.8
2)
 
±5.2 
100.0 
64.7
2)
 
±5.1 
p-nitroanisole 
 
70.8 
±5.6 
33.5 
±1.3 
68.9 
±4.8 
34.0 
±2.4 
1). 
yield for 2,4-diaminotoluene; 
2).
 Yield for 4-chloro-1,3-diaminobenzene. 
 
C. sporogenes DSM795 reduced aromatic nitro group with different yields 
depending on the substrate type and the electron donor used. The best substrates, 2,4-
dinitro-toluene and 1-chloro-2,4-dinitrobenzene, contained two nitro groups attached to 
the aromatic ring and gave higher yields when NADPH was used. The products of their 
reduction were 2,4-diaminotoluene and 4-chloro-1,3-diaminobenzene respectively. p-
Nitroanisole, the only substrate containing an electron donating group, was reduced with 
moderate yield about 34% for both NADH and NADPH. Nitrobenzene and chloro-
nitrobenzenes were poor substrates giving higher yields when NADH was present in the 
reaction. The biotransformations confirmed that protein extracts of C. sporogenes DSM795 
contain the nitroreductase activity. That activity may result from the presence of multiple 
enzymes preferring NADH or NADPH as the electron donor in the catalytic process. 
5.2.2. Identification of nitroreductases in C. sporogenes genome 
To identify nitroreductases, the genome of C. sporogenes ATCC15579 strain was 
screened for the presence of genes encoding proteins which show homology to 
nitroreductases known from the literature. Three protein sequences were used as a query: 
NRSal reductase from Salmonella typhimurium, NR reductase from Enterobacter cloacae 
and YqjM from Bacillus subtilis. Seven hypothetical genes were found which encoded 
unknown proteins annotated as hypothetical proteins: CLOSPO_01010, CLOSPO_ 01559, 
CLOSPO_01572, CLOSPO_01641, CLOSPO_01855, CLOSPO_02936 and CLOSPO_03559. The 
genes were named as CsNTR from 1 to 7 respectively. The gene sequences were extracted 
from the database (Appendix 8.17.) and used to identify corresponding genes in the 
genomes of C. sporogenes NCIMB10696 and C. botulinum A str. Hall ATCC3502. The 
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sequence alignments were prepared for each gene and PCR primers were designed to the 
fragments of the genes conserved between different Clostridium strains (Table 5.12.). 
Table 5.12. Hypothetical genes encoding nitroreductases identified in the genome of C. sporogenes 
ATCC15579. The primers used for identification of the genes in C. sporogenes DSM795 are listed. 
Enzyme Gene name 
Size of  
ORF (bp) 
Primers used for 
amplification 
Expected PCR 
product (bp) 
CsNTR1 CLOSPO_01010 579 PM023, PM024 820 
CsNTR2 CLOSPO_ 01559 627 PM025, PM026 1500 
CsNTR3 CLOSPO_01572 516 PM027, PM028 605 
CsNTR4 CLOSPO_01641 564 PM029, PM030 849 
CsNTR5 CLOSPO_01855 546 PM031, PM032 850 
CsNTR6 CLOSPO_02936 498 PM033, PM034 624 
CsNTR7 CLOSPO_03559 549 PM035, PM036 601 
 
 Primers were used in PCR on C. sporogenes DSM795 genomic DNA using the 
FailSafe Polymerase system containing different premixes for optimization of the reaction. 
The reaction mixtures were pooled and the products of reactions were analyzed by gel 
electrophoresis (Fig. 5.35.). 
 
Fig. 5.35. Electrophoresis of CsNTR1-7 PCR products. Products (10 ʅL of each) were 
ƌƵŶŽŶ ?A?ĂŐĂƌŽƐĞŐĞůǁŝƚŚ'ĞŶĞZƵůĞƌ ? ?ŬďWůƵƐE>ĂĚĚĞƌ ?&ĞƌŵĞŶƚĂƐ ) ? 
 
 The electrophoresis showed that PCR resulted in products of the expected length 
for each gene. The products were purified by gel electrophoresis, ligated into pJET1.2 
vector and analyzed by DNA sequencing. The analysis showed that six of the PCR products 
contained genes with high homology to genes encoding nitroreductases. The PCR product 
for identification of CsNTR2 did not show the presence of an open reading frame encoding 
nitroreductase-like protein. Thus it was assumed that this product is a result of an 
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unspecific PCR and that C. sporogenes DSM795 strain does not contain the gene encoding 
CsNTR2 reductase. The analysis of the sequences showed the CsNTR1 encoded an open 
reading frame of 179 aa., CsNTR3  - 172 aa., CsNTR4 - 173 aa., CsNTR5 - 182 aa., CsNTR6 - 
166 aa. and CsNTR7 - 183 aa.  The primary structures of C. sporogenes nitroreductases were 
analyzed by the Protein Conserved Domain Tool (Fig. 5.36.). 
 
NTR1 
 
NTR3 
 
NTR4 
 
NTR5 
 
NTR6 
 
NTR7 
Fig. 5.36. Analysis of the C. sporogenes nitroreductases primary structures in the Protein Conserved 
Domain Tool (http://www.ncbi.nlm.nih.gov/Structure/cdd/wrpsb.cgi?). 
 
 The analysis of the primary structure showed that all CsNTR proteins possessed 
domains characteristic for enzymes reducing nitrocompounds (at the expense of NADH or 
NADPH) and containing FMN or FAD as cofactors.  
5.2.3. Overexpression and activity of C. sporogenes nitroreductases 
 The gene sequences of CsNTRs were optimized for expression in the E. coli host 
(Appendix 8.17.) and synthetic plasmids carrying DNA inserts encoding the optimized 
nitroreductase genes were created by Biomatik, USA, LLC. The plasmids were digested 
using NdeI and NotI restriction enzymes and the inserts were transferred into pET20b(+) 
expression vector. The strains carrying the pET expression constructs were grown at a 100 
mL scale and the plasmids were purified using the Plasmid Midi Kit. The plasmids were 
sequenced using T7 promoter and T7 terminator primers and used to transform 
BL21(DE3)pLysS expression strain. The nitroreductases were expressed at 100 mL scale in 
anaerobic conditions at 30°C. Additionally, C. sporogenes OYE-like reductase was expressed 
to be tested for nitroreductase activity. The cells were harvested 5 h after induction of 
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expression. The protein extracts were prepared using the BugBuster reagent and the 
insoluble proteins were removed by centrifugation at 18000 x g for 20 min at 4°C. The 
protein extracts were analyzed using SDS-PAGE technique (Fig. 5.37.). 
 
Fig. 5.37. Expression of the nitroreductases CsNTR1-7 and the OYE-like reductase in 
E. coli in anaerobic conditions. M - WĂŐĞZƵůĞƌ ? WƌĞƐƚĂŝŶĞĚ WƌŽƚĞŝŶ >ĂĚĚĞƌ
(Fermentas). 
 
 The SDS-PAGE showed that all the C. sporogenes nitroreductases were successfully 
expressed as soluble proteins with very high yields, except for CsNTR4, which was mainly 
insoluble (data not shown). An attempt to optimize CsNTR4 expression by lowering the 
temperature of the culture and extending the incubation time before harvesting the cells 
did not improve the yield of protein produced (data not shown). 
  To test the activity of nitroreductases for reduction of aromatic nitro compounds, 
protein cell-free extracts of E. coli expressing empty pET20b(+) and CsNTR constructs were 
used as biocatalysts in the biphasic aromatic nitro reduction biotransformation. In the 
reactions NADH and NADPH were used as the electron donors. The reactions were 
incubated for 24 h at 30°C. The conversion of the substrates and formation of the products 
were determined by gas chromatography-mass spectroscopy (Tab. 5.13.). 
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Table 5.13. Aromatic nitro reduction biotransformation using CsNTR nitroreductases and OYE-like 
reductase from C. sporogenes. Results present means of three independent replicates.  
Substrate Sample 
Conv. (%) Yield (%) 
NADH NADPH NADH NADPH 
 
nitrobenzene 
pET20b(+) 31.7 46.6 1.2 1.4 
CsNTR1 29.4 55.7 0.1 0.3 
CsNTR3 29.6 51.9 1.0 1.0 
CsNTR4 31.4 49.2 2.0 1.5 
CsNTR5 27.3 44.7 0.6 0.6 
CsNTR6 25.2 50.2 0.2 0.2 
CsNTR7 22.6 47.0 0.2 0.3 
OYE 32.1 46.9 1.6 1.5 
 
2-chloro-nitrobenzene 
pET20b(+) 26.5 40.5 2.2 1.1 
CsNTR1 25.9 40.3 0.5 0.2 
CsNTR3 20.8 28.7 0.9 0.9 
CsNTR4 19.9 29.6 1.7 1.2 
CsNTR5 18.7 31.4 0.5 0.4 
CsNTR6 18.4 31.6 0.3 0.2 
CsNTR7 22.6 34.0 0.3 0.6 
OYE 25.2 33.9 1.5 1.2 
 
3-chloro-nitrobenzene 
pET20b(+) 30.5 46.7 4.6 3.6 
CsNTR1 27.0 41.7 1.7 1.9 
CsNTR3 31.9 40.5 2.3 2.7 
CsNTR4 28.8 45.0 3.9 4.0 
CsNTR5 22.8 43.6 2.1 2.2 
CsNTR6 25.1 35.2 2.1 2.2 
CsNTR7 24.5 38.2 2.0 2.4 
OYE 31.7 43.5 3.5 3.9 
 
4-chloro-nitrobenzene 
pET20b(+) 38.5 51.2 1.3 1.1 
CsNTR1 35.9 50.1 0.1 0.1 
CsNTR3 38.9 52.0 0.7 0.5 
CsNTR4 39.4 45.7 1.8 1.0 
CsNTR5 35.7 42.7 0.4 0.3 
CsNTR6 37.8 46.9 0.1 0.2 
CsNTR7 38.0 46.3 0.2 0.2 
OYE 38.3 49.3 1.0 0.8 
 
2,4-dinitrotoluene 
pET20b(+) 53.0 18.2 n.d. n.d. 
CsNTR1 33.3 1.3 n.d. n.d. 
CsNTR3 36.0 20.2 n.d. n.d. 
CsNTR4 51.3 14.8 n.d. n.d. 
CsNTR5 39.3 8.5 n.d. n.d. 
CsNTR6 28.8 9.5 n.d. n.d. 
CsNTR7 34.0 7.1 n.d. n.d. 
OYE 49.0 20.4 n.d. n.d. 
 
 
pET20b(+) 28.0 40.2 4.6 4.5 
CsNTR1 17.8 33.8 4.9 2.4 
CsNTR3 10.6 35.3 3.9 2.8 
CsNTR4 28.6 37.1 5.7 3.6 
CsNTR5 15.5 44.9 4.4 2.3 
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1-chloro-2,4-dinitro-
benzene 
CsNTR6 11.8 34.6 4.3 1.6 
CsNTR7 5.0 21.5 4.3 1.8 
OYE 29.4 27.3 6.6 3.8 
 
p-nitroanisole 
pET20b(+) 2.9 10.8 0.8 1.0 
CsNTR1 3.8 11.8 0.4 0.6 
CsNTR3 5.3 1.0 1.3 1.6 
CsNTR4 7.6 18.8 1.9 1.4 
CsNTR5 0.5 11.0 0.5 0.9 
CsNTR6 1.7 11.0 0.5 0.4 
CsNTR7 5.3 9.1 0.6 0.8 
OYE 13.3 11.6 0.7 1.1 
n.d. - not determined. 
 
 The results of the biotransformations showed that none of the enzymes improved 
the reduction of aromatic nitro compounds when compared to background activity 
determined by the control reaction using E. coli extracts expressing empty pET20(+). The 
yield of 2,4-dinitrotoluene reduction could not be measured as the peak of 2,4-
diaminotoluene was covered with a component coming from the protein extracts which 
had a similar mass spectroscopy fragmentation pattern. The substrate conversions in the 
reactions were much bigger than the yields showing that E. coli possessed enzymes 
converting the reaction substrates to unidentified alternative products. Therefore the 
substrate range of the C. sporogenes nitroreductases and the OYE-like reductase is 
unknown. 
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5.3. C. sporogenes proline reductase 
 Bifunctional compounds such as ʘ-aminocarboxylic acids are important 
intermediates in the chemical industry as they can be easily converted into polymers 
possessing unique physical and chemical properties. One especially demanded compound is 
6-aminocaproic acid which is an intermediate in the polymerization of Nylon-6. 
Proteolytic Clostridia can use L-proline as the electron acceptor in the Stickland 
type fermentation (Nisman, 1954). The L-proline reduction pathway contains two enzymes, 
a very active proline racemase and a D-proline reductase. The latter enzyme converts D-
proline into a bifunctional compound 5-aminovaleric acid. The reaction may be driven by 
pyridine nucleotides (NADH/NADPH) or dithiols such as dithiothreitol (Barker, 1981).  
 Pipecolic acid is a homolog of proline and comprises a non-aromatic ring formed of 
five carbon atoms and one nitrogen atom. Analysis of the metabolic pathway databases 
(KEGG, BioCyc) showed that L-pipecolic acid may be easily biosynthesised in a one-step 
reaction from L-lysine using lysine cyclodeaminase from Streptomyces hygroscopicus. The 
reductive cleavage of the L-pipecolic acid ring in a process analogous to L-proline reduction 
would result in formation of valuable 6-aminocaproic acid. Therefore, a route for 6-
aminocaproic acid biosynthesis starting from L-lysine was proposed and tested (Fig. 5.38.). 
 
Fig. 5.38. Proposed route for biocatalytic synthesis of Nylon 6 using clostridial proline racemase and 
proline reductase. 
 
  The feasibility of the proposed pathway depends on the substrate range of 
clostridial enzymes, proline racemase (prdF) and proline reductase (prdAB). Therefore, an 
attempt to use C. sporogenes as a biocatalyst for reduction of pipecolic acid was made. 
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5.3.1. Growth of C. sporogenes on D,L-pipecolic acid 
 Growth experiments of C. sporogenes DSM795 in the minimal Lovitt medium 
showed that L-proline is an excellent fermentation substrate acting as the electron acceptor 
in the Stickland reaction and significantly increases the growth rate and biomass production 
of the culture (see 5.1.2.2.). Thus, to test if C. sporogenes can use D,L-pipecolic acid as an 
alternative electron acceptor in the fermentation, the growth of C. sporogenes was 
determined in minimal medium supplemented with L-alanine (as the electron donor) and L-
proline and D,L-pipecolic acid (as the electron acceptors). The cultures (200 µL) were 
prepared in the wells of a 96-well plate and the growth of bacteria was observed for 50 h 
using automated NEPHELOstar plate reader in anaerobic conditions (Fig. 5.39.). 
 
Fig. 5.39. Growth of C. sporogenes DSM795 in Lovitt medium supplemented with 27 mM L-alanine as 
the electron donor (භ). 45 mM L-proline (Ŷ) or D,L-pipecolic acid (Ÿ) were tested for acting as 
electron acceptors in the Stickland fermentation. Average of four independent replicates with error 
bars corresponding to standard deviations. 
 
 The growth experiments showed that D,L-pipecolic acid significantly increased the 
growth rate and the biomass production of the C. sporogenes cultures when compared to 
the control. However, it was not as good a fermentation substrate as L-proline. 
5.3.2. Development of analytical method for detection of 6-aminocaproic acid 
 An analytical method for detection of 6-aminocaproic acid was developed based on 
the derivatization of amine groups with o-phthalaldehyde (Fig. 5.40.). 
 
 Fig. 5.40. The principle of primary amine derivatization using o-phthalaldehyde.   
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 o-Phthalaldehyde (OPA) reacts exclusively with primary amine groups, but not with 
secondary amines. The derivatized compound can be detected by measuring the intensity 
of fluorescence at 455 nm after excitation at 340. L-proline, D,L-pipecolic acid, 5-
aminovaleric acid and 6-aminocaproic acid were treated with OPA and the fluorescence of 
the reaction products was measured by FLUOROstar plate reader. The fluorescence was 
detected at 470 nm due to lack of 455 nm filter in the device (Fig. 5.41.). 
 
Fig. 5.41. Correlation between the fluorescence signal at 470 nm and the concentration of OPA-
derivatized L-proline (Ŷ), D,L-pipecolic acid (Ÿ), 5-aminovaleric acid (භ) and 6-aminocaproic acid(ź). 
Error bars represents standard deviations. 
 
 The experiment showed almost linear correlation between the concentration up to 
10 mM of OPA-derivatized 5-aminovaleric and 6-aminocaproic acids and the fluorescence 
signal at 470 nm. No fluorescence was observed for L-proline and D,L-pipecolic acid 
containing secondary amine functional groups. 
5.3.3. Proline reductase expression and activity assays 
 C. sporogenes DSM795 was grown in the Giesel medium at 30°C. To induce the 
expression of proline racemase and proline reductase, the medium was supplemented with 
27 mM D-glucose and 45 mM L-proline. The cells were harvested in the middle exponential 
and the early stationary phases of growth (4 h after inoculation, OD660 nm 2.5 and 8 h after 
inoculation, OD660 nm 5 respectively). The protein cell-free extracts were prepared using the 
cell disruptor at pressure of 40,000 psi. The membrane-free protein extracts were 
centrifuged at 75,000 x g for 20 min at 4°C and the soluble protein fractions were used in 
the proline reduction assay. DTT and NADH were used as the electron donors in the 
reactions. The heat inactivated protein extract was used as the negative control in the assay 
(Fig. 5.42.). 
123 
 
 
Fig. 5.42. L-proline reduction assay using protein extracts of C. sporogenes. Cells from exponential 
and stationary phases of growth were used to prepare the membrane-free protein extracts. Proteins 
were inactivated at 100°C for 20 min. DTT and NADH were used as electron donors. Data present 
means of four independent replicates with error bars representing standard deviations. 
 
 The proline reduction assay showed that proline racemase and reductase were 
successfully expressed during the C. sporogenes growth. Both DTT and NADH were good 
electron donors, however DTT showed a lower background in the control assay without the 
protein extracts. Although no difference in the L-proline reduction activity was observed 
between cells harvested at different phases of growth, the protein extract produced from 
the stationary phase cells showed a high fluorescence signal even when the reductase was 
inactivated by heat. That was probably caused by accumulation of 5-aminovaleric acid in 
the cells during C. sporogenes growth which was present later in the protein extracts. 
 Protein extracts of C. sporogenes grown on glucose/L-proline and harvested in the 
middle exponential phase of growth were used to reduce L-, D- and D,L-pipecolic acid in the 
expense of DTT (Fig. 5.43). L-proline was used as a control substrate, whereas the heat 
inactivated enzyme fraction was used as negative control.  
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Fig. 5.43. Pipecolic acid reduction assay using protein extracts of C. sporogenes harvested in the 
exponential phase of growth. Proteins were inactivated at 100°C for 20 min. DTT was used as 
electron donor. L-proline was used as a positive control. Data present means of four independent 
replicates with error bars representing standard deviations. 
 
The significant results showed that L-proline was successfully reduced to 5-
aminovaleric acid but no reductase activity was observed in the presence of L-, D- or D,L-
pipecolic acid. About a 20% increase in the fluorescence signal was observed for samples 
with the active proteins when compared to the ones with the heat inactivated extracts, 
even when no substrate was added to the reaction mixture. That could be explained by the 
presence of L-proline assimilated by the cells from the growth medium before production 
of the protein extracts. The residual L-proline was converted to the 5-aminovaleric acid in 
the assay and increased the fluorescence intensity. Therefore, the experiments showed 
that the proline reductase does not show activity towards L- and D-pipecolic acid. 
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6. Discussion  
6.1. Biocatalytic reduction of C=C double bonds  
Proteolytic Clostridia possess unique enzymatic activities as they can obtain energy 
and carbons from unusual reactions between two amino acids, where one of them acts as 
the electron donor and the second as the electron acceptor (discovered by Stickland, 1934; 
reviewed by Barker, 1980). A variety of electron acceptors, which can be used in this type of 
fermentation, make Clostridia an excellent source for screening of novel reductases. C. 
sporogenes was found to be an excellent biocatalyst for organic reductions in synthesis of 
high value chemicals. Its ability to hydrogenate activated alkenes, such as cinnamic acid and 
ŽƚŚĞƌɲ ?ɴ-unsaturated carboxylic acids (Bühler el al., 1980; Giesel et al., 1981; Bader et al., 
1982; Giesel and Simon, 1983; Bader and Simon, 1983; Dickert et al., 2000) and nitroolefins 
(Fryszkowska et al., 2008) was reported multiple times in the literature. The latter 
enzymatic activity was implemented into an industrially relevant chemoenzymatic route for 
synthesis of (S)-baclofen (Fryszkowska et al., 2010). However, proteins responsible for these 
enzymatic activities were never identified due to unsuccessful attempts of purification or 
lack of the C. sporogenes genome sequence (Fryszkowska et al., 2008).  
Proteolytic and saccharolytic Clostridia were found to reduce aromatic and aliphatic 
enoates (Tischer et al., 1979; Bühler el al., 1980) and genes encoding 2-enoate reductase 
were identified in C. kluyveri, C. tyrobutyricum and M. thermoacetica (Rohdich et al., 2001). 
The gene encoding hypothetical 2-enoate reductase (fldZ) was also identified in C. 
botulinum by homology search (Sebaihia et al., 2007). Since C. sporogenes is closely related 
to C. botulinum (separation of these taxa is now being questioned; Bradbury et al., 2012) it 
was likely that the fldZ homologue was responsible for the previously observed reductions 
of enoates and nitroolefins by C. sporogenes. A suitable way to test that would consist of 
identification, cloning and overexpression of C. sporogenes fldZ in a heterologous host. 
However, previous attempts to overexpress 2-enoate reductases in E. coli have met with 
limited success (Rohdich et al., 2001).  Therefore, an approach using production of genomic 
enoate reductase knock out mutants was chosen to confirm that fldZ is responsible for 
reduction of cinnamic acid and nitroolefins. 
The fldZ::CTermB mutant was created with the Clostron gene knock out system 
(Heap et al., 2007; Mordaka, 2010). In this thesis, successful insertional disruption of the 
fldZ gene in C. sporogenes was shown by the ability to grow on a selective medium, a series 
of polymerase chain reactions and Southern blot. The mutant was extremely stable for 
many generations, even without the selective pressure in the medium. Thus, the Clostron 
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was proved to be a very precise and efficient genetic tool for preparation of genomic knock 
out mutants in C. sporogenes and can give a significant impact on functional genomic 
studies in Clostridia. 
To confirm that the fldZ enoate reductase is responsible for reduction of 
unsaturated compounds, wild type C. sporogenes and the fldZ::CTermB mutant were used 
as biocatalysts. Cells grown on different energy substrates were used and 
biotransformations were driven using different electron donors. Inhibition of the reductase 
activities with air was also tested. The comparative analysis of reductase activities in the 
wild type and the mutant showed intriguing results (Tab. 6.1). 
Table 6.1. Summary of C=C double bond reductase activities present in DSM795 and fldZ::CTermB. 
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compared to the wild type; 
3)
 enzymatic activity was irreversibly inhibited by oxygen.  
 
Biotransformations showed that C. sporogenes possesses at least three C=C double 
bond reductases characterized by different substrate specificities, expression patterns and 
sensitivities to oxygen. 
FldZ was found to be capable of reduction of all unsaturated compounds tested. 
The expression of this enzyme was induced by amino acids present in the basal medium or 
L-phenylalanine. The enzyme could accept electrons delivered from all of electron donors 
that were used, however the greatest activity was observed for NADH. Biotransformations 
with protein extracts exposed to air showed that fldZ was not inactivated by oxygen or its 
activity was restored after removal of oxygen, which was previously reported for clostridial 
2-enoate reductases (Tischer et al., 1979). 
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C. sporogenes contains also another nitroalkene reductase, which ƌĞĚƵĐĞĚ ɴ-
nitrostyrene and (E)-2-nitro-1-phenylpropene when whole cells and protein extracts of the 
mutant were used in the biotransformations. The expression of the unknown reductase 
was induced by growth on L-phenylalanine and its activity was irreversibly inactivated by 
oxygen. The presence of the second reductase was previously observed in the attempts to 
purify enzymes responsible for reduction of (E)-2-nitro-1-phenylpropene (Karl Fisher, 
personal communication; Appendix 8.7.). 
The third C=C double bond reductase accepts cinnamic acid as a substrate. 
Confirming preliminary results published in Mordaka (2010), it was shown that in contrast 
to the wild type strain, the protein extracts of the mutant did not reduce cinnamic acid. 
However, biotransformations using whole cells of fldZ::CTermB and experiments on L-
phenylalanine fermentation in complex and minimal media showed that the mutant was 
able to produce 3-phenylpropionic acid. Thus, C. sporogenes contains two cinnamic acid 
reductases. FldZ is a soluble protein reducing cinnamic acid at the expense of NAD(P)H, 
whereas the second enzyme may not accept these electron donors. Cinnamic acid 
reduction was found to be coupled to vectorial transmembrane proton translocation 
allowing for ATP synthesis via electron transfer phosphorylation (Bader and Simon, 1983). It 
cannot be excluded that the second enzyme is a membrane associated/attached protein 
and could have been removed from the sample together with insoluble proteins and cell 
debris. It is also possible that the unknown enzyme does not accept free acid as the 
substrate, but acts on the coenzyme A derivative of cinnamic acid. Cinnamoyl-CoA can be 
enzymatically formed in two ways, as a result of activity of acyl-CoA ligase or CoA 
transferase (Dickert et al., 2000). The reaction with acyl-CoA ligase requires the presence of 
CoA-SH and nucleoside triphosphate, whereas CoA transferase needs a CoA donor to 
activate cinnamic acid. Thus, these two reactions probably could not occur when protein 
extracts were used, but are more likely to be driven by metabolically active whole cells. 
Evidence for the presence of fldZ and two other enzymes led to the analysis of C. 
sporogenes newly published genome, which allowed identification of two hypothetical 
proteins showing homology to flavin containing C=C double bond reductases, fldZ 2-enoate 
reductase (CLOSPO_02780) and OYE-like reductase (CLOSPO_03444), which were 
subsequently cloned, overexpressed and characterized.  
FldZ belongs to a family of reductases consisting of about 660 amino acids and 
containing FAD and iron-sulphur cluster as cofactors. It shows the highest homology to 2-
enoate reductase from proteolytic C. botulinum str. A (yellow highlight, Fig. 6.1.) and 2-
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enoate reductases from saccharolytic C. tyrobutyricum, C. kluyveri and M. thermoacetica 
strains (green). On the other hand the OYE-like CLOSPO_03444 reductase is similar to 
classical C=C double bond reductases consisting of proteins composed of about 330-400 
amino acids and possessing FMN as the cofactor (red).   
 
 
Fig. 6.1. Phylogenetic tree showing the evolutionary relationships among various C=C double bond 
reductases based upon similarities and differences in their primary amino acid sequences. The tree 
was created using the parsimony method with PHYLIP software. Yellow - 2-enoate reductases from 
proteolytic Clostridia, green - 2-enoate reductases from saccharolytic Clostridia, red - classical OYE-
like reductases. For the list of sequences used to create the tree see Appendix 8.18. 
 
The N-terminal domain of clostridial enoate reductases shares the structure with 
classical OYE-like C=C double bond reductases (FMN binding motif and substrate/catalytic 
site; for alignment and details see Appendix 8.19.). Clostridial enoate reductases contain 
also four conserved cysteine residues responsible for interaction with the iron-sulphur (Fe-
S) cluster. The C-terminal part of fldZ is occupied by a small NADH binding domain within a 
larger FAD binding domain. 
To characterize the catalytic activity, fldZ was cloned and overexpressed in E. coli. It 
was the first attempt to express a recombinant enoate reductase encoded by proteolytic 
Clostridium. Previous attempts to produce 2-enoate reductase from saccharolytic strains 
have met with limited success (Rohdich et al., 2001). The expression was possible thanks to 
optimization of the E. coli growth under anaerobic conditions and optimization of the 
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codon usage of the fldZ gene. Although the growth rate and biomass production of E. coli 
were much smaller when compared to aerobic conditions, the optimized medium and 
growth conditions allowed for production of significant amounts of soluble recombinant 
proteins. 
 For easier purification using affinity resins, fldZ was His-tagged. Attempts to purify 
the enzyme using three different purification methods, gravity-flow columns, spin columns 
and magnetic beads, were unsuccessful. This might be caused by structural changes in the 
secondary and tertiary structure of the reductase which were forced by binding process of 
the histidine tag to the resin. Thus, the reductase was treated with a range of strong and 
weak denaturants under different redox conditions, but the activity was not restored. A 
note must be made that this protein refolding technique would be suitable only if the 
enzyme was inactive because of the misfolded structure.  
However, the loss of activity could also be caused by stripping off or disruption of 
the iron-sulphur cluster by the interaction with the resin containing immobilized cobalt or 
nickel. Fe-S clusters are crucial components of oxidoreductases, as they mediate transfer of 
electrons within the enzyme, and are assembled biosynthetically by special enzymatic 
systems (Johnson et al., 2005) which were not present in the purified enzyme sample. 
Incubation of the iron-sulphur-depleted enzymes (such as aconitase-type hydrolase from 
Methanocaldococcus jannaschii or NADH-cytochrome c reductase from Pseudomonas 
arvilla) with ferrous ions and sulfide in the presence of 2-mercaptoethanol was found to led 
to reconstitution of iron-sulphur clusters and restoration of the enzymatic activity 
(Yamaguchi et al., 1981; Drevland et al., 2007). Therefore, this method should be tested for 
reconstitution of the activity of the purified His-tagged fldZ in the future.  
Alternatively, fldZ can be expressed as a fusion protein containing other tagging 
sequences than polyhistidine-tag. The pET vector system offers a wide range of N-terminal, 
C-terminal and internal fusion tags that can facilitate the purification of the target protein. 
T7-tag (11 amino acids) and S-tag (15 amino acids) allow rapid purification based on their 
interactions with monoclonal antibodies and S-protein respectively. The fusion proteins can 
be eluted under denaturing conditions disrupting interactions between the tag and the 
resin. To maintain mild conditions, the fusion proteins can also be released by digestion 
with protease recognising the cleavage site located in the linker encoded by the vector (Kim 
and Raines, 1993). GST-tag encoding 220 amino acids of the schistosomal glutathione S-
transferase domain has been reported to enhance solubility of its fusion proteins.  Tagged 
proteins can be eluted from the chromatography medium under mild, non-denaturing 
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conditions using reduced glutathione that often additionally preserves both protein 
structure and function (Harper and Speicher, 2011). Strep-tag is a short tag of 8 
undisturbing amino acids encoding improved streptavidin polypeptide, which usually does 
not require removal to restore full protein activity. It specifically binds to StrepTactin ligand 
immobilized on the base matrix and allows purification under physiological conditions with 
elution performed with desthiobiotin, which displaces the fusion protein at the biotin-
binding site. Strep-tag is recommended for expression of metalloproteins, membrane 
proteins and sensitive protein complexes with multiple subunits (Schmidt and Skerra, 
2007). Thus, fldZ containing different tags should be overexpressed in E. coli and active fldZ 
fusion proteins should be purified by the respective affinity purification methods. 
Since attempts to purify the fldZ reductase have met with the limited success, the 
enzyme was characterized using protein extracts of E. coli expressing the non-His-tagged 
wild type reductase. Cinnamic acid was chosen as the substrate in activity assays and 
biotransformations, as protein extracts of the wild type E. coli strain does not possess 
cinnamic acid reductase activity. The pH and temperature optima were determined as 7.0-
7.5 and 40-45°C respectively, which tallied with previous results reported by Bühler et al., 
1980 for partially purified C. sporogenes 2-enoate reductase, but significantly different than 
optimal reaction conditions of 2-enoate reductases from saccharolytic Clostridia (Tischer et 
al., 1979). Biotransformation of cinnamic acid with fldZ at the expense of NADH showed 
that the substrate is reduced to 3-phenylpropionic acid in stoichiometric amounts and the 
reaction is complete after 24 h. The enzyme was stable under anaerobic conditions at 4°C 
for at least few hours without losing activity. FldZ was found to be deactivated by the 
presence of oxygen and lost a half of the activity after 2 h exposure to air. Surprisingly the 
activity was not successfully restored after 1 h incubation under nitrogen flow. That differs 
from the results obtained for the (E)-1-nitro-2-phenylpropene reduction using C. 
sporogenes protein extracts exposed to air, which were discussed earlier. However, 
different amount and type of biocatalysts, different substrates and their concentrations, 
and different exposure and reaction times make these two experiments unable to be 
compared.  
The activity tests showed that fldZ possesses a very narrow substrate range. The 
highest reductase activity was observed towards cinnamic acid and p-coumaric acid. 
ŝŶŶĂŵŝĐ ĂĐŝĚ ƐƵďƐƚŝƚƵƚĞĚ ǁŝƚŚ ŵĞƚŚǇů ŐƌŽƵƉƐ Ăƚ ɲ- ĂŶĚ ɴ-carbons, caffeic acid, 3-
indoleacrylic acid and phenylnitropropenes were accepted as substrates, but the activity 
was very poor. Aliphatic 2-ĞŶŽĂƚĞƐ ĂŶĚ ɴ-nitrostyrene were not reduced at all. This 
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confirmed previously published findings that 2-enoate reductase of proteolytic Clostridia 
are characterized by a narrow substrate range, in contrast to reductases from saccharolytic 
Clostridia, which can accept both aromatic and aliphatic unsaturated carboxylic acids 
(Tischer et al., 1979; Bühler et al., 1980). 
FldZ was also tested for reduction of (E)-1-nitro-2-phenylpropene and (E)-2-nitro-1-
phenylpropene in biphasic biotransformation at the expense of NADH. Protein extracts of 
the wild type E. coli reduced both substrates with poor yields, possibly due to the presence 
of endogenous NEM reductase, which was previously shown to reduce unsaturated 
compounds such as 1-nitrocyclohexene (Williams et al., 2004). However, expression of the 
fldZ reductase significantly improved the yields of reduction for both substrates. It should 
be noted that despite background E. coli activity showing poor enantiomeric excess, 
hydrogenation of (E)-1-nitro-2-phenylpropene by protein extracts of E. coli expressing fldZ 
was characterized by a perfect enantioselectivity.  
The analysis of the fldZ::CTermB mutants showed that C. sporogenes possesses 
ĂŶŽƚŚĞƌ A? ĚŽƵďůĞ ďŽŶĚ ƌĞĚƵĐƚĂƐĞ ƚŚĂƚ ĐĂŶ ƌĞĚƵĐĞ ɴ-nitrostyrene and (E)-2-nitro-1-
phenylpropene. The OYE-like reductase (CLOSPO_03444) would be a perfect candidate for 
this enzymatic activity as homologous flavin containing reductases such as PETNR, KYE1, 
YersER and NRSal were found to reduce both these substrates (Toogood et al., 2008; Yanto 
et al., 2010; Yanto et al., 2011). The OYE-like reductase was successfully expressed as a 
soluble protein containing C-terminal His-tag and purified to homogeneity using affinity 
purification method. However, the reductase did not show perceptible activity towards 
unsaturated substrates in the spectrophotometric activity assays. Thus, the substrate range 
of the OYE-like reductase is unknown. It cannot be excluded that the enzyme was inactive 
because of the presence of His-tag inhibiting the catalytic activity, which was shown 
previously for NRSal reductase from Salmonella typhimurium (Yanto et al., 2010). On the 
other hand, the presence of the C-terminal His-tag in PETN reductase from E. cloacae did 
not affect the activity of the enzyme (Hulley et al., 2010). In the future to test the OYE-like 
reductase activity, crude protein extracts of E. coli expressing the wild type reductase 
should be used. As shown previously for the fldZ reductase, a barely perceptible activity 
towards nitroolefins in the spectrophotometric activity assays does not confirm that fldZ 
cannot efficiently reduce these substrates in biphasic biotransformations. Thus, 
biotransformations of nitroolefins with OYE-like reductase at the expense of NAD(P)H 
should be performed in the future as well. 
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Biotransformations using whole cells and physiological studies with the fldZ mutant 
showed that fldZ acts as a cinnamic acid reductase accepting NADH as the electron donor.  
However, it was also shown that fldZ is not involved the L-phenylalanine fermentation via 
the Stickland reaction and that C. sporogenes possesses another cinnamic acid reductase 
with different properties to fldZ. The analysis of the fld gene cluster encoding enzymes 
involved in the reduction of L-phenylalanine showed the presence of a hypothetical protein 
annotated as acyl-CoA dehydrogenase in an operon together with two electron transfer 
flavoproteins, which may be responsible for reduction of cinnamoyl-CoA to 3-
phenylpropionoyl-CoA (Fig. 6.2. A). A similar reductase carC was found to catalyze 
reduction of caffeyl-CoA to hydrocaffeyl-CoA by anaerobic bacterium A. woodii (Hess et al., 
2011). CarC is also co-transcribed with two electron transfer flavoproteins, which couple 
reduction of caffeyl-CoA with a chemiosmotic mechanism using sodium ions to produce 
ATP via electron transfer phosphorylation (Biegel et al., 2011). A similar process was 
described in C. sporogenes, in which reduction of cinnamic acid was coupled to generation 
of a proton motive force leading to ATP synthesis (Bader and et al., 1982). Moreover, fldA 
CoA transferase responsible for activation of phenyllactic acid in the previous step of the L-
phenylalanine reduction pathway was shown to be more active when 3-phenylpropionyl-
CoA was used as the CoA donor rather than cinnamoyl-CoA (Dickert et al., 2000). This may 
suggest that during fermentation cinnamic acid is reduced as a CoA derivative rather than a 
free acid. Therefore a new model of L-phenylalanine reduction in the Stickland reaction can 
be proposed with reduction of cinnamoyl-CoA by acyl-CoA reductase annotated now as 
fldD (Fig. 6.2. B). 
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Fig. 6.2. Arrangement of the fld gene cluster in C. sporogenes ATCC15579 (A). Proposed model of L-
phenylalanine reduction via the Stickland reaction in C. sporogenes (B). FldH  ? phenyllactate 
dehydrogenase; FldA  ? 3-phenylpropionyl-CoA:phenyllacte CoA transferase; fldBC  ? phenyllactate-
CoA dehydratase, fldD  ? cinnamoyl-CoA reductase, etfAB  ? electron transfer flavoprotein. 
 
According to the new pathway, the amino group is transferred from L-
phenylalanine to 2-oxoglutarate resulting in 3-phenylpyruvic acid formation, which is 
subsequently reduced to (R)-phenyllactic acid by phenyllactate dehydrogenase (fldH). 
Phenyllactate is activated by transfer of CoA group from 3-phenylpropionyl-CoA mediated 
by 3-phenylpropionyl-CoA:phenyllactate CoA transferase (fldA) and dehydrated by 
phenyllactate-CoA dehydratase (fldBC) to cinnamoyl-CoA. Then, cinnamoyl-CoA is reduced 
to 3-phenylpropionyl-CoA by cinnamoyl-CoA reductase (fldD) using electrons delivered by 
electron transfer proteins (etfAB), which couple the reaction to creation of the proton 
motive force and ATP synthesis. In the last step of the pathway, 3-phenylpropionic acid is 
released after transfer of the CoA group to (R)-phenyllactate by fldA.  
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To test this model, C. sporogenes physiology needs to be analysed by constructing 
the fldD deficient strain as well as the double mutants genes for both cinnamic acid 
reductases knocked out. Recently a new method for creation of multiple knock out mutants 
in Clostridia was developed based on the modified Clostron gene knock out system (Kuehne 
et al., 2010). Thus, this technique can now be used to produce single and double mutants 
for fldZ, fldD, etf1 and etf2 proteins. Overexpression of the fldD reductase in E. coli should 
also be performed. However the activity of fldD will depend on finding suitable electron 
donors and optimization of the cofactor regeneration system for this reaction. 
Since fldZ was shown not to be essential for L-phenylalanine fermentation via the 
Stickland reaction, its physiological function remains unknown. It is unlikely that fldZ is 
involved in dissimilation of amino acids, since homologous 2-enoate reductases are also 
present in saccharolytic strains such as C. kluyveri and C. tyrobutyricum. Preliminary 
experiments on growth of the fldZ::CTermB mutant in complex media showed decreased 
biomass production when glucose was used as the growth substrate (Mordaka, 2010), 
whereas no difference was observed between the wild type and the mutant growing on L-
phenylalanine. It is possible that fldZ may be responsible for regeneration of the 
intracellular NAD
+
 pool by reducing unsaturated carboxylic acids when an excess of the 
electron donor such as glucose is present in cells. If fldZ is knocked out, the pool of NAD
+
 
becomes limited, C. sporogenes has no alternative but to switch to production of butyrate, 
butanol and ethanol. This would result in decreased ATP production and in decreased 
growth as observed experimentally. When the medium is balanced and stoichiometric 
amounts of electron donors and acceptors are present, the growth substrates are fully 
metabolized via the Stickland reaction and no differences in the growth between DSM795 
and fldZ::CTermB are observed. This hypothesis will be tested in the future by series of 
growth experiments in media containing different concentrations of electron donors and 
acceptors for fermentation. A note must be made that although fldZ and fldD catalyse 
similar reactions, the presence of fldZ would not disrupt the L-phenylalanine reduction 
pathway as starting from the phenyllactate dehydration stage all enzymes in the Stickland 
reaction act on CoA derivatives, not on free acids.    
The physiological experiments in minimal defined media showed that C. sporogenes 
grown on L-tryptophan accumulated skatole as a fermentation product. At present, skatole 
is recovered from coal tar and used as a fragrance and fixative in many perfumes and as an 
aroma compound. A few Clostridium species were found to produce skatole as a result of 
decomposition of protein materials (Rosenberger, 1958), but this activity was never 
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reported in C. sporogenes. Skatole could be the product of decarboxylation of 2-
indoleacetic acid produced in the oxidative branch of the Stickland reaction. Thus, C. 
sporogenes can be used for biosynthetic production of skatole starting from renewable 
feedstock thanks to 2-indoleacetic acid decarboxylase activity. Since this enzymatic activity 
is present, it is possible that C. sporogenes can also be used for production of more 
industrially relevant chemicals such as toluene and p-cresol, which would be final products 
of L-phenylalanine and L-tyrosine oxidative fermentation respectively. Footprint analysis of 
the L-phenylalanine fermentation in minimal medium did not show the presence of 
toluene. However, the analytical method used for detection of fermentation products was 
not compatible with chemicals characterized with such a low boiling point (Pons et al., 
1984). On the other hand formation of p-cresol could not be determined as L-tyrosine was 
not used in the growth experiments due to its poor water solubility. Similar reactions have 
been reported in other Clostridia grown on L-phenylalanine (Pons et al., 1984) and L-
tyrosine respectively (Selmer and Andrei, 2001). 
6.2. Biocatalytic reduction of aromatic nitro groups  
Reduction of nitrobenzene to aniline by whole cells of C. sporogenes at the expense 
of hydrogen gas was reported by Dipeolu (Dipeolu, 2008; Dipeolu et al., 2009). However, 
this enzymatic activity was not detected in biotransformations using whole cells of C. 
sporogenes presented herein. On the other hand, when protein extracts were used in the 
monophasic biotransformation with an ionic liquid as a co-solvent, C. sporogenes produced 
aniline at the expense of NADH and NADPH, but not with hydrogen gas. Therefore, the 
nitrobenzene reductase was present in C. sporogenes, but was not detected when whole 
cells were used probably due to insufficient amount of biocatalysts used in the reaction or 
inability to use reducing equivalents delivered by hydrogen gas.  
In further experiments a small library of aromatic nitro compounds was used to test 
the reductase activity of C. sporogenes in biphasic biotransformations. The substrates were 
reduced with different yields depending on the substrate structure and electron donor used 
in the reaction.  
A strategy was chosen for identification for C. sporogenes nitroreductases. Since no 
data about potential nitroreductases was present in the literature, the computational 
analysis of C. sporogenes genome was undertaken to identify enzymes showing homology 
to proteins reducing nitrogen-containing compounds from other organisms. Then, the six 
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promising enzymes were overexpressed and their nitroreductase activities were tested in 
biotransformations. 
Biocatalytic reduction of aromatic nitro compounds with E. coli protein extracts 
showed poor amine product formation, however the conversion of substrates was 
significant. A high background activity was observed even for the strain expressing empty 
vector, which might be a result of activity of endogenous E. coli nitroreductases. Two types 
of nitroreductases have been identified in this organism, oxygen-insensitive and oxygen-
sensitive (Linwu et al., 2009). However none of them was ever examined for reduction of 
aromatic nitro compounds tested in this study.  
The most probable route for aromatic nitro group reduction is by addition of pair of 
electrons forming nitroso and hydroxylamino intermediates before forming the amine 
group (Roldán et al., 2008; Fig. 6.3.). Moreover, nitroso and hydroxylamino groups can form 
an azoxy intermediate as a result of spontaneous dehydration (Yanto et al., 2010). Some of 
the substrates can also undergo side reactions such as dechlorination or demethylation 
(Dipeolu, 2008). 
 
Fig. 6.3. Proposed reaction scheme for nitrobenzene reduction (adapted from Yanto et al., 2010). 
 
The presence of the recombinant C. sporogenes nitroreductase (CsNTR1 and 3-7) 
did not significantly change substrate conversions or amine product yields when compared 
to the control reactions. However, CsNTR nitroreductases were expressed and tested 
separately. It cannot be excluded that in C. sporogenes, CsNTR reductases act synergistically 
and different enzymes are responsible for different stages of reduction of nitro groups to 
amines. Using the current analytical method, intermediates of the nitro reduction could not 
be identified as protein cell-free extracts were used as biocatalysts, which gave high 
background in the gas chromatography analysis, and no analytical standards were available 
to determine their retention times. Therefore, C. sporogenes nitroreductases should be 
purified and their activity towards reduction of aromatic nitro compounds and 
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intermediates will be tested separately and as a blend. Alternatively, the nitroreductases 
could be co-expressed and tested in whole cell biotransformations. 
6.3. Outlook for bio-nylon derived from renewable feedstock 
Nylon 6 fibres are used in a broad range of products requiring strength and 
elasticity (Mark, 2009). Currently, Nylon 6 is synthesised by ring- opening polymerization of 
ɸ-caprolactam at 260°C under atmosphere of nitrogen. There are a few disadvantages of 
using caprolactam as the substrate for the synthesis of Nylon. For the industrial scale 
caprolactam can be synthesized from cyclohexenone (by condensation with hydroxylamine 
followed by acid-catalyzed rearrangement of an oxime to an amide; Gawley, 1988) or 
cyclohexane (by synthesis of cyclohexenone oxime by photoreaction of nitrosyl chloride; 
Naylor and Anderson, 1953). Thus, the substrates for caprolactam synthesis are derived 
mainly from non-renewable resources such as petroleum and other fossil fuels. Moreover, 
in contrast to 6-aminocaproic acid (a monomer of Nylon), caprolactam has been annotated 
as a carcinogenic substance. However, its harmfulness is not clear and now being 
questioned by International Agency for Research on Cancer (http://monographs.iarc.fr/ 
ENG/Classification/ClassificationsAlphaOrder.pdf; 2012).  
 The method of 6-aminocaproic acid biosynthesis presented in this thesis has a 
major advantage over the currently used Nylon synthesis route. It starts from L-lysine 
which, in contrast to caprolactam, is a renewable resource and has been manufactured 
using genetically engineered Corynebacterium glutamicum with production exceeding 
750,000 tons per year in 2006 (Pfefferle et al., 2003; Wittmann and Becker, 2007). 
Conversion of L-lysine to pipecolic acid by lysine cyclodeaminase followed by reduction to 
6-aminocaproic acid by D-proline reductase would provide a simple and carbon efficient 
route, which fulfils the main principles of the green chemistry (Anastas and Warner, 1998). 
The expression of D-proline reductase was successfully induced in C. sporogenes 
and the enzyme was tested for reduction of D- and L-pipecolic acid. Although the crude 
extracts of DSM795 reduced proline to 5-aminovaleric acid, the enzyme did not show any 
activity towards pipecolic acid.  
Initially, growth experiments in minimal medium showed that the presence of 
pipecolic acid significantly increased the growth rate and biomass production of C. 
sporogenes. However, it was not accepted by D-proline reductase as a substrate and could 
not serve as the electron acceptor for energy conservation in the Stickland fermentation. 
D,L-Pipecolic acid was never reported to be an intermediate in any of clostridial metabolic 
pathways. Pipecolic acid is an important precursor of microbial secondary metabolites such 
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as immunosuppressant rapamycin, the antitumor agent swainsonine, the peptide antibiotic 
virginiamycin and the anthelmintic agent marcfortine (He, 2006). In Pseudomonas putida 
and human brain pipecolic acid is involved in L-ůǇƐŝŶĞ ĚĞŐƌĂĚĂƚŝŽŶ ƉĂƚŚǁĂǇ ƚŽ ɲ-
aminoadipate, which is subsequently converted via glutaryl-CoA to acetyl-CoA (IJlst et al., 
2000; Revelles et al., 2005). Since Clostridia metabolize L-lysine to acetate, butyrate and 
ammonia via a cleavage of the six-carbon chain (Barker, 1981), the presence of the former 
metabolic pathway is unlikely. Thus, the stimulatory effect of pipecolic acid on the C. 
sporogenes growth remains unclear and requires further analysis such as footprints of 
cultures grown on pipecolic acid. 
To make the 6-aminocaproic acid biosynthesis route feasible two conditions need 
to be met. At first, a route for D-pipecolic acid synthesis needs to be established as all 
existing routes for converting lysine into pipecolic acid result in formation of the L-
enantiomer (Fig. 6.4.).  
 
Fig. 6.4. Possible routes for biocatalytic synthesis of pipecolic acid (Miller and Rodwell, 1971; He, 
2006). Enzymes: 1. L-lysine cyclodeaminase; 2. saccharopine synthase and saccharopine oxidase; 3. 
spontaneous reaction; 4. ȴ ?-pyrroline-5-carboxylate reductase; 5. L-lysine ɸ-aminotransferase; 6. L-
ůǇƐŝŶĞɲ-oxidase; 7. spontaneous rection; 8. ȴ ?-piperideine-2-carboxylate reductase. 
 
The proline racemase, which is responsible for interconversion of L- and D-proline 
(Stadtman and Elliott, 1957), needs to be tested for activity towards L- and D-pipecolic acid. 
C. sporogenes protein extracts will be incubated with a solution of L-pipecolic acid and the 
rotation of the polarized light will be determined. A note must be made that pipecolic acid 
was found to have an inhibitory effect on the activity of homologous proline racemase from 
C. sticklandii (Cardinale and Abeles, 1968). Therefore, another route for D-pipecolic acid 
synthesis must be considered. D-Pipecolic acid can possibly be obtained by oxidation of L-
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ůǇƐŝŶĞɲ-amino group (Fig. 6.4., reaction 6.) followed by enantioselective hydrogenation of 
ŝŵŝŶĞ ?ȴ ?-piperideine-2-carboxylate, using a chiral transition metal catalyst (Willoughby and 
Buchwald, 1992). However, this method would employ a chemical reaction step and make 
the synthesis route more complex and less environmentally friendly. 
The second challenge that needs to be accomplished is evolution of the D-proline 
reductase to accept pipecolic acid as a substrate for the reductive cleavage of the ring. 
Naturally occurring enzymes are shown to be excellent biocatalysts, but many of their 
properties need to be tailored to fulfil requirements of specific applications. Thus, protein 
engineering methods are used to alter enzymes properties such as activity, selectivity, 
specificity, stability and solubility (Rubin-Pitel and Zhao, 2006). Using rational design 
approach is technically easy and inexpensive. However, the limited knowledge about the 
structure of D-proline reductase and the mechanism of enzyme catalysis may make this 
method unsuitable. On the other hand, random mutagenesis using directed evolution does 
not require structural knowledge of a protein, but analysis of large numbers of mutants is 
essential (Reetz, 2011). The fluorescence method for detection of 6-aminocaproic acid 
described in this thesis can be easily adapted to a high-throughput format and used for 
screening of reductases accepting D-pipecolic acid as a substrate. This approach can also be 
used to change the enantioselectivity of the D-proline reductase to make it accept L-
enantiomers of proline and pipecolic acid, which would limit the whole biosynthetic 
pathway just to two reactions (Reetz, 2011). 
6.4. Conclusions 
As a whole, the presented work revealed interesting aspects of C. sporogenes 
physiology and enzymatic activities that were not previously reported. It has given a new 
insight into the metabolic pathway by which C. sporogenes obtains carbon and energy for 
growth on certain amino acids. This can be used for better understanding of metabolism of 
Clostridia and potentially result in generation of the new medicines against clostridial 
pathogens. The fldZ reductase was succesfully overexpressed and was shown to be an 
efficient biocatalyst in the enantioselective reduction of nitroolefins and hydrogenation of 
aromatic enoates. That allows clostridial enoate reductases to be fully exploited in industial 
applications. A new idea about using clostridial enzymes for biosynthesis of Nylon 6 from 
renewable feedstocks has also been presented. Even though attempts to oxerexpress and 
characterize novel C=C double bond and aromatic nitro group reductases have met with the 
limited success, C. sporogens turns out to be a very promising subject for futher research as 
a source of industrially desirable enzymes. 
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8. Appendices 
8.1. Generation of C. sporogenes fldZ knockout mutant 
C. sporogenes DSM795 fldZ knockout mutant was designed and generated by Dr. 
Benjamin Blount and Prof. Nigel Minton (Clostridia Research Group, Centre for 
Biomolecular Sciences, University of Nottingham). To create the strain with the inactivated 
gene encoding the clostridial enoate reductase, the first generation ClosTron mutagenesis 
method was chosen as the most efficient and convenient one (Heap et al., 2007). The data 
in section 8.1. were provided by Dr. Benjamin Blount. 
8.1.1. Sequencing of fldZ gene in C. sporogenes DSM795 
A 969 bp region of fldZ was PCR amplified on genomic DNA from C. sporogenes 
DSM795 using the FailSafe PCR system with primers designed using the C. botulinum Hall A 
ATCC3502 sequence (primers ENR-F1 and ENR-R1 897 - 1865 bp). PCR product was agarose 
gel purified and excised.  Gel band was purified using a QIAGEN gel extraction kit.  The PCR 
product was then sequenced using the ENR-F1 and ENR-R2 primers.  The 949 bp region was 
successfully sequenced as follows: 
>fldZ C. sporogenes DSM 795 (partial sequence) 
TCCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGCTTTGGTAGAGTAAGTATACCATCT
ATTGTAGGAAAAGTGGCAGTAGCACCTTCTAAAATTCCACATAGATTTTTACCAGGAGTAACTTGTCG
TGAGTTAACTACAGAAGAAGTAAAAGAATATGTAAAAGCCTTTGGTGAATCAGCAGAAATTGCAAAAA
AAGCCGGATTTGATGGTGTAGAAATTCATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATT
TCTTTCTTTAACCATCGTACTGATGAATATGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGA
GGTTGTACAAGAAATTAAGAAACGTTGTGGACAAGACTTCCCAGTTTCACTTAGATACAGTATAAAAA
GCTTCATTAAGGATTGGTGTAAGGGTGGCTTACCAGATGAAGAATTTGAAGAAAAAGGAAGAGATATT
CCAGAAGGAATTGAAGCTGCTAAAATACTTGTTGCAGCAGGATATGATGCTTTAAATGGAGATGTTGG
GTCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACCTTCCATACA
ATGAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCAGGAAGAATGGAAGACCCTGAACTA
TCAAGTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGGCCACTTCTTGCAGATGC
AGAAATTCCAAATAAGATTTTTGAAGATAAATATGATAAAGTTAGACCTTGTTTATCTTGTCAAGAAG
GGTGTATGGGAAGATTACAGAATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAA
AAAGAGTATGGACTAAAAAAAGCAGAACAGATTAAGAAAGTTCTTGTTGTAGGTGGCGGTGTTGC 
 
8.1.2. Retargeting pMTL007C-E2 
The C. sporogenes fldZ fragment sequence was entered into the intron design tool, 
using the Perutka algorithm (access at http://clostron.com).  The output for the best hit was 
as follows: 
Sequence       Pos  Score 
-30                           +1          +15 
AATGAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCA 641|642s 6.158 
 
fldZ-IBS: AAAAAAGCTTATAATTATCCTTAGTAGTCGATGTAGTGCGCCCAGATAGGGTG 
fldZ-EBS1d: CAGATTGTACAAATGTGGTGATAACAGATAAGTCGATGTACCTAACTTACCTTTC-
TTTGT 
fldZ-EBS2: TGAACGCAAGTTTCTAATTTCGATTACTACTCGATAGAGGAAAGTGTCT 
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Expected fldZ targeting region (PCR product): 
AAAAAAGCTTATAATTATCCTTAGTAGTCGATGTAGTGCGCCCAGATAGGGTGTTAAGTCAAGTAGTT
TAAGGTACTACTCTGTAAGATAACACAGAAAACAGCCAACCTAACCGAAAAGCGAAAGCTGATACGGG
AACAGAGCACGGTTGGAAAGCGATGAGTTACCTAAAGACAATCGGGTACGACTGAGTCGCAATGTTAA
TCAGATATAAGGTATAAGTTGTGTTTACTGAACGCAAGTTTCTAATTTCGATTACTACTCGATAGAGG
AAAGTGTCTGAAACCTCTAGTACAAAGAAAGGTAAGTTAGGTACATCGACTTATCTGTTATCACCACA
TTTGTACAATCTG 
 
 
 The insertion was targeted between bases 641 and 642 of the fragment in a sense 
direction.  This corresponded to bases 936 and 937 of the full gene. Alternative unused sites 
were as follows: 
 
GCCGGATTTGATGGTGTAGAAATTCATGCAGTACATGAAGGATAC 236|237s 5.699 
AATATGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAGG 327|328s 5.676 
CTGCTGATTCACCAAAGGCTTTTACATATTCTTTTACTTCTTCTG 162|163a 5.622 
GGAAAAACAGATATGATTGCTTTAGGAAGGCCACTTCTTGCAGAT 731|732s 5.359 
ATTGAAGCTGCTAAAATACTTGTTGCAGCAGGATATGATGCTTTA 515|516s 5.308 
CTTCTTGCAGATGCAGAAATTCCAAATAAGATTTTTGAAGATAAA 764|765s 5.291 
TAGCAAATTGATCTAATAAGTATCCTTCATGTACTGCATGAATTT 240|241a 5.081 
CCACTTCTTGCAGATGCAGAAATTCCAAATAAGATTTTTGAAGAT 761|762s 4.979 
TTTCACGTCCACAGGCAGGATTTACTGCACAGGATACTGTTGCAA 855|856a 4.707 
GCAGAAATTGCAAAAAAAGCCGGATTTGATGGTGTAGAAATTCAT 218|219s 4.220 
AGAATGGAAGACCCTGAACTATCAAGTGATGCAATTTTGTCAGGA 689|690s 3.680 
AATACCATGAATCATAAGACCCAACATCTCCATTTAAAGCATCAT 534|535a 3.415 
TATCAGCAGGCTTTGGTAGAGTAAGTATACCATCTATTGTAGGAA 63|64s 3.391 
TTTGAAGAAAAAGGAAGAGATATTCCAGAAGGAATTGAAGCTGCT 482|483s 3.318 
CATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATTTCT 260|261s 3.316 
GATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTGCAGCA 500|501s 3.192 
TTCCTTCTGGAATATCTCTTCCTTTTTCTTCAAATTCTTCATCTG 456|457a 3.131 
CTCCATTTAAAGCATCATATCCTGCTGCAACAAGTATTTTAGCAG 507|508a 3.101 
GAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCAGGA 644|645s 2.984  
 
The fldZ targeting vector pMTL007C-E2::Csp-fldZ-936s was synthesised by Eurofins 
Genetic Service. 
8.1.3. Insertional inactivation of fldZ 
Initially pMTL007C-E2::Csp-fldZ-936s was transformed into E. coli TOP10 and then 
subsequently into the E. coli CA434 conjugal donor strain by electroporation.  A stationary 
overnight culture of E. coli CA434 pMTL007C-E2::Csp-fldZ-936s was centrifuged, washed 
with PBS buffer and re-suspended with stationary overnight C. sporogenes DSM795.  The 
mixture was spotted onto anaerobic 1% agar TYG media and incubated anaerobically for 8 
h. Plates were washed with phosphate saline buffer (PBS) and the resultant slurry was 
plated onto TYG agar with cycloserine (250 ʅg/mL) to select against the E. coli donor and 
thiamphenicol (15 ʅg/mL) to select for recipients of the plasmid. Plates were incubated 
anaerobically for 48 h and thiamphenicol resistant colonies were re-streaked onto TYG agar 
with cycloserine (250 ʅg/mL) and erythromycin (10 ʅg/mL) to select for insertion of the 
intron. 
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Six erythromycin resistant colonies were selected and genomic preparations were 
performed on overnight cultures. The cultures were spun down, resuspended in 5% Chelex 
100, boiled at 100°C for 10 min and then spun down again.  The supernatants were 
transferred to fresh microtubes. PCR screening was performed on the genomic 
preparations to determine correct insertion with primer pairs as follows: 
F-junction screening: 
ENR-)¶± GACAGAAAGAGTCCATGCATATGG ± ¶ 
(%68QL¶± CGAAATTAGAAACTTGCGTTCAGTAAAC ± ¶ 
 
R-junction screening: 
ENR-5¶± TCCATTCCTGCAACACCGCCACC ± ¶ 
ErmRAM-5¶± ACGCGTGCGACTCATAGAATTATTTCCTCCCG ± ¶ 
 
Flanking screening: 
ENR-)¶± GACAGAAAGAGTCCATGCATATGG ± ¶ 
ENR-R1: ¶± TCCATTCCTGCAACACCGCCACC ± ¶ 
 
ErmRAM Screening: 
ErmRAM-)¶± ACGCGTTATATTGATAAAAATAATAATAGTGGG ± ¶ 
ErmRAM-5¶± ACGCGTGCGACTCATAGAATTATTTCCTCCCG ± ¶ 
 
Two of the colonies (fldZ::CTerm B and E) showed a band of a size approximate to 
the 871 bp product expected for the F-junction screening (Fig. 8.1). There were no bands 
present in the R-junction screening. The two colonies did not show a wild type band in the 
flanking screen, indicating that the gene has been interrupted.   
 
 
Fig. 8.1. Electrophoresis of the PCR products. Reaction mixtures (10 ʅL) were run on 1% agarose gel 
with NEB 2-log ladder (M). F-junction screen PCR templates: 1  ? fldZ::CTermB, 2  ? C. sporogenes 
DSM795, 3 - pMTL007C-E2::Csp-fldZ-936s, 4  ? dH2O.  R-junction screen PCR templates: 5  ? 
fldZ::CTermB, 6  ? C. sporogenes DSM795, 7 - pMTL007C-E2::Csp-fldZ-936s, 8  ? dH2O.   
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The ErmRAM screen yielded a product of 900 bp and no 1300 bp product indicating 
that the only ErmRAM present was that in the insertion and that the strains had been cured 
of the plasmid (Fig. 8.2).   
 
Fig. 8.2. Electrophoresis of PCR products. Reaction mixtures (10 ʅL) were run on 1% agarose gel with 
NEB 2-log ladder (M). Flanking screen PCR templates: 1  ? fldZ::CTermB, 2  ? C. sporogenes DSM795, 3 
- pMTL007C-E2::Csp-fldZ-936s, 4  ? dH2O.  ErmRAM screen PCR templates: 5  ? fldZ::CTermB, 6  ? C. 
sporogenes DSM795, 7 - pMTL007C-E2::Csp-fldZ-936s, 8  ? dH2O.   
 
To confirm this, the strains were restreaked onto thiamphenicol selective media 
and showed no growth. The PCR product from the F-junction screening was sequenced by 
using the ENR-F1 and EBSUni primers (Fig. 8.3). 
 
 
Fig. 8.3. Sequencing of F-junction screening PCR product using ENR-F1 and EBSUni primers:  
1 and 2  ? fldZ::CTermB colony B EBSUni and ENR-F1 sequencing reads, 3  ? fldZ::CTermB colony E 
ENR-F1 sequencing read, 4  ? C. sporogenes fldZ ƐĞƋƵĞŶĐĞ  ? ? ŽĨ ŝŶƐĞƌƚŝŽŶ, 5  ? ClosTron insert 
sequence, 6  ? consensus sequence. 
 
The sequencing confirmed that integration of the intron into fldZ gene was 
successful. Colony B was stored at -80°C as C. sporogenes DSM 795 fldZ::CTermB. 
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8.2. Optimization of the C. sporogenes high-throughput growth experiments 
Nephelometry is a method of measuring light scattered by particles suspended in 
solutions at right angles to the light beam (Fig. 8.4.). It is widely used in different analytical 
approaches in clinical immunology, drug discovery and clinical chemistry. It was also found 
to be useful in the monitoring of microbial growth in high-throughput systems (Angersbach 
et al., 2005).  
 
 
Fig. 8.4. Diagram presenting the principle of NEPHELOstar measurement (Angersbach et al., 2005). A 
clear solution (on the left hand side) causes minimal light scattering resulting in low nephelometry 
signal. High density solution with particles scatters the light and results in high signal (right).  
 
 
The NEPHELOstar (BMG LABTECH) is a microplate nephelometer using a red laser 
diode (633 nm) as the light source. It was shown that data obtained by measuring 
scattering of light using a nephelometer were comparable to optical density readings using 
a transmission reader. A good correlation between the two methods was shown for 
Corynebacterium glutamicum, a linear correlation up to OD600nm 4 (Angersbach et al., 2005), 
and Clostridium tyrobutiricum (Rebros et al., 2009). 
To test the correlation between optical density readings at 660 nm using a 
spectrophotometer (polystyrene cuvettes, 10 mm pathlength, Agilent 8453 
spectrophotometer) and nephelometry measurements in 96-well plates using a 
NEPHELOstar, C. sporogenes DSM795 was grown in TYG medium. Overnight cultures were 
centrifuged, the residual medium was decanted and the cells were washed with 50 mM 
potassium phosphate buffer pH 7.0. The cells were centrifuged again and resuspended in 
the same buffer to give an OD660 nm 2.5. A series of dilutions in the buffer was prepared to 
give samples in a range of OD660 nm from 0.1 to 2.1. The samples (200 µL) were transferred 
into the wells of a 96-well plate (Corning) and the nephelometry signal was measured using 
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a NEPHELOstar plate reader. The nephelometry signal was also determined when the plate 
was covered with a Breathe-Easy film (Diversified Biotech) and a lid (Fig. 8.5.). 
 
 
Fig. 8.5. Correlation between optical density of C. sporogenes DSM795 and nephelometry signal 
measured by a NEPHELOstar plate reader.   
 
It was shown that there is a good correlation between these two analytical 
methods up to OD660 1. For optical densities higher than 1.5, the device reached the highest 
level of sensitivity resulting in almost constant nephelometry signal. Presence of the 
Breathe-Easy film significantly increased the background of the measurement when 
compared with the plate only and the plate covered with a lid. Although it made the 
measurement less sensitive for low concentrated samples, a Breathe-Easy film was used in 
the experiments to provide necessary sterility of the wells, prevent cross-contamination 
between different wells of one plate and prevent loss of samples by evaporation.   
A NEPHELOstar allows the operator to set the laser diode parameters such as 
intensity of the beam (gain, from 0 to 240) and its diameter (beam focus, from 0.5 to 4.5 
mm). Both factors were optimized to give the best correlation between the nephelometry 
signal and the optical density of C. sporogenes cells in the range of OD660 nm from 0 to 1 (Fig. 
8.6 and 8.7). For the determination of laser intensity, the nephelometry signal was 
normalized to the signal of a sample with OD660 nm 0.85. The low laser gain (10-30) showed 
decreased slope of the calibration curve what lowered the sensitivity of the measurement. 
When the gain was increased to 40 and more no further improvement of the sensitivity was 
observed. A similar experiment with changing the laser beam width showed that the best 
correlation occurs for the beam set to 2.0 mm. Both parameters (gain 40 and beam focus 
2.0 mm) were used in the subsequent C. sporogenes growth experiments. 
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Fig. 8.6. Correlation between the nephelometry signal and optical density (660 nm) at 
different laser intensities of the NEPHELOstar diode. Values were normalized (as 100%) 
to the nephelometry signal of the sample with OD660 nm 0.85.  
 
 
Fig. 8.7. Correlation between the nephelometry signal and optical density (660 nm) at 
different laser bean width (from 1.5 to 3.5 mm). 
 
 
To prove that NEPHELOstar can be used as a reliable device for monitoring of C. 
sporogenes growth under anaerobic conditions, the plate reader was placed in an 
AtmosBag (Sigma, size L) and flushed with nitrogen for 2 h before use. In the anaerobic 
cabinet C. sporogenes DSM795 pre-culture in TYG medium (10 mL) was started from a 
single colony taken from a TYG agar plate and cultivated overnight at 30°C with shaking. 
The pre-culture (from 0 to 800 µL) was used to inoculate experimental cultures in TYG 
medium (final volume 10 mL). After short adaptation phase (1 h at 30°C with shaking, 200 
rpm) the cultures (200 µL) were transferred into wells of a sterile 96-well plate and the 
wells were sealed using a Breathe-Easy film. The plate was taken out of the anaerobic 
cabinet and transferred into a NEPHELOstar plate reader. The cultures were incubated at 
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30°C for 24 h with orbital shaking (shaking width 4 mm). The light scattering in the wells 
was measured every 20 min (2 s per well, period delay 0.5 s). The gain was set at 40, with 
the laser beam focus at 2.5 mm. The average of growth curves of the triplicate cultures are 
presented in Fig. 8.8. 
 
 
Fig. 8.8. Growth curves of C. sporogenes DSM795 obtained from monitoring cell 
growth by laser nephelometry. The series present the volume of the pre-culture used 
for inoculation of the experimental culture. The data present an average of at least 
three independent samples. 
 
Reproducible growth curves were obtained up to the value of 2000 relative 
nephelometry units. Later, some fluctuation of the growth curves occurred probably due to 
flocculation of high density microbial cultures (characteristic for C. sporogenes DSM795) 
and condensation of water beneath the Breathe-Easy film. The described application 
showed that NEPHELOstar can be used to successfully and rapidly monitor C. sporogenes 
cell growth in 96-well plates. 
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8.3. Dry-weight biomass calibration curve for C. sporogenes 
To determine the standard biomass calibration curve, a 500 mL culture of C. 
sporogenes DSM795 was maintained until the early stationary phase of growth. The culture 
was centrifuged at 10000 rpm for 10 min, the residual medium was decanted and the cells 
were resuspended in deionised water to the theoretical OD660nm value 10 based on the OD 
readings of the growing culture (UVmini 1240, Shimadzu). A series of dilutions was 
prepared in a range of optical density values from 0.5 to 8. OD660nm of samples was 
measured again using the UV spectrophotometer to avoid pipetting errors leading to 
volume discrepancies. The samples were transferred to pre-dried and pre-weighed 27 mL 
glass vials. The vials were dried to constant weight (for about 48 h) and the OD values were 
plotted against the dry-weight values for each sample (Fig. 8.9.).  
 
 
Fig. 8.9. Standard curve of optical density versus cell dry weight 
of C. sporogenes DSM795. 
 
By linear regression it was shown that 1 mg/mL of the C. sporogenes dry biomass 
equals to 2.3 units of OD660nm. This value is similar to the data obtained by Dipeolu, 2005 
and Mordaka, 2010. 
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8.4. Protein assay calibration curve (an example) 
Total protein concentration in the samples was determined by using DC Protein 
Assay (Bio-Rad). Bovine serum albumin protein standard (BSA; Bio-Rad or Sigma) was 
dissolved in the same buffer as used for the preparation of experimental samples.  Some of 
the protein extraction buffers contained different concentrations of reducing agents (such 
as DTT, THP), cofactors (FMN, FAD) or detergents (BugBuster), which changed the 
sensitivity and background of the assay. To avoid errors, the calibration curve was freshly 
prepared for each experiment together with the unknown protein samples. BSA (2 mg) was 
dissolved in the buffer (1 mL) and a series of dilutions was prepared (from 0.2 to 1.5 
mg/mL). Each sample (0.1 mL) was transferred into a clean and dry 15 mL test tube and 
ŵŝǆĞĚǁŝƚŚZĞĂŐĞŶƚ ? ? ? ?5 mL) and Reagent B (4 mL). After 15 min incubation, absorbance 
at 750 nm was determined using the spectrophotometer (Agilent 8453). An example of the 
protein assay calibration curve is presented in Fig. 8.10. 
 
 
Fig. 8.10. An example of the protein assay calibration curve. The trend 
line equation was determined to be y = 0.125x + 0.019. 
 
The trend line was determined using a linear regression approach. The 
concentrations of the unknown protein samples in the range between 0.2 and 1.5 mg/mL 
were calculated based on the equation of the trend line.  
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8.5. Calibration curves for cinnamic acid and 3-phenylpropionic acid 
Calibration curves of cinnamic and 3-phenylpropionic acid were prepared according 
to the method presented in section 4.2.8.2. 
1. Calibration curve for cinnamic acid (derivatized with (trimethylsilyl)diazomethane, peak 
area was normalized to the peak area of the internal standard, tert-butylbenzene):  
 
Fig. 8.11. Calibration curve for cinnamic acid. 
 
2. Calibration curve for 3-phenylpropionic acid (derivatized with (trimethylsilyl) 
diazomethane, peak area was normalized to the peak area of the internal standard, tert-
butylbenzene):  
 
 
Fig. 8.12. Calibration curve for 3-phenylpropionic acid. 
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8.6. Calibration curves for aromatic nitro reduction 
Calibration curves for substrates and products of the aromatic nitro reduction 
biotransformation were prepared as described in section 4.2.8.4. The peak areas were 
normalized to the peak area of the internal standards, limonene (for heptane fraction) or 
3,4-diaminotoluene (for aqueous fraction). 
1. Calibration curves for nitrobenzene and aniline: 
 
 
Fig. 8.13. Calibration curve for aniline (භ ) ĂŶĚ ŶŝƚƌŽďĞŶǌĞŶĞ  ?Ŷ) in the 
heptane phase. 
 
 
Fig. 8.14. Calibration curve for aniline  ?භ )in the aqueous phase. 
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2. Calibration curve for 2-chloronitrobenzene and 2-chloroaniline: 
 
Fig. 8.15. Calibration curve for 2-chloroaniline  ?භ ) ĂŶĚ  ?-
chloronitrobenzene (Ŷ) in the heptane phase. 
 
3. Calibration curve for 3-chloronitrobenzene and 3-chloroaniline: 
 
Fig. 8.16. Calibration curve for 3-chloroaniline  ?භ ) ĂŶĚ  ?-
chloronitrobenzene (Ŷ) in the heptane phase. 
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4. Calibration curve for 4-chloronitrobenzene and 4-chloroaniline: 
 
Fig. 8.17. Calibration curve for 4-chloroaniline  ?භ ) ĂŶĚ  ?-
chloronitrobenzene (Ŷ) in the heptane phase. 
 
5. Calibration curves for 2,4-dinitrotoluene and 2,4-diaminotoluene: 
 
 
Fig. 8.18. Calibration curve for 2,4-dinitrotoluene (Ŷ) in the heptane 
phase. 
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Fig. 8.19. Calibration curve for 2,4-diaminotoluene (භ) in the aqueous 
phase. 
 
6. Calibration curves for 1-chloro-2,4-dinitrobenzene and 4-chloro-1,3-diaminobenzene: 
 
Fig. 8.20. Calibration curve for 1-chloro-2,4-dinitrobenzene (Ŷ) in the 
heptane phase. 
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Fig. 8.21. Calibration curve for 4-chloro-1,3-diaminobenzene (භ) in the 
aqueous phase. 
 
7. Calibration curves for p-nitroanisole and p-anisidine: 
 
Fig. 8.22. Calibration curve for p-nitroanisole (Ŷ) in the heptane phase. 
 
 
Fig. 8.23. Calibration curve for p-anisidine (භ) in the aqueous phase. 
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8.7. Partial purification of (E)-2-nitro-1-phenylpropene reductase from C. sporogenes  
An attempt to purify the reductase was performed by Dr. Karl Fisher, Manchester 
Interdisciplinary Biocentre, University of Manchester, UK. C. sporogenes DSM795 was 
grown in the Giesel medium (2 L) supplemented with 12.1 mM L-phenylalanine as the 
growth substrate. Overnight culture was harvested and cell-free protein extracts were 
prepared using a French press under a flow of nitrogen. To the extract solid ammonium 
sulphate was added until 56% saturation. The suspension was stored for 1 h and 
centrifuged at 26500 x g for 20 min. The supernatant was loaded onto DEAE-Sepharose 
column and the enzyme was separated by elution with the elution buffer (50 mM 
potassium phosphate buffer, pH 7.5; 0.1 mM EDTA; sucrose, 85.6 g/L; 0.01% v/v 2-
mercaptoethanol). The protein fractions showing activity towards 2-nitro-1-phenylpropene 
in the spectrophotometric reduction assay were applied to hydrophobic interaction 
chromatography (HIC) column. The proteins were eluted using a gradient 0-100% B of 
elution buffers A (20 mM sodium phosphate, pH 7.0 + 1.0 M ammonium sulphate) and B 
(20 mM sodium phosphate, pH 7.0). Protein fractions (7.5 mL) from A1 to C12 were tested 
in the biphasic phenylnitroalkene reduction biotransformation (Fig. 8.24). 
 
 
Fig. 8.24. Results of the phenylnitroalkene reduction biotransformation. Protein fractions from A1 to 
C12 were used to reduce 1.7 mM (E)-2-nitro-1-phenylpropene in the expense of NADH. Columns 
represent product and substrate concentrations after 24 h. The line represents the enantiomeric 
excess of the products. 
 
Further steps of the 2-nitro-1-phenylpropene reductase purification and 
determination of its amino acid sequence were unsuccessful due to a loss of the enzymatic 
activity. However, results of the phenylnitroalkene biotransformation after purification 
using a HIC column showed that C. sporogenes DSM795 possessed multiple enzymes 
reducing 2-nitro-1-phenylpropene with different enantioselectivities. 
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8.8. Identification of fldZ gene in C. sporogenes 
8.8.1. Fragment of C. sporogenes fldZ gene identified during creation of the fldZ enoate 
reductase mutant:  
 
>Csp795.fldZ.949bp 
TCCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGCTTTGGTAGAGTAAGTATACCATCTATTGTAGG
AAAAGTGGCAGTAGCACCTTCTAAAATTCCACATAGATTTTTACCAGGAGTAACTTGTCGTGAGTTAACTACAGAA
GAAGTAAAAGAATATGTAAAAGCCTTTGGTGAATCAGCAGAAATTGCAAAAAAAGCCGGATTTGATGGTGTAGAAA
TTCATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATTTCTTTCTTTAACCATCGTACTGATGAATATGG
TGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAGGTTGTACAAGAAATTAAGAAACGTTGTGGACAAGACTTC
CCAGTTTCACTTAGATACAGTATAAAAAGCTTCATTAAGGATTGGTGTAAGGGTGGCTTACCAGATGAAGAATTTG
AAGAAAAAGGAAGAGATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTGCAGCAGGATATGATGCTTTAAA
TGGAGATGTTGGGTCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACCTTCCA
TACAATGAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCAGGAAGAATGGAAGACCCTGAACTATCAA
GTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGGCCACTTCTTGCAGATGCAGAAATTCCAAA
TAAGATTTTTGAAGATAAATATGATAAAGTTAGACCTTGTTTATCTTGTCAAGAAGGGTGTATGGGAAGATTACAG
AATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAAAAAGAGTATGGACTAAAAAAAGCAGAAC
AGATTAAGAAAGTTCTTGTTGTAGGTGGCGGTGTTGC 
 
8.8.2. Amino acid sequence encoded by Csp.fldZ.949bp DNA fragment: 
>Csp795.fldZ.949bp 
HAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGESAEIAKKAGFDGVEI
HAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVSLRYSIKSFIKDWCKGGLPDEEFE
EKGRDIPEGIEAAKILVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAGRMEDPELSS
DAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLKKAEQ
IKKVLVVGGGV 
 
8.8.3. Amino acid sequence of fldZ enoate reductase from C. sporogenes ATCC15579 
(CLOSPO_02780) 
 
>Csp15579.fldZ 
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALP
SMPCPTINPLNFITTGNEMTERVHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVK
EYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKCCGQDFPVS
LRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVSAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNE
ILKKVVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFA
TVSCAVNPACGREKEYGLKKAEQIKKVLIVGGGVAGMEAARVAAIRGHKVTLIEKNGYLGGNIVPGGVPDFKDDDR
ALVKWYEGILKDLGVEIKLNVDASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVLMERKNVGEKVIVIG
GGLVGCETALWLKQQGKEVTIVEMQNDILQVGGPLCHANHDMLNDLIKFNKIDVKTSSYITKKTDKGFVLNTDGQE
SIINADSAVVAIGYLSEKDLYSEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI 
 
8.8.4. FldZ enoate reductase gene from C. sporogenes ATCC15579: 
 
>Csp15579.fldZ 
ATGAAGGATAAGTATAAGGTACTTTATGACCCAATTAAAATTGGAAAATTGGAGATTAAAAATAGATATGTTCTTG
CTCCAATGGGACCAGGAGGAATGTGTAACGCCGATGGTAGTTTTAATAAAAGAGGAATTGAGTTTTATGTAGAACG
TGCAAAAGGCGGAACTGGATTAATTATGACAGGTGTAACAATGGTAGAAAATAATATTGAAAAATGTGCCCTGCCA
TCTATGCCATGTCCAACAATTAACCCTTTAAACTTTATTACAACAGGTAACGAAATGACAGAAAGAGTTCATGCAT
ATGGATCAAAAATATTTTTACAATTATCAGCAGGATTTGGTAGAGTAAGTATACCATCTATTGTAGGAAAAGTAGC
AGTAGCACCTTCTAAAATTCCACACAGATTTTTACCAGGAGTAACCTGTCGTGAGTTAACTACAGAAGAAGTAAAA
GAATATGTAAAAGCATTTGGTGAATCAGCAGAAATTGCAAAAAAAGCTGGATTTGATGGTGTGGAAATTCATGCAG
TACATGAAGGATACTTATTAGATCAATTTGCTATTTCTTTCTTTAATCATCGTACTGATGAATATGGTGGATCATT
AGAAAATCGTTTAAGATTTGCCTGTGAAGTTGTACAAGAGATTAAGAAATGTTGTGGACAAGACTTCCCAGTTTCA
CTTAGATACAGTATTAAGAGCTTCATTAAGGATTGGTGTAAGGGCGGCTTACCGGATGAAGAATTTGAAGAAAAGG
GAAGAGATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTTCAGCAGGATATGATGCGCTAAATGGAGACGT
TGGATCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACCTTCCATACAATGAA
ATACTTAAAAAGGTAGTAGACGTACCTATTATTACAGCAGGAAGAATGGAAGATCCTGAACTATCAAGTGATGCAA
TTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGACCACTTCTTGCAGATGCAGAAATTCCAAATAAAATCTT
TGAAGATAAATATGATAAAGTTAGACCTTGCTTATCTTGTCAGGAAGGATGTATGGGAAGATTACAGAATTTTGCA
ACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAAAAGGAGTATGGACTAAAAAAAGCAGAACAGATTAAGA
AAGTTCTTATTGTAGGTGGCGGTGTTGCAGGAATGGAAGCCGCAAGAGTTGCAGCTATTCGTGGACATAAAGTAAC
ATTGATTGAAAAGAATGGTTATCTTGGCGGAAATATTGTACCAGGAGGAGTTCCAGATTTCAAAGATGACGATCGT
171 
 
GCACTTGTTAAGTGGTATGAAGGCATATTGAAAGATTTAGGTGTTGAAATAAAATTAAATGTGGATGCATCAAAGG
AAAATATCAAAGAATTTGGAGCTGATGAAGTGCTTTTAGCAACAGGTTCTAGTCCAAGAACATTGACTATTGAAGG
AGCTGATAAGGTTTATTCAGCAGAAGATGTATTAATGGAAAGAAAAAATGTTGGTGAAAAGGTTATCGTAATTGGT
GGAGGACTTGTTGGATGTGAAACAGCTCTTTGGTTAAAACAACAAGGTAAAGAGGTTACAATTGTAGAGATGCAAA
ATGATATCCTGCAAGTAGGTGGACCTTTATGCCATGCAAACCATGATATGCTTAATGATTTAATTAAATTTAATAA
GATTGATGTTAAGACAAGTTCCTATATCACCAAGAAGACAGATAAAGGTTTTGTTTTAAATACAGATGGACAAGAA
TCAATTATTAATGCTGATAGTGCCGTTGTAGCTATTGGATATTTATCTGAAAAAGACTTATATAGTGAAGTTAGAT
TTGATATTCCAAATGCAAGGCTGATTGGAGATGCTAATAAAGTTCAAAATATTATGTATGCTATTTGGAGTGCATA
TGAAGTAGCTAAAAATATTTAA 
 
8.8.5. Sequences of fldZ genes with flanking regions from C. sporogenes ATCC15579, C. 
sporogenes NCIMB10696 and C. botulinum ATCC3502: 
 
>Csp10696.fldZ 
ATAGAGAAGCAGGATAATCTTTTAACAAATACCTAAAGTGACTTTAGGCAGAAAGGAGAAAATTATGAGATATAGT
ATTACAGATTTAGCAGAAATTCTTGGATGTACTACAAGTGCTATTCACTATTTTGAAAAAGAACATTTAATTGAAG
TGGAAAAAGGAAAAAATGGTCATCGTTATTATAATGTTGTAGATGTATTTCGATTGCTTTCTTATACAAAGTATCG
TTCTATGGAAATACCTATGAAAACTATTATTGCACAATTTGGCGGGGAAGAAAATAATTATAAATTAATAGAAAAA
AGAGAAACAATGTATCAATTAGAGGCCTTAAAAAGAGCCCAATATTATATGAATTTAGCAGATGCTATTGGGGAAC
ATCTTGTTAGCATAAGAAGAATTGAAGAACTATTGAATAAGTATGAATTTGCAAAGTCACCTGAAGTAACGATTAT
GTGTGATGATGAGTGTGGGTGGCTTTCAAAAAAGCGTAGTTCACAAAAGATAATTCATGAATGGGTAAAAGCAATG
CCAACAGTGCAGCTAGGGGTATTTGATTCAAGAATGGGAATGAGTAACTTTGGATATTTGGTAAAAACTAAAAAGC
GAGAAGAATTAGAACTTCCGCTAGGGTTATATGCCAAAGAGCTAAAAAGTACATCTTGTATACATACAATTGTAAT
GGCAGATGAAGATTTCACACAACAACCACAGAAGGTTTTTAAAAAGGCTTCTGAATTTGCAATAAAAAAAGGTCTT
GAAATAGGTGAAATAGCCTGGGGAAAGATATTATTAGTTGAGGTTGAAAAGGGAGCTAAATTGCATCCATACATAG
AATTATGGATTTCGATAAAAATATAACAATATCCTCTTGAAAGTAAAGCTACTTTATGCTCTATACTGAAGGTAAC
AGGAAAATAAAAAAATACAAATGTGAATTCAGAAAGGAGAAAGAAAATGAAGGATAAGTATAAGGTACTTTACGAC
CCAATTAAAATTGGAAAATTGGAGATTAAAAATAGATATGTTCTTGCTCCAATGGGACCAGGAGGAATGTGTAACG
CCGATGGCAGTTTTAATAAAAGAGGAATTGAGTTTTATGTAGAACGTGCAAAAGGCGGAACTGGATTAATTATGAC
AGGTGTAACAATGGTGGAAAACAATATTGAAAAATGTGCCCTGCCATCCATGCCATGTCCAACAATTAACCCTCTA
AACTTTATTACAACAGGTAATGAAATGACAGAAAGAGTTCATGCATATGGATCAAAAATATTTTTACAATTATCAG
CAGGCTTTGGTAGAGTAAGTATACCATCTATTGTAGGAAAAGTGGCAGTAGCACCTTCTAAAATTCCACATAGATT
TTTACCAGGAGTAACTTGTCGTGAGTTAACTACAGAAGAAGTAAAAGAATATGTAAAAGCCTTTGGTGAATCAGCA
GAAATTGCAAAAAAAGCCGGATTTGATGGTGTAGAAATTCATGCAGTACATGAAGGATACTTATTAGATCAATTTG
CTATTTCTTTCTTTAACCATCGTACTGATGAATATGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAGGT
TGTACAAGAAATTAAGAAACGTTGTGGACAAGACTTCCCAGTTTCACTTAGATACAGTATAAAAAGCTTCATTAAG
GATTGGTGTAAGGGTGGCTTACCAGATGAAGAATTTGAAGAAAAAGGAAGAGATATTCCAGAAGGAATTGAAGCTG
CTAAAATACTTGTTGCAGCAGGATATGATGCTTTAAATGGAGATGTTGGGTCTTATGATTCATGGTATTGGAGTCA
TCCACCAATGTATCAAAAGAAGGGATTATACCTTCCATACAATGAAATACTTAAAAAGGTAGTAGATGTACCTATT
ATTACAGCAGGAAGAATGGAAGACCCTGAACTATCAAGTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTT
TAGGAAGGCCACTTCTTGCAGATGCAGAAATTCCAAATAAGATTTTTGAAGATAAATATGATAAAGTTAGACCTTG
TTTATCTTGTCAAGAAGGGTGTATGGGAAGATTACAGAATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGT
GGACGTGAAAAAGAGTATGGACTAAAAAAAGCAGAACAGATTAAGAAAGTTCTTGTTGTAGGTGGCGGTGTTGCAG
GAATGGAAGCTGCAAGAGTTACAGCTGTTCGTGGACACAAAGTAACATTGATTGAAAAGAATGGTTATCTTGGTGG
AAATATTGTACCAGGAGGAATTCCAGATTTCAAAGATGATGATCGTGCACTTGTTAAATGGTATGAAGGAATATTG
AAAGATTTAGGTGTTGAAATAAAATTAAATGTGGGTGCATCAAAGGAAAATATCAAAGAATTTGGAGCGGATGAAG
TGCTTTTAGCAACAGGCTCTAGTCCAAGAACATTGACTATTGAAGGAGCAGATAAGGTTTATTCAGCAGAAGATGT
GTTAATGGAAAGAAAAACTGTTGGTGAAAAAGTTATTGTGATTGGTGGAGGACTTGTTGGATGTGAAACAGCTCTT
TGGTTAAAACAACAAGGTAAAGAGATTACAATTGTAGAGATGCAAAATGATATCCTGCAAGTAGGTGGACCTTTAT
GTCATGCAAACCACGATATGCTTGTTGATTTAATTAAATTCAATAAGATTGATGTTAAGACAAGCTCCTATATCAG
CAAGAAAACAGATGAAGGATTTGTTTTAAATACAAATGGAGAAGAATCAATTATTAATGCTGATAGTGCTGTTGTA
GCTATTGGATATTTATCTGAAAAAGACTTATATAGTGAAGTTAGATTTGATATTCCAAATGCAAGACTAATTGGAG
ATGCTAATAAAGTTCAAAATATTATGTATGCTATTTGGAGTGCATATGAAGTCGCTAAAAATATTTAAATAAACTT
TTGCAAAAAACTAGAATGGGTTTATATACATATCTAGTTTTTTGTTTTTTACTGAAATTCTATAAGTATATGAGTG
TTTGTTATATATTTATTATAAAATACTAATTATTTAAAAATTTATTTAATGAATCATTATCTTTAAATAGGTTTCT
TAAGTTCCCATATTTTTGTTCTAAATTTTTTCTATCATATTTATAGGATTTTTCTCCTATATTCTCTACATTAAAT
TTAATAATTTCAGCATTTGATATAAGATATAATAATACCACTGCATTCTTTTCTAAAAAATTGTTAGCTTTTTTAT
CATTCCAAAATTTATTATAATTTTCTTCTCCTAAATTTTCATTTGTTTTATAGTTAACGGTTATTTCATAAGGTTC
TTTAGTAGTTTGTAGGCTAAATCCAGCACTATATTCATTGGCAGGTAAATTTTTTATAATACTTCCTACAGAACTA
TTATCACCTACATATGTGTCTTTATATTTTATCAAATCATATGTTTCAACCTTAGAACTATTCTTCGCATTCTCCT
TTAATTTTTTTTCAGAATTTACTCCACAACCTATTAAATTTAATGATAGGATGAGTACTAAAGGTACTAATATTTT
AGACTTGTTTTTCATATAATGCCTCCTGTTTTACAATTATATATTAGATTATGCTGTAAGTATAGTTGGATTATAA
CATTAATTACAATATAATGGTATCCATTTTTAGTGGTCATTTTGACATGGGTATTGAATATATTTACTTTTAATAA
AATTAATATTATTTTAGAATTAAGCAAAAGAAGAATATTTTATAATCTTTACGGTCAGTTTTAAAAATAGCAAAAT
AAGAACAGAAAAATATTTTGTTTTGTTATATCATAATAATAGCTTTATAAAGTAGGTGAGTATTTAATGAATTATA
GAAAAGATATAGAAAATTGTATTGATTATATAGAAGAGCATATTAAAGAGCCTCTTACACTTAAAGAAATTACACA
GGAAATAGGGTACTCATCATATCATTTCTGCAGAGTTTTTTCTTTTTTAAAGGGTATGCCCTTAATGGAATATGTA
172 
 
AGAAAAAGGAGACTTTCTTTATCTACTATAGATTTATTAGAAGGTAAAAAAATAATAGATGTTGCCTTTAAGTGGG
GATTTGAAACTCCAAGTAGTTTTGCAAGAGCCTTTAGAAAAGAGTTTGGATGTAGTCCAAGTCAATATATTAAAAA
AATGAAATCCTATTACAAAAGTGAAAATAATTTAATCCTAAGTAAGTTTATGAATGACCCATATATTGTTAAAAAG
CATGGATTTAAAGTTGCTGGATATGGTATTAAAACTAATGTGGCAGATAGTAAATATACAAAGGATGTGGCCTCCT
TTTGGAGCAATTATAATGGAGAAAATTTAGAAAGTAAACTATATAAAATTTTATCACCATTAAAACATGGGGAAGT
TGGATTATGCATACCTTGTTCTGATAGTGGGGATATAACCTATTTATTAGGGGTTATTGTTGAGGATTTTTCTAAG
GTAACTTCTGATATGATAACTGTTGAAGTACCAAAGGCTCAGTATGCAGTATTTACTACAAATCCTGTTAATACGG
TAGACAGCAAAGATCAAAGGGAATTTGCAAAGATTATTAAAGAATCATGGAAATATATATTTGATGAATGGTTTAA
AAATAATGATTACGAATATGATGAAGAAAAATTGGATTTTGAATTTTATGATGAAAGATGTCATTTAAGACCAGAC
ACAGTTATGGATATTTATGTGCCAATAAAAAAGT 
 
>Csp15579.fldZ 
TAAATTTATTGTTACTAATTAAAGGAATAGTAAATTATTTTAATAGAGAAGCAGGATAATCTTTTAACAAATACCT
AAAGTGACTTTAGGCAGAAAGGAGAAAATTATGAGATATAGTATTACAGATTTAGCAGAAATTCTTGGATGTACTA
CAAGTGCTATTCACTATTTTGAAAAAGAACATTTAATTGAAGTGGAAAAAGGAAAAAATGGTCATCGTTATTATAA
TGTTGTAGATGTATTTCGATTGCTTTCTTATACAAAGTATCGTTCTATGGAAATACCTATGAAAACTATTATTGCA
CAATTTGGCGGGGAAGAAAATAATTATAAATTAATAGAAAAAAGAGAAACAATGTATCAATTAGAGGCCTTAAAAA
GAGCCCAATATTATATGAATTTAGCAGATGCCATTGAAGAACATCTTGTTAGCATAAGAAGAATTGAAGAACTATT
GAATAAGTATGAATTTGCAAAGTCACCTGAAGTAACGATTATGTGTGATGATGAGTGTGGGTGGCTTTCAAAAAAG
CGTAGTTCACAAAAGATAATTCATGAATGGGTAAAAGCAATGCCAACAGTTCAGCTGGGGGTATTTGATTCAAGAA
TGGGAATGAGTAACTTTGGATATTTGGTAAACACCAAAAAGCTAGAAGAATTAGAGCTTCCATTAGGTCTACACAC
AAAACAATTAAAAAGCACCTCTTGTATACATACAATTGTAATGGCAGATGAGGATTTTACACAACATCCTCAGAAA
GTTTTTAAAAAGGCATCTGAATTTGTAATAAAAAAAGGTCTTGAAATAGGTGAAATAGCCTGGGGAAAGATATTAT
TAGTTGAGGTTGAAAAGGGAGCAAAATTACATCCATATATAGAATTGTGGATTTCGATAAAAATATAACAATATCC
TCTTGAAAGTAAAGCTGCTTTATGCTCTATACTGAAGGTGACAGGAAAATAAAAAAATACAAATGTGAATTCAGAA
AGGAGAAAGAAAATGAAGGATAAGTATAAGGTACTTTATGACCCAATTAAAATTGGAAAATTGGAGATTAAAAATA
GATATGTTCTTGCTCCAATGGGACCAGGAGGAATGTGTAACGCCGATGGTAGTTTTAATAAAAGAGGAATTGAGTT
TTATGTAGAACGTGCAAAAGGCGGAACTGGATTAATTATGACAGGTGTAACAATGGTAGAAAATAATATTGAAAAA
TGTGCCCTGCCATCTATGCCATGTCCAACAATTAACCCTTTAAACTTTATTACAACAGGTAACGAAATGACAGAAA
GAGTTCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGATTTGGTAGAGTAAGTATACCATCTATTGT
AGGAAAAGTAGCAGTAGCACCTTCTAAAATTCCACACAGATTTTTACCAGGAGTAACCTGTCGTGAGTTAACTACA
GAAGAAGTAAAAGAATATGTAAAAGCATTTGGTGAATCAGCAGAAATTGCAAAAAAAGCTGGATTTGATGGTGTGG
AAATTCATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATTTCTTTCTTTAATCATCGTACTGATGAATA
TGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAAGTTGTACAAGAGATTAAGAAATGTTGTGGACAAGAC
TTCCCAGTTTCACTTAGATACAGTATTAAGAGCTTCATTAAGGATTGGTGTAAGGGCGGCTTACCGGATGAAGAAT
TTGAAGAAAAGGGAAGAGATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTTCAGCAGGATATGATGCGCT
AAATGGAGACGTTGGATCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACCTT
CCATACAATGAAATACTTAAAAAGGTAGTAGACGTACCTATTATTACAGCAGGAAGAATGGAAGATCCTGAACTAT
CAAGTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGACCACTTCTTGCAGATGCAGAAATTCC
AAATAAAATCTTTGAAGATAAATATGATAAAGTTAGACCTTGCTTATCTTGTCAGGAAGGATGTATGGGAAGATTA
CAGAATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAAAAGGAGTATGGACTAAAAAAAGCAG
AACAGATTAAGAAAGTTCTTATTGTAGGTGGCGGTGTTGCAGGAATGGAAGCCGCAAGAGTTGCAGCTATTCGTGG
ACATAAAGTAACATTGATTGAAAAGAATGGTTATCTTGGCGGAAATATTGTACCAGGAGGAGTTCCAGATTTCAAA
GATGACGATCGTGCACTTGTTAAGTGGTATGAAGGCATATTGAAAGATTTAGGTGTTGAAATAAAATTAAATGTGG
ATGCATCAAAGGAAAATATCAAAGAATTTGGAGCTGATGAAGTGCTTTTAGCAACAGGTTCTAGTCCAAGAACATT
GACTATTGAAGGAGCTGATAAGGTTTATTCAGCAGAAGATGTATTAATGGAAAGAAAAAATGTTGGTGAAAAGGTT
ATCGTAATTGGTGGAGGACTTGTTGGATGTGAAACAGCTCTTTGGTTAAAACAACAAGGTAAAGAGGTTACAATTG
TAGAGATGCAAAATGATATCCTGCAAGTAGGTGGACCTTTATGCCATGCAAACCATGATATGCTTAATGATTTAAT
TAAATTTAATAAGATTGATGTTAAGACAAGTTCCTATATCACCAAGAAGACAGATAAAGGTTTTGTTTTAAATACA
GATGGACAAGAATCAATTATTAATGCTGATAGTGCCGTTGTAGCTATTGGATATTTATCTGAAAAAGACTTATATA
GTGAAGTTAGATTTGATATTCCAAATGCAAGGCTGATTGGAGATGCTAATAAAGTTCAAAATATTATGTATGCTAT
TTGGAGTGCATATGAAGTAGCTAAAAATATTTAAATATACCTTTGCAAAAAACTAGAATGGGTTTATATCCATATC
TAGTTTTTTGTTTTGTATTCCAATTCTACAAGTATAGGGAGTGTTCGTTATATATTTATTATAAAATACTAATTAT
TTAAAAATTTATTTAGTGAGTCATTATCTTTAAATAAGTTTTTTAAGTTTCCATATTTTTGTTCTAAATTTTTTCT
ATCATATTTAAAGGATTCTTCTCCTATATTGTCTACATTAAACTTAACAATTTCAGCGTTTGGTATAAGAGATAAT
AGTACCACCGCAATCTTTTCTAAAAGCTTGTTAGCTTTTTTGTCACTCCAAAATTTATTATAATTTTCTTCACCTA
AATTTTCATTTGCTTTATAGTTAACAGTTATTTCATAGGGCTCTTTACTAGTTTGTAGACTAAATCCAGCACTATA
TTCATTGGCAGGTAAATTTTTTATAATACTTCCTACAGAACTATTATCGCCTATATATGTGCCTTTATATTTTATC
AAATCATATGTTTCAGCTTTAGAATTATTTTTTATATTTTCCTTTGATTTTTTTTCAGAATTCATTCCACAACCTA
CTAAATTTAATGATAGGATTATTATTAAAGGTATTAATATTTTAAGTTTGTTTTTCATATAATGCCTCCTATTTTG
CAATGTATTGTATCACAATCATACATTAGATTAAGGTGTAACTATAGTTGGATTATAGCATTAATTGCAATATAAT
GGTATCCATTTTTAGTTGTTATTTTCACATGGGTATTGAACATATTCATTTTTAATAAAATTAATATTATTTTAGA
ATTAAGCAAAAGAAGAATATTTTATAATCTTTACGGTCAGTTTTAATAATAAAAATAGCAAAATAAGAACAGAAAA
ACATTTTGTTTTGTTATATTATAATAATAGCTTTATAAAGTAGGTGAGTATTTAATGAATTATAGAAAAGATATAG
AAAATTGTATTGATTATATAGAAGAGCATATTAAAGAGCCCCTTACACTTAAAGAAATTACACAAGAAATAGGGTA
CTCATCATATCATTTCTGCAGAGTTTTTTCTTTTTTAAAGGGTATGCCCTTAATGGAATATGTAAGAAAAAGAAAA
CTTTCTTTATCTACTATAGATTTATTAGAAGGTAAAAAAATAATAGATGTTGCTTTAAAATGGGGATTTGAAACAC
CAAGTAGTTTTGCAAGAGCCTTTAGAAAAGAGTTTGGATGTAGTCCAAGTCAATATATAAAAAAAATGAAATCCTA
173 
 
TTACAAAAGTGAAAATAATTTAATCCTAGGTAAGTTTATGAATGATCCATATATAGTTAAAAAGCATGGATTTAAA
GTTGCTGGATATGGTATTAAAACTAATGTGGCAGATAGTAAATACACAAAGGATGTAGCCTCCTTTTGGAGCAATT
ATAATGGAGAAAATCTAGAAAGTAAACTATACAAAATTCTATCACCCTTAAAACATGGGGAAGTTGGATTATGCAT
ACCTTGTTCTGATAGTGGGGATATAACCTATTTATTAGGGGTTATTGTTGAGGATTTTTCCAAGGTAACTTCTGAT
ATGATAACTGTTGAAGTACCAAAAGCCCAGTATGGAGTATTTACTACAAATCCTGTTAATACAGTAGATAGCAAAG
ATCAAAGGGAATTTGCAAAGATTATTAAAGAATCATGGAAGTATATATTTGATGAATGGTTTAAAAATAATGATTA
CGAATACGATGAAGAAAAATTGGATTTTGAATTTTATGATGAAAGATGTCATTTAAGACCAGACACAGTTATGGAT
ATTTATGTGCCAATAAAAAAGTTGGAAAGGTGATATTAAATGATTAATTATTATGGAAGTTTATGTACAGTAATGT
ATGAGTTACTACATCCTCATGCACCAGAAGATGAGCTGCAATTTTATTTACAATATGCAAAAAAGGAGATGAAAAT
ACTAGAACCACTTTGTGGAAGTGGTAGATTTCTAGTACCTTTTTTAGAAAGAGGCTTT 
 
>Cbot3502.fldZ 
TAAATTATTTTAATAAAGCAGAAGGATAATCTTTTAACAAATACCTAAAGTGACTTTAGGCAGAAAGGAGAGAATT
ATGAGATATAGTATTACAGATTTAGCAGAAATTCTTGGATATACTACAAGTGCTATTCACTATTTTGAAAAAGAAC
ATTTAATTGAAGTGGAAAAAGGAAAAAATGGTCATCGTTATTATAATGTTGTAGATGTATTTCGATTGCTTTCTTA
TACAAAGTATCGTTCTATGGAAATACCTATGAAAACTATTATTGCACAATTTGGCGGGGAAGAAAATAATTATAAA
TTAATAGAAAAAAGAGAAACAATGTATCAATTAGAGGCCTTAAAAAGAGCCCAATATTATATGAATTTAGCAGATG
CCATTGAAGAACATCTTGTTAGCATAAGAAGAATTGAAGAGCTATTGAATAAGTATGAATTTGCAAAGTCACCTGA
AGTAACCATTATGTGTGATGATGAGTGTGGGTGGCTTTCAAAAAAGCGTAGTTCACAAAAGATAATTCATGAATGG
GTAAAAGCAATGCCAACAGTGCAGCTAGGGGTATTTGATTCAAGAATGGGAATAAGTAACTTTGGATATTTGGTAA
AAACTAAAAAGCGAGAAGAATTAGAGCTTCCACTAGGGTTACATGCCAAAGAGATAAAAAGTACATCTTGTATACA
TACAATTGTAATGGCAGATGAGGACTTCACACAACAACCACAGAAGGTTTTTAAAAAGGCATCTGAATTTGCAATA
AAAAAAGGTCTTGAAATAGGCGAAATAGCTTGGGGAAAGATATTATTAGTTGAGGTTGAAAAGGGAGCAAAATTAC
ATCCATATATAGAATTGTGGATTTCGATAAAAATATAACAATATCCTCTTGAAAGTAAAGCTGCTTTATGCTCTAT
ACTGAAGGTGACAGGAAAATAAAAAAATACAAATGTGAATTCAGAAAGGAGAAATAAAATGAAGGATAAGTATAAG
GTACTTTATGACCCAATTAAAATTGGAAAATTGGAGATTAAAAATAGATATGTTCTTGCTCCAATGGGACCAGGAG
GAATGTGTAACGCCGATGGTAGTTTTAATAAAAGAGGAATTGAGTTTTATGTAGAACGTGCAAAAGGCGGAACTGG
ATTAATTATGACAGGTGTAACAATGGTGGAAAACAATATTGAAAAATGTGCATTGCCATCCATGCCATGTCCAACA
ATTAACCCTTTAAACTTTATTACAACAGGTAATGAAATGACAGAAAGAGTCCATGCATATGGATCAAAAATATTTT
TACAATTATCAGCAGGATTTGGTAGAGTAAGTATACCATCTATTGTAGGAAAAGTGGCAGTAGCACCTTCTAAAAT
TCCACATAGATTTTTACCAGGAGTAACCTGTCGTGAGTTAACTACAGAAGAAGTAAAAGAATATGTAAAAGCCTTT
GGTGAGTCAGCAGAAATTGCAAAAAAAGCTGGATTTGATGGTGTAGAAATTCACGCAGTACATGAAGGATACTTAT
TAGATCAATTTGCTATTTCTTTCTTTAACCATCGTACTGATGAATATGGTGGATCATTAGAAAATCGCTTAAGATT
TGCCTGTGAAGTTGTACAAGAGATTAAGAAACGTTGTGGACAAGACTTCCCAGTTTCACTTAGATACAGTATTAAG
AGCTTCATTAAGGATTGGTGTAAGGGCGGCTTACCGGATGAAGAATTTGAAGAAAAGGGAAGAGATATTCCAGAAG
GAATTGAAGCTGCTAAAATACTTGTTGCAGCAGGATATGATGCGCTAAATGGAGACGTTGGATCTTATGATTCATG
GTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACCTTCCATACAATGAAATACTTAAAAAGGTAGTA
GACGTACCTATTATTACAGCAGGAAGAATGGAGGATCCTGAACTATCAAGTGATGCAATTTTGTCAGGAAAAACAG
ATATGATTGCTTTAGGAAGACCACTTCTTGCAGATGCAGAAATTCCAAATAAAATCTTTGAAGATAAATATGATAA
AGTTAGACCTTGCTTATCTTGTCAGGAAGGATGCATGGGAAGATTACAGAATTTTGCAACAGTATCCTGTGCAGTA
AATCCTGCCTGTGGACGTGAAAAGGAGTATGGACTAAAAAAAGCAGAACAGATTAAGAAAGTTCTTATTGTAGGTG
GCGGTGTTGCAGGAATGGAAGCCGCAAGAGTTGCAGCTATTCGTGGACACAAAGTAACATTGATTGAAAAGAATGG
TTATCTTGGAGGAAATATTGTACCAGGAGGAGTTCCAGATTTCAAAGATGACGATCGTGCACTTGTTAAGTGGTAT
GAATGCATATTGAAAGATTTAGGTGTTGAAATAAAATTAAATGTGGATGCATCAAAGGAAAATATCAAAGAATTTG
GAGCTGATGAAGTGCTTTTAGCAACAGGTTCTAGTCCAAGAACATTGACTATTGAAGGAGCTGATAAGGTTTATTC
AGCAGAAGATGTGCTAATGGAAAGAAAAAATGTTGGTGAAAAGGTTATTGTAATTGGTGGAGGACTTGTTGGATGT
GAAACAGCTCTTTGGTTAAAACAACAAGGTAAAGAGGTTACAATTGTAGAGATGCAAAATGATATTCTACAAGTAG
GTGGACCTTTATGTCATGCAAACCATGATATGCTTGTTGATTTAATTAAATTCAATAAGATTGATGTTAAGACAAG
CTCCTATATCAGCAAGAAAACAGATGAAGGATTTGTTTTAAATACAAATGGAGAAGAATCAATTATTAATGCTGAT
AGTGCTGTTGTAGCTATTGGATATTTATCTGAAAAAGACTTATATAGTGAAGTTAGATTTGATATCCCAAATGCAA
GACTTATTGGAGATGCTAATAAAGTTCAAAATATTATGTATGCTATTTGGAGTGCATATGAAGTAGCTAAAAATAT
TTAAATGAACCTTTGTAAAAACTAGAATGGATTTATATCCATATCTAGTTTTTGCTCTTTACTGAAATTCTATAAG
TATATGGGTGTTTGTTATGTACTATTTGTGTATATTTAAAGCTTTCCAAGTGAACTCAAATTCAAAGCCTATTCTA
AGCATTGATATATAAGGATTAGAATAGGTTTTTATTATGTATTTTTTAAAAAGCAGAATCACTTGGAAAAATTTCT
TTAAAACCTTGTAAAATCAATGGGTATATGATATTCTTAGAAATAAGGAATGCCTATTTTACTATGATTGAACAAT
AACATAGGATGTATTTAAATTCTTTATATAGATGCATATCTTCTAATACTCCACCTGTTGAACATTAACATGAGAT
GTATTTAAGCAGGGAATCCAAATTCCTGATTTGGTATGAGTCGCTTACTCCTTCGAAAAATAGAAGAAGTAGTTTT
ATTAATGAACATAGTGTATATATAATTAAATTTTTCCAAGTGAATTTAATCTTCAAACCTATCCTACCCATTGAAA
TATAAGGATTAGGATAGGTTTTTATTGTGTATTTATGAAAAAACAAAATCACTTGGAAAAATTTCTACAAAACCTT
GTAAAATCAATGGATATATGATATTCTTGTAAATAAAGAATGGCTATTTTACTATGGTTGAACAGTAACATAGGAT
GTATTTAAATATTTGTCCAAATAACAATATTTATCACCCCCTATTCGTGTTGAACAGTAACATAAGATGTATTTAA
ATTTTCTATTTTCTTTAAAAAATTGCCTATCTACATTTGTTGAACAGTAATATAGAATGTATTTAAATATAGATAA
ACAACTCTGAAGATATGCTTTGCTTACCAGTTGAACCTTAACATGATATGTATTTAAGCAGAGAACCCAAATCTGT
GATTTGGTGTGAATCGCTTACTCCTTCGAGAAGAGGAGAAGGAGTTTCATTAAATAATAATTAGACACTTAGTATT
TTAAGCTTAAGTATGATCTGAAAAGGTTGAACATTAACATGAGATGTATTTAAATTATTTACATTCTGTTATACCA
CAACATTTACAACATGTTGAACAATAACATAAGATGTATTTAAGCAGAGAACTCAACTTTACGATTTGGAGTAAGT
TGTTTATTTCCTGTAGAGGAGAAGTATGAGACTCATTAATGAGCATAGTATATATATCATATCTAATTAAATTTTT
CCAAGTGAATTTAAATTTAAAACCTATTCTAGCCATCGATATGTAAGGATTAGGGTAGATTTTTATTATGTATTTA
174 
 
TGAAAAATAAGAATCGGTTGGGAAAATTTCTTTAAAACCTTGTAAAATCAATGTGTATATGCTATTCTTAAAAATA
AGGAATGGCTATTTTACTATGGTTGAACATTAACATGAGATGTATTTAAATTCTAAATCTTTTGCACTTGCTAATT
TACCTTTTTCGTTGAACATTAACATGAAATGTATTTAAATTTAATATATTTACCAAGGTTTTATATTATCATACTT
AAGTTGAACATTAACATGAGATGTATTTAAATACTACTGCAGTAACGGAATGTGGTGGCAAACCTAATGTTGAACA
TTAACATGAGATGTATTTAAATAAGGGTTCTCCACACTCTAGTTCTTTCATAAGTTCAGTTGAACATTAACATGAG
ATGTACTTAAGCAAGAAATGCAATCATCTGATTTAGAATAATCATTTATACATGGCAATAATTTTTTGCTTTATTA
CTTCTTGAGTTAAATTGTGGGATTTTATTGACTAAAATATTTTTAAAATATAGTTTTAATTTTGGTTGTGCTTTAA
AGTAGTGTTGGAATTTTAAACCCCATTAAAAGAAGTTAAATATTTTCTTTTAATGGGGTTTATATAAATTGTAAGA
TACTAATTATTTAAAAATTTATTTAATGAATCATTATCTTTAAATAAGTCTTTTAAGTTACCGTATTTTTGTCCTA
AATTTTTTCTATCATATTTATAGGATTC 
 
8.8.6. Consensus sequence of fldZ-ORF product (of 5 PCR products that were sequenced): 
 
>fldZ-ORF 
GAAGATCCATGGCTATGAAGGATAAGTATAAGGTACTTTATGACCCAATTAAAATTGGAAAATTGGAGATTAAAAA
TAGATATGTTCTTGCTCCAATGGGACCAGGAGGAATGTGTAACGCCGATGGCAGTTTTAATAAAAGAGGAATTGAG
TTTTATGTAGAACGTGCAAAAGGCGGAACTGGATTAATTATGACAGGTGTAACAATGGTGGAAAACAATATTGAAA
AATGTGCCCTGCCATCCATGCCATGTCCAACAATTAACCCTCTAAACTTTATTACAACAGGTAATGAAATGACAGA
AAGAGTTCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGCTTTGGTAGAGTAAGTATACCATCTATT
GTAGGAAAAGTGGCAGTAGCACCTTCTAAAATTCCACATAGATTTTTACCAGGAGTAACTTGTCGTGAGTTAACTA
CAGAAGAAGTAAAAGAATATGTAAAAGCCTTTGGTGAATCAGCAGAAATTGCAAAAAAAGCCGGATTTGATGGTGT
AGAAATTCATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATTTCTTTCTTTAACCATCGTACTGATGAA
TATGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAGGTTGTACAAGAAATTAAGAAACGTTGTGGACAAG
ACTTCCCAGTTTCACTTAGATACAGTATAAAAAGCTTCATTAAGGATTGGTGTAAGGGTGGCTTACCAGATGAAGA
ATTTGAAGAAAAAGGAAGAGATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTGCAGCAGGATATGATGCT
TTAAATGGAGATGTTGGGTCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGGATTATACC
TTCCATACAATGAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCAGGAAGAATGGAAGACCCTGAACT
ATCAAGTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGGCCACTTCTTGCAGATGCAGAAATT
CCAAATAAGATTTTTGAAGATAAATATGATAAAGTTAGACCTTGTTTATCTTGTCAAGAAGGGTGTATGGGAAGAT
TACAGAATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAAAAAGAGTATGGACTAAAAAAAGC
AGAACAGATTAAGAAAGTTCTTGTTGTAGGTGGCGGTGTTGCAGGAATGGAAGCTGCAAGAGTTACAGCTGTTCGT
GGACACAAAGTAACATTGATTGAAAAGAATGGTTATCTTGGTGGAAATATTGTACCAGGAGGAATTCCAGATTTCA
AAGATGATGATCGTGCACTTGTTAAATGGTATGAAGGAATATTGAAAGATTTAGGTGTTGAAATAAAATTAAATGT
GGGTGCATCAAAGGAAAATATCAAAGAATTTGGAGCGGATGAAGTGCTTTTAGCAACAGGCTCTAGTCCAAGAACA
TTGACTATTGAAGGAGCAGATAAGGTTTATTCAGCAGAAGATGTGTTAATGGAAAGAAAAACTGTTGGTGAAAAAG
TTATTGTGATTGGTGGAGGACTTGTTGGATGTGAAACAGCTCTTTGGTTAAAACAACAAGGTAAAGAGATTACAAT
TGTAGAGATGCAAAATGATATCCTGCAAGTAGGTGGACCTTTATGTCATGCAAACCACGATATGCTTGTTGATTTA
ATTAAATTCAATAAGATTGATGTTAAGACAAGCTCCTATATCAGCAAGAAAACAGATGAAGGATTTGTTTTAAATA
CAAATGGAGAAGAATCAATTATTAATGCTGATAGTGCTGTTGTAGCTATTGGATATTTATCTGAAAAAGACTTATA
TAGTGAAGTTAGATTTGATATTCCAAATGCAAGACTAATTGGAGATGCTAATAAAGTTCAAAATATTATGTATGCT
ATTTGGAGTGCATATGAAGTAGCTAAAAATATTGCGGCCGCTTATCTTGCTGAAA 
 
Consensus sequence of fldZ- ? ?ƉƌŽĚƵĐƚ ?ŽĨ ?WZƉƌŽĚƵĐƚƐƚŚĂƚǁĞƌĞƐĞƋƵĞŶĐĞĚ ) P 
 
>fldZ-¶ 
GATGGATGTACTACAAGTGCTATTCACTATTTTGAAAAAGAACATTTAATTGAAGTGGAAAAAGGAAAAAATGGTC
ATCGTTATTATAATGTTGTAGATGTATTTCGATTGCTTTCTTATACAAAGTATCGTTCTATGGAAATACCTATGAA
AACTATTATTGCACAATTTGGCGGGGAAGAAAATAATTATAAATTAATAGAAAAAAGAGAAACAATGTATCAATTA
GAGGCCTTAAAAAGAGCCCAATATTATATGAATTTAGCAGATGCTATTGGGGAACATCTTGTTAGCATAAGAAGAA
TTGAAGAACTATTGAATAAGTATGAATTTGCAAAGTCACCTGAAGTAACGATTATGTGTGATGATGAGTGTGGGTG
GCTTTCAAAAAAGCGTAGTTCACAAAAGATAATTCATGAATGGGTAAAAGCAATGCCAACAGTGCAGCTAGGGGTA
TTTGATTCAAGAATGGGAATGAGTAACTTTGGATATTTGGTAAAAACTAAAAAGCGAGAAGAATTAGAACTTCCGC
TAGGGTTATATGCCAAAGAGCTAAAAAGTACATCTTGTATACATACAATTGTAATGGCAGATGAAGATTTCACACA
ACAACCACAGAAGGTTTTTAAAAAGGCTTCTGAATTTGCAATAAAAAAAGGTCTTGAAATAGGTGAAATAGCCTGG
GGAAAGATATTATTAGTTGAGGTTGAAAAGGGAGCTAAATTGCATCCATACATAGAATTATGGATTTCGATAAAAA
TATAACAATATCCTCTTGAAAGTAAAGCTACTTTATGCTCTATACTGAAGGTAACAGGAAAATAAAAAAATACAAA
TGTGAATTCAGAAAGGAGAAAGAAAATGAAGGATAAGTATAAGGTACTTTACGACCCAATTAAAATTGGAAAATTG
GAGATTAAAAATAGATATGTTCTTGCTCCAATGGGACCAGGAGGAATGTGTAACGCCGATGGCAGTTTTAATAAAA
GAGGAATTGAGTTTTATGTAGAACGTGCAAAAGGCGGAACTGGATTAATTATGACAGGTGTAACAATGGTGGAAAA
CAATATTGAAAAATGTGCCCTGCCATCCATGCCATGTCCAACAATTAACCCTCTAAACTTTATTACAACAGGTAAT
GAAATGACAGAAAGAGTTCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGCTTTGGTAGAGTAAGTA
TACCATCTATTGTAGGATCGTCTAGA 
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Consensus sequence of fldZ- ? ?ƉƌŽĚƵĐƚ ?ŽĨ ?WZƉƌŽĚƵĐƚƐƚŚĂƚǁĞƌĞƐĞƋƵĞŶĐĞĚ ) P 
 
>fldZ-¶ 
GATCTATTATTACAGCAGGAAGAATGGAAGACCCTGAACTATCAAGTGATGCAATTTTGTCAGGAAAAACAGATAT
GATTGCTTTAGGAAGGCCACTTCTTGCAGATGCAGAAATTCCAAATAAGATTTTTGAAGATAAATATGATAAAGTT
AGACCTTGTTTATCTTGTCAAGAAGGGTGTATGGGAAGATTACAGAATTTTGCAACAGTATCCTGTGCAGTAAATC
CTGCCTGTGGACGTGAAAAAGAGTATGGACTAAAAAAAGCAGAACAGATTAAGAAAGTTCTTGTTGTAGGTGGCGG
TGTTGCAGGAATGGAAGCTGCAAGAGTTACAGCTGTTCGTGGACACAAAGTAACATTGATTGAAAAGAATGGTTAT
CTTGGTGGAAATATTGTACCAGGAGGAATTCCAGATTTCAAAGATGATGATCGTGCACTTGTTAAATGGTATGAAG
GAATATTGAAAGATTTAGGTGTTGAAATAAAATTAAATGTGGGTGCATCAAAGGAAAATATCAAAGAATTTGGAGC
GGATGAAGTGCTTTTAGCAACAGGCTCTAGTCCAAGAACATTGACTATTGAAGGAGCAGATAAGGTTTATTCAGCA
GAAGATGTGTTAATGGAAAGAAAAACTGTTGGTGAAAAAGTTATTGTGATTGGTGGAGGACTTGTTGGATGTGAAA
CAGCTCTTTGGTTAAAACAACAAGGTAAAGAGATTACAATTGTAGAGATGCAAAATGATATCCTGCAAGTAGGTGG
ACCTTTATGTCATGCAAACCACGATATGCTTGTTGATTTAATTAAATTCAATAAGATTGATGTTAAGACAAGCTCC
TATATCAGCAAGAAAACAGATGAAGGATTTGTTTTAAATACAAATGGAGAAGAATCAATTATTAATGCTGATAGTG
CTGTTGTAGCTATTGGATATTTATCTGAAAAAGACTTATATAGTGAAGTTAGATTTGATATTCCAAATGCAAGACT
AATTGGAGATGCTAATAAAGTTCAAAATATTATGTATGCTATTTGGAGTGCATATGAAGTCGCTAAAAATATTTAA
ATAAACTTTTGCAAAAAACTAGAATGGGTTTATATACATATCTAGTTTTTTGTTTTTTACTGAAATTCTATAAGTA
TATGAGTGTTTGTTATATATTTATTATAAAATACTAATTATTTAAAAATTTATTTAATGAATCATTATCTTTAAAT
AGGTTTCTTAAGTTCCCATATTTTTGTTCTAAATTTTTTCTATCATATTTATAGGATTTTTCTCCTATATTCTCTA
CATTAAATTTAATAATTTCAGCATTTGATATAAGATATAATAATACCACTGCATTCTTTTCTAAAAAATTGTTAGC
TTTTTTATCATTCCAAAATTTATTATAATTTTCTTCTCCTAAATTTTCATTTGTTTTATAGTTAACGGTTATTTCA
TAAGGTTCTTTAGTAGTTTGTAGACTAAATCCAGCACTATCTTCT  
 
8.8.7. C. sporogenes DSM795 fldZ gene: 
 
>Csp795.fldZ-full.sequence 
GGATGTACTACAAGTGCTATTCACTATTTTGAAAAAGAACATTTAATTGAAGTGGAAAAAGGAAAAAATGGTCATC
GTTATTATAATGTTGTAGATGTATTTCGATTGCTTTCTTATACAAAGTATCGTTCTATGGAAATACCTATGAAAAC
TATTATTGCACAATTTGGCGGGGAAGAAAATAATTATAAATTAATAGAAAAAAGAGAAACAATGTATCAATTAGAG
GCCTTAAAAAGAGCCCAATATTATATGAATTTAGCAGATGCTATTGGGGAACATCTTGTTAGCATAAGAAGAATTG
AAGAACTATTGAATAAGTATGAATTTGCAAAGTCACCTGAAGTAACGATTATGTGTGATGATGAGTGTGGGTGGCT
TTCAAAAAAGCGTAGTTCACAAAAGATAATTCATGAATGGGTAAAAGCAATGCCAACAGTGCAGCTAGGGGTATTT
GATTCAAGAATGGGAATGAGTAACTTTGGATATTTGGTAAAAACTAAAAAGCGAGAAGAATTAGAACTTCCGCTAG
GGTTATATGCCAAAGAGCTAAAAAGTACATCTTGTATACATACAATTGTAATGGCAGATGAAGATTTCACACAACA
ACCACAGAAGGTTTTTAAAAAGGCTTCTGAATTTGCAATAAAAAAAGGTCTTGAAATAGGTGAAATAGCCTGGGGA
AAGATATTATTAGTTGAGGTTGAAAAGGGAGCTAAATTGCATCCATACATAGAATTATGGATTTCGATAAAAATAT
AACAATATCCTCTTGAAAGTAAAGCTACTTTATGCTCTATACTGAAGGTAACAGGAAAATAAAAAAATACAAATGT
GAATTCAGAAAGGAGAAAGAAAATGAAGGATAAGTATAAGGTACTTTATGACCCAATTAAAATTGGAAAATTGGAG
ATTAAAAATAGATATGTTCTTGCTCCAATGGGACCAGGAGGAATGTGTAACGCCGATGGCAGTTTTAATAAAAGAG
GAATTGAGTTTTATGTAGAACGTGCAAAAGGCGGAACTGGATTAATTATGACAGGTGTAACAATGGTGGAAAACAA
TATTGAAAAATGTGCCCTGCCATCCATGCCATGTCCAACAATTAACCCTCTAAACTTTATTACAACAGGTAATGAA
ATGACAGAAAGAGTTCATGCATATGGATCAAAAATATTTTTACAATTATCAGCAGGCTTTGGTAGAGTAAGTATAC
CATCTATTGTAGGAAAAGTGGCAGTAGCACCTTCTAAAATTCCACATAGATTTTTACCAGGAGTAACTTGTCGTGA
GTTAACTACAGAAGAAGTAAAAGAATATGTAAAAGCCTTTGGTGAATCAGCAGAAATTGCAAAAAAAGCCGGATTT
GATGGTGTAGAAATTCATGCAGTACATGAAGGATACTTATTAGATCAATTTGCTATTTCTTTCTTTAACCATCGTA
CTGATGAATATGGTGGATCATTAGAAAATCGTTTAAGATTTGCCTGTGAGGTTGTACAAGAAATTAAGAAACGTTG
TGGACAAGACTTCCCAGTTTCACTTAGATACAGTATAAAAAGCTTCATTAAGGATTGGTGTAAGGGTGGCTTACCA
GATGAAGAATTTGAAGAAAAAGGAAGAGATATTCCAGAAGGAATTGAAGCTGCTAAAATACTTGTTGCAGCAGGAT
ATGATGCTTTAAATGGAGATGTTGGGTCTTATGATTCATGGTATTGGAGTCATCCACCAATGTATCAAAAGAAGGG
ATTATACCTTCCATACAATGAAATACTTAAAAAGGTAGTAGATGTACCTATTATTACAGCAGGAAGAATGGAAGAC
CCTGAACTATCAAGTGATGCAATTTTGTCAGGAAAAACAGATATGATTGCTTTAGGAAGGCCACTTCTTGCAGATG
CAGAAATTCCAAATAAGATTTTTGAAGATAAATATGATAAAGTTAGACCTTGTTTATCTTGTCAAGAAGGGTGTAT
GGGAAGATTACAGAATTTTGCAACAGTATCCTGTGCAGTAAATCCTGCCTGTGGACGTGAAAAAGAGTATGGACTA
AAAAAAGCAGAACAGATTAAGAAAGTTCTTGTTGTAGGTGGCGGTGTTGCAGGAATGGAAGCTGCAAGAGTTACAG
CTGTTCGTGGACACAAAGTAACATTGATTGAAAAGAATGGTTATCTTGGTGGAAATATTGTACCAGGAGGAATTCC
AGATTTCAAAGATGATGATCGTGCACTTGTTAAATGGTATGAAGGAATATTGAAAGATTTAGGTGTTGAAATAAAA
TTAAATGTGGGTGCATCAAAGGAAAATATCAAAGAATTTGGAGCGGATGAAGTGCTTTTAGCAACAGGCTCTAGTC
CAAGAACATTGACTATTGAAGGAGCAGATAAGGTTTATTCAGCAGAAGATGTGTTAATGGAAAGAAAAACTGTTGG
TGAAAAAGTTATTGTGATTGGTGGAGGACTTGTTGGATGTGAAACAGCTCTTTGGTTAAAACAACAAGGTAAAGAG
ATTACAATTGTAGAGATGCAAAATGATATCCTGCAAGTAGGTGGACCTTTATGTCATGCAAACCACGATATGCTTG
TTGATTTAATTAAATTCAATAAGATTGATGTTAAGACAAGCTCCTATATCAGCAAGAAAACAGATGAAGGATTTGT
TTTAAATACAAATGGAGAAGAATCAATTATTAATGCTGATAGTGCTGTTGTAGCTATTGGATATTTATCTGAAAAA
GACTTATATAGTGAAGTTAGATTTGATATTCCAAATGCAAGACTAATTGGAGATGCTAATAAAGTTCAAAATATTA
TGTATGCTATTTGGAGTGCATATGAAGTAGCTAAAAATATTTAAATAAACTTTTGCAAAAAACTAGAATGGGTTTA
TATACATATCTAGTTTTTTGTTTTTTACTGAAATTCTATAAGTATATGAGTGTTTGTTATATATTTATTATAAAAT
176 
 
ACTAATTATTTAAAAATTTATTTAATGAATCATTATCTTTAAATAGGTTTCTTAAGTTCCCATATTTTTGTTCTAA
ATTTTTTCTATCATATTTATAGGATTTTTCTCCTATATTCTCTACATTAAATTTAATAATTTCAGCATTTGATATA
AGATATAATAATACCACTGCATTCTTTTCTAAAAAATTGTTAGCTTTTTTATCATTCCAAAATTTATTATAATTTT
CTTCTCCTAAATTTTCATTTGTTTTATAGTTAACGGTTATTTCATAAGGTTCTTTAGTAGTTTGTAGACTAAATCC
AGCACT 
 
8.8.8. C. sporogenes DSM795 fldZ reductase amino acid sequence: 
>Csp795.fldZ-full.sequence 
MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALP
SMPCPTINPLNFITTGNEMTERVHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVK
EYVKAFGESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKRCGQDFPVS
LRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGDVGSYDSWYWSHPPMYQKKGLYLPYNE
ILKKVVDVPIITAGRMEDPELSSDAILSGKTDMIALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFA
TVSCAVNPACGREKEYGLKKAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDR
ALVKWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVLMERKTVGEKVIVIG
GGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVDLIKFNKIDVKTSSYISKKTDEGFVLNTNGEE
SIINADSAVVAIGYLSEKDLYSEVRFDIPNARLIGDANKVQNIMYAIWSAYEVAKNI 
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8.9. Identification of the OYE-like reductase gene in C. sporogenes 
8.9.1. CLOSPO_03444 amino acid sequence:  
 
>Csp15579.OYE-like.reductase 
MKSLFDKTCIKTMELKNRFVRSATWEGMATEEGHITERLLNLYEELAKGGVGLIITSYTTIFDYDKPSLRILGIYD
DSFIEEYKLLTDTIHKCGAKVLMQIVLGENYINNKTGSEFYGLSENMPEDDIKAIVKSFAEAAKRAKESGFDGIQI
HGAHGYFLSRTLSPLFNKRKDKYGGSVEKRGALILEVYDKIRKTVGEDFHISIKINCSDFEEGGATFKECEFVCRE
LSKKGIDSIEISGGGTIWTETNKKESIYKEYASKIAEQVDTPIILVGMNRSYNNMDQILNNSKIEYFSMARPFIRE
PDLINKFEKDENRKAKCISCGKCYGENGIRCIFNM 
 
8.9.2. C. sporogenes ATCC15579 gene encoding CLOSPO_03444 reductase:  
 
>Csp15579.OYE-like.reductase 
TTAAATATTAGAATTTTCAACTCTCTCATCATTTTTATATTCACCAATGAAAATTTCACCATTAGAGTGAATGTAC
ATACCTTTTCCATGTCTTAAATCATTTACCCATTGACCAATATATTTATCTCCATGGTTGCAAACATAAACTCCAT
GTCCATGACGAAAATCACAAATCCAATCACCAGTATAAACATCACCATCGGACCAAGTATAAATACCCTGACCGGA
TTTTAAATCATTTTCCCAATATCCAACATAACTTTCTCCATCAGGCCAAGTATATATGCCATATCCATGTTTTTCA
TCATCTTTCCAACTACCAGTATATTTTTCACCAGAAGCCCAAATTAAAACACCTTCACCATGCATCATGTTTTCTT
TCCAGTAACCTACATATTTAGTTCCGTTAGTGTAAGTATATGTACCAAAACCATGCATTTTCCCATCTTTTCTCTC
ACCTTCATATACTCCACTATGACTATGATGATGTTCATTAGAAATAACAGCTTCAGATGCTGTAGCTTTAACACAT
ATAACATTCAATTCATGATTTTTAGGATTTTCTATTTTAAATTTATTCATATTATATACCTTACCTTTCTAATATT
AGTTATATTTATCTAATTTTTTAATATATTTATATAAATGATTTTTCATTTCATTTAATAATGAATAGCAAGTATA
AAATATTATATCATAAAATATTGAAAACAAGATACTAAAAATCAATAATTTTATTGATTTTTTAGTATCTGAAAAT
CTTATTTAATATATTCTGTATGTTTGTTTTAAGAAGCTATTTTATTTTAATAAGTAAGTAAAAATTAAGTTCATTA
ATATTAATATAATTTAAGATTTTTGTATATGAAAACAGGCTAATCATAATCATAATTTCTAATATTGGGTACAATA
AATAAATTTTAACAATAGAATCTTTTAAAAAATAGAGGAAGAGTTAATATATTTAAAGTAATATATAAGAGATAGT
TAAAAAATCTGTTTTAACTCCTTTGCTGAAAGTTCAACATTAAATCAAACTATGCTAATATAATAATATAGAATTG
AAATAAAACAGGGGGAACTTTTATGAAAAGTTTATTTGATAAAACCTGCATAAAAACAATGGAACTTAAAAATAGA
TTTGTTCGTTCAGCCACCTGGGAGGGCATGGCCACAGAAGAAGGACATATCACGGAGAGATTACTTAATTTATATG
AAGAATTAGCAAAGGGTGGAGTTGGATTAATAATAACTAGTTACACTACTATATTTGATTATGATAAGCCAAGTCT
TAGAATCCTTGGAATTTATGATGACAGTTTTATTGAAGAATATAAGCTTTTAACAGATACAATTCATAAATGTGGG
GCTAAAGTATTAATGCAAATAGTCTTAGGCGAGAATTATATTAATAATAAAACTGGTAGTGAATTTTATGGACTAA
GTGAAAATATGCCAGAAGATGATATAAAGGCTATAGTAAAATCTTTTGCTGAGGCAGCTAAAAGGGCTAAAGAGTC
AGGTTTTGATGGAATTCAAATTCATGGAGCACATGGATATTTTTTAAGTAGAACATTAAGTCCTCTTTTTAATAAA
AGAAAGGATAAATACGGTGGTTCAGTGGAAAAGAGAGGTGCATTAATACTAGAAGTTTATGATAAGATAAGAAAAA
CAGTAGGAGAGGATTTTCATATATCCATAAAAATTAATTGTTCTGATTTTGAAGAAGGAGGAGCAACCTTTAAGGA
ATGTGAATTTGTTTGCAGGGAACTTTCTAAGAAAGGTATAGATTCTATAGAAATCAGCGGTGGAGGAACAATTTGG
ACAGAAACTAATAAAAAGGAATCTATATATAAAGAGTATGCTTCCAAAATAGCAGAACAAGTAGATACTCCTATAA
TTTTAGTTGGTATGAATAGAAGTTATAATAATATGGATCAAATATTAAACAATAGTAAGATAGAATATTTTTCAAT
GGCTAGACCTTTTATAAGGGAACCAGATTTAATAAATAAATTTGAAAAAGATGAAAATAGAAAAGCTAAATGTATA
TCCTGTGGGAAATGTTATGGTGAAAATGGAATAAGATGTATATTTAATATGTAAAATAAATATAAGGATGGAGAAT
TCAAGTGAAATTCTTCATCCTTTATTTATGTAAACATTATTTTAAAACATAGCAAATTAATATTTTAAAAACTAAA
GGGTGATAATTACTAAAGTATTAAACAAATACTATAAAAAATTGATATTTTATTAAAAAATATATTGACTTAATGA
TAAAATTACGATAATATCTAATATATAATTAATAAATTGATTTTGGATATAATAATCATAATGTTAGTACTAATAG
GTAATTATTTAATCCTAGATATAAGACTATAGGGTTTATGTAAAATAATTTTGAAGAAAGTTTTAGGAGGGAAACA
TATGATAAAATTTAAAGATAGATTAATGATACCTGAAGGATATGAATCCACATTAGGAATAAGAGAAACAGAGGTT
GCAATAAAAAAGGTTAAAGATTTTTTTGAAAGAACTTTAGCAGAAAAGTTGAACCTTACAAGAGTTTCAGCACCTT
TATTTGTAAGAAAAAATACAGGTATGAATGATAACTTAAATGGAGTAGAAAGACCAGTAGCTTTTGATATGAAAGA
TCTAAAGGAAGAAATGATAGAAATAGTACATTCTTTAGCTAAGTGGAAAAGAATGGCTTTACACAGATATGATTTT
AAAGTTGGTGAAGGTCTTTATACAGATATGAATGCCATAAGAAGAGATGAGGATTTAGATAACCTTCATTCTATAT
ATGTGGATCAATGGGATTGGGAAAAAGTTATTAAAAAAGAAGATAGAAACAAAGAAACTTTAAAGTCTATAGTTAA
CAAAATATATAGTGTATTTAAGGAAACAGAGAGAGAGATTTGTAGCCAATATGAGGGATTCAATGAAATATTACCA
GAGGAAATATGTTTTATAACTTCTCAAGAACTCGAAGATACTTATCCGGATTTAGATTCAAAGGAAAGAGAAGATG
CTATAACTAAAGAAAAGGGAGCAGTATTTTTAATGGAAATAGGGGGAGTTTTAGCCTCAGGAGAAAAGCATGATGG
AAGAGCTCCAGATTATGATGACTGGACATTGAACGGAGATATATTATTTTGGAATCCAGTATTAGAAAGAGCCTTT
GAATTATCTTCTATGGGGATAAGAGTAGATGAAGAATCTCTAGAAAAACAACTTAAAATAGCAGGTTGTGAAGATA
GAAAAAATCTAGAATTTCATAGATTGCTTTTAGAGGGTAAATTGCCATATACCGTTGGTGGTGGAATTGGACAGTC
AAGAATATGTATGTATTTTTTAAGAAAAGCACATATAGGGGAAGTTCAAGCATCCATATGGCCAGATTTAATGATA
GAGGATTGTGAAAAAGCAAAAATCAACTTGCTATAG 
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8.9.3. C. sporogenes DSM795 gene encoding CLOSPO_03444 reductase:  
 
>Csp795.OYE-like.reductase 
CATTAAATCAAATTATGCTAATATAATAATATAGAATTGAAATAAAACAGGGGGAACTTTTATGAAAAGTTTATTT
GATAAAACCTGCATAAAAACAATGGAACTTAAAAATAGATTTGTTCGTTCAGCTACTTGGGAGGGTATGGCAACAG
AAGAAGGACATATCACGGAGAGATTACTTAATTTATATGAAGAATTAGCAAAGGGTGGAGTTGGATTAATAATAAC
TAGTTACACTACTATATTTGATTATGATAAACCAAGTCTTAGAATCCTTGGAATTTATGATGACAGTTTTATTAAA
GAATATAAGCTTTTGACAGATACAATTCATAAATATGGAGCTAAAGTATTAATGCAAATAGTCTTAGGAGAAAATT
ATATAAATAATGAAACCGGTAGTGAATTTTACGGATTAAGTGAAAATATGCCAGAAGATGATATAAAGGCTATAGT
GAAATCTTTTGCCGAAGCAGCTAAAAGGGCTAAAGAGTCAGGTTTTGATGGAATTCAAATTCATGGAGCACATGGA
TATTTTTTAAGTAGAACATTAAGTCCTCTTTTTAATAAAAGAAAGGATAAATACGGTGGTTCAGTAGAAAAGAGAG
GTGCATTAATACTAGAGGTTTATGATGAGATAAGAAAAGCAGTGGGAAAAGATTTTCATATATCCATAAAAATTAA
TTGTTCTGATTTTGAAGAGGGAGGAGCAACCTTTAAGGAATGTGAATTTGTTTGCAGGGAACTCTCTAAGAAAGGT
ATAGATTCTATAGAAATCAGCGGTGGAGGAACAATTTGGACAGAAACTAATAAAAAGGAATCTATATATATAGAGT
ATGCTTCCAAAATAGCTGAAGAAGTAGATACTCCCATAATTTTAGTTGGTATGAATAGAAGTTATGACAATATGAA
TGAAATATTAAATAATAGTAAGATCGAATATTTTTCAATGGCTAGACCTTTTATAAGGGAACCGGATTTGATAAAT
AAATTTGAAAAAGGTGAGGATAGAAAAGCTAAATGTATATCCTGTGGAAAATGTTATGGTGAAAATGGAATAAGGT
GCATATTTAATATGTAAAATATATATAAGGATGGAGAATTTAAGTGAAATTCTTCATCCTTTATTTATGTAAACAT
TATTTTAAAACATAGCAAATTAATATTTTAAAAATTAAGGGATGATAATTACTAAAGTATTAAACAAATACTATAA
AAAATTGATATTTTATTAAAAAATATATTGACTTAATGATAAAATTACGATAATATCTAATATATAATTAATAAAT
TGATTTTGGATATAATAATCATAATGTTAGTACTAATAGGTAATTATTTAATCCTATAGGATTTATGTAAAATAAT
TTTGAAGAAAGTTTTAGGAGGGAAACATATGATAAAATTTAAAGATAGATTAATGATACCTGAAGGATATGAATCC
ACATTAGGAATAAGAGAAACAGAGGTTG 
 
8.9.4. C. sporogenes OYE-like reductase (CLOSPO_03444):  
 
>Csp795.OYE-like.reductase (CLOSPO_03444) 
MKSLFDKTCIKTMELKNRFVRSATWEGMATEEGHITERLLNLYEELAKGGVGLIITSYTTIFDYDKPSLRILGIYD
DSFIKEYKLLTDTIHKYGAKVLMQIVLGENYINNETGSEFYGLSENMPEDDIKAIVKSFAEAAKRAKESGFDGIQI
HGAHGYFLSRTLSPLFNKRKDKYGGSVEKRGALILEVYDEIRKAVGKDFHISIKINCSDFEEGGATFKECEFVCRE
LSKKGIDSIEISGGGTIWTETNKKESIYIEYASKIAEEVDTPIILVGMNRSYDNMNEILNNSKIEYFSMARPFIRE
PDLINKFEKGEDRKAKCISCGKCYGENGIRCIFNM 
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8.10. Identification of the hypothetical cinnamic acid reductase 
8.10.1. CLOSPO_00312 acyl-CoA dehydrogenase ATCC15579:  
 
>Csp15579.CLOSPO_00312 
MFFTEQHELIRKLARDFAEQEIEPIADEVDKTAEFPKEIVKKMAQNGFFGIKMPKEYGGAGADNRAYVTIMEEISR
ASGVAGIYLSSPNSLLGTPFLLVGTDEQKEKYLKPMIRGEKTLAFALTEPGAGSDAGAVATTAREEGDYYILNGRK
TFITGAPISDNIIVFAKTDMSKGTKGITTFIVDSKQEGVSFGKPEDKMGMIGCPTSDIILENVKVHKSDILGELNK
GFITAMKTLSVGRIGVAAQALGIAQAAVDEAVKYAKQRKQFNRPIAKFQAIQFKLANMETKLNAAKLLVYNAAYKM
DCGEKADKEASMAKYFAAESAIQIVNDALQIHGGYGYIKDYKIERLYRDVRVIAIYEGTSEVQQMVIASNLLK 
 
8.10.2. CLOSPO_00312 acyl-CoA dehydrogenase ATCC15579:  
 
> Csp15579.CLOSPO_00312 
ATGTTTTTCACAGAACAACATGAACTTATTAGAAAATTAGCAAGAGATTTTGCAGAGCAGGAAATAGAGCCTATTG
CAGATGAAGTAGATAAAACTGCCGAGTTCCCTAAAGAAATTGTGAAAAAAATGGCCCAAAATGGTTTCTTTGGAAT
AAAAATGCCTAAAGAATATGGTGGAGCTGGAGCAGATAATAGAGCCTATGTAACTATAATGGAAGAGATATCAAGA
GCATCTGGTGTAGCTGGTATATATTTATCATCACCAAATTCATTGCTTGGCACACCATTCCTACTAGTTGGTACAG
ATGAACAAAAGGAAAAATATTTAAAACCAATGATTAGAGGAGAAAAGACATTAGCTTTTGCTTTAACAGAGCCAGG
TGCAGGTTCAGATGCAGGAGCAGTTGCAACAACTGCTAGAGAAGAAGGGGACTATTATATATTAAATGGAAGAAAA
ACTTTTATTACAGGAGCTCCAATATCTGATAATATCATAGTGTTCGCAAAAACAGATATGAGCAAAGGAACAAAGG
GAATTACTACATTTATAGTAGATAGTAAACAAGAAGGTGTATCTTTTGGTAAGCCTGAAGACAAGATGGGGATGAT
TGGTTGCCCTACTAGTGATATTATTTTAGAAAATGTAAAGGTCCATAAATCTGATATACTTGGAGAATTAAATAAA
GGATTTATAACAGCAATGAAGACTTTAAGTGTTGGCCGTATAGGAGTTGCTGCGCAAGCTTTAGGAATAGCACAAG
CTGCTGTAGATGAAGCTGTTAAATATGCAAAACAAAGAAAGCAATTTAATAGACCTATAGCAAAATTCCAAGCTAT
TCAATTTAAATTGGCTAATATGGAAACAAAATTAAATGCAGCAAAATTATTAGTGTATAATGCTGCTTATAAAATG
GATTGTGGAGAAAAGGCAGATAAAGAAGCTTCTATGGCAAAATATTTTGCTGCTGAATCTGCTATACAAATCGTAA
ATGACGCACTACAAATTCATGGTGGTTATGGATACATAAAAGATTATAAAATAGAAAGATTATATAGAGATGTTAG
AGTAATTGCTATATATGAAGGAACTTCTGAAGTTCAACAAATGGTAATCGCATCAAATCTTTTAAAGTAA 
 
8.10.3. CLOSPO_00312 acyl-CoA dehydrogenase DSM795:  
 
> Csp795.CLOSPO_00312 
ATGTTTTTCACAGAACAACATGAACTTATTAGAAAATTAGCAAGAGATTTTGCAGAGCAGGAAATAGAGCCTATTG
CAGATGAAGTAGATAAAACTGCCGAGTTCCCTAAAGAAATTGTGAAAAAAATGGCCCAAAATGGTTTTTTTGGAAT
AAAAATGCCTAAAGAATATGGTGGAGCTGGAGCAGATAATAGAGCCTATGTAACTATAATGGAAGAGATATCAAGA
GCATCTGGTGTAGCTGGTATATATTTATCATCACCAAATTCATTGCTTGGCACACCGTTCCTACTAGTTGGTACAG
ATGAACAAAAGGAAAAATATCTAAAACCAATGATTAGAGGAGAAAAAACATTAGCTTTTGCTTTAACAGAACCAGG
TGCAGGTTCAGACGCAGGAGCACTTGCAACAACTGCTAGAGAAGAAGGGGACTATTATATATTAAATGGAAGAAAA
ACTTTTATTACAGGAGCTCCAATATCTGATAATATCATAGTGTTCGCAAAAACAGATATGAGCAAAGGAACAAAGG
GAATTACTACATTTATAGTAGATAGTAAACAGGAAGGTGTATCTTTTGGTAAACCTGAAGACAAGATGGGTATGAT
TGGTTGCCCTACTAGTGATATTATTTTAGAGAATGTAAAGGTTCATAAATCTGATATACTTGGAGAAGTAAATAAA
GGCTTTATAACAGCAATGAAGACTTTAAGTGTTGGTCGTATAGGAGTTGCTTCTCAAGCTTTAGGAATAGCACAAG
CTGCTGTAGATGAAGCTGTTAAATATGCAAAACAAAGAAAACAATTTAATAGACCTATAGCAAAATTTCAAGCTAT
TCAATTTAAATTGGCTAACATGGAAACAAAATTAAATGCGGCAAAATTATTAGTGTATAATGCTGCTTATAAAATG
GATTGTGGAGAAAAGGCAGATAAAGAAGCTTCTATGGCAAAATATTTTGCTGCTGAATCTGCTATACAAATCGTAA
ATGACGCACTACAAATCCATGGTGGTTATGGATACATAAAAGATTATAAAATAGAAAGATTATATAGAGATGTTAG
AGTAATTGCTATATATGAAGGAACTTCTGAAGTTCAACAAATGGTAATCGCATCAAATCTTTTAAAGTAA 
 
8.10.4. CLOSPO_00312 acyl-CoA dehydrogenase DSM795:  
 
> Csp795.CLOSPO_00312 
MFFTEQHELIRKLARDFAEQEIEPIADEVDKTAEFPKEIVKKMAQNGFFGIKMPKEYGGAGADNRAYVTIMEEISR
ASGVAGIYLSSPNSLLGTPFLLVGTDEQKEKYLKPMIRGEKTLAFALTEPGAGSDAGALATTAREEGDYYILNGRK
TFITGAPISDNIIVFAKTDMSKGTKGITTFIVDSKQEGVSFGKPEDKMGMIGCPTSDIILENVKVHKSDILGEVNK
GFITAMKTLSVGRIGVASQALGIAQAAVDEAVKYAKQRKQFNRPIAKFQAIQFKLANMETKLNAAKLLVYNAAYKM
DCGEKADKEASMAKYFAAESAIQIVNDALQIHGGYGYIKDYKIERLYRDVRVIAIYEGTSEVQQMVIASNLLK 
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8.11. Sequencing of fldZ expression constructs  
>fldZ 
ATGAAAGACAAATACAAAGTGCTGTATGACCCGATTAAAATCGGCAAATTGGAAATCAAGAATCGCTATGTCCTGG
CACCTATGGGGCCAGGCGGGATGTGCAATGCAGATGGGTCCTTTAACAAACGTGGGATCGAATTCTATGTTGAACG
CGCAAAAGGCGGTACTGGCCTGATTATGACGGGTGTCACGATGGTGGAAAACAACATTGAGAAATGTGCGCTCCCT
AGCATGCCCTGTCCCACTATCAACCCGCTGAATTTCATTACCACCGGGAACGAAATGACCGAACGTGTGCACGCGT
ACGGTTCGAAAATTTTCCTGCAACTTTCAGCGGGCTTTGGCCGCGTATCCATTCCAAGTATCGTTGGGAAAGTAGC
GGTGGCACCCTCGAAGATCCCGCATCGCTTTCTGCCAGGTGTCACCTGCCGTGAACTGACCACCGAAGAAGTGAAA
GAGTACGTTAAGGCGTTTGGTGAGTCTGCCGAAATCGCGAAGAAAGCGGGTTTTGATGGAGTGGAAATTCATGCCG
TCCACGAAGGCTATCTGCTGGATCAGTTTGCTATCTCTTTCTTTAACCACCGTACCGATGAATATGGCGGTTCTCT
GGAAAACCGCTTACGTTTTGCGTGCGAGGTGGTTCAAGAGATTAAAAAGCGCTGTGGTCAGGACTTCCCGGTTTCT
CTGCGCTACAGCATTAAGAGCTTTATCAAGGACTGGTGCAAAGGAGGCTTACCGGACGAAGAATTCGAAGAGAAAG
GCCGGGATATTCCAGAAGGTATTGAGGCCGCCAAAATTCTGGTGGCTGCGGGGTATGATGCCCTGAACGGCGACGT
GGGCAGTTATGATAGCTGGTATTGGTCGCATCCTCCGATGTACCAGAAAAAAGGGCTCTACTTACCGTATAACGAG
ATTCTGAAAAAGGTGGTGGATGTCCCGATTATCACCGCAGGCCGTATGGAGGATCCAGAACTGAGCAGCGATGCCA
TTCTTTCTGGCAAAACGGACATGATTGCGCTTGGACGCCCGCTCTTGGCTGATGCGGAGATTCCGAATAAAATCTT
TGAAGATAAGTACGACAAAGTCCGCCCGTGCCTTTCATGCCAGGAAGGCTGTATGGGTCGTCTGCAGAACTTTGCT
ACCGTTAGTTGTGCAGTAAATCCTGCATGCGGTCGCGAAAAAGAATACGGTTTAAAGAAAGCGGAACAGATCAAAA
AAGTACTGGTGGTTGGCGGCGGTGTAGCGGGTATGGAAGCTGCCCGCGTCACAGCCGTTCGTGGCCACAAAGTGAC
CCTGATTGAAAAGAACGGCTATTTAGGCGGGAATATCGTACCGGGAGGCATTCCGGACTTTAAAGACGATGATCGT
GCACTGGTTAAATGGTATGAAGGCATTCTGAAAGATCTGGGCGTCGAAATCAAACTGAATGTGGGTGCGAGCAAAG
AGAACATCAAAGAGTTCGGGGCTGACGAAGTGCTCTTAGCTACAGGAAGCAGTCCGCGCACATTGACGATTGAGGG
TGCGGACAAAGTTTATTCGGCCGAAGATGTGTTAATGGAACGGAAAACGGTCGGTGAGAAAGTGATCGTTATTGGT
GGCGGCTTGGTTGGTTGCGAAACTGCACTTTGGCTGAAACAACAGGGCAAAGAAATCACCATTGTGGAAATGCAAA
ACGATATCCTGCAAGTGGGTGGACCGCTCTGTCATGCAAACCATGACATGTTGGTTGACTTGATTAAATTTAACAA
AATTGATGTCAAAACTTCCTCGTACATTTCCAAAAAAACGGATGAAGGCTTCGTCTTGAATACGAATGGTGAGGAA
AGCATTATCAATGCCGATAGTGCTGTGGTTGCCATCGGATACCTGTCAGAGAAAGATCTGTACTCCGAGGTACGCT
TCGATATCCCCAATGCCCGTCTGATTGGTGATGCGAATAAGGTCCAGAACATCATGTATGCGATTTGGTCAGCCTA
TGAAGTAGCGAAGAATATTTGA 
 
>fldZ:pelB 
ATGAAATACCTGCTGCCGACCGCTGCTGCTGGTCTGCTGCTCCTCGCTGCCCAGCCGGCGATGGCCATGAAAGACA
AATACAAAGTGCTGTATGACCCGATTAAAATCGGCAAATTGGAAATCAAGAATCGCTATGTCCTGGCACCTATGGG
GCCAGGCGGGATGTGCAATGCAGATGGGTCCTTTAACAAACGTGGGATCGAATTCTATGTTGAACGCGCAAAAGGC
GGTACTGGCCTGATTATGACGGGTGTCACGATGGTGGAAAACAACATTGAGAAATGTGCGCTCCCTAGCATGCCCT
GTCCCACTATCAACCCGCTGAATTTCATTACCACCGGGAACGAAATGACCGAACGTGTGCACGCGTACGGTTCGAA
AATTTTCCTGCAACTTTCAGCGGGCTTTGGCCGCGTATCCATTCCAAGTATCGTTGGGAAAGTAGCGGTGGCACCC
TCGAAGATCCCGCATCGCTTTCTGCCAGGTGTCACCTGCCGTGAACTGACCACCGAAGAAGTGAAAGAGTACGTTA
AGGCGTTTGGTGAGTCTGCCGAAATCGCGAAGAAAGCGGGTTTTGATGGAGTGGAAATTCATGCCGTCCACGAAGG
CTATCTGCTGGATCAGTTTGCTATCTCTTTCTTTAACCACCGTACCGATGAATATGGCGGTTCTCTGGAAAACCGC
TTACGTTTTGCGTGCGAGGTGGTTCAAGAGATTAAAAAGCGCTGTGGTCAGGACTTCCCGGTTTCTCTGCGCTACA
GCATTAAGAGCTTTATCAAGGACTGGTGCAAAGGAGGCTTACCGGACGAAGAATTCGAAGAGAAAGGCCGGGATAT
TCCAGAAGGTATTGAGGCCGCCAAAATTCTGGTGGCTGCGGGGTATGATGCCCTGAACGGCGACGTGGGCAGTTAT
GATAGCTGGTATTGGTCGCATCCTCCGATGTACCAGAAAAAAGGGCTCTACTTACCGTATAACGAGATTCTGAAAA
AGGTGGTGGATGTCCCGATTATCACCGCAGGCCGTATGGAGGATCCAGAACTGAGCAGCGATGCCATTCTTTCTGG
CAAAACGGACATGATTGCGCTTGGACGCCCGCTCTTGGCTGATGCGGAGATTCCGAATAAAATCTTTGAAGATAAG
TACGACAAAGTCCGCCCGTGCCTTTCATGCCAGGAAGGCTGTATGGGTCGTCTGCAGAACTTTGCTACCGTTAGTT
GTGCAGTAAATCCTGCATGCGGTCGCGAAAAAGAATACGGTTTAAAGAAAGCGGAACAGATCAAAAAAGTACTGGT
GGTTGGCGGCGGTGTAGCGGGTATGGAAGCTGCCCGCGTCACAGCCGTTCGTGGCCACAAAGTGACCCTGATTGAA
AAGAACGGCTATTTAGGCGGGAATATCGTACCGGGAGGCATTCCGGACTTTAAAGACGATGATCGTGCACTGGTTA
AATGGTATGAAGGCATTCTGAAAGATCTGGGCGTCGAAATCAAACTGAATGTGGGTGCGAGCAAAGAGAACATCAA
AGAGTTCGGGGCTGACGAAGTGCTCTTAGCTACAGGAAGCAGTCCGCGCACATTGACGATTGAGGGTGCGGACAAA
GTTTATTCGGCCGAAGATGTGTTAATGGAACGGAAAACGGTCGGTGAGAAAGTGATCGTTATTGGTGGCGGCTTGG
TTGGTTGCGAAACTGCACTTTGGCTGAAACAACAGGGCAAAGAAATCACCATTGTGGAAATGCAAAACGATATCCT
GCAAGTGGGTGGACCGCTCTGTCATGCAAACCATGACATGTTGGTTGACTTGATTAAATTTAACAAAATTGATGTC
AAAACTTCCTCGTACATTTCCAAAAAAACGGATGAAGGCTTCGTCTTGAATACGAATGGTGAGGAAAGCATTATCA
ATGCCGATAGTGCTGTGGTTGCCATCGGATACCTGTCAGAGAAAGATCTGTACTCCGAGGTACGCTTCGATATCCC
CAATGCCCGTCTGATTGGTGATGCGAATAAGGTCCAGAACATCATGTATGCGATTTGGTCAGCCTATGAAGTAGCG
AAGAATATTGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
>fldZ:NtH 
ATGGGCAGCAGCCATCATCATCATCATCACAGCAGCGGCCTGGTGCCGCGCGGCAGCCATATGAAAGACAAATACA
AAGTGCTGTATGACCCGATTAAAATCGGCAAATTGGAAATCAAGAATCGCTATGTCCTGGCACCTATGGGGCCAGG
CGGGATGTGCAATGCAGATGGGTCCTTTAACAAACGTGGGATCGAATTCTATGTTGAACGCGCAAAAGGCGGTACT
GGCCTGATTATGACGGGTGTCACGATGGTGGAAAACAACATTGAGAAATGTGCGCTCCCTAGCATGCCCTGTCCCA
CTATCAACCCGCTGAATTTCATTACCACCGGGAACGAAATGACCGAACGTGTGCACGCGTACGGTTCGAAAATTTT
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CCTGCAACTTTCAGCGGGCTTTGGCCGCGTATCCATTCCAAGTATCGTTGGGAAAGTAGCGGTGGCACCCTCGAAG
ATCCCGCATCGCTTTCTGCCAGGTGTCACCTGCCGTGAACTGACCACCGAAGAAGTGAAAGAGTACGTTAAGGCGT
TTGGTGAGTCTGCCGAAATCGCGAAGAAAGCGGGTTTTGATGGAGTGGAAATTCATGCCGTCCACGAAGGCTATCT
GCTGGATCAGTTTGCTATCTCTTTCTTTAACCACCGTACCGATGAATATGGCGGTTCTCTGGAAAACCGCTTACGT
TTTGCGTGCGAGGTGGTTCAAGAGATTAAAAAGCGCTGTGGTCAGGACTTCCCGGTTTCTCTGCGCTACAGCATTA
AGAGCTTTATCAAGGACTGGTGCAAAGGAGGCTTACCGGACGAAGAATTCGAAGAGAAAGGCCGGGATATTCCAGA
AGGTATTGAGGCCGCCAAAATTCTGGTGGCTGCGGGGTATGATGCCCTGAACGGCGACGTGGGCAGTTATGATAGC
TGGTATTGGTCGCATCCTCCGATGTACCAGAAAAAAGGGCTCTACTTACCGTATAACGAGATTCTGAAAAAGGTGG
TGGATGTCCCGATTATCACCGCAGGCCGTATGGAGGATCCAGAACTGAGCAGCGATGCCATTCTTTCTGGCAAAAC
GGACATGATTGCGCTTGGACGCCCGCTCTTGGCTGATGCGGAGATTCCGAATAAAATCTTTGAAGATAAGTACGAC
AAAGTCCGCCCGTGCCTTTCATGCCAGGAAGGCTGTATGGGTCGTCTGCAGAACTTTGCTACCGTTAGTTGTGCAG
TAAATCCTGCATGCGGTCGCGAAAAAGAATACGGTTTAAAGAAAGCGGAACAGATCAAAAAAGTACTGGTGGTTGG
CGGCGGTGTAGCGGGTATGGAAGCTGCCCGCGTCACAGCCGTTCGTGGCCACAAAGTGACCCTGATTGAAAAGAAC
GGCTATTTAGGCGGGAATATCGTACCGGGAGGCATTCCGGACTTTAAAGACGATGATCGTGCACTGGTTAAATGGT
ATGAAGGCATTCTGAAAGATCTGGGCGTCGAAATCAAACTGAATGTGGGTGCGAGCAAAGAGAACATCAAAGAGTT
CGGGGCTGACGAAGTGCTCTTAGCTACAGGAAGCAGTCCGCGCACATTGACGATTGAGGGTGCGGACAAAGTTTAT
TCGGCCGAAGATGTGTTAATGGAACGGAAAACGGTCGGTGAGAAAGTGATCGTTATTGGTGGCGGCTTGGTTGGTT
GCGAAACTGCACTTTGGCTGAAACAACAGGGCAAAGAAATCACCATTGTGGAAATGCAAAACGATATCCTGCAAGT
GGGTGGACCGCTCTGTCATGCAAACCATGACATGTTGGTTGACTTGATTAAATTTAACAAAATTGATGTCAAAACT
TCCTCGTACATTTCCAAAAAAACGGATGAAGGCTTCGTCTTGAATACGAATGGTGAGGAAAGCATTATCAATGCCG
ATAGTGCTGTGGTTGCCATCGGATACCTGTCAGAGAAAGATCTGTACTCCGAGGTACGCTTCGATATCCCCAATGC
CCGTCTGATTGGTGATGCGAATAAGGTCCAGAACATCATGTATGCGATTTGGTCAGCCTATGAAGTAGCGAAGAAT
ATTTGA 
 
>fldZ:CtH 
ATGAAAGACAAATACAAAGTGCTGTATGACCCGATTAAAATCGGCAAATTGGAAATCAAGAATCGCTATGTCCTGG
CACCTATGGGGCCAGGCGGGATGTGCAATGCAGATGGGTCCTTTAACAAACGTGGGATCGAATTCTATGTTGAACG
CGCAAAAGGCGGTACTGGCCTGATTATGACGGGTGTCACGATGGTGGAAAACAACATTGAGAAATGTGCGCTCCCT
AGCATGCCCTGTCCCACTATCAACCCGCTGAATTTCATTACCACCGGGAACGAAATGACCGAACGTGTGCACGCGT
ACGGTTCGAAAATTTTCCTGCAACTTTCAGCGGGCTTTGGCCGCGTATCCATTCCAAGTATCGTTGGGAAAGTAGC
GGTGGCACCCTCGAAGATCCCGCATCGCTTTCTGCCAGGTGTCACCTGCCGTGAACTGACCACCGAAGAAGTGAAA
GAGTACGTTAAGGCGTTTGGTGAGTCTGCCGAAATCGCGAAGAAAGCGGGTTTTGATGGAGTGGAAATTCATGCCG
TCCACGAAGGCTATCTGCTGGATCAGTTTGCTATCTCTTTCTTTAACCACCGTACCGATGAATATGGCGGTTCTCT
GGAAAACCGCTTACGTTTTGCGTGCGAGGTGGTTCAAGAGATTAAAAAGCGCTGTGGTCAGGACTTCCCGGTTTCT
CTGCGCTACAGCATTAAGAGCTTTATCAAGGACTGGTGCAAAGGAGGCTTACCGGACGAAGAATTCGAAGAGAAAG
GCCGGGATATTCCAGAAGGTATTGAGGCCGCCAAAATTCTGGTGGCTGCGGGGTATGATGCCCTGAACGGCGACGT
GGGCAGTTATGATAGCTGGTATTGGTCGCATCCTCCGATGTACCAGAAAAAAGGGCTCTACTTACCGTATAACGAG
ATTCTGAAAAAGGTGGTGGATGTCCCGATTATCACCGCAGGCCGTATGGAGGATCCAGAACTGAGCAGCGATGCCA
TTCTTTCTGGCAAAACGGACATGATTGCGCTTGGACGCCCGCTCTTGGCTGATGCGGAGATTCCGAATAAAATCTT
TGAAGATAAGTACGACAAAGTCCGCCCGTGCCTTTCATGCCAGGAAGGCTGTATGGGTCGTCTGCAGAACTTTGCT
ACCGTTAGTTGTGCAGTAAATCCTGCATGCGGTCGCGAAAAAGAATACGGTTTAAAGAAAGCGGAACAGATCAAAA
AAGTACTGGTGGTTGGCGGCGGTGTAGCGGGTATGGAAGCTGCCCGCGTCACAGCCGTTCGTGGCCACAAAGTGAC
CCTGATTGAAAAGAACGGCTATTTAGGCGGGAATATCGTACCGGGAGGCATTCCGGACTTTAAAGACGATGATCGT
GCACTGGTTAAATGGTATGAAGGCATTCTGAAAGATCTGGGCGTCGAAATCAAACTGAATGTGGGTGCGAGCAAAG
AGAACATCAAAGAGTTCGGGGCTGACGAAGTGCTCTTAGCTACAGGAAGCAGTCCGCGCACATTGACGATTGAGGG
TGCGGACAAAGTTTATTCGGCCGAAGATGTGTTAATGGAACGGAAAACGGTCGGTGAGAAAGTGATCGTTATTGGT
GGCGGCTTGGTTGGTTGCGAAACTGCACTTTGGCTGAAACAACAGGGCAAAGAAATCACCATTGTGGAAATGCAAA
ACGATATCCTGCAAGTGGGTGGACCGCTCTGTCATGCAAACCATGACATGTTGGTTGACTTGATTAAATTTAACAA
AATTGATGTCAAAACTTCCTCGTACATTTCCAAAAAAACGGATGAAGGCTTCGTCTTGAATACGAATGGTGAGGAA
AGCATTATCAATGCCGATAGTGCTGTGGTTGCCATCGGATACCTGTCAGAGAAAGATCTGTACTCCGAGGTACGCT
TCGATATCCCCAATGCCCGTCTGATTGGTGATGCGAATAAGGTCCAGAACATCATGTATGCGATTTGGTCAGCCTA
TGAAGTAGCGAAGAATATTGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
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8.12. FldZ expression variants alignment (ClustalW) 
fldZ            ----------------------MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADG 38 
fldZ_NtH        --MGSSHHHHHHSSGLVPRGSHMKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADG 58 
fldZ_CtH        ----------------------MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADG 38 
fldZ_pelB       MKYLLPTAAAGLLLLAAQPAMAMKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADG 60 
                                      ************************************** 
 
fldZ            SFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTER 98 
fldZ_NtH        SFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTER 118 
fldZ_CtH        SFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTER 98 
fldZ_pelB       SFNKRGIEFYVERAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTER 120 
                ************************************************************ 
 
fldZ            VHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAF 158 
fldZ_NtH        VHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAF 178 
fldZ_CtH        VHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAF 158 
fldZ_pelB       VHAYGSKIFLQLSAGFGRVSIPSIVGKVAVAPSKIPHRFLPGVTCRELTTEEVKEYVKAF 180 
                ************************************************************ 
 
fldZ            GESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIK 218 
fldZ_NtH        GESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIK 238 
fldZ_CtH        GESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIK 218 
fldZ_pelB       GESAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIK 240 
                ************************************************************ 
 
fldZ            KRCGQDFPVSLRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGD 278 
fldZ_NtH        KRCGQDFPVSLRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGD 298 
fldZ_CtH        KRCGQDFPVSLRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGD 278 
fldZ_pelB       KRCGQDFPVSLRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGD 300 
                ************************************************************ 
 
fldZ            VGSYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAGRMEDPELSSDAILSGKTDMI 338 
fldZ_NtH        VGSYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAGRMEDPELSSDAILSGKTDMI 358 
fldZ_CtH        VGSYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAGRMEDPELSSDAILSGKTDMI 338 
fldZ_pelB       VGSYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAGRMEDPELSSDAILSGKTDMI 360 
                ************************************************************ 
 
fldZ            ALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGL 398 
fldZ_NtH        ALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGL 418 
fldZ_CtH        ALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGL 398 
fldZ_pelB       ALGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGL 420 
                ************************************************************ 
 
fldZ            KKAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRAL 458 
fldZ_NtH        KKAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRAL 478 
fldZ_CtH        KKAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRAL 458 
fldZ_pelB       KKAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRAL 480 
                ************************************************************ 
 
fldZ            VKWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVL 518 
fldZ_NtH        VKWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVL 538 
fldZ_CtH        VKWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVL 518 
fldZ_pelB       VKWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGADKVYSAEDVL 540 
                ************************************************************ 
 
fldZ            MERKTVGEKVIVIGGGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVDL 578 
fldZ_NtH        MERKTVGEKVIVIGGGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVDL 598 
fldZ_CtH        MERKTVGEKVIVIGGGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVDL 578 
fldZ_pelB       MERKTVGEKVIVIGGGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVDL 600 
                ************************************************************ 
 
fldZ            IKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSEKDLYSEVRFDIPN 638 
fldZ_NtH        IKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSEKDLYSEVRFDIPN 658 
fldZ_CtH        IKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSEKDLYSEVRFDIPN 638 
fldZ_pelB       IKFNKIDVKTSSYISKKTDEGFVLNTNGEESIINADSAVVAIGYLSEKDLYSEVRFDIPN 660 
                ************************************************************ 
 
fldZ            ARLIGDANKVQNIMYAIWSAYEVAKNI----------- 665 
fldZ_NtH        ARLIGDANKVQNIMYAIWSAYEVAKNI----------- 685 
fldZ_CtH        ARLIGDANKVQNIMYAIWSAYEVAKNIAAALEHHHHHH 676 
fldZ_pelB       ARLIGDANKVQNIMYAIWSAYEVAKNIAAALEHHHHHH 698 
                ***************************            
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8.13. Spectral changes during the cinnamic acid spectrophotometric assay  
 
Fig. 8.25. Spectral changes in the cinnamic acid reduction assay using the protein 
cell-free extract of E. coli expressing the wild type fldZ. 
 
 
Fig. 8.26. Traces of the cinnamic acid spectrophotometric assay using the protein 
cell-free extract of E. coli expressing fldZ (භ), fldZ:NtH (Ŷ) and pET20b(+) control 
(Ÿ). 
 
 
 
 
 
 
184 
 
8.14. Traces of the fldZ activity assay at different temperature and pH 
 
Fig. 8.27. Traces of the cinnamic acid spectrophotometric assay using the protein 
cell-free extract of E. coli expressing fldZ at a range of temperatures. The NADH 
concentration in the reaction mixture was increased from 0.125 mM to 0.157 mM. 
 
 
Fig. 8.28. Traces of the cinnamic acid spectrophotometric assay using the protein 
cell-free extract of E. coli expressing fldZ at a range of pH. The NADH concentration 
in the reaction mixture was increased from 0.125 mM to 0.157 mM. 
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8.15. Gas chromatograms and mass spectra for biotransformation using fldZ 
 
 
Fig. 8.29. Gas chromatogram of the control pET20b(+) sample collected after 24 h and derivatized 
with trimethylsilyldiazomethane. Mass spectrum of the cinnamic acid methyl ester peak at 11.261 
min. 
 
 
 
Fig. 8.30. Gas chromatogram of the sample containing the fldZ reductase collected after 24 h and 
derivatized with trimethylsilyldiazomethane, mass spectrum of the 3-phenylpropionic acid methyl 
ester peak at 10.861. 
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8.16. Sequencing of OYE-like reductase expression constructs 
8.16.1. OYE nucleotide and amino acid sequences:  
 
>OYE  
ATGAAAAGTTTATTTGATAAAACCTGCATAAAAACAATGGAACTTAAAAATAGATTTGTTCGTTCAGCTACTTGGG
AGGGTATGGCAACAGAAGAAGGACATATCACGGAGAGATTACTTAATTTATATGAAGAATTAGCAAAGGGTGGAGT
TGGATTAATAATAACTAGTTACACTACTATATTTGATTATGATAAACCAAGTCTTAGAATCCTTGGAATTTATGAT
GACAGTTTTATTAAAGAATATAAGCTTTTGACAGATACAATTCATAAATATGGAGCTAAAGTATTAATGCAAATAG
TCTTAGGAGAAAATTATATAAATAATGAAACCGGTAGTGAATTTTACGGATTAAGTGAAAATATGCCAGAAGATGA
TATAAAGGCTATAGTGAAATCTTTTGCCGAAGCAGCTAAAAGGGCTAAAGAGTCAGGTTTTGATGGAATTCAAATT
CATGGAGCACATGGATATTTTTTAAGTAGAACATTAAGTCCTCTTTTTAATAAAAGAAAGGATAAATACGGTGGTT
CAGTAGAAAAGAGAGGTGCATTAATACTAGAGGTTTATGATGAGATAAGAAAAGCAGTGGGAAAAGATTTTCATAT
ATCCATAAAAATTAATTGTTCTGATTTTGAAGAGGGAGGAGCAACCTTTAAGGAATGTGAATTTGTTTGCAGGGAA
CTCTCTAAGAAAGGTATAGATTCTATAGAAATCAGCGGTGGAGGAACAATTTGGACAGAAACTAATAAAAAGGAAT
CTATATATATAGAGTATGCTTCCAAAATAGCTGAAGAAGTAGATACTCCCATAATTTTAGTTGGTATGAATAGAAG
TTATGACAATATGAATGAAATATTAAATAATAGTAAGATCGAATATTTTTCAATGGCTAGACCTTTTATAAGGGAA
CCGGATTTGATAAATAAATTTGAAAAAGGTGAGGATAGAAAAGCTAAATGTATATCCTGTGGAAAATGTTATGGTG
AAAATGGAATAAGGTGCATATTTAATATGTAA 
 
>OYE 
MKSLFDKTCIKTMELKNRFVRSATWEGMATEEGHITERLLNLYEELAKGGVGLIITSYTTIFDYDKPSLRILGIYD
DSFIKEYKLLTDTIHKYGAKVLMQIVLGENYINNETGSEFYGLSENMPEDDIKAIVKSFAEAAKRAKESGFDGIQI
HGAHGYFLSRTLSPLFNKRKDKYGGSVEKRGALILEVYDEIRKAVGKDFHISIKINCSDFEEGGATFKECEFVCRE
LSKKGIDSIEISGGGTIWTETNKKESIYIEYASKIAEEVDTPIILVGMNRSYDNMNEILNNSKIEYFSMARPFIRE
PDLINKFEKGEDRKAKCISCGKCYGENGIRCIFNM 
 
8.16.2. OYE:CtH nucleotide and amino acid sequences:  
 
>OYE:CtH 
ATGAAAAGTTTATTTGATAAAACCTGCATAAAAACAATGGAACTTAAAAATAGATTTGTTCGTTCAGCTACTTGGG
AGGGTATGGCAACAGAAGAAGGACATATCACGGAGAGATTACTTAATTTATATGAAGAATTAGCAAAGGGTGGAGT
TGGATTAATAATAACTAGTTACACTACTATATTTGATTATGATAAACCAAGTCTTAGAATCCTTGGAATTTATGAT
GACAGTTTTATTAAAGAATATAAGCTTTTGACAGATACAATTCATAAATATGGAGCTAAAGTATTAATGCAAATAG
TCTTAGGAGAAAATTATATAAATAATGAAACCGGTAGTGAATTTTACGGATTAAGTGAAAATATGCCAGAAGATGA
TATAAAGGCTATAGTGAAATCTTTTGCCGAAGCAGCTAAAAGGGCTAAAGAGTCAGGTTTTGATGGAATTCAAATT
CATGGAGCACATGGATATTTTTTAAGTAGAACATTAAGTCCTCTTTTTAATAAAAGAAAGGATAAATACGGTGGTT
CAGTAGAAAAGAGAGGTGCATTAATACTAGAGGTTTATGATGAGATAAGAAAAGCAGTGGGAAAAGATTTTCATAT
ATCCATAAAAATTAATTGTTCTGATTTTGAAGAGGGAGGAGCAACCTTTAAGGAATGTGAATTTGTTTGCAGGGAA
CTCTCTAAGAAAGGTATAGATTCTATAGAAATCAGCGGTGGAGGAACAATTTGGACAGAAACTAATAAAAAGGAAT
CTATATATATAGAGTATGCTTCCAAAATAGCTGAAGAAGTAGATACTCCCATAATTTTAGTTGGTATGAATAGAAG
TTATGACAATATGAATGAAATATTAAATAATAGTAAGATCGAATATTTTTCAATGGCTAGACCTTTTATAAGGGAA
CCGGATTTGATAAATAAATTTGAAAAAGGTGAGGATAGAAAAGCTAAATGTATATCCTGTGGAAAATGTTATGGTG
AAAATGGAATAAGGTGCATATTTAATATGGCGGCCGCACTCGAGCACCACCACCACCACCACTGA 
 
>OYE:CtH 
MKSLFDKTCIKTMELKNRFVRSATWEGMATEEGHITERLLNLYEELAKGGVGLIITSYTTIFDYDKPSLRILGIYD
DSFIKEYKLLTDTIHKYGAKVLMQIVLGENYINNETGSEFYGLSENMPEDDIKAIVKSFAEAAKRAKESGFDGIQI
HGAHGYFLSRTLSPLFNKRKDKYGGSVEKRGALILEVYDEIRKAVGKDFHISIKINCSDFEEGGATFKECEFVCRE
LSKKGIDSIEISGGGTIWTETNKKESIYIEYASKIAEEVDTPIILVGMNRSYDNMNEILNNSKIEYFSMARPFIRE
PDLINKFEKGEDRKAKCISCGKCYGENGIRCIFNMAAALEHHHHHH 
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8.17. Identification and overexpression of nitroreductases 
8.17.1. CsNTR1 (CLOSPO_01010) 
>Csp795.CsNTR1 
ATGCTTGAAGAAATAAGATCAAGAAGAAGTATACGAAAATATATAAATAAGCCTATTGAAGATGAGAAAATAAATC
AGCTTATTGAAAGTGCTAGAATGGCACCATCTGGTTCTAATACACAGCCTTGGCATTTTATTGTGGTAAAATCTGA
TACTACTAGGGAAAAGTTAGCTAAGGTATCCCATAATCAAGGATGGATGATGGGTGCGCCAGTTTTTATTGTATGT
GTTGCAGATATACGCTCTAGGATTAAAAAAGATATAGAACTATCATTGAATGAAAATAGCCCGCAATTAGAGCTTA
AGCAAATAATAAGAGATACATCTATAGCTATAGAACATTTAGTACTTTCTGCTGAGAAATTTGGCTTAGGAACTTG
TTGGGTCGCATGGTTTACTCAAGAAGAGATTAGACCAATTTTAAATATACCTTCTGATAAATATGTGGTTAGTATT
ATTACACTTGGATATTCAAATGAATTACCTAAAGATAGGCCACATAAAAAATTAGAAGATATAATACATTATGAAA
AATGGTAA 
 
>CsNTR1 
MLEEIRSRRSIRKYINKPIEDEKINQLIESARMAPSGSNTQPWHFIVVKSDTTREKLAKVSHNQGWMMGAPVFIVC
VADIRSRIKKDIELSLNENSPQLELKQIIRDTSIAIEHLVLSAEKFGLGTCWVAWFTQEEIRPILNIPSDKYVVSI
ITLGYSNELPKDRPHKKLEDIIHYEKW 
 
>CsNTR1-adapted 
ATGCTGGAAGAGATTCGCTCGCGTCGGTCAATTCGCAAATACATCAACAAACCGATTGAAGATGAGAAAATCAATC
AGCTGATCGAAAGTGCCCGTATGGCTCCTTCAGGGAGCAATACCCAACCGTGGCATTTCATCGTGGTCAAATCCGA
CACGACTCGCGAGAAATTGGCGAAAGTGAGCCATAATCAGGGTTGGATGATGGGTGCACCAGTATTCATTGTCTGC
GTTGCAGACATTCGCTCTCGCATTAAGAAAGATATCGAACTGTCGCTGAATGAAAACAGTCCGCAACTGGAGCTCA
AGCAGATTATCCGCGATACGTCTATCGCGATTGAACATCTGGTGTTAAGCGCCGAAAAGTTTGGCTTAGGAACCTG
TTGGGTAGCGTGGTTTACACAGGAAGAAATTCGTCCGATCTTGAACATTCCGAGCGACAAATACGTTGTGTCGATT
ATTACCCTGGGCTATTCCAACGAACTGCCCAAAGATCGTCCACACAAGAAACTTGAAGATATTATCCACTATGAGA
AATGGTAA 
 
8.17.2. CsNTR3 (CLOSPO_01572) 
>Csp795.CsNTR3 
ATGGATTTTTTAGACTTAGCTAAAGAAAGATATTCTGTAAGAAATTTTGATACTAAAAAGATCGAACAAGAAAAAC
TAGATTTAATTTTAAAAGCAGGACAATTAGCCCCAACTGCTGTAAATTATCAGCCTCAAAGAATTTTAGTAATTGA
AAGTAATGATGCTCTTGCAAAACTAAAAACTTGCACAATTTATCACTTCAATGCACCCATGGCTCTACTTATATGC
GCGGACAAAGATGAAGCCTGGAAACGTAGTTATGACGGAAAAAGCCATACTGATATTGATGGGAGTATTGTTGCTA
CACATATGATGCTACAAGCTGCTGAACTTGGCTTGGGTACAACATGGGTTGGTCATTTTGATCCAAGTGCTATTCG
TAATGCTTTTAGTATACCAGCAAATCTTGAACCAATATGCCTTTTGCCAGTAGGTTACCCAAGTAAGGATGCAAAA
CCAAATCCTAATCACAAAAAAAGAAAAGATATTTCCCAAACTGTTTTTTATAATCATTTTTAA 
 
>CsNTR3 
MDFLDLAKERYSVRNFDTKKIEQEKLDLILKAGQLAPTAVNYQPQRILVIESNDALAKLKTCTIYHFNAPMALLIC
ADKDEAWKRSYDGKSHTDIDGSIVATHMMLQAAELGLGTTWVGHFDPSAIRNAFSIPANLEPICLLPVGYPSKDAK
PNPNHKKRKDISQTVFYNHF 
 
>CsNTR3-adapted 
ATGGATTTTCTGGATCTGGCCAAAGAGCGTTACAGCGTACGTAACTTCGACACCAAGAAAATCGAACAGGAGAAAC
TGGATCTGATCCTGAAAGCGGGACAATTGGCACCCACCGCAGTGAACTATCAGCCACAGCGCATTCTCGTGATCGA
ATCGAATGATGCGCTTGCTAAACTGAAAACGTGCACCATTTACCACTTCAATGCCCCTATGGCGCTGCTGATTTGT
GCCGATAAAGACGAAGCGTGGAAACGCTCGTATGATGGCAAGAGCCATACGGATATTGACGGTTCAATTGTTGCGA
CCCACATGATGCTGCAAGCTGCTGAACTCGGCTTAGGGACAACTTGGGTTGGCCATTTTGACCCGAGTGCAATCCG
GAATGCATTCAGCATTCCGGCGAACTTGGAACCGATTTGCCTTTTACCAGTCGGTTATCCGTCCAAAGATGCCAAA
CCTAATCCGAACCATAAGAAGCGCAAAGACATCTCTCAGACTGTGTTTTACAACCACTTTTAA 
 
8.17.3. CsNTR4 (CLOSPO_01641) 
>Csp795.CsNTR4 
ATGTTAGATTTATTAAAACAAAGAAGAAGTATAAGAAAGTTTCAGCAAAAGCCAATAGAAGAGGAAAAAGTAGAAG
CTCTAAAAAAGGCATTACTTTTAGCCCCATCCTCTAGAAATATAAAACCTTTAGAGTTTATATTTTTAGAAGATAA
GGAAATTTTAAAGGATATTTCAAACTGTAAATCTCATGGAGGAACTTTTATAAAGGATGCAGCCTTAGCAGTAGTT
ATATTAGGGGATGAGGATAAAAGTGATGTATGGGTAGAGGATGCCTCTATAGCCTCTATAATACTACAACTTGAAG
CAGAATCTCTAGGATTAGGATCTTGCTGGTCACAAATAAGAAATAGAAGCTATGATGAAAATAAAATGGCGGAGGA
TTATATAAAAGAAAAACTAAACATAAAAGAGAATTATAAAGTAGAATCTATAATAGCCATAGGCTACAAAGATGAA
GTTAAGGAACCTATAAGTGAAGAAAAATTAGATTTTGATAAAATTCATGTTAACAAATTTATTTAA 
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>CsNTR4 
MLDLLKQRRSIRKFQQKPIEEEKVEALKKALLLAPSSRNIKPLEFIFLEDKEILKDISNCKSHGGTFIKDAALAVV
ILGDEDKSDVWVEDASIASIILQLEAESLGLGSCWSQIRNRSYDENKMAEDYIKEKLNIKENYKVESIIAIGYKDE
VKEPISEEKLDFDKIHVNKFI 
 
>CsNTR4-adapted 
ATGCTGGATCTGCTGAAACAACGTCGCAGTATTCGCAAATTCCAGCAAAAGCCGATTGAAGAAGAGAAAGTCGAAG
CACTCAAGAAAGCGTTACTGCTGGCACCAAGTTCCCGCAATATTAAGCCTTTGGAATTTATCTTTCTGGAGGACAA
AGAGATCCTGAAAGACATCTCGAATTGCAAATCTCATGGTGGAACCTTCATCAAAGATGCCGCTTTGGCTGTTGTG
ATTCTGGGCGATGAAGATAAAAGCGATGTATGGGTTGAGGATGCCTCGATTGCGAGCATTATTCTTCAGCTGGAAG
CCGAATCTTTAGGTCTTGGCAGCTGTTGGTCACAGATTCGGAATCGTTCCTATGACGAAAACAAAATGGCGGAAGA
TTACATCAAAGAGAAACTCAACATCAAAGAGAACTACAAAGTCGAATCAATCATTGCGATCGGGTATAAAGATGAA
GTGAAGGAACCGATTAGCGAAGAAAAGCTGGACTTTGACAAAATTCACGTGAACAAATTCATTTAA 
 
8.17.4. CsNTR5 (CLOSPO_01855) 
>Csp795.CsNTR5 
ATGGATTTTTATGATGTTATTGAAGATAGAAAAAGTATAAGAAAATTTAAAAATGGAGAGATTTGTAAAGAAAAGA
TGGCAAGAGTAATAAATGCAGCTATGAGATCACCTTCTTGGAAGAACGAAACTTCTTATAAATTTATAATAGTACA
AGATGGAACTAAAAGAATGGAATTAGCTAGTGCTATAATAAATAAATCTGATGAAGCTTCAGAAGCTATAAGAGTA
GCACCTGTAACAGCTGTGGTTGTTGCAGATCCAGATAAATCGGGTACTATAGAAAACAAACAATATTATCTAGTAG
ATAGTGCTATAGCTATGGAGCATTTTATATTAGCAGCTACAGCAGAAGGCTACGGTACTTGTTGGATAGGAGCTTT
TGATGAAGATAAAGTAAAAGGTGTATTAGATATACCTCAAAATTATAAAGTAGTTGGCATGACTCCTGTAGGAGAA
TCAAATGAAAATAAAGAAAGTCATCCTAAAAAAGATGTGAGAGAATATGTGTTTTTAGATAAATGGCATAATTCAT
ATACAGAAAATATATAA 
 
>CsNTR5 
MDFYDVIEDRKSIRKFKNGEICKEKMARVINAAMRSPSWKNETSYKFIIVQDGTKRMELASAIINKSDEASEAIRV
APVTAVVVADPDKSGTIENKQYYLVDSAIAMEHFILAATAEGYGTCWIGAFDEDKVKGVLDIPQNYKVVGMTPVGE
SNENKESHPKKDVREYVFLDKWHNSYTENI 
 
>CsNTR5-adapted 
ATGGACTTTTATGATGTGATTGAGGATCGCAAATCCATTCGCAAATTCAAGAATGGCGAAATTTGCAAAGAGAAAA
TGGCACGTGTGATCAATGCCGCAATGCGTTCACCTTCGTGGAAGAATGAAACGAGCTACAAATTCATCATTGTCCA
AGATGGCACGAAACGGATGGAATTAGCGTCTGCGATCATCAACAAATCGGACGAAGCGAGTGAAGCCATTCGCGTT
GCTCCAGTTACAGCGGTAGTCGTTGCTGATCCGGACAAAAGTGGCACCATCGAAAACAAACAGTACTATCTGGTTG
ATAGCGCGATTGCTATGGAACACTTCATTTTGGCCGCAACTGCCGAAGGCTATGGTACCTGTTGGATTGGAGCGTT
TGATGAGGACAAAGTGAAAGGGGTCCTGGATATTCCGCAGAATTACAAAGTGGTAGGTATGACCCCGGTAGGTGAA
AGCAACGAAAACAAGGAGTCTCATCCCAAGAAAGATGTGCGTGAGTATGTGTTTCTGGACAAATGGCATAACTCCT
ATACCGAAAACATCTAA 
 
8.17.5. CsNTR6 (CLOSPO_02936) 
>Csp795.CsNTR6 
ATGAATGCTATATTAAAGAGAAGAAGTATAAGAAAATACAAGGATAAAAAGATAAGTGATGATATTGTTGAAGAAT
TATTAAGAGCAGGAATGGCTGCACCTTCTGCTGTAAATGAACAACCTTGGCAATTTATAGTGTTAAGAGATAAAGA
AACTATGAAAAAGATAACTAAGGTGCATGAGTATTCAAAGATGTTATTAGAGGCAGATGTTGCAATTGTAGTTTGT
GGAGATAAATCAAAAGAGTTAGTAGATGATTTTTGGGTACAAGATTGTTCAGCAGCTACAGAGAACATATTAATAG
AGGCACAAGATAAAGGATTAGGCGCAGTATGGTTAGGTGTTTATCCAATAAAAGAGAGAGTAGATGGAATAAAAGA
AATTCTAAATTTACCAGAAGGTATAACTCCTTTATCTGTAATACCTATAGGATATCCAGATGAAAAAAAGGAGCCA
GCAGATAGATCTAATAAAGAAAGAGTACATTATGATAAATGGTAATAA 
 
>CsNTR6 
MNAILKRRSIRKYKDKKISDDIVEELLRAGMAAPSAVNEQPWQFIVLRDKETMKKITKVHEYSKMLLEADVAIVVC
GDKSKELVDDFWVQDCSAATENILIEAQDKGLGAVWLGVYPIKERVDGIKEILNLPEGITPLSVIPIGYPDEKKEP
ADRSNKERVHYDKW 
 
>CsNTR6-adapted 
ATGAATGCCATCCTCAAACGCCGGTCAATCCGCAAATACAAAGACAAGAAAATCTCCGATGATATTGTCGAAGAAC
TGTTACGTGCCGGTATGGCTGCTCCATCTGCGGTAAACGAACAGCCTTGGCAGTTCATTGTGCTGCGTGACAAAGA
AACCATGAAGAAGATTACCAAAGTGCATGAGTACAGCAAAATGCTGCTTGAAGCGGATGTTGCGATTGTCGTTTGT
GGCGATAAATCGAAAGAATTGGTTGACGACTTTTGGGTCCAAGATTGCAGTGCAGCAACGGAAAACATTCTGATTG
AGGCCCAGGATAAAGGCTTAGGTGCGGTTTGGTTGGGTGTGTATCCGATCAAAGAGCGTGTGGATGGGATCAAAGA
GATTCTGAATCTGCCAGAAGGAATCACTCCGCTGAGCGTGATTCCGATTGGCTATCCGGATGAGAAGAAAGAACCC
GCAGATCGCTCGAACAAAGAACGCGTACACTATGACAAATGGTAA 
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8.17.6. CsNTR7 (CLOSPO_02936) 
>Csp795.CsNTR7 
ATGAATACTGTATTACAAACTATAAAAAATAGAAGAAGTATAAGAGGTTATAAATCTGAGCAAATAAAAGAAGAAG
AACTTCAATGTATATTAGAAGCTGGAATCTATGCTCCTTCTGGTTGTAATCATCAATCCTGGCATTTTACTGTTAT
TCAAAACAGAGAATTAATTACAACTATGAGCAATGTGGCTAAAGAAAAACTTAAAGATTCACCTAATGAAAATTTT
AGAAATATGGGTAATAATGAAAAACTTGATTTAACTCATGGTGCACCTACTTTAATTGTAGTATCAGGGAAAGAAG
GTAACTATTCCCCTTTAGTTGATTGTTCTGCTGCCATAGAAAATATGCTAATTGCTGCTGAAAGCTTAAATATAGG
TTCTTTATGGATAGGCCTTATTTCACTAGCTTTTGAAAATAAAGAAATCATGGAAAAATTAAATATACCTAAGGGA
TATAAACCTTATTTTGGCATAGCTTTAGGATATAAAAACGTAAGTGAAGCTAAAGCTCCTAAAAGAAATGAAAATG
TAATAACTTACATAAGATAA 
 
>CsNTR7 
MNTVLQTIKNRRSIRGYKSEQIKEEELQCILEAGIYAPSGCNHQSWHFTVIQNRELITTMSNVAKEKLKDSPNENF
RNMGNNEKLDLTHGAPTLIVVSGKEGNYSPLVDCSAAIENMLIAAESLNIGSLWIGLISLAFENKEIMEKLNIPKG
YKPYFGIALGYKNVSEAKAPKRNENVITYIR 
 
>CsNTR7-adapted 
ATGAATACCGTACTGCAAACGATCAAGAACCGTCGTAGCATTCGTGGCTACAAAAGCGAACAGATCAAAGAGGAGG
AACTGCAGTGCATTCTGGAAGCGGGTATCTATGCGCCATCTGGCTGCAATCACCAAAGCTGGCATTTTACCGTCAT
TCAGAATCGCGAACTGATCACCACCATGTCTAATGTGGCGAAAGAGAAACTGAAAGATTCCCCGAATGAAAACTTC
CGCAATATGGGCAACAATGAGAAACTGGATCTTACTCATGGAGCACCTACACTCATCGTCGTTTCGGGTAAAGAAG
GGAACTATTCGCCGTTGGTTGACTGTAGTGCTGCCATTGAAAACATGTTGATTGCTGCAGAAAGCCTGAACATTGG
TTCCTTATGGATCGGCTTAATCTCACTTGCGTTCGAAAACAAAGAAATTATGGAGAAACTCAACATTCCGAAGGGG
TATAAGCCCTACTTTGGTATTGCACTGGGCTATAAGAACGTGAGTGAAGCCAAAGCCCCGAAACGCAATGAAAACG
TGATCACGTACATTCGGTAA 
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8.18. List of protein sequences used for the phylogenetic analysis  
Q99190 enoyl reductase Saccharomyces cerevisiae; 
YP_002987388 NADH:flavin oxidoreductase Dickeya dadantii; 
YP_878535 reductase Clostridium novyi; 
CAA76082 2-enoate reductase Moorella thermoacetica; 
CAA76083 2-enoate reductase Clostridium kluyveri; 
CAA71086 2-enoate reductase Clostridium tyrobutyricum; 
YP_001254661 2-enoate reductase Clostridium botulinum str. A; 
fldZ 2-enoate reductase CLOSPO_02780 Clostridium sporogenes (this study); 
A6ZRN6 2,4-dienoyl-CoA reductase Saccharomyces cerevisiae; 
OYE-like hypothetical protein CLOSPO_03444 Clostridium sporogenes (this study); 
ZP_06424320 NADH oxidase Peptostreptococcus anaerobius; 
P54550 Bacillus subtilis; 
Q9FEW9 OPR3 Lycopersicon esculentum;  
Q9XG54 OPR1 Lycopersicon esculentum; 
E7KDJ6 Oye2p Saccharomyces cerevisiae; 
YP_003226383 NADH:flavin oxidoreductase Zymomonas mobilis; 
3KFT_A PETNR Enterobacter cloacae. 
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8.19. Similarities in the structure between clostridial 2-enoate reductases and OYEs 
C. sporogenes        ---------MKDKYKVLYDPIKIGKLEIKNRYVLAPMGPGGMCNADGSFNK-RGIEFYVE 50 
C. tyrobutyricum     -----------MKNKSLFEPIKIGKVEVKNKISMAPMGAFGLVDNEGCYNQ-RAVDYYVE 48 
C. kluyveri          -----------MKNKSLFEPIKIGNMEVKNKIAMAPMGAFGLVDNECCFNQ-RAVDYYVE 48 
M. thermoacetica     ----------MVAYTRLFEPIKIGKVEIKNKIAMTPMGVLGLATHDGCFSK-RVVDYYVE 49 
PETNR                ------------SAEKLFTPLKVGAVTAPNRVFMAPLTRLRSIEPGDIPTP-LMGEYYRQ 47 
OYE2                 MSFVKDFKPQALGDTNLFKPIKIGNNELLHRAVIPPLTRMRAQHPGNIPNRDWAVEYYAQ 60 
 
C. sporogenes        RAKGGTGLIMTGVTMVENNIEKCALPSMPCPTINPLNFITTGNEMTERVHAYGSKIFLQL 110 
C. tyrobutyricum     RAKGGTGLIITSITKVENEIDKVVPGVIPIISINPGRFIMTSSEMTERVHAYGSKIFLQL 108 
C. kluyveri          RAKGGTGLIITSVVKVENELDKVLTGVLPITSINPAKFIMTSSEMTERVHAYGSKIFLQL 108 
M. thermoacetica     RAKGGTGLIITSVTKVDNEIERFKAGAVPVATANPLHFIATAGELTERVHAYGTKIFLQL 109 
PETNR                RAS--AGLIISEATQISAQAKGYAGAPGLHSPEQIAAWKKITAGVHAEDGRIAVQLWHTG 105 
OYE2                 RAQRPGTLIITEGTFPSPQSGGYDNAPGIWSEEQIKEWTKIFKAIHEKKSFAWVQLWVLG 120 
 
C. sporogenes        SAGFGRVSIP-SIVGKV---------AVAPSKIPHRFLPGVTCRELTTEEVKEYVKAFGE 160 
C. tyrobutyricum     TMGFGRSGAPGTLLTSQ---------PVSASSVPNYWDPTVTCRELTTSEVEWIVAKFIQ 159 
C. kluyveri          SMGFGRSGAPGGLLTSQ---------PVSASAVPNYWDPTVTCRELTTSEVEWIVEKFAE 159 
M. thermoacetica     GMGFGRVAAP-ILLESQ---------PVAPSALPNFWDPSITCRELTTAEVETLVQRASE 159 
PETNR                RISHSSIQPGGQAPVSASALNANTRTSLRDENGNAIRVDTTTPRALELDEIPGIVNDFRQ 165 
OYE2                 WAAFPDTLARDGLRYDS----ASDNVYMNAEQEEKAKKANNPQHSITKDEIKQYVKEYVQ 176 
 
C. sporogenes        SAEIAKKAGFDGVEIHAVHEGYLLDQFAISFFNHRTDEYGGSLENRLRFACEVVQEIKKR 220 
C. tyrobutyricum     GAAIAQKAGFDGVEIHAVHEGYLLDQFTLSIFNRRTDKYGGDLRGRLQLPIEIVQGIKAQ 219 
C. kluyveri          GAKIAHKAGFDGVEIHAVHEGYLLDQFTLSIFNRRTDKYGGDLRGRLQLPIEIVEAIKTE 219 
M. thermoacetica     AAEIAVEAGFDGVEIHAMHEGYLLDQFTIALFNRRGDKYGGALEDRLTFPIEIVRAIKDR 219 
PETNR                AVANAREAGFDLVELHSAHG-YLLHQFLSPSSNQRTDQYGGSVENRARLVLEVVDAVCNE 224 
OYE2                 AAKNSIAAGADGVEIHSANG-YLLNQFLDPHSNNRTDEYGGSIENRARFTLEVVDAVVDA 235 
 
C. sporogenes        CGQDFPVSLRYSIKSFIKDWCKGGLPDEEFEEKGRDIPEGIEAAKILVAAGYDALNGDVG 280 
C. tyrobutyricum     VGSDFPVGLRYSVKSCIKDWRQGGLPDEDYVEKGRDLEEGLESPQILEAAGYDELNTDVG 279 
C. kluyveri          VGSNFPVGLRYSVKSCIKDWGQGGLAEEDYVEKGRDLEEGLEAAKILEAAGYDAFNADLG 279 
M. thermoacetica     VGKDFPVVLRFSIKNYIKDWRQGGLPGENFQEKGRDVEEPLAAAKILEGAGYDGFDADAG 279 
PETNR                WSADR-IGIRVSPIGTFQNVD-NGPNE--EADALYLIEELAKRG-----IAYLHMSETDL 275 
OYE2                 IGPEK-VGLRLSPYGVFNSMS-GGAETGIVAQYAYVLGELERRAKAGKRLAFVHLVEPRV 293 
 
C. sporogenes        SYDSWYWSHPPMYQKKGLYLPYNEILKKVVDVPIITAG-RMEDPELSSDAILSGKTDMIA 339 
C. tyrobutyricum     TYDAWYWSHPPLYQKDGLYLPYTQELEKVVKIPVIVAG-KLGVPQEAEKALDEGGADMIG 338 
C. kluyveri          TYDAWYWAHPPLYQKDGLYLPYTKELKKVVKIPVMVAG-KMGMPDVAEGALEDEAADMVT 338 
M. thermoacetica     SYDAWYWAHPPVYQKHGCYLPLTQRLKEVVKVPVIVAG-RLEIPELAEEALVKGQADMIA 338 
PETNR                A------GGKPYSE------AFRQKVRERFHGVIIGAG--AYTAEKAEDLIGKGLIDAVA 321 
OYE2                 TNPFLTEGEGEYNG------GSNEFAYSIWKGPIIRAGNFALHPEVVREEV-KDPRTLIG 346 
 
C. sporogenes        LGRPLLADAEIPNKIFEDKYDKVRPCLSCQEGCMGRLQNFATVSCAVNPACGREKEYGLK 399 
C. tyrobutyricum     LARPLLSDAYWPKKVLSGHPERIRPCIGCHVACLGRGFEGKPLSCAVNPAAGRERYYEIR 398 
C. kluyveri          LGRPLLCDAYWPKKVFTGQIDRIRPCIGCHTGCMGRGFEGRPLSCTVNPAAGRERYYEVK 398 
M. thermoacetica     IGRGLLTDPYWVNKVMTGRSKNIRPCIGCHDGCLGRGFLGRPLSCTVNPACGREEEYAID 398 
PETNR                FGRDYIANPDLVARLQKKAELNPQRPESFYGGGAEGYTDYPSL----------------- 364 
OYE2                 YGRFFISNPDLVDRLEKGLPLNKYDRDTFYKMSAEGYIDYPTYEEALKLGWDKH------ 400 
 
C. sporogenes        KAEQIKKVLVVGGGVAGMEAARVTAVRGHKVTLIEKNGYLGGNIVPGGIPDFKDDDRALV 459 
C. tyrobutyricum     PAAIPKKVLIAGGGVAGMEAARMAVLRGHKVTLYESTDQLGGEIVPGSVPDFKIDDRRLL 458 
C. kluyveri          PAAAPKKVMIVGGGVAGMEAARITAMRGHKVSMYEGTKELGGQVIPASVPDFKIDDRRLL 458 
M. thermoacetica     RAPEAKQVMVIGGGVAGMEAARVPALRGHRVSLYEKSDRLGGHVVEAAVPDFKADDGRLL 458 
PETNR                ------------------------------------------------------------ 
OYE2                 ------------------------------------------------------------ 
 
C. sporogenes        KWYEGILKDLGVEIKLNVGASKENIKEFGADEVLLATGSSPRTLTIEGA--DKVYSAEDV 517 
C. tyrobutyricum     DWYRNEMKELKINVIFNTEVTDKLVGKEQPDVVIVATGANDVKIKLPGMEKDKVSTAVDI 518 
C. kluyveri          DWYRNEMKELKVKLVLDTNVTEEVVEKEKPDVVIIATGAKEIKLNLPGIEKDKVATVIEV 518 
M. thermoacetica     EWYKTELGELQVEIHLNQEVTPEFVEEKNPDVVVVATGSTPAIPDIPGVNKDKVTTVSDL 518 
PETNR                ------------------------------------------------------------ 
OYE2                 ------------------------------------------------------------ 
 
C. sporogenes        LMERKTVGEKVIVIGGGLVGCETALWLKQQGKEITIVEMQNDILQVGGPLCHANHDMLVD 577 
C. tyrobutyricum     LNGTKKSGKNVLIVGGGLVGCETALYLAKAGKKVAIVEAKDKILDAGKPIPHMNKIMLED 578 
C. kluyveri          LKGSKQVGENVLMVGGGLAGCETALYLAKQGKKVTIIEARDTILNAGKPVPHMNKIMLID 578 
M. thermoacetica     LLGKKQAGDRVVIIGGGLVGCETALWLAQQGKDVTIIEILDDLMRAGIPVPYMNRMMLLD 578 
PETNR                ------------------------------------------------------------ 
OYE2                 ------------------------------------------------------------ 
 
C. sporogenes        LIKFNKIDVKTSSYISKKTDEGFVLN-TNGEESIINADSAVVAIGYLSEKDLYSEVRFDI 636 
C. tyrobutyricum     LIKKYNIKVITGNSLLEVTDAGAVLIDSKFKQQEVSADTVVISIGFKSNRKLYNKLHGKV 638 
C. kluyveri          LLKNSGVNIITETSLLEVTDRGAILIDNKFKKQNIDADTVVIAVGFKADRELYNKLRDKV 638 
M. thermoacetica     LLKMNGVKWLTETSVLEVTDDGVTLIGKNYQRSPLPADTVILAVGFGADQRLYNALRDKI 638 
PETNR                ------------------------------------------------------------ 
OYE2                 ------------------------------------------------------------ 
 
C. sporogenes        PNARLIGDANKVQNIMYAIWSAYEVAKNI 665 
C. tyrobutyricum     TDLYLIGDAYQAANIMDAIWSGNEIGLNC 667 
C. kluyveri          ADLYLVGDANESANIMNAIWSANEIALNC 667 
M. thermoacetica     PNLYLIGDSREPRNILAGIWEGYEVGRGI 667 
PETNR                ----------------------------- 
OYE2                 ----------------------------- 
Fig. 8.31. Alignment showing homology of clostridial 2-enoate reductases and OYE-reductases. 
Functional residues are highlighted: GREEN - 4Fe-4S cluster binding site; BLUE - FMN binding site; 
YELLOW - substrate binding and active site; GRAY - FAD binding domain. 
